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Abstract 
I. Completion of a Total Synthesis of Peloruside A 
The completion of a 22 step synthesis of the marine natural product peloruside A 
is presented. The second generation strategy cuts 10 steps from longest linear sequence of 
the Evans group’s first generation synthesis of peloruside A by changing the order of 
fragment coupling operations and maintaining C1 and C9 at their final oxidation states 
over the course of most of the synthesis. Key steps include two highly diastereoselective 
aldol fragment couplings, a tin tetrachloride mediated hydrosilylation and a 
macrolactonization on a seco acid containing no cyclic templating elements.  
II.  Studies Toward the Total Synthesis of Spiro-prorocentrimine 
The development of an intermolecular Diels–Alder approach toward the marine 
natural product spiro–prorocentrimine is described. This work began with the adaptation 
of the Evans group’s previous intramolecular Diels–Alder approach. It was found that 
protonated imines bearing non-coordinating counterions were of sufficient reactivity to 
allow cycloaddition to occur even on dienes that were unreactive under the previous best 
conditions. In the course of these studies, isomerization of a macrocyclic diene during the 
course of a Diels–Alder reaction complicated the stereochemical outcome of the reaction.  
Reaction conditions to suppress the isomerization and obtain Diels–Alder adducts bearing 
the correct configuration at both C9 and C33 were developed based on a qualitative 
consideration of the pKas of species present in the reaction. The intrinsic facial selectivity 
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of several macrocyclic dienes was examined to help explain the course of the Diels–
Alder reaction. Other key steps include an iron catalyzed olefin formation, the highly 
diastereoselective hydrogenation of a trisubstituted olefin in the presence of an enol ether, 
protecting group studies to suppress the contraction of a 15 membered lactone to a 6 
membered lactone and studies of a protecting group strategy to allow installation of a 
sulfate. Lessons learned from this work and previous efforts are combined in a proposal 
for a bioinspired synthesis of spiro-prorocentrimine with a longest linear sequence of less 
than 30 steps. 
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Chapter 1 
Introduction to Peloruside A1,2 
I.  Isolation of Peloruside A 
The structure of peloruside A (1) was disclosed by Northcote and coworkers in 2000 
(Figure 1.1).3 Peloruside A was obtained from specimens of Mycale hentscheli sponges in 
the Pelorus Sound on the South Island of New Zealand. The initial isolation yielded 3 mg 
of peloruside A from 170g wet weight of sponge. Only samples of sponge collected at the 
deeper range at which the sponge species grew contained peloruside A. Peloruside A 
contains a 16 membered macrocyclic lactone, with an embedded tetrahydropyran. The 
structure is highly oxygenated. Other features of interest include geminal dimethylation at 
C10 and a Z olefin at C16–C17. The structure of peloruside A was determined by extensive 
1H NMR studies. The numbering shown in the figure below is used to describe the 
various fragment couplings in the remainder of this chapter.  
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Figure 1.1 The structure and absolute configuration of peloruside A. 
                                                
(1) Reproduced in part with permission from Evans, D. A.; Welch, D. S.; Speed, A. W. H.; Moniz, G. A.; 
Reichelt, A.; Ho, S. “An Aldol-Based Synthesis of (+)-Peloruside A, A Potent Microtuble Stabilizing 
Agent” J. Am. Chem. Soc. 2009, 131, 3840-3841. © 2009 by The American Chemical Society. 
(2)Work conducted by my coworker Dr. Dennie Welch, and work conducted by my predecessors Dr. 
George Moniz and Dr. Andreas Reichelt is summarized within this chapter. 
(3) West, L. M., Northcote, P. T., Battershill, C. N. J. Org. Chem. 2000, 65, 445-449. 
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Workers at Northcote’s institution had attempted to determine the absolute configuration 
of peloruside A by chiral GC analysis of the products of an ozonolytic or 
dihydroxylation/ lead tetracetatate cleavage of the alkene in 2, derived from the 
peracetylation of peloruside A (Equation 1.1). Unfortunately neither set of conditions 
resulted in any compound with a GC retention time equivalent to either enantiomer of an 
authentic racemic sample of 3 on a chiral column. This failure was attributed to the 
sensitivity of aldehyde 3 to oxidative conditions and the small scale on which the reaction 
was attempted (0.25 mg).4 
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The absolute configuration of (+)–peloruside A was therefore not known at the time of 
Northcote’s initial disclosure. The assigned structure was confirmed and the absolute 
configuration was determined with the completion of the first total synthesis by De 
Brabander and co-workers in 2003.5 De Brabander synthesized (-)–peloruside A, 
meaning that the initial structure drawn by Northcote and the initial synthesis by De 
Brabander were enantiomeric with the actual absolute configuration. 
Biological Activity of Peloruside A 
In Northcote’s initial communication, it was disclosed that peloruside A was cytotoxic to 
p388 murine leukemia cells at a concentration of 10 ng/mL (18 nM).3 Subsequent 
experiments revealed that peloruside A acts to stimulate microtubule polymerization, 
which causes cell cycle arrest during the G2/M phase, triggering apoptosis.6 When 
                                                
(4) Stocker, B. L. Ph.D. Thesis, Victoria University of Wellington, 2004. P 46 
(5) Liao, X.; Wu, Y.; De Brabander, J. K. Agnew. Chem. Int. Ed. 2003, 42, 1648- 1652. 
(6) Hood, K. A.; West, L. M.; Rouwé, B. Northcote, P. T.; Berridge, M. V.; Wakefield, St. J.; Miller, J. H. 
Canc. Res. 2002, 62, 3356-3360. 
  3 
allowed to compete with the microtubule stabilizers paclitaxel (Taxol®) (4) epothilone A, 
(5) and (+) discodermolide (6), shown in Figure 1.2, it was found that peloruside A 
bound at a different site.7 This was deduced because of the presence of microtubules that 
incorporated stoichiometric amounts of both paclitaxel and peloruside A. Molecules 4, 5 
and 6 compete for the same binding site so only one of each molecule binds to any one 
microtubule. 
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Figure 1.2 Compounds with similar mode of action to peloruside A. 
Most microtubule binding agents compete with the prototypical paclitaxel binding site on 
microtubule constituent β-tubulin, while initial NMR and molecular modeling studies 
suggest that peloruside A binds to α-tubulin.8 Later experiments by Huzil and co-workers 
suggested that peloruside A binds to a non-taxoid site on β-tubulin on the basis of 
hydrogen-deuterium exchange mass spectrometry.9 These experiments used a mass 
spectrometry/ protein sequencing approach to identify binding sites based on amino acid 
residues that are deficient in deuterium labeling after a deuterium exchange on the subject 
protein bound to the ligand. The ligand physically blocks deuterium exchange. 
                                                
(7) Gaitanos, T. N.; Buey, R. M.; Díaz, J. F.; Northcote, P. T.; Teesdale-Spittle, P.; Andreu, J. M.; Miller, J. 
H. Canc. Res. 2004, 64, 5063-5067. 
(8) Jiménez-Barbero, J.; Canales, A.; Northcote, P. T.; Buey, R. M.; Andreu, J. M.; Díaz, J. F. J. Am. 
Chem. Soc. 2006, 128, 8757-8765. 
(9) Huzil, J. T.; Chik, J. K.; Slysz, G. W.; Freedman, H.; Tuszynski, J.; Taylor, R. E.; Sackett, D. L.; 
Schriemer, D. C. J. Mol. Biol. 2008, 378, 1016- 1030. 
  4 
Subsequent work with both molecular modeling and experiments with synthetic tritiated 
[3H] peloruside A appear to support the presence of the site on β-tubulin.10 Cell lines that 
contain mutations in the site on β-tubulin that is believed to bind peloruside A were 
found to have resistance to the action of peloruside A.11An unusual mode of action such 
as this has implications for the discovery of new drugs that target cell lines that have 
become resistant to drugs such as paclitaxel. A different binding site on tubulin may not 
have developed the same mutations that confer resistance. This raises the potential that 
peloruside A or analogues could be used to treat paclitaxel resistant cancers. Another 
molecule, laulimalide (7), is also believed to bind to the same site as peloruside A (Figure 
1.3). Laulimalide does compete with Peloruside A in microtubule binding experiments, 
however it is much less stable in solution and is not considered a good drug candidate.6,10  
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Figure 1.3 Structure of laulimalide. 
Studies on both synthetic and semisynthetic analogues of peloruside A have indicated 
that the tetrahydropyran moiety is crucial to the activity of peloruside A. Semisynthetic 
analogue 8, prepared by NaBH4 reduction of peloruside A was reported to have a 26 fold 
decrease in cytotoxicity,6 while synthetic analogue 9 was found to be several hundred-
fold less potent (Figure 1.4).12  
                                                
(10) Nguyen, T. L.; Xu, X.; Gussio, R.; Ghosh, A. K.; Hamel, E.; J. Chem. Inf. Model. 2010, 50, 2019-
2028. 
(11) Begaye, A.; Trostel, S.; Zhao, Z.; Taylor, R. E.; Schriemer, D. C.; Sackett, D. L. Cell Cycle. 2011,  10, 
3387-3396. 
(12) Wullschleger, C. W.; Gertsch, Altmann, K.-H. Org Lett., 2010, 12, 1120-1123. 
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Figure 1.4 Less potent analogues of peloruside A. 
Attempts to Produce Peloruside A via Aquaculture 
In light of the promising biological activity of peloruside A, efforts were made to 
cultivate the M. hentscheli species from which it was isolated.13 These efforts were 
partially successful, allowing the cultivation of less than 7.5 kg of sponge, from which 
85.5 mg of peloruside A could be isolated. The large-scale isolation also allowed the 
discovery of related compounds peloruside B, 10, peloruside C, 11, and peloruside D, 12, 
shown in Figure 1.5.14 These compounds were isolated in sub milligram amounts. 
Peloruside C was found to be active against a human myeloid leukemia cell line (HL-60) 
with an IC50 value of 221 nM, which was 15 times less potent than the activity of 
peloruside A in the same assay. It was observed that HL-60 cells treated with 11 were not 
arrested at the G2/M cycle, suggesting a different mode of action than peloruside A. 
Peloruside D was not significantly active against the HL-60 line. These results are in line 
with the notion that the tetrahydropyran moiety must be conserved for biological activity.  
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Figure 1.5 Structures of pelorusides B- D. 
                                                
(13) Page, M. J.; Northcote, P. T.; Webb, V. L.; Mackey, S.; Handley, S. J.; Aquaculture, 2005, 250, 256- 
269. 
(14) Singh, A.J.; Razzak, M.; Teesdale-Spittle, P.; Gaitanos, T. N.; Wilmes, A.; Paterson, I.; Goodman, J. 
M.; Miller, J. H.; Northcote, P. T. Org. Biomol. Chem. 2011, 9, 4456- 4466. 
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Aquaculture attempts were complicated by the observation that the production of 
peloruside A in cultured M. hentscheli was specific to both the geographical area in 
which the sponge was cultivated (removal of the sponge to a different bay resulted in 
cessation of peloruside A production) and the specific strain of M. hentscheli (moving a 
sponge originating from a geographically distant location into the Pelorus sound did not 
result in the commencement of peloruside A production). It is unclear if this is due to the 
presence of a symbiotic organism or environmental factors.15 Until this problem is 
solved, it appears that total synthesis of peloruside A may be the most efficient way of 
obtaining multi-milligram quantities of this compound. 
II. Brief Summary of Approaches to Peloruside A  
In light of the relatively simple structure of peloruside A, coupled with its promising 
biological activity, a number of synthesis efforts towards this target were initiated. 
The purpose of this section is to summarize all disclosed completed total syntheses of 
peloruside A, and selected incomplete efforts with chemistry bearing similarities to our 
own route. It should not be considered a comprehensive summary. Complementary 
summaries may be found in selected Ph.D theses of other students who have worked on 
peloruside A.16 It should be noted that C9 of peloruside A is at the ketone oxidation state. 
Most of the synthesis work summarized below does not maintain this oxidation state 
throughout the synthesis. While the stereochemistry at this position in the alcohol 
oxidation state is ultimately inconsequential, it can have a very important effect on the 
stereoselectivity of reactions as described in great detail in section IV of this chapter. 
Accordingly this is emphasized where appropriate. 
 
                                                
(15) Page, M. J.; West, L.; Northcote, P. T.; Battershill, C.; Kelly, M. J. Chem. Ecol. 2005, 31, 1161-1174. 
(16) Wuest, W. M. Ph.D. Thesis, University of Pennsylvania, 2008. Engers, D. W. Ph.D. Thesis, University 
of Texas at Austin, 2006. Jeon, J. Ph.D. Thesis, University of Minnesota, 2009. Xu, X. Ph.D. Thesis, 
Purdue University, 2008. McGowan, M. A. Ph.D. Thesis, Harvard University, 2010. Schiffler, M. A., 
Ph.D. Thesis, Harvard University, 2008. 
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The DeBrabander Synthesis 
The first synthesis of peloruside A to be disclosed was that of DeBrabander in 2003.5 The 
synthesis established the absolute configuration of peloruside A, as the synthesis resulted 
in material with the opposite optical rotation as the natural material. The intermediates in 
the configuration used by DeBrabander en route to ent-peloruside A are shown below 
(Figure 1.6). De Brabander’s approach involved a late stage macrocyclization of a seco 
acid 13 with a fully elaborated pyran component. Coupling fragments 14 and 15 in an 
aldol reaction assembled this seco acid.  
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Figure 1.6 De Brabander’s synthesis plan. 
The synthesis of fragment 14 was comparatively short and is shown in Scheme 1.1. The 
stereocentre at C18 was set by a Hoveyda ethylmagnesiation on 2,5-dihydrofuran 16 
generating alcohol 17 in 99% ee. Acylation with methacroloyl chloride yielded diene 18. 
This was followed by a ring closing metathesis using Grubbs’ second generation catalyst 
to yield lactone 20, followed by conversion of the lactone to a methyl ketone and 
protection of the resultant alcohol yielding fragment 14 in only 5 steps.  
Scheme 1.1 
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The synthesis of fragment 15 was more involved. The important disconnections are 
shown in figure 1.7. Stereochemistry was controlled by the use of asymmetric allylation 
reactions/ oxidative olefin cleavage as aldol surrogates, and a substrate controlled 
epoxidation and allylation. A notable point was the successful use of a MOM group to 
protect the hydroxyl at C2. 
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Figure 1.7 Bond constructions in fragment 15. 
The bond construction between C13 and C14 involved an aldol reaction mediated by 
Et2BOTf in the presence of a free alcohol at C11 on fragment 15. The aldol reaction 
proceeded in good yield (87%) with modest diastereoselectivity to afford aldol adduct 22. 
A selective methylation of the C13 alcohol was followed by reduction of the C15 ketone 
with CBS catalyst and hydrolysis of the C1 methyl ester gave seco acids 23 and 24 
(Scheme 1.2). Both configurations of the alcohol at C15 could be accessed depending on 
which antipode of the CBS catalyst was used. 
Scheme 1.2 
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2,6-di-tert-butyl-4-methylpyridine, CH2Cl2, c) (R) or (S) B-Me 
CBS catalyst (see text), BH3SMe2 CH2Cl2 d)0.3 N LiOH(aq), THF  
Seco acids 23 and 24 could be subject to a Mitsunobu macrolactonization. Interestingly 
both seco acids converged to give a common product, macrolactone 25, which means that 
seco acid 23 is undergoing an invertive Mitsunobu reaction, while seco acid 24 is 
undergoing a Mitsunobu reaction with retention. The yields were 47% for each seco acid, 
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rising to 52% on a 1:1 mixture of the two (Scheme 1.3). DeBrabander speculates that the 
retentive Mitsunobu proceeds through an acyloxophosphonium intermediate. An 
alternative explanation is that 24 is not stereoelectonically disposed to undergo a SN2 
reaction, so the intermediate ionizes and an attack of the carboxylate on the allyl cation 
proceeds with retention of stereochemistry. 
Scheme 1.3 
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The final macrolactone 25 was deprotected by exposure to 4N HCl in THF, which 
established the robustness of peloruside A to these conditions. DeBrabander’s synthesis 
showed the viability of using 4N HCl in the deprotection, the possibility of using a MOM 
group to protect the hydroxyl at C2 and also proved both the stereochemical assignment 
and the absolute configuration of peloruside A. The synthesis had a longest linear 
sequence of 32 steps, with an impressive overall yield of 1.5% based on multiplication of 
the yields given in the paper. 
 
The Taylor Synthesis 
In 2005, the Taylor group disclosed their synthesis of peloruside A.17 This synthesis 
involved a late stage elaboration of pyranone macrocycle 26 shown in Figure 1.8. The 
synthesis of 26 relied on the macrocyclization of a pyranone containing seco acid 27. The 
seco acid was assembled from two fragments, C8–C19 fragment 28 and C1–C7 fragment 
29 by a lithium aldol reaction. The C8–C19 fragment was assembled using similar 
                                                
(17) Jin, M.; Taylor, R. E. Org. Lett. 2005, 7, 1303-1305. 
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chemistry to our C10–C19 fragment (vide infra)18 while the C1 to C7 fragment arose an 
epoxide opening and Evans aldol sequence.  
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Figure 1.8 Taylor retrosynthesis. 
The key fragment coupling between fragment 28 and 29 was accomplished by a lithium 
aldol reaction, followed by oxidation of the aldol product to a 1,3 diketone, followed by 
deprotection of the TES protected alcohol at C5 and cyclization to form a pyranone 
(Scheme 1.4). Deprotection of the TBS group protecting the alcohol at C15, followed by 
cleavage of the oxazolidinone at C1 yielded seco acid 30. This was subject to a 
Yamaguchi reaction to produce macrolactone 26.  
Scheme 1.4  
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Macrolactone 26 was then elaborated by a Luche reduction to compound 31 (Scheme 
1.5). Directed epoxidation and methanolysis yielded diol 32. Selective methylation of the 
equatorial alcohol at C7 afforded macrolactone 33. Deprotection with 4N HCl gave 
peloruside A.  
 
                                                
(18) Taylor, M. E.; Jin, M. Org. Lett. 2003, 5, 4959- 4961. 
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The Taylor synthesis is most noteworthy in that the synthesis of fragment 28 bears co-
incidental similarities to the synthesis of our C19–C10 fragment. This synthesis also 
showed that an oxazolidinone at the C1 terminus could be carried through several steps. 
The Taylor synthesis had a longest linear sequence of 30 steps, with an overall yield of 
0.38% based on multiplication of reported yields of the longest linear sequence. 
The Ghosh Synthesis 
The Ghosh Synthesis was disclosed in 2007, while our second generation effort was 
underway.19 The synthesis of late stage macrocycle 34 is notable as it is the first disclosed 
synthesis to rely on a macrolactonization of a seco acid 35 that does not contain a pyran, 
with formation of the pyran after macrolactonization (Figure 1.9).20 This is also the 
strategy we employed. However, the Ghosh seco acid does contain acetonide protection 
of the C7 and C8 alcohols, which introduces a cyclic templating element. The linear seco 
acid is generated from a reductive aldol coupling of C1–C10 fragment 36 and C11–C19 
fragment 37. Fragment 36 was prepared in 21 steps from tartaric acid while fragment 37 
was prepared in 12 steps by an iterative allylation strategy.21 
                                                
(19) Ghosh, A. K.; Xu, X.; Kim, J.-H.; Xu, C.-X. Org. Lett. 2008, 10, 1001-1004. 
(20) It should be noted our group’s first generation strategy employing the cyclization of a linear seco acid, 
followed by pyran formation during the global deprotection had resulted in a successful synthesis of 
Peloruside A by Dr. Dennie Welch prior to Ghosh’s disclosure. 
(21) Ghosh, A. K.; Kim, J.-H. Tetrahedron Lett. 2003, 44, 7659-7662. 
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Figure 1.9 Ghosh synthesis plan. 
In the forward direction, synthesis proceeded by treatment of fragment 36 by L-
selectride, which resulted in the formation of an enolate from 1,4 addition of the hydride 
(Scheme 1.6). Addition of fragment 37 resulted in aldol adduct 38 in 92% yield with a 
5:1 dr. Throughput for the synthesis was affected by a low yield for conversion of the 
aldol product to macrolactone 34 (23% over 3 steps). The necessity of having C1 in the 
alcohol oxidation state was presumably dictated by the reducing conditions of the 
fragment coupling. Selective macrolactonization for the C15 alcohol occurred despite the 
presence of a free alcohol at C11. 
Scheme 1.6 
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After the macrocyclization, several steps were needed to complete the synthesis (Scheme 
1.7). Concomitant deprotection of the acetonide protecting the alcohols at C7 and C8 and 
the TBS group protecting the alcohol at C5 resulted in the cyclization of the C5 alcohol on 
to the C9 ketone to form pyran 39. Selective methylation of the equatorial alcohol at C7 
yielded protected peloruside A 40, which was deprotected by transfer hydrogenolysis of 
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the C19 benzyloxy protecting group followed by cleavage of the MOM group protecting 
the alcohol at C2 with 4N HCl to yield peloruside A. 
Scheme 1.7 
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The Ghosh Synthesis was the first synthesis disclosed that employed macrocyclization of 
a seco acid in the absence of the pyran moiety. The reductive aldol fragment coupling and 
protection of the C19 alcohol as a benzyloxy group were also used in the Jacobsen 
synthesis (vide infra). Several oxidation state manipulations and short homologations 
affect material throughput of this synthesis. The longest linear sequence was 30 steps 
with an overall yield of 1.1%, obtained by multiplying the reported yields along the 
longest linear sequence. 
The Evans Synthesis 
The Evans first generation synthesis of peloruside A, completed by Dr. Dennie Welch 
followed the Taylor synthesis and preceded disclosure of the Ghosh synthesis. This work 
is described in Section IV of this chapter. The second-generation synthesis strategy, 
developed by Dr. Dennie Welch and implemented by Dr. Dennie Welch, Stephen Ho and 
myself was published in February 2009 and is described in Chapter 2.1 
The Jacobsen Synthesis 
The synthesis of peloruside A by the Jacobsen group was disclosed in May of 2010.22 
Their strategy involved cyclization of a linear seco acid, which was constructed through a 
reductive aldol coupling of C1–C10 fragment 42 with C11–C19 fragment 43 (Figure 1.10).  
                                                
(22) McGowan, M. A.; Stevenson, C. P.; Schiffler, M. A.; Jacobsen, E. N.; Angew. Chem. Int. Ed. 2010, 
49, 6147- 6150. 
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Figure 1.10 Jacobsen retrosynthesis. 
The synthesis of fragments 42 and 43 showcased a number of transformations mediated 
by salen catalysts. The synthesis of fragment 42 was from hetero Diels–Alder adduct 44 
arising from diene 45 and aldehyde 46 (Scheme 1.8). Catalyst control by 47 enabled a 7:1 
dr in the Diels–Alder reaction, while the natural bias of 46 as explored by an achiral 
catalyst was 1:2 dr the other way.  
Scheme 1.8  
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Fragment 43 was obtained in 9 steps from epoxide 48, obtained via a 2 step Jacobsen 
epoxidation/ HKR sequence on pent-1-en-3-yne 49. Another epoxide, obtained in high 
optical purity by HKR on the racemate was also employed in the synthesis of this piece.  
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Figure 1.11 Retrosynthesis of fragment 43. 
Fragment coupling was conducted using a reductive aldol reaction employing L-
Selectride similar to the Ghosh reaction. Unfortunately only a modest diastereoselectivity 
of 1.7 to 1 was obtained, with the overall yield of the desired product 50 being 52%. 
Subsequently the TBS protected C1 alcohol was selectively deprotected and oxidized in a 
2-step sequence, which after deprotection of the PMB group afforded seco acid 41 
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(Scheme 1.9). Macrocyclization using Yamaguchi conditions led to protected peloruside 
A 51. As with our synthesis, the macrolactonization was site selective for the alcohol at 
C15 despite the presence of free alcohol at C11. Compound 51 was deprotected in a 2-step 
hydrogenolysis/ 4N HCl sequence in a manner reminiscent of Ghosh to afford peloruside 
A. 
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The Jacobsen route is noteworthy for being the shortest disclosed route at 20 longest 
linear steps. Unfortunately the modest diastereoselectivity in the reductive aldol based 
C10–C11 bond construction and the necessity to adjust the C1 oxidation state late in the 
synthesis because of the use of the reductive aldol coupling detract from the efficiency of 
the synthesis. Regardless, the synthesis had an impressive longest linear sequence of 20 
steps, with an overall yield of 0.7% based on multiplication of the yields reported for 
steps on the longest linear sequence. The yield rises to 1.2% if the yield of the first step 
(the enantioselective Payne reaction, followed by protection, overall yield 56% is 
omitted).23 
                                                
(23) It is preferable to have a low yielding step at the beginning or end of a synthesis, since if the step is at 
the beginning there should be a low material cost, allowing large scale reactions to provide ample material. 
For synthesis where the goal is to attain the target, and not generate large quantities of material for further 
study, if the problematic step is at the end, a bottleneck is not created as material throughput for subsequent 
steps is not required. 
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The Hoye Synthesis 
The Hoye synthesis was disclosed in July 2010 after the Jacobsen synthesis.24 Their 
synthesis strategy also involved macrocyclization of a linear seco acid 52 (Figure 1.12). 
This was prepared from a fragment coupling between a C1–C11 fragment 53 and a C12–
C19 fragment 54. This disconnection is also the one employed in our synthesis, and in fact 
their fragment 54 is identical to ours, although prepared by a different route. Special 
attention will be given to this bond construction since it was successful with C9 in the 
alcohol oxidation state, while this transformation failed in a very similar substrate in our 
case (this will be discussed in section II of chapter 2).  
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Figure 1.12 Hoye retrosynthesis. 
The synthesis of the aldehyde in 53 was from an ozonolysis of an alkene and the methyl 
ketone in 54 arose from Wacker oxidation of an alkene. This meant that doing an 
ozonolysis on the precursor to 54 and Wacker on the precursor to 53 would have allowed 
exploration of a C12–C13 bond disconnection. 
 
The synthesis of fragment 53 began with C2 symmetric tetraol 55, prepared by a 
Sharpless asymmetric dihydroxylation of the corresponding di-enoate (Scheme 1.10). 
Differentiation of the diols was achieved by transketalization followed by methylation to 
afford 56. Subsequently, 56 was elaborated to alcohol 57 in 5 steps. Pseudo-symmetric 
                                                
(24) Hoye, T. R.; Jeon, J., Kopel, L. C.; Ryba, T. D.; Tennakoon, M. A.; Wang, Y. Angew. Chem. Int Ed. 
2010, 49, 6151-6155. 
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alcohol 57 was transformed to compound 58 by a diastereoselective lactonization, which 
sets the stereochemistry at C5 as the compound no longer possesses an axis of symmetry 
through this carbon. The translactonization was mediated by tetramethylguanidine 59. A 
15 step sequence then allowed this intermediate to be converted to fragment 53. 
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The synthesis of fragment 54 involved the addition of the anion of acetonitrile to an 
aldehyde 60 derived from (R)- citronellene (Scheme 1.11). The epimeric alcohols at C15 
were resolved by enzymatic means (Novozyme 453). Subsequent tethering of this 
diastereomerically pure alcohol 61 with alcohol 62 via a silicon tether yielded diene 63, 
which was subject to relay ring closing metathesis to yield 8 membered ring 64 that was 
converted to fragment 54 in 5 steps. The structure and spectra of this fragment matched 
our corresponding fragment (See Scheme 1.20). 
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The fragment coupling was mediated by Cy2BCl and Et3N in diethyl ether giving 65 in 
essentially perfect diastereoselection at C11 in 62% yield (Scheme 1.12). It is very 
interesting that this fragment coupling was successful. As will be explained more fully in 
section III of chapter 2, a fragment coupling attempt in our route under the same 
conditions with the same fragment 54, and a version fragment 53 differing only in the 
substituents at C9, C5 and C1 showed no reactivity at all. After the fragment coupling, a 5-
step sequence afforded seco acid 52. This was cyclized under Yamaguchi conditions with 
selective cyclization onto the C15 alcohol despite the presence of a free alcohol at C9. 
Oxidation of the C9 alcohol afforded macrolactone 66. The above sequence was followed 
by a 2 step global deprotection to afford peloruside A. Additionally, an isomer of 
peloruside A, 67 bearing a lactone cyclized onto the C5 alcohol rather than the C15 
alcohol was obtained in low yield. It is likely that this material formed in other synthesis 
efforts as well, but was overlooked. 
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The Hoye synthesis involved a clever desymmetrization of a pseudo C2 symmetric C1–C9 
compound. Unfortunately material throughput was affected by the lengthy sequence 
required to convert this compound to fragment 53. The fragment coupling between 53 
and 54 was remarkable as it revealed very subtle protecting group effects when coupled 
with data from our group. The Hoye synthesis had a longest linear sequence of 36 steps, 
with an overall yield calculated from multiplication of reported yields on the longest 
linear sequence of 0.36%. 
The Smith Approach 
The Smith group approach involved a cyclization of a linear seco acid 68 prepared from 
C1–C8 fragment 69 and C9–C19 fragment 70 (Figure 1.13).25 This fragment coupling was 
conducted by the addition of the anion of a dithiane into an aldehyde. Fragments 69 and 
70 were also prepared using anion relay chemistry involving the alkylation of silylated 
dithiane anions by epoxides followed by Brook rearrangement.   
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Figure 1.13 Smith synthesis plan. 
The cyclization of the seco acid 68 initially involved the use of a Mitsunobu 
macrocyclization (Scheme 1.13). Contrary to DeBrabander’s substrates, a substrate 
designed for cyclization via inversion at C15 failed to macrolactonize. The epimer at C15, 
71, was prepared by an oxidation/CBS reduction sequence, and could cyclized using a 
Yamaguchi reaction to give macrocycle 72, however forcing conditions were required. A 
                                                
(25) Smith, A. B.; Cox, J. M.; Furuichi, N.; Kenesky, C. S.; Zheng, J.; Atasoylu, O.; Wuest, W. M. Org. 
Lett. 2008, 10, 5501- 5504.  
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3-step sequence resulted in the synthesis of compound 73 that was epimeric with 
peloruside A at C2.  
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Extensive NMR and computational studies suggested that the epimerization had taken 
place during the forcing conditions of the Yamaguchi macrolactonization. 
The Paterson Approach 
An approach to peloruside A by the Patterson group was disclosed in 2003.26 The 
Patterson synthesis analysis targeted a linear seco acid 74, constructed through the same 
bond disconnections as our second generation strategy, namely an aldol construction 
between C6 and C7 followed by elaboration and then an aldol disconnection between C11 
and C12 (Figure 1.14). This strategy was devised before the absolute configuration of 
Peloruside A was known, so the structures shown are in the configurations as prepared by 
Paterson.   
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Figure 1.13 The Paterson synthesis plan. 
The C1–C6 fragment 75 was prepared in 12 steps from methyl acetoaceonate employing a 
Sharpless asymmetric dihydroxylation to set the stereocentres at C2 and C3. 
                                                
(26) Paterson, I.; Di Francesco, E. M.; Kühn, T. Org. Lett. 2003, 5, 599- 602. 
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The C7–C11 fragment 76 was prepared in 8 steps from neopentyl glycol, also using a 
Sharpless asymmetric dihydroxylation to set the stereocentres at C8 and C9. This results 
in syn oxygenation, which has implications for the subsequent fragment coupling. 
Accessing the anti diol with this strategy would be difficult since Z dienes are poor 
substrates for the Sharpless asymmetric dihydroxylation.27  
The C12–C19 fragment 77 was prepared in 10 steps employing a Paterson aldol. Paterson 
did not disclose full fragment couplings, but instead employed simple models for each 
fragment coupling. The fragment coupling of C11–C19 fragment 77 with model aldehyde 
78, derived from neopentyl glycol, was uneventful, proceeding in > 95:5 dr at C11with 1,5 
anti induction observed in aldol adduct 79 (Scheme 1.14). An Evans–Tishchenko 
reduction effectively relayed stereochemistry from the C11 alcohol to the reduction of the 
C13 ketone, enabling the construction of the C9- C19 fragment of peloruside A. This bears 
coincidental similarity to work conducted by Dr. George Moniz in this group that will be 
described in section III of this chapter. 
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An aldol reaction with isobutyraldehyde and C1-C6 fragment 75 proceeded in modest 
yield 61% with a moderate (75: 25: preference for the desired diastereomer (equation 
1.2).  
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(27) Sharpless, K. B.; Amberg, W.; Beller, M.; Chen, H.; Hartung, J.; Kawanami, Y.; Lübben, D.; 
Manoury, E.; Ogino, Y.; Shibata, T.; Ukita, T.; J. Org. Chem. 1991, 56, 4585- 4588. 
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The part with most significance to our route involved the attempts at the C6–C7 bond 
construction (equation 1.3). The addition of acetone enolates into the C7 aldehyde 76 
showed either no selectivity for the desired diastereomer 82 as with the Cy2B enolate (57: 
43 dr for 82: 83), or the a preference for the incorrect diastereomer 83 as was seen with 
the lithium enolate (25: 75) or Mukaiyama conditions (7: 93). The only conditions that 
provided good selectivity for the desired diastereomer (75:25, 69% yield) required the 
use of (+)–Ipc2BCl 84 to produce a chiral enolate. Using (-)–Ipc2BCl overturns the 
selectivity (10:90, 88% yield).  
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Paterson states that it may be anticipated that the use of chiral C1–C6 fragment 75 may 
enhance the diastereoselectivity of this step in a triple diasterodifferentiating aldol since 
75 has a modest intrinsic preference for the desired outcome. The results in section III of 
this chapter will reveal that an anti disposition of the oxygenation at C8 and C9 is essential 
to obtaining high diastereoselectivity in the C6–C7 bond construction, so it is likely that 
this bond construction was not successful as planned. The Paterson approach is 
noteworthy in that it uses the same bond disconnections as our second-generation 
synthesis. Our findings that are reported in section I of chapter 2 suggest that Paterson 
would have encountered difficulties with a selective C6–C7 bond construction based on 
his choice of the configuration of the alcohol at C9. It is also unclear from either our work 
or Hoye’s work if the C11 to C12 bond construction will work with syn oxygenation at C8 
and C9. Had the C9 stereocentre been epimeric, Hoye’s precedent suggests the fragment 
coupling would be successful, albeit with careful choice of protecting groups. 
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The Roush Approach 
The Roush approach is notable in that it provides the most efficient reported synthesis of 
a C1–C11 fragment (Scheme 1.15).28 This employs Roush’s double allylboration 
methodology. Hydroboration of allenylborane 85 with a chiral borane delivers diboron 
intermediate 86 which is allowed to react with aldehyde 87, derived from neopentyl 
glycol. This produces intermediate allylborane 88, which is then allowed to react with 
aldehyde 89. This produces a C3–C11 fragment 90 in one pot, with the correct 
stereochemistry at C5 and diastereomer at C9. Use of (Ipc)2BH 91 gave 90 in 77% yield 
with 85% ee, while use of (2-dIcr)2BH 92 gave 90 in 36% yield in >95% ee. The decision 
was made to use the higher yielding reaction and separate diastereomers that would result 
from coupling with an enantiomerically pure piece at a later stage. 
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This fragment was elaborated in 11 steps to another C3–C11 fragment 93 bearing full 
oxygenation with appropriate protecting groups for further elaboration (Scheme 1.16). 
This elaborated fragment was then subject to an glycolate Evans Aldol reaction with 
oxazolidinone 94 which provided aldol adduct 95 in an impressive 86% yield.29 The 
minor diastereomer resulting from the fact the aldehyde was 85% ee was removed at this 
point. Subsequently the aldol adduct 95 was methylated and elaborated to aldehyde 96. 
                                                
(28) Owen, R. M.; Roush, W. R.; Org. Lett. 2005, 7, 3941-3944. 
(29) Typical yields for the glycolate aldol employed in our C2 to C3 bond construction on much simpler 
substrates were in the 60% range. 
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The synthesis plan then involved conducting another double allylboration to combine C1–
C11 aldehyde 96 and C15–C19 aldehyde 97. The allylboration reagent would be the C12–
C14 linker.  
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Given the difficulties we had with the C11–C12 bond construction with C9 in the alcohol 
oxidation state, it can be anticipated that the Roush group would have run into difficulties 
with this transformation. The double allylboration provided an impressive route to a 
sparsely functionalized C3-C11 piece, and despite the 11 steps required to fully oxygenate 
this piece, the approach to this piece remains competitive to ours in both yield and step 
count. 
III. Summary of Evans Group’s First Approaches30 
The Moniz Approach 
Dr. George Moniz, a post-doctoral fellow in our group, initiated the peloruside project in 
2001.31 At the time the absolute configuration of peloruside A was not known, but Dr. 
                                                
(30) A detailed summary of the approaches was prepared in the post-doctoral reports of Dr. George Moniz, 
Dr. Andreas Reichelt and Dr. Dennie Welch. Since this information is not available in the public domain, 
information most pertinent to the second generation synthesis designed by Dr. Dennie Welch is presented 
here. Accordingly this summary follows the same framework as that prepared by Dr. Dennie Welch 
although the prose and schemes are my own. 
(31) Moniz, G. A. Postdoctoral Report, Harvard University, 2003. 
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Moniz applied Celmer’s rule to successfully predict the correct configuration.32 Celmer’s 
rule is based on the observation that a number of “unusual” macrolides, which have 
oxygenation at the C7 position, usually in the L configuration, uniformly have an  D- 
configuration at the macrolactone terminus in their Fischer projections.  
O
HO H
H OMe
HH
OHH
HH
MeO
HHO
O
Me Me
HO H
H H
H OMe
H H
R H
O
7
D-Configured
L-ConfiguredH
O
OMe
HO
O
HO
Me Me
OMe
OH
Me
Et
MeO
HO
HOHO
1
7
9
15
15
(+)-Peloruside A
1
9
98
 
Figure 1.15 Application of Celmer’s rule to predict the configuration of peloruside A. 
The synthesis plan involved macrolactonization of a seco acid 99 containing an 
elaborated pyran. This in turn would arise from a 1,5 anti aldol reaction between C12–C19 
fragment 54 and C1–C11 fragment 100. The initial disconnections were chosen to 
highlight 1,5-anti aldol methodology in the construction of the C11-C12 bond (Figure 
1.16).33   
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Figure 1.16 The first generation synthesis plan. 
                                                
(32) Cane, D. E.; Celmer, W. D.; Westley, W. J. Am. Chem. Soc. 1993, 105, 3594- 3600. 
(33) Evans, D. A.; Côté, B.; Coleman, P. J.; Connell, B. T.; J. Am. Chem. Soc. 2003, 125, 10893-10898. 
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The synthesis of the C12-C19 fragment commenced with a titanium-mediated alkylation of 
butanoyl-loaded oxazolidinone 101 (Scheme 1.17).34 The benzyl group was removed by 
hydrogenolysis and replaced with a TBS group to give compound 102 in 83% yield over 
3 steps. This was then converted to aldehyde 103 in a 2-step sequence in 87% yield. This 
was subject to an Ando olefination with phosphonate 104 to give enoate 105 in 77% yield 
with a Z/E ratio > 20:1.35 A 2-step sequence was used to convert enoate 105 into enal 
106. Enal 106 was subject to a Brown allylation to afford homoallylic alcohol 107.36 This 
alcohol was then protected as a PMB ether to give compound 108. The PMB ether was 
chosen, as β-benzyloxy groups are effective controllers in 1,5-anti aldol reactions.33,37 
Finally the ketone was installed by a Wacker oxidation to afford C12–C19 fragment 54.38,1 
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The Moniz C11 to C12 Bond Construction 
Concurrently, Dr. Moniz prepared a C1–C11 fragment 100 (Scheme 1.18). As this route 
was ultimately superseded by a different strategy, individual steps will not be described 
                                                
(34) Evans, D. A.; Urpi, F.; Somers, T. C.; Clark, J. S.; Bilodeau, M. T. J. Am. Chem. Soc. 1990, 112, 
8215-8216. 
(35) Ando, K. J. Org. Chem. 1998, 63, 8411-8416. 
(36) Brown, H. C.; Jadhav, P. K. J. Am. Chem. Soc. 1983, 105, 2092-2093 
(37) Paterson, I.; Gibson, K. R.; Oballa, R. M.; Tetrahedron Lett. 1996, 37, 8585-8588. 
(38) Tsuji, J.; Shimizu, I.; Yamamoto, K. Tetrahedron Lett. 1976, 17, 2975-2976. 
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in detail. Meso anhydride 109 was desymmetrized using (S)-β-naphthylethanol 110.39 
Pyranone 111 was prepared in 37% yield in 7 steps from compound 109. Pyranone 111 
was elaborated to compound 112 in a 5-step sequence in 54% yield. The C2–C3 bond was 
formed by elaboration of compound 112 to the corresponding aldehyde 113 followed by 
a glycolate aldol with oxazolidinone 114 to afford aldol adduct 115. 3 more steps served 
to elaborate this aldol adduct to the final C1–C11 fragment 100. 
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Dr. Moniz then investigated an aldol reaction of C12-C19 fragment 54 with pivaldehyde as 
a model system (Equation 1.5). The dibutyl boron triflate mediated reaction proceeded in 
good yield to give aldol adduct 116 with superb diastereoselectivity.  
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(39) Theisen, P. D.; Heathcock, C. H.; J. Org. Chem. 1988, 53, 2374- 2378. 
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Unfortunately, the fragment coupling between 54 and 100 failed to give any product 
under the same conditions, or using LDA to enolize fragment 54 (Equation 1.6).  
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Dr. Moniz speculated that the steric bulk of the protected hydroxyls at C7 and C8 led to 
the low reactivity in fragment 100. Accordingly, he attempted the aldol reaction with less 
sterically hindered compound 117, derived from pyranone intermediate 111. This 
underwent the desired aldol reaction in acceptable yield with superb diastereoselectivity 
(Scheme 1.19). The increase in reactivity was attributed to the lower steric demand 
around the C11 aldehyde by having an sp2 centre at C9. Aldol adduct 118 was then 
elaborated to intermediate 119 in a sequence that involved an Evans–Tishchenko 
reduction, followed by a Luche reduction, directed epoxidation and methanolysis. 
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Dr. Moniz’s key contributions to the project involved the synthesis of C12–C19 fragment 
54 and the demonstration that this fragment could undergo highly selective 1,5-anti aldol 
reactions. A very important contribution was the observation that the C11–C12 bond 
construction was sensitive to sterics, and that this reaction could proceed with a β- 
vinylogous keto aldehyde in substrate 117. 
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The Reichelt Approach 
The project was taken over by Dr. Andreas Reichelt. Dr. Reichelt preformed the same 
bond construction on more elaborate pyranone 120, using a C19 TBDPS analogue of 
ketone 54. Aldol adduct 121 was elaborated by Evans–Tishchenko reduction and 
methylation to yield peloruside A backbone 122 (Scheme 1.20). Unfortunately 
elaboration of the pyranone was not possible at this stage as concomitant cleavage of the 
oxazolidinone was observed. It was decided to conduct pyranone elaboration after the 
macrolactonization, which was the strategy used by Taylor.17,40  
 
Scheme 1.20   
OH Me Me
O
H
OMe
OPMB
O
O N
Bn
O
120
1 11 O
OH
Me MeH
OMe
NO
O
Bn
O
OPMB
19
1
PMBOO
Me
OTBS
Et
O O
121
O
AcO
Me MeH
OMe
NO
O
Bn
O
OPMB
19
1
PMBOMeO
Me
OTBS
Et
O
122
O
AcO
Me MeH
OMeO
OPMB
151
HOMeO
Me
OTBS
Et
O
123
HO
a
b, c
d, e
f
74 %
O
OMeO
PMBO
Me Me
AcO
O
MeO
Me
Et
OTBS
O
124
O
OMeO
PMBO
Me Me
AcO
O
MeO
Me
Et
OTBS
125
OH
OMe
OMe O
OMeO
PMBO
Me Me
HO
O
MeO
Me
Et
OTBS
OH
OMe
OMe
11 11
92 %
80 %
64 %
28 %
a) Bu2BOTf, 54, iPr2NEt, then 120 toluene, -78 °C b) MeCHO, SmI2, THF c) Me3OBF4, Proton Sponge
d) DDQ, CH3CN e) LiOH, H2O2, THF f) 2,4,6-trichlorobenzoyl chloride, DMAP, benzene, rt  
The PMB group at the C15 hydroxyl could be selectively cleaved in the presence of the C2 
PMB protection, followed by oxazolidinone cleavage to yield seco acid 123. Yamaguchi 
macrolactonization gave pyranone 124, which was elaborated in a 4-step sequence to 
                                                
(40) The synthesis of Taylor had not been disclosed at this point. 
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protected peloruside A 125. Unfortunately, the acetate group on the C11 hydroxyl, 
originating in the Evans–Tishchenko reduction could not be cleaved.  
 
The acetate group could be removed at an earlier stage to generate seco acid 126 with 
free hydroxyl groups at both C11 and C15. This did undergo a site selective Yamaguchi 
reaction (Equation 1.7) to yield 127. Unfortunately elaboration of the pyranone according 
to the method that worked on 124 was unsuccessful on this intermediate.  
O
HO
Me MeH
OMeO
OPMB
151
HOMeO
Me
OTBS
Et
O
HO 11
O
OMeO
PMBO
Me Me
HO
O
MeO
Me
Et
OTBS
O
126 127
a
a) 2,4,6-trichlorobenzoyl chloride, DMAP, benzene, rt
77 %
(1.7)
 
At this stage it was decided to revise the strategy for the synthesis of the molecule given 
the difficulties in elaborating the pyranone at the late stage. An important finding from 
this work was that the C11–C12 bond could be constructed with an oxazolidinone at C1. 
Second Generation Reichelt Approach 
The second generation strategy involved cyclization of a pyran containing seco acid 128, 
arising from a non- pyran containing piece 129, which in turn would be assembled from 
C1–C6 fragment 130, C7–C11 fragment 131 or 132 and C12–C19 fragment 133 (Figure 
1.17). It was anticipated constructing the C11–C12 bond on a non pyran-containing piece 
would be possible because of lowered steric demand at a C11 aldehyde in the absence of 
the pyran. The formation of the pyran would occur through cyclization of a C5 alcohol 
onto the C9 ketone, and would precede the macrocyclization, but would come after the 
C11–C12 bond construction. Accordingly, an orthogonal group would be employed to 
protect the C9 hydroxyl. This would be removed and the C9 alcohol oxidized before pyran 
formation. The BOM group in fragment 131 or the DMB group in 132 were envisioned 
as such protecting groups. Fragments 131 and 132 both contain latent aldehydes at C7 and 
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C11. Fragment 131 was designed for a convergent strategy, where the C6–C7 bond 
construction would precede the C11–C12 bond construction, with a labile TES group at C11 
being envisioned to be removed after the first fragment coupling to enable C11 oxidation 
to the aldehyde for the second fragment coupling. Fragment 132 was designed for a less 
convergent strategy, where C11–C12 bond construction would occur first. The use of a 
monosubstituted olefin was to ensure that oxidative cleavage could then take place in the 
presence of the trisubstituted C16–C17 olefin. The protecting group strategy employed at 
the C5 alcohol, would vary according to the fragment coupling strategy employed, 
however one option would employ a TBS group, so in anticipation of a selective 
deprotection at that position, the a TBDPS group was employed to protect the C19 alcohol 
in fragment 133.  
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Figure 1.17 Second generation approach. 
The synthesis of the C1–C6 fragment involved a glycolate aldol reaction of oxazolidinone 
134 into aldehyde 135, followed by protecting group manipulations on aldol adduct 136 
to afford fragment 130 in 4 steps (Scheme 1.21). 
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Scheme 1.21  
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The configuration at C9 of fragments 131 and 132 is ultimately inconsequential as C9 is 
oxidized to the ketone oxidation state at later stages in the synthesis. However, the 
relative configuration of the C8 and C9 positions has a great deal of importance on the C6–
C7 bond construction. The use of an anti arrangement of C8 and C9 was chosen based on 
the results of an extensive series of investigations into aldol reactions into α,β- 
oxygenated aldehydes conducted in our group by Dr. Sarah Siska and Dr. Victor Cee.41 
The implications of this study to our strategy will be discussed in more detail in the 
summary on Dr. Dennie Welch’s work. 
Synthesis of C7–C11 fragment 131 proceeded in 6 steps from (S)-pantolactone 137 
(Scheme 1.22). BOM protection, opening of the lactone with Weinreb amine and TES 
protection of the resultant alcohol proceeded in high yield to afford Weinreb amide 138 
in high yield. Addition of the Grignard reagent derived from 1-bromo-2-methylprop-1-
ene and chelate controlled reduction with Zn(BH4)2 proceeded in modest yield to afford 
alcohol 139. The choice of the highly substituted Grignard reagent was based on slowing 
competing 1,4 hydride reduction in the reduction step. Protection afforded fragment 131. 
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(41) Evans, D. A. Cee, V. J.; Siska, S. J. J. Am. Chem. Soc. 2006, 128, 9433- 9441. 
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 The C7–C11 fragment 132 was prepared by DMB protection of (S)-pantolactone, 
followed by monoaddition of vinyllithium and acetylation of the resultant primary 
alcohol giving enone 140. Chelate controlled reduction, and TBS protection gave 
fragment 132 (Scheme 1.23). 
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Initial fragment coupling investigations were carried out with ketone 130 and aldehyde 
141, derived from ozonolysis of fragment 131 (Scheme 1.24). Unfortunately enolization 
of 130 with 9-BBN triflate, the reagent used in the Cee and Siska studies did not work. 
Decomposition was attributed to the sensitivity of the C2 OTBS group. Use of 
dibutylboron triflate gave resulted in the formation of aldol adduct 142 but with only 2:1 
diastereoselection the correct way. An investigation using model methyl ketone 143 
showed that dicyclohexylboryl enolates gave predominantly the incorrect configuration at 
C7 in compound 144 with a dr of 4:1.  
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Use of LDA with 143 gave the desired stereochemistry at C7 in compound 145 with a 
selectivity of > 95:5. Unfortunately fragment 130 was not stable to LDA, undergoing 
decomposition due to the electrophilicity of the C1 carboxylate. Unfortunately efforts to 
elaborate compound 145 to a later intermediate were stymied by issues with the C3 PMB 
protecting group.  
 
At this point, the decision was made to investigate the C11-C12 bond construction 
(Scheme 1.25). The crucial C11-C12 bond construction proceeded in excellent yield and 
diastereoselectivity (95%, dr > 95:5) between 133 and aldehyde 146, derived from 
fragment 132. Aldol adduct 147 was obtained in high yield despite the fact that C9 was in 
alcohol oxidation state.  Subsequent Evans–Tishchenko reaction relayed the 
stereochemistry from C11 to C13, followed by methylation of the C13 alcohol, acetate 
removal at C11 and TES protection at C11 afforded compound 148, which could be 
converted to C7-C19 aldehyde 149 in a 2 step sequence.  
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Given the results obtained in Scheme 1.24, a lithium aldol reaction was used to construct 
the C6-C7 bond. Since 133 was decomposed by LDA, the more resistant Weinreb amide 
150 was synthesized and employed. The key fragment coupling proceeded in good yield, 
but with excellent stereoselectivity (79%, dr 95:5) to afford peloruside A backbone 151 
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(Equation 1.8). Unfortunately 10 equivalents of 133 were needed, as self-condensation 
was still somewhat operative. At this point, Dr. Dennie Welch joined the project, and was 
tasked with investigating the C6–C7 bond construction.  
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IV. The Welch Synthesis 
Discovery of Boron Ligand Effects in the C6 to C7 Bond Construction 
Dr. Welch began a systematic investigation of boron aldol reactions to construct the C6-
C7 bond. It was hoped that boron aldol reactions would allow stoichiometric use of the C-
1-C6 fragment. A decision was also made to use compounds with a group at C1 that could 
be more readily cleaved to the carboxylic acid. Accordingly compound 130 was revisited 
and 152, shown in Figure 1.18 were prepared based on the route shown in Scheme 1.26.  
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Figure 1.18 Methyl ketones utilized by Dr. Welch. 
The intrinsic diastereoselectivity of this reaction was probed using isobutyraldehyde 
(Table 1.1) yielding aldol adducts 153. It should be noted this reaction did not have a 
wide degree of sensitivity to the identity of the boron reagent, although 9-BBN appeared 
to be slightly inferior. 
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Table 1.142 
R
Bn
Bn
Bn
9-BBN
9-BBN
Bu2B
M
CH2Cl2
toluene
toluene
solvent dr
O N
O
Bn
O
130 or 152
OR
MeO
conditions
O
H
Me
Me
O N
O
Bn
O
153
OR
MeO O
Me
Me
OHOM
Bn
TBS
TBS
Cy2B
9-BBN
Cy2B
toluene
toluene
toluene
2.0 : 1
2.0 : 1
2.8 : 1
3.0 : 1
N.R.
2.0 : 1
entry
1
2
3
4
5
6  
The behavior of model enolates derived from methyl isobutyl ketone with aldehyde 149 
was also studied (table 1.2). The lithium enolate gave a very high diastereoselectivity for 
154 as would be expected given the fragment coupling shown in equation 1.8. The low 
diastereoselectivity with the 9-BBN enolate is noteworthy given results that will be 
reported in Chapter 2 and also surprising as the Cee and Siska results had high selectivity 
with 9-BBN enolates on anti α,β oxygenated aldehydes.41 
 
Table 1.2 Investigation intrinsic diastereoselectivity of 149.42  
Cy2B
9-BBN
Li
M
<5 : 95
1.0 : 1.2
>95 : 5
entry
1
2
3
Me Me
OTESOMe OPMB
Me
Et
OTBDPS
TBSO
O
H
149
OR
OM
Me
Me
Me Me
OTESOMe OPMB
MeTBSO 154
O OH OR
Me
Me
7,8-anti : 7,8-syn
R = DMB
7
8
OTBDPS
Et
 
Finally, ketones 152 and 153 were allowed to react with C7-C19 fragment 149 under a 
variety of enolization conditions to give adduct 155. The lithium enolates of compound 
152 and 153 are not stable, undergoing a destructive self-cyclization, so this study was 
limited to Boron enolates (Table 1.3). 
 
 
                                                
(42) The following table is reproduced with permission from Dr. Dennie Welch. 
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Table 1.3 Fragment coupling Investigation.42 
 
O
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OMe
Xc
Me Me
OTESOMe OPMB
Me
OTBDPS
TBSO 155
O ODMBOR
7,8-anti : 7,8-syn
Xc
O
130 or 152
OR
MeO OM
R
Bn
Bn
TBS
9-BBN
Cy2B
Cy2B
M
4 : 1
1 : 10
<5 : 95
TBS Bu2B 1 : 2
entry
1
2
3
4
8
7
Me Me
OTESOMe OPMB
Me
Et
OTBDPS
TBSO
O
H
149
ODMB
Et
 
It can be seen from the above results that the diastereoselectivity of these aldol reactions 
is highly dependant on the identity of the Boron species used with the best result being 9-
BBN triflate mediated enolization of 152. Unfortunately, 9-BBN triflate did not result in 
a successful enolization of 130 with a TBS group at the C2 alcohol, and it was felt at the 
time that a benzyl protection at this position would be incompatible with global 
deprotection because of the C16-C17 alkene.43 Accordingly the decision was made to the 
conditions that produced 151. Elaboration of 151 was carried out via 1,3 anti reduction 
mediated by Me4N HB(OAc)3 in greater than 10:1 dr,44 followed by selective TBS 
protection of the C5 alcohol and methylation of the C7 alcohol to product fully protected 
peloruside A backbone 156 (Scheme 1.26). 
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(43) This was prior to the hydrogenolysis of the C19 benzyloxy group reported by Ghosh. It is unclear if a 
benzyl group on the much more sterically hindered C2 position could be subject to selective hydrogenolysis 
in the presence of the C16-C17 alkene. 
(44) Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc. 1988, 110, 3560- 3578. 
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At this point, Dr. Welch decided to investigate a switch in the order pyran formation and 
macrocyclization. Dr. Welch felt there was literature precedent that suggested that 
formation of the pyran adjacent to the geminal dimethyl group at C10 that was planned in 
synthesis plan intermediate 128 might be difficult.45 Accordingly Dr. Welch decided to 
attempt a macrocyclization of a linear seco acid 157 followed by pyran formation during 
the global deprotection. This work was conceived prior to Ghosh’s disclosure of such a 
strategy. Since Dr. Welch was working with material protected with a DMB group on the 
alcohol at C9 and a PMB group on the alcohol at C15, removal of the C15 alcohol-
protecting group would also result in the deprotection of the alcohol at C9. A solution to 
avoid a protecting group swap at C9 would be to attempt a selective macrocyclization on 
seco acid 157 containing free alcohols at both C9 and C15. This was deemed to be feasible 
given the steric congestion around C9. Oxidation of C9 on macrolactone 158 to the ketone 
would precede pyran formation at the global deprotection. (Figure 1.19) 
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Figure 1.19 Revised cyclization order. 
Dr. Welch was able to elaborate compound 156 to seco acid 157. Unfortunately, this 
compound proved to be unstable, attributable to lability of the TBS protecting group on 
                                                
(45) Keck, G. E.; Yu, T.; McLaws, M. D.; J. Org. Chem. 2005, 70, 2543- 2550. 
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the C2 alcohol. Lability of OTBS groups α to carboxylic acids has been observed during 
synthesis efforts towards peloruside46, tedanolide,47 and psymberin.48  
Dr. Welch then decided to follow the precedent of DeBrabander and Taylor and employ a 
MOM protecting group at the C2 alcohol. The supply of the C7–C19 aldehyde 149 was 
growing short, and Dr. Welch wanted to test the feasibility of the pyran formation 
following macrolactonization without having to do another scale up. Accordingly, a Piv 
ester was chosen to protect the C1 terminus of the C1–C6 fragment since this would 
anticipated to be resistant to self-condensation, resulting in a stable lithium enolate and 
hopefully a reliable fragment coupling. The required C1–C6 fragment 159 was prepared 
by in 7 steps from oxazolidinone 134 by way of aldol adduct 160 (Scheme 1.27) 
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Revised C1-C6 fragment 159 was employed in the C6-C7 bond construction with high 
diastereoselectivity to give aldol adduct 160.49 Elaboration by 1,3-anti reduction, 
followed by C5 silylation and C7 methylation afforded peloruside A backbone 161. This 
was converted into seco acid 162 in a 4-step sequence (Scheme 1.28).  
 
 
 
                                                
(46) Zheng, J. Ph.D. Thesis, University of Pennsylvania, 2003.  
(47) Hassfeld, J.; Eggert, U.; Kalesse, M. Synthesis, 2005, 7, 1183- 1199. 
(48) Kiren, S.; Williams, L. J. Org. Lett. 2005, 7, 2905- 2908. 
(49) The reaction was complicated by up to 40% E1CB elimination of methanol from C3, producing an 
inseparable olefin. This was removed by treatment with OsO4 after the 1,3 anti reduction step, yielding a 
readily separable tetraol. 
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The crucial macrolactonization to 163 proceeded in 71% yield under Yamaguchi 
conditions. The reaction was site selective for macrocyclization onto the C15 alcohol 
despite the presence of a free alcohol at C9. This important result showed that the linear 
seco acid could be cyclized. Oxidation of the C9 alcohol to the ketone with Dess- Martin 
periodinane proceeded uneventfully to give fully protected peloruside A 164. Exposure of 
macrolactone 164 to 4N HCl did not result in the formation of peloruside A, as it 
appeared that the TBDPS group was still on. Exposure of TBDPS macrolactone to HF-
Py, py, followed by 4N HCl did result in the synthesis of peloruside A, validating the 
concept of forming the pyran after macrocyclization.50 
 
                                                
(50) Dr. Welch completed this synthesis on June 4th 2007, which preceded Ghosh’s publication of a similar 
strategy on February 5th 2008. 
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Dr. Welch’s work resulted in the validation of the strategy of cyclization of a linear seco 
acid, showed that a site selective macrolactonization was feasible, and showed that boron 
ligand effects influenced the diastereoselectivity of the C6–C7 bond construction. This 
first generation synthesis had a longest linear sequence of 31 steps, and it was readily 
appreciated that there was room for improvement since the strategy of late pyran 
formation had been conducted on material that originally had a protecting group strategy 
for another purpose. 
 
The Second Generation Welch Retrosynthesis 
Critical examination of the first generation synthesis showed several areas that detracted 
from the overall efficiency. Synthesis of the C12–C19 fragment 133 or 54 requires 12 
steps, while synthesis of the C7–C11 fragment 131 is 6 steps and the C1–C6 fragment 159 
also 6 steps. By placing the C11–C12 bond construction before the C6–C7 bond 
construction, the C11–C21 fragment synthesis is within the longest linear sequence, 
impacting the overall convergency of the synthesis. The problems encountered in the C6–
C7 bond construction necessitated the use of a C1–C6 fragment 159 with the C1 terminus 
in an alcohol rather than carboxylate oxidation state and represented an obvious target for 
improvement. Targeting a MOM group to protect the alcohol at C2 while C1 was in the 
carboxylate oxidations state would provide new substrates that had not been successful 
with C2 OTBS fragment 130 or C2 OBn fragment 152. A final improvement in efficiency 
was targeted in when the ketone oxidation state was introduced at C9. It was anticipated 
that having a ketone at C9 could actually enhance the reactivity of a C11 aldehyde in the 
C11–C12 bond construction. In that case, the alcohols at C9 and C11 could be protected 
with protecting groups that could be cleaved under the same conditions, and both 
alcohols could be oxidized concurrently.  
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Figure 1.20 New synthesis plan devised by Dr. Welch. 
This would enable a further 2 steps to be cut from the synthesis. It should be noted an 
early oxidation of C9 would result in the requirement for directed reduction of the C13 
ketone in the presence of the C9 ketone. It was anticipated that the C10 geminal dimethyl 
group would decrease the reactivity of the C9 ketone such that this reaction could be 
achieved. These considerations resulted in the synthesis plan shown in Figure 1.20 with a 
projected longest linear sequence of 23 steps. 
 
Peloruside A would arise from macrolactone 165, which bears a free hydroxyl at C11. 
This would arise from the cyclization of linear seco acid 166 with C9 already at the 
ketone oxidation state. Seco acid 166 would be synthesized from peloruside A backbone 
167, which in turn would arise from an aldol reaction between known fragment 54 (see 
Scheme 1.17) and β-keto aldehyde 168. Compound 168 would be prepared from ketone 
169, which bears similarity to known intermediates 130 (see Scheme 1.21), and aldehyde 
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170 which would be made in a similar method to compound 131 (see Scheme 1.22). The 
implementation of this strategy will be described in the next chapter. 
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Chapter 2 
Completion of the Total Synthesis of Peloruside A1,2 
I.  Assembly of the Carbon Backbone of Peloruside A 
The second generation synthesis plan for peloruside A, 1, developed by Dr. Welch in the 
previous chapter, targeted a linear seco acid 2 arising from a C6–C7 bond construction 
that preceded the C11–C12 bond construction (Figure 2.1). The seco acid contains 1,3-anti 
relationships between C5 and C7 and C11 and C13 that may arise from 1,3-anti reductions. 
Also, 1,5-anti relationships between C3 and C7 and C11 and C15 are apparent that may 
arise from 1,5-anti aldol reactions. The C6–C7 bond construction would arise between C1–
C6 fragment 3 and C7–C11 fragment 4. These fragments bear close resemblance to 
fragments prepared by Dr. Reichelt and Dr. Welch as described in the preceding chapter. 
The C11–C12 bond construction would involve C12–C19 fragment 5, which is known from 
Dr. Moniz’s work.  
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Figure 2.1 Fragments targeted in this work. 
                                                
(1) Reproduced in part with permission from Evans, D. A.; Welch, D. S.; Speed, A. W. H.; Moniz, G. A.; 
Reichelt, A.; Ho, S. “An Aldol-Based Synthesis of (+)-Peloruside A, A Potent Microtuble Stabilizing 
Agent” J. Am. Chem. Soc. 2009, 131, 3840-3841. © 2009 by The American Chemical Society. 
(2) Much of the work described in this chapter was conducted in conjunction with Dr. Dennie Welch, and 
Mr. Stephen Ho, an undergraduate student in our lab. This is noted accordingly were applicable.  
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 I joined the project shortly after Dr. Welch began work on this second generation 
strategy. My initial task was to synthesize the new C1–C6 fragment via an adaptation of 
the previous work done by Dr. Welch and Dr. Reichelt. I then proceeded to investigate 
the C6–C7 bond construction with aldehydes prepared by Dr. Welch. A strong precedent 
for this bond construction may be found in the work of Dr. Sarah Siska and Dr. Victor 
Cee.3 The results most pertinent to the peloruside A bond construction are shown in table 
2.1. Anti aldehyde 6 delivered highly diastereoselective reactions with lithium and 9-
BBN methyl ketone enolates with a 1,2-anti relationship in aldol adduct 7. Syn aldehyde 
8 did not show this same highly selective formation for aldol adduct 9. However since the 
ketone enolate we intended to employ was also chiral, both syn and anti aldehydes would 
be investigated. In addition, only 9-BBN boron enolates are employed in the Cee and 
Siska work. Given the boron ligand effect discovered by Dr. Welch (Tables 1.2 and 1.3), 
a more thorough investigation of boron reagents was in order. 
Table 2.1 Cee and Siska precedent.4 
R
OM
solvent
H i-Pr
O
OTBS
OPMB
i-Pr
OTBS
OPMB
R
O OH
R
OM
solvent
H i-Pr
O
OTBS
OPMB
i-Pr
OTBS
OPMB
R
O OH
R
Me
i-Pr
t-Bu
 65 : 35 (83)
 41 : 59 (95)
 09 : 91 (89)
CH2Cl2
M = TMS/BF3·OEt2
91 : 09 (88)
86 : 14 (92)
81 : 19 (90)
CH2Cl2
M = 9-BBN
>99 : 01 (95)
>99 : 01 (98)
>99 : 01 (98)
THF
M = Li
1,2-anti : 1,2-syn (% yield)
R
Me
i-Pr
t-Bu
 67 : 33 (78)
 49 : 51 (67)
 18 : 82 (37)
CH2Cl2
M = TMS/BF3·OEt2
45 : 55 (86)
36 : 64 (83)
33 : 67 (86)
CH2Cl2
M = 9-BBN
 63 : 37 (95)
 84 : 16 (87)
 66 : 34 (70)
THF
M = Li
1,2-anti : 1,2-syn (% yield)
6 7
8 9
1
2
2
1
 
 
 
                                                
(3) Evans, D. A.; Cee, V. J.; Siska, S. J.; J. Am. Chem Soc. 2006, 128, 9433- 9441. 
(4) This table is reproduced with the permission of Dr. Dennie Welch from his post-doctoral report. 
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Synthesis of the C1–C6 Fragment 
The synthesis of the C1–C6 fragment 3 was straightforward. Compound 3 was prepared 
according to the procedures developed by Dr. Welch (scheme 1.27)5, and hydrolysis of 
the acetal produced 3, which was used for the subsequent fragment coupling studies.  
Scheme 2.1  
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O
Bn
O
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The intrinsic diastereoselectivity of aldol reactions of this methyl ketone with 
isobutyraldehyde to give aldol adduct 13 were also explored. In light of Dr. Welch’s 
results showing that the ligands on boron could have an effect on the diastereoselectivity 
of the C6–C7 bond construction, enolizations using 9-BBNOTf, Bu2BOTf, PhBCl2 and 
Cy2BCl were all attempted (Table 2.2). Use of Bu2BOTf and PhBCl2 led to 
decomposition of ketone 3. Enolizations with 9-BBNOTf and Cy2BCl both gave modest 
diastereoselectivity favoring the desired product. The diastereoselectivity is lower than 
what is typically observed in 1,5-anti aldol reactions, but consistent with that observed 
with Paterson in similar experiments on his C1–C6 peloruside fragment (Equation 1.2) and 
those by Dr. Welch (Table 1.1).  
Table 2.2 Studies of intrinsic bias of 3. 
Bu2B
Cy2B
PhBCl
M
toluene
toluene
toluene
solvent dr
O N
O
Bn
O
3
OR
MeO
conditions
O
H
Me
Me
O N
O
Bn
O
13
OMOM
MeO O
Me
Me
OHOM
9-BBN toluene
decomposition
1.9 : 1
decomposition
4.0 : 1
entry
1
2
3
4
 
                                                
(5) In this sequence I began by using the C2 benzyloxy analogue of 12 prepared by Mr. Stephen Ho, an 
undergraduate in our lab, and also prepared compounds 10 and 12 myself. Compound 11 was prepared by 
Mr. Stephen Ho. The C2 benzyloxy compound may be converted to 3 by the following sequence: 
methylation of the C3 alcohol, C2 benzyloxy hydrogenolysis, C2 MOM protection, and C5 ketal hydrolysis. 
The overall yield for this sequence was inferior to the sequence shown. 
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Entry 1 was repeated twice, to ensure that the observed decomposition of 3 was not a 
fluke. Since Bu2BOTf caused decomposition, its use was not investigated any further in 
the C6–C7 bond construction studies. The most important result from this table, was that 
9-BBNOTf, the most effective reagent in the Cee and Siska studies for addition into anti- 
α,β oxygenated aldehydes bearing our protecting group strategy, was compatible with a 
MOM group at the C2 alcohol.6 
Concurrently, Dr. Welch had prepared aldehydes 4, 14 and 15 (Figure 2.2). Their 
preparation will not be discussed in detail as it bears close resemblance to fragments 
employed by Dr. Reichelt (see scheme 1.22) and this protecting group strategy was 
ultimately superseded as will be shown shortly. 
 
TBSO
OBn
Me Me
OBOMO
H
4
11
7
TBSO
OBn
Me Me
OBOMO
H
14
11
7
TESO
OBn
Me Me
OBOMO
H
15
11
7
 
Figure 2.2 Aldehydes prepared by Dr. Welch 
I conducted preliminary fragment coupling investigations, which showed that a 9-BBN 
triflate mediated aldol reaction with anti aldehyde 4 would be effective for the bond 
construction producing aldol adduct 16. Conditions could not be found to produce aldol 
adduct 17 from syn- aldehyde 14 in high diastereoselectivity. 
Table 2.3 Preliminary investigation of the C6-C7 bond construction 
 
9-BBN
Cy2B
M
toluene
toluene
solvent 7,8 anti: 7,8 syn
> 20:1
1: 2.5
entry
1
2
NO
O
Bn
O
OMOM
MeO O
TBSO
OBn
Me Me
OBOM
8
7
OH
3 + 4
9-BBN
Cy2B
M
toluene
toluene
solvent 7,8 anti: 7,8 syn
1: 1.4
entry
1
2
NO
O
Bn
O
OMOM
MeO O
TBSO
OBn
Me Me
OBOM
8
7
OH
3 + 14 1: 2.4
16
17  
                                                
(6) Recall Dr. Welch’s finding that 9-BBNOTf was ineffective at effecting an aldol reaction on a C2 OTBS 
protected version of 4 (Table 1.1). 
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Dr. Welch wished to improve the yield of the global deprotection, and he felt that the C8 
alcohol was one of the most crowded in the molecule. Accordingly he prepared aldehyde 
15 with the anticipation that a TES group protecting the C8 alcohol would ultimately 
increase the ease of global deprotection. I conducted a preparative scale fragment 
coupling on this compound (Scheme 2.2). Interestingly the diastereoselectivity in aldol 
adduct 18 fell to 10:1, which must be related to the smaller size of the TES protecting 
group. 
Scheme 2.2  
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Dr. Welch carried the material I had prepared forward to elaborated fragment coupling 
product 19, and unfortunately found that the TES group at the C8 alcohol was labile 
towards the hydrogenolysis employed to remove the benzyl and BOM groups at C9 and 
C11 in the preparation of 20.7 Accordingly Dr. Welch designed C7–C11 fragment 22 with 
TBS protection at C8, shown in figure 2.3. It was also decided to exploit the lability of a 
TES group to hydrogolysis conditions and use this protecting group on C11. This avoided 
difficult separations early in the synthesis associated with byproducts of BOM chloride. 
 
                                                
(7) The lability of TES to hydrogenolysis has been reported: (a) Kim, S.; Jacobo, S. M.; Chang, C.-T.; 
Bellone, S.; Powell, W. S.; Rokach, J. Tetrahedron Lett. 2004, 45, 1973- 1976. (b) Rotulo- Sims, D.; 
Prunet, J. Org. Lett. 2002, 4, 4701- 4704. 
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Figure 2.3 Redesigned C7–C11 fragments 
I hypothesized that an alternate C7–C11 fragment, 23, could be prepared by a crossed 
organocatalytic aldol of aldehyde 24 and aldehyde 25 followed PMB oxidation.8 The 
oxidatively formed PMP acetal would serve as a common protecting group on C9 and 
C11. Unfortunately aldehyde 25, prepared in 2 steps from neopentyl glycol proved to be 
unreactive in the crossed aldol, which may be attributed to steric hindrance. 
Dr. Welch encountered some difficulty in the synthesis of the redesigned C7–C11 
fragment, so I joined him to assist on this task. 
Synthesis of the Anti C7–C11 Fragment 
(S)-Pantolactone 26 was converted into Weinreb amide 27 in 3 steps by Dr. Dennie 
Welch and Mr. Stephen Ho (Scheme 2.3). Dr. Welch discovered that addition of 
Grignard reagent 28 to this Weinreb amide resulted in decomposition related to TES 
group cleavage. This decomposition was attributed to the Lewis acidic nature of the 
magnesium salts.  On small scale, the addition of vinyllithium 29 was found by Dr. 
Welch to be a viable route to enone 30. Scaling of this reaction proved to be difficult. Dr. 
Welch found that the lithium halogen exchange reaction was very slow, and premature 
addition of the enone resulted in products that did not arise from vinyllithium addition. I 
ultimately developed a procedure that could be run on gram scale with high yield. The 
method of preparation of the vinyllithium was crucial to the success of the reaction. The 
lithium halogen exchange was conducted at 0 °C, and aged for an hour before addition of 
the enone. Failure to perform this aging process or running the lithium halogen exchange 
at lower temperatures led to recovery of an amide containing product 31 where the OMe 
                                                
(8) Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 6798-6799. 
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group was absent.9 Conversely, if the temperature of the lithium halogen exchange was 
allowed to rise to more than 15 °C over the course of the addition of the vinyl bromide, 
an enone containing product 32, incorporating a diene derived from two of the vinyl 
moieties was detected, presumably through the intermediacy of vinylidene carbenes.10 
The aging process presumably involves destruction of t-butyllithium by reaction with 
diethyl ether. Such a process creates ethylene, which can react with t-butyllithium to 
produce neohexyllithium. Fortunately, no products arising from neohexyllithium addition 
to the Weinreb amide were observed. It should be noted Dr. Welch also developed a 
procedure that involved a longer warming at a lower temperature with MTBE as solvent, 
and this gave a similar result, but was not run on a scale greater than 300 mg. Dr. Welch 
showed that enone 30 could be converted into anti diol 33 and TBS protection and 
ozonolysis produced aldehyde 22. 
Scheme 2.3   
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I conducted the scale-up of these reactions, and the procedures and yields reported in the 
supporting information were from my work. 
 
 
 
                                                
(9) Beak, P.; Selling, G. W. J. Org. Chem. 1989, 54, 5574-5580.  
(10) The structure of the diene containing product and the Des-OMe Weinreb amide were elucidated by Dr 
Welch. 
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Synthesis of the Syn C7–C11 Fragment 
To conduct a more thorough investigation into the key fragment coupling, a fragment 
epimeric with 22 at C9 was prepared.11 I prepared this fragment from ent-30 via a 
reduction using DiBAlH to give allylic alcohol 34. Subsequent protection and ozonolysis 
afforded fragment 35 (Scheme 2.4). Dr. Welch had used this method to prepare fragment 
14 in the old protecting group scheme. 
Scheme 2.4  
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Investigation of the C6–C7 Bond Construction with the Anti C7–C11 Fragment 
The results described in Scheme 2.2 and Table 2.3 led us to be optimistic about the 
success of the projected fragment coupling with methyl ketone 3. However, for the 
purposes of being thorough, the intrinsic facial preferences of fragment 22 were studied 
using methyl isobutyl ketone (MIBK) as an achiral enolate, leading to aldol adducts 36 
(Table 2.4). 
Table 2.4 Investigation of the intrinsic diastereoselectivity of 22.  
9-BBNOTf
Cy2BCl
M
toluene
toluene
solvent 36a: 36b
no reaction
1: 3
entry
1
2
O
TBSO
OBn
Me Me
OTES
8
7
OH
36a
Me
Me
3 Bu2BOTf toluene 1: 1
TBSO
OBn
Me Me
OTESO
H
22
11
7
a) methyl isobutyl ketone, M, NEt3, then 22, -78 °C
O
TBSO
OBn
Me Me
OTES
8
7
OHMe
Me
36b
a
 
Surprisingly, the 9-BBN enolate of MIBK  did not react under these conditions. The 
Cy2B enolate gave primarily the undesired stereochemistry at C7, while the Bu2B enolate 
                                                
(11) There is a significant price difference between (S)- Pantolactone 26 ($133 for 1 g, 7.7 mmol, only size 
available from Aldrich, April 22nd 2012) and (R)-Pantolactone ($52 for 25g, 192 mmol, largest size 
available from Aldrich, April 22nd, 2012). Since the synthesis of 22 uses the more expensive enantiomer, 
this may have implications for the synthesis of sufficient quantities of peloruside A to conduct 
pharmaceutical trials. An approach to peloruside A using the less expensive 35 bears investigating.  
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gave no selectivity. Fortunately despite the results of table 2.4, the desired fragment 
coupling worked very well to afford aldol adduct 37 (equation 2.1).  
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Me Me
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11
7 NO
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OBn
Me Me
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7
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Me
O
OMOM
OMe
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3
6
1 +
81 %
37
(2.1)
9-BBNOTf
NEt3 , toluene
 
The diastereoselectivity in this reaction is over 30:1, which is greater than the 20:1 
diastereoselectivity obtained with BOM at C11 (Table 2.3, entry 1) It is unclear if this is a 
remote gearing effect, or if the diastereoselectivity increases with increased reaction 
scale. It is also unclear why 9-BBN triflate works so well in this reaction, but does not 
mediate a reaction with MIBK. Since 9-BBN enolates of simple methyl ketones work 
well in the Cee and Siska work (Table 2.1) we presume that the C10 geminal dimethyl 
group reduces the reactivity of 22. The 9-BBN enolate of 3 must be more reactive than 
the 9-BBN enolate of MIBK. It was noted that the enolates of 3 formed with 9-BBN 
triflate are deep red- violet in colour, while the 9-BBN enolate of MIBK was relatively 
colourless. This colour could indicate some sort of charge transfer complex, which may 
increase the reactivity of the enolate. An interesting future line of work would be 
conducting EPR measurements on 9-BBN enolates, or allowing them to react in reactions 
that may involve the intermediacy of radicals.12 
 
The reasons for the ligand effects observed on boron throughout this work are also 
unclear. A minimization of dipoles leading to a Cornforth transition state model 38 in the 
Cee and Siska work was proposed to account for the high diastereoselectivity of additions 
into anti α,β-oxygenated aldehydes (Figure 2.4).3 For the fragment coupling between 3 
and 22, this may be merged with the Goodman model for 1,5-anti aldol induction 
                                                
(12) Enolates of metals that are arguably d0, such as Ti(IV) are known have radical character. See:  
Beaumont, S.; Ilardi, E. A.; Monroe, L. R.; Zakarian, A. J. Am. Chem. Soc. 2010, 132, 1482-1483. And 
references therein. Boron centered radicals are also known: Walton, J. C.; Brahmi, M. M.; Monot, J.; 
Fensterbank, L.; Malacria, M.; Curran, D. P., Lacôte, E. J. Am. Chem. Soc. 2011, 133, 10312- 10321. 
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involving a formyl hydrogen bond and boat- like closed transition state, shown in model 
39. 13  
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Figure 2.4 Possible transition states for the C6–C7 bond construction. 
From inspection of model 39, it appears the 9-BBN ligand on the boron does not 
significantly interact with anything else. The substituents on the ligand are in effect “tied 
back”. The larger cyclohexyl ligands shown in 40 would interact with C6 of the methyl 
ketone. In a non-boat transition state, shown in 41, the ligands on the boron interact with 
C3. Unfortunately this does not explain the ligand effect observed in table 2.4, since 
MIBK does not contain oxygenation β’ to the ketone, yet shows a ligand effect in the 
aldol reactions. An alternate explanation that does not rely on the Goodman model may 
be that bulky boron species such as dicyclohexylboryl do not undergo reactions via 
closed transition states with α,β-oxygenated aldehydes. In the Cee and Siska work, 
Mukaiyama aldol reactions were unselective with anti α-silyloxy, β-benzyloxy aldehydes 
(Table 2.1 M= TMS/BF3•Et2O). 
 
Investigation of the C6–C7 Bond Construction With the Syn C7–C11 Fragment 
The aldol reactions with syn aldehyde 35 were also studied. The initial experiments 
examined ligand effects on the intrinsic stereochemistry. The results are summarized in 
table 2.5. 
 
                                                
(13) Paton, R. S.; Goodman, J. M.; J. Org. Chem. 2008, 73, 1253- 1263. 
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Table 2.5 Intrinsic diastereoselectivity of 35.  
9-BBNOTf
Cy2BCl
M
toluene
toluene
solvent 42: 43
1: 9
1: 1.4
entry
1
2
O
TBSO
OBn
Me Me
OTES
8
7
OH
42
Me
Me
TBSO
OBn
Me Me
OTESO
H
35
11
7
a) methyl isobutyl ketone, M, NEt3, then 35, -78 °C
O
TBSO
OBn
Me Me
OTES
8
7
OHMe
Me
43
 
In this case, a reaction did proceed under both conditions to give aldol adducts 42 and 43. 
In neither case was there selectivity for the desired product. The d.r. observed for 9-
BBNOTf was higher than any observed in the Cee and Siska cases for syn α,β-
oxygenated aldehydes. This bias for the incorrect stereochemistry at C7 is in line with the 
results obtained for aldehyde 14 in table 2.3. The aldol reaction between 3 and 35 was 
done and found to have a 2:1 preference for undesired C7 stereochemistry 44 to desired 
C7 stereochemistry 45 (equation 2.2).  
O
Me
O
OMOM
OMe
NO
Bn
O
3
6
1
TBSO
OBn
Me Me
OTESO
H
35
11
7
9-BBNOTf,
Et3N
O O
OMOM
OMe
NO
Bn
O
44
1
TBSO
OBn
Me Me
OTESOH
7
O O
OMOM
OMe
NO
Bn
O
45
1
TBSO
OBn
Me Me
OTESOH
7
(2.2)
 
Elaboration to the β-Keto Aldehyde 
Aldol adduct 37 was elaborated by Dr. Welch in preparation for the next fragment 
coupling. A 1,3-anti reduction of the C5 ketone proceeded in >10:1 selectivity when 
[Me4N][HB(OAc)3] was used as the reductant.14 The sodium salt gave inferior 
diastereoselectivity. Selective TBS protection followed by methylation gave the fully 
protected C1–C11 fragment 47. Exposure to hydrogenolysis conditions permitted the 
cleavage of both the benzyl group protecting the C9 alcohol and the TES group protecting 
the C11 alcohol leading to diol 48. Finally, a Dess–Martin periodinane mediated oxidation 
                                                
(14) Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc. 1988, 110, 3560-3578.  
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delivered β-keto aldehyde 49. In the course of scale-up, it was found that telescoping the 
reduction, silylation and methylation steps resulted in slightly higher yield. Ultimately 
Dr. Welch and I prepared over 2 g of aldehyde 49. 
Scheme 2.5  
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a) Me4N HB(OAc)3, AcOH, CH3CN, -30 °C; b) TBSCl, Et3N, DMF; c)Me3OBF4, Proton Sponge!, CH2Cl2; 
d) Pd(OH)2/C, EtOAc, H2; e) DMP, py, CH2Cl2  
The C11–C12 Bond Construction 
Dr. Welch had prepared a large quantity of C12–C19 fragment 5, and he subsequently 
investigated the C11–C12 bond construction. An initial aldol reaction attempt was made 
using Cy2BCl on a 0.01 mmol scale. This reaction gave a 2.8:1 mixture of diastereomers 
in the desired direction with a combined yield of 56%. With this modest yield and 
selectivity, attention turned to using a Bu2BOTf aldol reaction (Table 2.6).  
Table 2.6 The C11-C12 Bond Construction  
Cy2BCl
Bu2BOTf
9-BBNOTf
M
56 %
79%- 0%
92 %
yield dr
2.1 :1
12 : 1
20: 1
entry
1
2
3
5 + 49
O OTBS
OMOM
OMe
NO
Bn
O
1
TBSO
O
Me Me
OHOMe
115
O OPMB
OTBS
Et
Me
50
a
a) i-Pr2NEt, M,Et2O, -100 °C  
This 1,5-anti aldol reaction proceeded in high yield and diastereoselectivity (79% yield, 
12:1 dr) in two attempts, on scales of 0.04 and 0.170 mmol (table 2.6) to afford 
peloruside backbone 50. It was remarkable that the reaction was over in 15 minutes at an 
internal temperature of -100 °C. We surmise that the electron withdrawing nature of the 
β-keto substituent and the low steric profile of the sp2 centre combine to increase the 
electrophilicity of aldehyde 49. In the course of Dr. Welch’s studies, I prepared more 
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aldehyde 49, and also successfully ran the reaction twice for myself using Dr. Welch’s 
conditions. In the first attempt, on 0.127 mmol of 49, the reaction did not work the first 
time I ran the reaction, but the starting materials were recovered and did react in the 
second attempt. In the second successful reaction the reaction was run without incident 
on 0.196 mmol of 49. 
 
Perplexingly, after my two successful runs of this reaction, I could no longer repeat it, 
despite subsequent batches of aldehyde 49 having the same analytical properties, even 
when run on a similar scale under the same conditions.15 Five failed attempts on scales 
from 0.090 to 0.429 mmol of 49 were made in total. Attempts to run the reaction at 
higher temperatures also yielded only trace amounts of product. Aldehyde 49 could be 
recovered if an oxidative work-up was not employed, but was destroyed if an oxidative 
work-up was employed. Ketone 5 could always be recovered. All reagents and solvents 
were repurified, and different batches of Bu2BOTf were screened but I was not able to 
identify what variable had permitted the previously successful reaction.16 I was able to 
successfully run an aldol reaction between isobutyraldehyde, ketone 5 and Bu2BOTf from 
the same batches that failed in the main bond coupling (equation 2.3) to produce aldol 
adduct 51 in high yield and diastereoselectivity. This experiment showed that the 
Bu2BOTf had not gone bad.  
                                                
(15) Dr. Welch left the lab after my first successful repetition of the reaction using Bu2BOTf and before the 
second time I ran it successfully using Bu2BOTf. Since the problem arose after he left, he could not help 
me troubleshoot the reaction in person. Through e-mail correspondence, neither of us could locate a 
variable reliant on our experimental technique. This problem is mentioned in the thesis since it may bear 
investigating if this route is ever used for future analogue synthesis or preparation of bulk quantities of 
Peloruside A. 
(16) Had the reaction with Bu2BOTf not initially worked for Dr. Welch, he would have undoubtedly tried 
9-BBNOTf next, hence this unknown variable would not have jeopardized the completion of the molecule. 
In retrospect it unfortunate that Bu2BOTf worked on the first attempt. While an initial failure at the C11-C12 
bond construction would have been discouraging, using 9-BBNOTf from the start would have saved 
several hundred milligrams of 49 from destruction during failed scale-up attempts. 
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As 9-BBNOTf had been so fruitful in prior aldol reactions, I investigated it in the C11–C12 
bond construction. Fortunately this reaction worked, in a higher yield and 
diastereoselectivity than the successful Bu2BOTf cases. The aldol reaction mediated with 
9-BBNOTf17 was a robust reaction. It was conducted successfully 7 times out of 7 tries 
on scales ranging from 0.070 to 0.534 mmol of 49. The last reaction was the highest 
yielding, at 92%, giving 600 mg of the peloruside A carbon backbone in a single reaction 
(equation 2.4).  
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II. The C9- C13 Ketone Selectivity Problem 
After Dr. Welch obtained aldol adduct 50, he attempted to conduct a 1,3-anti reduction to 
relay the stereochemistry from C11 to C13 to give C11–C13 diol 51. Unfortunately, little site 
selectivity for the C13 ketone was observed, with competitive reduction of the C9 ketone 
occurring (equation 2.5). The products were readily separable as the reduction of the C9 
ketone led to the formation of hemiacetal 52.  
                                                
(17) Two different batches of 9-BBNOTf were used, one prepared by Dr. Welch and freshly distilled, and 
one prepared by Dr. Jason Burch in 2004 and not repurified since its initial purification. Both gave similar 
results. The Burch 9-BBN triflate was used in the highest yielding reaction. 
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Dr. Welch attempted to optimize this reaction by changing the solvent composition to run 
the reaction at a lower temperature, but no improvement was noted. We had not initially 
predicted that this transformation would be problematic since we felt that the geminal 
dimethyl group at C10 would prevent reduction of the C9 ketone. In retrospect, since this 
transformation goes through a chair-like transition state 53, the geminal methyl groups 
are as far as possible from the ligands on the boron, so the lack of a steric effect is 
understandable. A final attempt was made to do an intramolecular hydrosilylation as 
reported by Davis.18 Accordingly aldol adduct 50 was silylated with 
chlorodiisopropylsilane to give silyl hydride 54 and exposed to MgCl2. Unfortunately this 
resulted in decomposition and no formation of silyl acetal 55 (Scheme 2.6).19  
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At this point, Dr. Welch’s post-doctoral stay in the Evans group came to an end, and I 
took over primary responsibility for the project.  
                                                
(18) Anwar, S.; Davis, A. P. Tetrahedron. 1988, 44, 3761-3770. 
(19) Dr. Welch felt that MgCl2 was the mildest Lewis acid among those reported by Davis in his substrate 
table. We had a great deal of trepidation about the prospects of the proposed transformation since there are 
so many Lewis basic ethers and carbonyls on 54. Because of this trepidation, I made the decision to 
abandon this approach prematurely. The successful implementation of this approach may be found in 
section III of this Chapter. 
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I initially attempted several other reductions to reduce C13 (Table 2.7). SmI2 in methanol 
resulted in decomposition of 50.20 An attempt to effect a PMB directed 1,3-syn reduction 
with Zn(BH4)2 in Et2O/CH2Cl2 also failed. The free alcohol on 50 was masked with a 
TES group to give TES protected aldol adduct 56. Selectivity for reduction of the C13 
over C9 ketone could be achieved on 56 with CBS catalyst and borane THF, but no facial 
selectivity was observed giving diastereomeric compounds 57.21 Finally, the Zn(BH4)2 
reduction was re-attempted on 56, but in this case the substrate failed to react 
Table 2.7 Attempts at C13 ketone reduction.  
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Attempt to Construct the C11–C12 Bond with C9 at the Alcohol Oxidation State 
With these discouraging results, the decision was made to sacrifice some of the 
convergency of the synthesis, and attempt the C11–C12 bond construction with C9 still in 
the alcohol oxidation state. It was unclear if the buried benzyl group could be removed by 
hydrogenolysis in the presence of the C16–C17 olefin, but a study to prove the principle 
could be tested before any protecting group modifications needed to be made. 
                                                
(20) Keck, G. E.; Wager, C. A.; Sell, T.; Wager, T. T. J. Org. Chem. 1999, 64, 2172-2173. 
(21) The choice of (R)-CBS catalyst was arbitrary. The enantiomeric catalyst was not tried. It was not 
obvious from inspection of the substrate that C13 on 56 had a large and small substituent, which was 
probably confirmed by the absence of diastereoselectivity in the reduction. 
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Accordingly the TES group of compound 47 was deprotected and oxidized to yield 
aldehyde 58. Aldol reactions were attempted with ketone 5 using 9-BBNOTf, Bu2BOTf 
and Cy2BCl. In none of these cases was any aldol adduct 59 isolated (Scheme 2.7). 
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At the time, the lack of reactivity was attributed to the increased steric hindrance at C9. It 
is surprising in light of the analogous bond construction reported by Hoye.22 The boron 
aldol reaction attempts shown in scheme 2.7 were repeated several times, and so the 
conclusion this substrate was not reactive is judged to be reliable. Since Dr. Welch, Dr 
Reichelt and I have all conducted C11–C12 aldol bond constructions on systems that are 
truncated at C6 (for example see reaction c in Scheme 1.25), it seems reasonable to 
surmise that the failure of 58 to react is an example of long range gearing effect. 
 Studies on C13 Keto Seco Acids 
Since the ketone at C9 appeared to be necessary for the C11–C12 bond construction with 
our current protecting group scheme, and since no viable method appeared to exist to 
selectively reduce the C13 ketone in the presence of the C9 ketone on a linear substrate, 
the idea of conducting a macrocyclization with both the C13 and C9 ketones in place, 
followed by a selective reduction of the C13 ketone was considered. Such a reduction 
would now take place on a macrocycle such as 60, opening the possibility that one face 
of the ketone would be shielded by pointing inside the macrocycle (Figure 2.5).  
                                                
(22) See Scheme 1.12 in Chapter 1.  
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Figure 2.5 Imagined peripheral attack selective for C13 ketone. 
A peripheral attack could lead to high facial selectivity, but the sense of this selectivity 
was not immediately obvious.23 Higher selectivity for the C13 ketone over the C9 ketone 
was anticipated for an intermolecular hydride delivery, since the C10 geminal dimethyl 
group would potentially be in a position to interact with an oncoming nucleophile in a 
Bürgi-Dunitz trajectory. This scheme could be implemented quickly from the materials 
available, and was tested.  
Synthesis of the C11 OH Seco Acid 
Aldol adduct 50 was subject to DDQ to remove the C15 alcohol PMB protecting group, 
yielding diol 61, followed by lithium hydroperoxide cleavage of the oxazolidinone at C1 
to yield seco acid 62 (Scheme 2.8).24  
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(23) Still, W. C.; Galynker, I. Tetrahedron. 1981, 37, 3981-3996. 
(24) Evans, D. A.; Britton, T. C.; Ellman, J. A. Tetrahedron. Lett. 1987, 28, 6141-6144.  
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Macrolactonization under either Shiina or Yamaguchi conditions gave very messy 
mixtures. Mass spectral analysis showed minor peaks corresponding to the mass of 
macrolactone 63, but the major peaks corresponded to that mass minus water.  
 
Dehydration of the C11 alcohol by an E1CB mechanism following macrolactonization was 
postulated based on an NMR analysis showing extra alkenes, and the presence of an ester 
attachment on the C15 oxygenation (based on a downfield change in the chemical shifts of 
the C15 CH signal). Because of the downfield shift of the C15 CH, macrocyclization site 
selectivity between the C11 and C15 alcohol was not judged to be a problem. 
 
Synthesis of the C11 TES Seco Acid and Macrolactonization Studies 
After this disappointing setback, it was decided to try the analogous sequence of events 
with C11 TES protected macrolactone in the hopes that this would not undergo an E1CB 
elimination (Scheme 2.9). Accordingly C11 TES protected aldol adduct 57, available from 
the reduction studies in table 2.7 was converted to diol 64 and then to seco acid 65. 
Gratifyingly, seco acid 65 could be cyclized under Yamaguchi conditions to gave 
macrocycle 66. 
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O
OMOM
MeO MeO
TBSO Me Me
TBSO OTES
Me
OPMB
15Xc
O
13
OTBS
Et
O O
OMOM
MeO MeO
TBSO Me Me
TBSO OTES
Me
OH
15Xc
O
13
OTBS
Et
Oa
O
OMOM
MeO MeO
TBSO Me Me
TBSO OTES
Me
OH
15HO
O
13
OTBS
Et
O
111
O
OMe
MOMO
O
TESO
Me Me
OMe
OTBS
Me
Et
TBSO
OTBS
O
115
9O
80 %
c
a) DDQ, pH 7 Buffer, CH2Cl2; b) LiOH, H2O2, THF c) 2,4,6 trichlorobenzoyl chloride, i-Pr2NEt, then DMAP, toluene
50 64
6566
b
54%
(2 steps)
 
 
 
  63 
Attempts to Reduce the C13 Ketone 
With C13 keto macrocycle in hand, reduction attempts of the C13 ketone were attempted 
(Equation 2.6).  
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Surprisingly the ketone at C13 was amazingly resistant to reduction. Treatment with 
reductants such as K-Selectride®, L-Selectride®, sodium borohydride, lithium 
borohydride, tetramethylammonium triacetoxyborohydride and potassium 
triethylborohydride resulting in either recovery of starting material or decomposition. 
Nothing with a mass corresponding to 67 was ever isolated. Treatment with multiple 
equivalents of sodium borohydride in methanol resulted in low yields of a compound 
with a mass equivalent to a compound with both ketones reduced. It was speculated that 
the C13 ketone was unexpectedly hindered, but upon reduction of the C9 ketone under 
forcing conditions, a conformational change occurred and the C13 ketone was 
immediately reduced. The C11 TES group may provide too much steric hindrance to 
enable reduction of the C13 ketone. Removal of the C11 TES group was not attempted 
since the efforts described in the next discussion became fruitful and so efforts were 
switched to that strategy. 
III. Completion of the Synthesis 
In light of the difficulties encountered in reducing the ketone at C13 on macrocycle 66, 
attention returned to reducing the ketone at C13 on a linear substrate. Inspection of our 
chemical inventory revealed several mg of silane 54. The original Davis reference 
showed that tin tetrachloride gave the highest yield for intramolecular hydride delivery in 
several substrates, accordingly silane 54 was exposed to 20 mol% tin tetrachloride in 
dichloromethane for 2 hours at -78 °C. Monitoring by TLC showed no apparent reaction, 
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and allowing an aliquot to warm to higher temperatures showed extensive decomposition. 
The reaction was accordingly quenched in anticipation of recovering the substrate to 
screen other Lewis acids.25 However, NMR analysis of the recovered material from the 
reaction revealed that the desired reaction had indeed taken place with exquisite site and 
diastereoselectivity (equation 2.7). 
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Our hypothesis for the high site selectivity is that the bulky Lewis acid tin tetrachloride 
selectively complexes to the less hindered ketone, promoting hydride delivery to that site 
as shown chair-like transition state 68 (Figure 2.6). 
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Figure 2.6 Rationale for site and diastereoselectivity. 
Elaboration to the Seco Acid and Macrolactonization 
The silyl acetal in 55 proved to be relatively robust, being resistant to both a basic 
aqueous work-up and chromatography. Brief exposure to acetic acid buffered TBAF 
resulted in a cleavage of the silyl acetal without competitive deprotection of the other 
silyl protecting groups in the molecule. The diol so obtained matched diol 51, prepared 
by Dr. Dennie Welch. Exposure of diol 51 to a large excess of Meerwein salt allowed 
selective methylation of the C13 alcohol to produce 69. It should be noted that extended 
reaction times resulted in the methylation of the C11 alcohol as well, so the reaction was 
                                                
(25) This is a potentially career-changing example of the importance of taking crude NMR spectra. 
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carefully monitored.26 Cleavage of the C15 PMB group and hydrolysis of the 
oxazolidinone at C1 yielded the desired seco acid 70 (Scheme 2.10). 
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The seco acid was subjected to Yamaguchi macrolactonization conditions, and the 
desired macrolactone 71 was obtained in good yield. The seco acid contains alcohol 
functionality at both C11 and C15, so we were gratified to observe only one macrocycle, 
corresponding to macrolactonization at the C15 alcohol only. Deprotection of the 
macrolactone to yield peloruside A (1) required slight optimization. In our initial route, 
application of the DeBrabander conditions was uneventful, however a low yield was 
noted when compound 71 was exposed to these conditions. Our previous route had 
involved cleavage of all of the silyl groups and cyclization to a tetrahydropyran before 
exposure to 4N HCl. It was hypothesized that exposure of the ketone containing 
macrocycle to a 1:1 solution of THF and 4N HCl at room temperature may promote 
decomposition related to the ketone functionality. We found switching the solvent to 
                                                
(26) Extended reaction times with fewer equivalents of Meerwein salt led to inferior outcomes. We 
speculate cyclization of the C13 alcohol onto the C9 ketone is competitive. 
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methanol as precedented by Smith improved the cleanliness of the reaction and first 
running the reaction at 0 °C then warming to ambient temperature further increases the 
yield. We hypothesize that removal of the silyl protecting groups and concomitant 
formation of the tetrahydropyran occurs under the milder conditions, and subsequent 
MOM removal at ambient temperature is now taking place in the absence of the 
potentially labile keto functionality. 
Conclusion 
A 23 step synthesis of peloruside A was completed. The synthesis was more efficient 
than the earlier synthesis conducted by Dr. Dennie Welch. Efficency came from changing 
the order of fragment couplings and maintaining C9 and C1 at high oxidation states for as 
long as possible. Having C9 at a ketone oxidation state resulted in chemoselectivity 
problems in the reduction, which were solved by a tin mediated intramolecular 
hydrosilylation, the most complicated application of this reaction reported to date. 
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IV. Graphical Summary 
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VIII. Experimental Data 
General Information. Unless otherwise noted, all reactions were carried out under 
an atmosphere of nitrogen in flame-dried glassware with magnetic stirring.  Reaction 
temperatures are reported as the temperature of the bath surrounding the vessel.  Diethyl 
ether and tetrahydrofuran (THF) were dried by passage through two columns of activated 
neutral alumina under an atmosphere of argon.  Dichloromethane and toluene were dried 
by passage through a column of neutral alumina and a column of Q5 reactant under an 
atmosphere of argon.  Benzene was distilled from calcium hydride under an atmosphere 
of nitrogen.  Reagents were bought as the best grade available, subject to 1H NMR 
analysis and used without further purification unless stated otherwise. Analytical thin 
layer chromatography was performed on EM Reagent 0.25 mm silica gel 60-F plates.  
Visualization was accomplished with short wave UV light, vanillin, anisaldehyde, cerium 
ammonium nitrate, and/or KMnO4 staining solutions followed by heating.  Purification of 
reaction products was carried out by flash chromatography using EM Reagents silica gel 
60 (230–400 mesh) according to Still’s protocol,27 eluting with solvents as indicated. All 
transfers from tubes to round bottom flasks were washed 3x with CH2Cl2. 
 Percent yields are reported for compounds that were ≥95% pure as judged by 
NMR, and that were pumped to a constant weight on a vacuum manifold at 
approximately 0.5 torr, unless otherwise states.  Melting points are uncorrected.  Optical 
rotations were measured on a Jasco DIP-0181 digital polarimeter with a sodium lamp and 
are reported as follows: [α]λT[°C] (c = g/100 mL, solvent).  Infrared spectra were recorded 
a Perkin Elmer 1600 series FT-IR spectrometer.  1H NMR spectra were recorded on 
Varian Unity Inova600 (600 MHz) or Varian Unity Inova500 (500 MHz) spectrometers 
and are reported in ppm using solvent as the internal standard (CDCl3 at 7.27 ppm, C6D6 
                                                
(27) Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925.   
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at 7.15 ppm).  Data are reported as: (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br: broad, app: apparent, coupling constant(s) in Hz, integration).  13C NMR 
spectra were recorded on Varian Unity Inova500 (125 MHz) or Varian Mercury400 (100 
MHz) spectrometers.  Chemical shifts are reported in ppm with the solvent resonance 
employed as the internal standard (CDCl3 at 77.0 ppm and C6D6 at 128.0 ppm).  High-
resolution mass spectra were obtained on Agilent 6210 TOF, Jeol AX-505, or SX-102 
spectrometers in the Harvard University Mass Spectrometry Laboratory. 
 
(S)-4-benzyl-3-((2S,3R)-3-hydroxy-2-(methoxymethoxy)-4-(2-methyl-1,3-
dioxolan-2-yl)butanoyl)oxazolidin-2-one (12)28 
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 To a stirring solution of glycolate oxazolidinone 10 (945 mg, 3.41 mmol, 1.0 
equiv), Et3N (449 mg, 4.44 mmol, 1.3 equiv), and CH2Cl2 (8.5 mL) in a flame-dried 50 
mL round-bottom flask under an atmosphere of Ar, at –30 ˚C, was added Bu2BOTf (1.03 
g, 3.76 mmol, 1.1 equiv) dropwise via syringe.  Special care was taken to maintain the 
internal temperature of the reaction between –30 and –25 ˚C.  The reaction was then 
cooled to –78 ˚C and allowed to proceed for 3 h.  The reaction was warmed to 0 ˚C, held 
for 30 min and then cooled to –78 ˚C.  Aldehyde 11 (459 mg, 3.53 mmol, 1.03 equiv), in 
CH2Cl2 (2.4 mL), was added to the reaction mixture dropwise via cannula.  The reaction 
was allowed to proceed at –70 ˚C for 15.5 h and then warmed to 0 ˚C.  The reaction was 
quenched by the dropwise addition of a 1:1 mixture of MeOH and pH 7.0 buffer (6 mL).  
A 30% aqueous solution of H2O2 (1.5 mL) was added dropwise, over 10 min, to the 
stirring reaction mixture.  This hydrolysis process was allowed to proceed for 30 min.  
                                                
(28) The following procedure was first carried out by Dr. Dennie Welch. I ran the procedure on the scale 
indicated here, and obtained the characterization data reported below. 
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The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were washed with brine, dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give a yellow oil.  Purification was accomplished 
by flash column chromatography to yield aldol adduct 12 (894 mg, 2.19 mmol, 64% 
yield) as a colorless oil:  
Rf = 0.40 (30% acetone/hexanes, faintly UV active, stains blue in CAM);  
 
[α]20D = +52 (c 0.90, CHCl3);  
 
1H NMR (CDCl3, 500 MHz) δ 7.38 – 7.20 (m, 5 H), 5.36 (d, J = 3.4 Hz, 1 H), 4.80 (d, J 
= 6.8 Hz, 1 H), 4.74 (d, J = 6.8 Hz, 1 H), 4.75 – 4.70 (m, 1 H), 4.35 (ddd, J = 10.0, 2.9, 
2.7 Hz, 1 H), 4.27 – 4.22 (m, 1 H), 4.19 (dd, J = 9.3, 2.4 Hz, 1 H), 4.02 – 3.94 (m, 4 H), 
3.43 (s, 3 H), 3.33 (dd, J = 13.4, 3.2 Hz, 1 H), 2.82 (dd, J = 13.4, 9.5 Hz, 1 H), 2.17 (s, 1 
H), 2.10 (dd, J = 14.6, 4.9 Hz, 1 H), 2.01 (dd, J = 14.6, 2.4 Hz, 1 H), 1.40 (s, 3 H);  
 
13C NMR (CDCl3, 125 MHz) δ 170.5, 153.6, 135.4, 129.7, 129.2, 127.6, 110.1, 96.7, 
76.9, 68.7, 66.8, 64.9, 64.5, 56.7, 55.7, 40.8, 37.7, 24.4;  
 
IR (film)  3441, 2936, 2892, 1778, 1699, 1454, 1350, 1211, 1154, 1110, 918, 824, 762, 
703 cm–1;  
 
LRMS (ES) calc for C20H27NO8 (M + Na),  432.16, found 432.16. 
(S)-4-benzyl-3-((2S,3R)-3-methoxy-2-(methoxymethoxy)-4-(2-methyl-1,3-dioxolan-2-
yl)butanoyl)oxazolidin-2-one (S1)28 
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To a stirring solution of β-hydroxy ketone 12 (2.32 g, 5.67 mmol, 1.0 equiv) and CH2Cl2 
(60 mL) under an atmosphere of Ar, at rt, was added 4 Å molecular sieves, proton sponge 
(6.0 g, 28 mmol, 5.0 equiv) and trimethyloxonium tetrafluoroborate (2.5 g, 17 mmol, 3.0 
equiv). The reaction was allowed to proceed in the dark for 20 h after which time 
additional trimethyloxonium tetrafluoroborate (0.5 g, 3.4 mmol, 0.60 equiv) was added. 
After an additional 4 h, TLC indicated complete consumption of the starting material. 
The reaction mixture was diluted with EtOAc (100 mL) and filtered over a pad of 
Celite® (5 × 2 cm). The filtrate was washed with a 0.5 M aqueous solution of NaHSO4 (5 
× 30 mL), a saturated aqueous solution of NaHCO3 (2 × 30 mL), and brine (2 × 20 mL). 
The organic layer was then dried over Na2SO4, filtered, and concentrated under reduced 
pressure to yield viscous brown oil. Purification was accomplished via flash column 
chromatography (5 × 20 cm), eluting with 25% acetone/hexanes and collecting 20 mL 
fractions. The product containing fractions (20−40) were combined and concentrated 
under reduced pressure to give acetal S1 (2.16 g, 0.510 mmol, 90% yield) as a viscous 
and colorless oil: 
Rf = 0.30 (40% acetone/hexanes, faintly UV active, stains grey in CAM);  
 
[α]20D = +42.1 (c 1.40, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.36 – 7.32 (m, 2 H), 7.30 – 7.23 (m, 3 H), 5.55 (d, J = 4.1 
Hz, 1 H), 4.82 (d, J = 7.0 Hz, 1 H), 4.73 (d, J = 7.0 Hz, 1 H), 4.69 – 4.65 (m, 1 H), 4.25 – 
4.16 (m, 2 H), 4.03 – 3.93 (m, 4 H), 3.87 – 3.83 (m, 1 H), 3.43 (s, 3 H), 3.37 (s, 3 H), 
3.34 (dd, J = 13.5, 3.2 Hz 1 H), 2.81 (dd, J = 13.5, 9.7 Hz, 1 H), 2.21 (dd, J = 14.8, 4.5 
Hz, 1 H), 1.92 (dd, J = 14.9, 6.7 Hz, 1 H), 1.38 (s, 3 H); 
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13C NMR (CDCl3, 125 MHz) δ 170.7, 153.3, 135.2, 129.5, 129.0, 127.3, 108.8, 99.4, 
97.6, 77.7, 76.3, 66.4, 64.3, 58.3, 56.4, 55.8, 38.0, 37.5, 24.5 ; 
 
 IR (film)  2936, 2892, 1778, 1701, 1454, 1350, 1212, 1152, 1109, 1047, 918, 824, 762, 
703 cm–1;  
 
Exact Mass Calc. for C21H29NO8 [M + Na]+ 446.17854, found 446.17439 (ESI) 
 
(2S,3R)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-3-methoxy-2-(methoxymethoxy)-
hexane-1,5-dione (3)  
S1
NO
O
Bn
O
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3  
To a stirring solution of acetal S1 (2.50 g, 5.90 mmol, 1.0 equiv), acetone (59 mL), and 
water (5.9 mL) was added pyridinium p-toluenesulfonate (74 mg, 0.295 mmol, 0.050 
equiv). The reaction was conducted at reflux for 8.5 h (until 1H NMR of an aliquot 
showed complete conversion) and then allowed to cool. The acetone was removed under 
reduced pressure. The resulting residue was dissolved in 50% EtOAc/hexanes (100 mL), 
and then washed with a saturated aqueous solution of NaHCO3 (2 × 30 mL) and brine (20 
mL). Removal of solvent under reduced pressure yielded ketone 3 (2.10 g, 5.54 mmol, 
94%) as a colorless and viscous oil: 
 
Rf = 0.30 (40% acetone/hexanes, faintly UV active, stains faint grey in CAM);  
 
[α]20D = +88.6 (c 0.570, CHCl3);  
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1H NMR (CDCl3, 600 MHz) δ 7.36 – 7.32 (m, 2 H), 7.30 – 7.24 (m, 3 H), 5.68 (d, J = 5.0 
Hz, 1 H), 4.78 (d, J = 7.0 Hz, 1 H), 4.68 (d, J = 6.7 Hz, 1 H), 4.70 – 4.66 (m, 1 H), 4.24 – 
4.10 (m, 3 H), 3.41 (s, 3 H), 3.39 (s, 3 H), 3.34 (dd, J = 13.0, 3.7 Hz, 1 H), 2.88 (dd, J 
=17.0, 3.2 Hz, 1 H), 2.82 – 2.72 (m, 2 H), 2.20 (s, 3 H) ;  
 
13C NMR (CDCl3, 125 MHz) δ 206.5, 170.9, 153.2, 135.2, 129.4, 129.0, 127.4, 97.5, 
77.1, 74.1, 66.3, 59.5, 56.3, 55.7, 44.2, 37.6, 30.9 ;  
 
IR (film) 2934, 2831, 1778, 1711, 1604, 1453, 1391, 1350, 1212, 1153, 1111, 1046, 918, 
761, 702 cm–1;  
 
Exact Mass Calc. for C19H25NO7 [M +  K]+ 418.12626, found 418.12895 (ESI)  
 
(S)-4-benzyl-3-((2S,3R,7R)-7-hydroxy-3-methoxy-2-(methoxymethoxy)-8-methyl-5-
oxononanoyl)oxazolidin-2-one (13) 
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Oxazolidinone ketone 3 (50 mg, 0.13 mmol, 1 eq) was dissolved in 1.3 mL toluene and 
triethylamine (22 µL, 0.158 mmol, 1.2 eq) was added. The solution was cooled to -78 ºC 
and Cy2BCl (32 µL, 0.145 mmol, 1.1 eq) was added. The solution was stirred for 1 hour 
and 15 minutes and then isobutyraldehyde (36 µL, 0.395 mmol, 3 eq) was added. and the 
reaction was stirred for 2 hours. TLC analysis (20% EtOAc/hexanes, CAM) showed 
complete consumption of starting material, so the reaction was quenched by the addition 
of 2 mL of a 1:1 mixture of pH 7 buffer and methanol. The reaction was warmed to 0 ºC 
and 1 mL of 30% H2O2(aq) was added. After 1 hour, the reaction was diluted with 50 mL 
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90% EtOAc/hexanes and washed with 5 mL sat Na2SO3(aq) and brine, then dried over 
Na2SO4. Crude 1H NMR showed a 2.4:1 ratio of diastereomers, which were separated by 
flash chromatography (20% to 30% to 40% EtOAc/hexane). The more polar isomer is the 
major one. 
 
Oxazolidinone ketone 3 (50 mg, 0.13 mmol, 1 eq) was dissolved in 1.3 mL toluene and 
triethylamine (22 µL, 0.158 mmol, 1.2 eq) was added. The solution was cooled to -78 ºC 
and 9-BBN triflate (31 µL, 0.145 mmol, 1.1 eq) was added. The orange solution was 
stirred for 1 hour and then isobutyraldehyde (36 µL, 0.395 mmol, 3 eq) was added and 
the resulting purple reaction was stirred for 2 hours. TLC analysis (20% EtOAc/hexanes, 
CAM) showed complete consumption of starting material, so the reaction was quenched 
by the addition of 2 mL of a 1:1 mixture of pH 7 buffer and methanol. The reaction was 
warmed to 0 ºC and 1 mL of 30% H2O2(aq) was added. After 1 hour, the reaction was 
diluted with 50 mL 90% EtOAc/hexanes and washed with 5 mL sat Na2SO3(aq) and brine, 
then dried over Na2SO4. Crude 1H NMR showed a 4:1 ratio of diastereomers, which were 
separated by flash chromatography (20% to 30% to 40% EtOAc/hexane). The more polar 
isomer is the major one. 
Analytical data for the major diastereomer is given below: 
Rf  = 0.45 (30% acetone/ hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +76 (c 0.60, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.34 (ap. t, J = 7.0 Hz, 2H), 7.28 (ap. d, J = 7.5 Hz, 2H), 
7.25 (ap. t, J = 7.0 Hz, 1H), 5.70 (d, J = 5.1 Hz, 1H), 4.78 (d, J = 6.9 Hz, 1H), 4.68 (d, J = 
6.7 Hz, 1H), 4.70- 4.65 (m, 1H), 4.23- 4.17 (m, 3H), 3.87 – 3.82 (m, 1H), 3.41 (s, 3H), 
3.38 (s, 3H), 2.93- 2.85 (m, 2H), 2.81- 2.74 (m, 2H), 2.62 (m, 1H), 2.61 (d, J = 3.1 Hz, 
1H), 1.69 (sept., J = 6.7 Hz, 1H), 0.93 (d, J = 6.7 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H); 
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13C NMR (125 MHz, CDCl3) δ 210.0, 170.8, 153.2, 135.2, 129.4, 129.0, 127.4, 97.5, 
77.1, 74.0, 72.1, 66.4, 59.5, 56.4, 55.7, 47.3, 44.1, 37.5, 33.0, 18.3, 17.2; 
 
IR(film)  3542.4, 2960.8, 1779.4, 1708.1, 1289.3, 1350.4, 1212.1, 1111.9, 1045.8 cm-1; 
 
Exact Mass Calc. for C23H33NO8 [M + Na]+ : 474.20984; found: 474.21113 (ESI) 
 
 
(S)-5-(benzyloxy)-2,6,6-trimethyl-7-(triethylsilyloxy)hept-2-en-4-one (10)29 
O
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To a 250 mL round-bottom flask containing 64 mL diethyl ether (64 mL) under an 
atmosphere of Ar, at 0 °C, was added a 1.7 M solution (pentane) of t–BuLi (18 mL, 30.6 
mmol, 3.8 equiv), followed by the dropwise addition of 1-bromo-2-methylpropene (2.18 
g, 16.2 mmol, 2 equiv) over 2 minutes. The reaction was aged for 2 h at 0 ˚C.  Amide 27 
(3.20 g, 8.1 mmol, 1.0 equiv) in Et2O (7 mL) was added dropwise to the reaction solution 
over 1 minute.  After 15 min, TLC analysis indicated complete consumption of starting 
material.  The reaction was then quenched by the rapid addition of aqueous NaHSO4 (pH 
2.0, 5 mL).  The mixture was diluted with 10% EtOAc/hexanes (30 mL), washed with 
NaHSO4 (pH 2.0, 4 × 5 mL), brine (2 × 5 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give a pale yellow oil.  Purification was 
accomplished by flash column chromatography (2.5 × 7 cm), eluting with 5% 
                                                
(29) Dr. Dennie Welch obtained the characterization data reported below. I developed and ran the 
procedure that is reported below. 
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Et2O/hexanes (50 mL) and collecting 8 mL fractions.  The product containing fractions 
(5−22) were combined and concentrated under reduced pressure to give enone 30 (3.1 g 
g, 7.9 mmol, 97% yield) as a colorless oil: 
 
Rf  = 0.38 (10% Et2O/hex, strongly UV active, stains faint blue in CAM);  
 
[α]20D = –27.1 (c = 2.27, CHCl3); 
 
 1H NMR (CDCl3, 600 MHz) δ 7.37 – 7.27 (m, 5 H), 6.51 – 6.48 (m, 1 H), 4.53 (d, J = 
11.2 Hz, 1 H), 4.35 (d, J = 11.2 Hz, 1 H), 3.76 (s, 1 H), 3.57 (d, J = 9.3 Hz, 1 H), 3.26 (d, 
J = 9.3 Hz, 1 H), 2.19 (s, 3 H), 1.92 (d, J = 1.0 Hz, 3 H), 0.95 (t, J = 8.3 Hz, 9 H), 0.92 (s, 
3 H), 0.91 (s, 3 H), 0.54 – 0.62 (m, 6 H);  
 
13C NMR (CDCl3, 125 MHz) d 203.2, 156.1, 138.6, 128.4, 127.9, 127.7, 122.3, 88.8, 
72.9, 69.1, 40.2, 28.3, 21.8, 21.2, 20.4, 7.1, 4.6;  
 
IR (thin film) 2957, 2876, 1683, 1617, 1456, 1379, 1096, 1014, 820.1, 733 cm–1;  
 
Exact Mass Calc. for C23H38O3Si [M + H]+ 391.26630, found 391.27174 (ESI) 
 
(S)-3-(benzyloxy)-2,2,7-trimethyl-5-(propan-2-ylidene)-1-(triethylsilyloxy))oct-6-en-
4-one (32) 
O
MeMe OBn OTES
Me Me
9
Me Me
H
32  
 
Rf = 0.60 (10% Et2O/hexanes, strongly UV active, stains blue in CAM) 
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[α]20D = +160.3 (c 1.09, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.34- 7.24 (m, 5H), 5.78 (br. s, 1H), 4.52 (s, 1H), 4.51 (d, 
J = 11.6 Hz, 1H), 4.21 (d, J = 11.6 Hz, 1H), 3.62 (d, J = 9.4 Hz, 1H), 3.14 (d, J = 9.2 Hz, 
1H), 1.97 (d, J = 1.8 Hz, 3H), 1.77 (d, J = 1.2 Hz, 3H), 1.70 (d, J = 1.0 Hz, 3H), 1.52 (d, 
J = 0.7 Hz, 3H), 0.96 (ap. t, J = 7.9 Hz, 9H), 0.92 (s, 3H), 0.88 (s, 3H), 0.58 (ap. q, J = 
7.9 Hz, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 205.8, 143.0, 138.7, 137.7, 136.6, 128.1, 127.7, 127.3, 
122.0, 82.9, 71.9, 69.4, 40.7, 25.0, 23.0, 21.9, 21.4, 19.7, 19.5, 6.8, 4.5; 
 
IR(film) 2956.5, 2876.5, 1684.9, 1455.5, 1376.4, 1093.9, 730.4 cm-1; 
 
Exact Mass Calc. for C27H44O3Si [M + Na]+ : 467.29519; found: 467.29548 (ESI) 
 
(4R,5S)-5-(benzyloxy)-2,6,6-trimethyl-7-(triethylsiloxy)hept-2-en-4-ol (33)28 
O
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To a stirring solution (0.2 M, in Et2O) of Zn(BH4)2 (29 mL, 5.74 mmol, 3.00 equiv) in a 
flame dried 100 mL round-bottom flask under an atmosphere of Ar, at –20 ˚C, was added 
a solution of enone 30 (747 mg, 1.91 mmol, 1.00 equiv) in Et2O (7 mL) dropwise via 
cannula. The reaction was allowed to proceed 14 h, at –20 ˚C, after which time the 
reaction mixture was cooled to 0 ˚C.  After an additional 5 h, TLC analysis showed 
complete consumption of the enone. The reaction was quenched by the addition of a 
saturated aqueous solution of NH4Cl (30 mL). The mixture was diluted with 50% 
EtOAc/hexanes (100 mL) and the layers were separated. The aqueous layer was extracted 
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with an additional 50% EtOAc/hexanes (50 mL). The combined organic layers were 
washed with brine (2 × 20 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was then azeotroped with MeOH (2 × 10 mL). Purification 
was accomplished via flash column chromatography a (2 × 15 cm), eluting with 10% 
Et2O/hexanes (100 mL), 20% Et2O/hexanes (200 mL), and collecting 10 mL fractions. 
The product containing fractions (15−30) were combined and concentrated under reduced 
pressure to give alcohol 33 (622mg, 1.58 mmol, 83% yield) as a clear  and colorless oil: 
Rf = 0.29 (20% Et2O/hexanes, not UV active, stains blue in CAM); 
 
[α]20D = +14.6 (c 0.490, CHCl3); 
 
 1H NMR (CDCl3, 600 MHz) δ 7.55 – 7.45 (m, 4 H), 7.30 – 7.20 (m, 1 H), 5.50 – 5.46 
(m, 1 H), 4.76 (d, J = 11.2 Hz, 1 H), 4.59 (d, J = 11.4 Hz, 1 H), 4.55 – 4.47 (m, 1 H), 3.51 
(d, J = 9.8 Hz, 1 H), 3.44 (d, J = 4.8 Hz, 1 H), 3.36 (d, J = 9.8 Hz, 1 H), 2.87 (d, J = 4.6 
Hz, 1 H), 1.73 (d, J = 1.4 Hz, 3 H), 1.68 (d, J = 1.4 Hz, 3 H), 0.97 (t, J = 8.0 Hz, 9 H), 
0.94 (s, 3 H), 0.92 (s, 3 H), 0.61 (q, J = 8.0 Hz, 6 H) ;  
 
13C NMR (CDCl3, 125 MHz) δ 139.5, 135.0, 128.2, 127.4, 127.2, 125.5, 87.0, 75.4, 69.6, 
69.2, 40.4, 26.0, 22.2, 21.2, 18.4, 6.8, 4.3 ; 
 
 IR (film) 3438, 2957, 2876, 1454, 1239, 1091, 1006, 818, 731 cm–1;  
 
Exact Mass Calc. for C23H40O3Si [M + Na] 415.26893, found 415.26799 (ESI) 
(5R,6S)-6-(benzyloxy)-10,10-diethyl-2,2,3,3,7,7-hexamethyl-5-(2-methylprop-1-enyl)-
4,9-dioxa-3,10-disiladodecane (S2)28 
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To a stirring solution of alcohol 33 (445 mg, 1.13 mmol, 1.00 equiv) and DMF (1.2 mL) 
in a flamed dried 5 mL round-bottom flask under an atmosphere of N2, at rt, was added 
Et3N (237 µL, 1.69 mmol, 1.50 equiv) dropwise via syringe. The mixture was cooled to 0 
˚C and then DMAP (14 mg, 0.11 mmol, 0.10 equiv) and TBSCl (245 mg, 1.47 mmol, 
1.30 equiv) were added successively. The reaction was allowed to proceed for 5 h at 0 ˚C 
and then warmed to rt. After an additional 20 h, TLC analysis showed complete 
consumption of starting material. The reaction was diluted with 25% EtOAc/hexanes 
(100 mL) and washed with a saturated aqueous solution of NaHCO3 (1 × 20 mL), water 
(4 × 20 mL), and brine (20 mL). The organic layer was dried over Na2SO4, filtered, and 
concentrated under reduced pressure. Purification was accomplished by passing the 
orange oil over a pad of silica (3 × 5 cm), eluting 5% Et2O/hexanes (50 mL). Removal of 
the solvent under reduced pressure yielded alkene S2 (553 mg, 1.09 mmol, 97% yield) as 
a pale yellow oil:  
Rf = 0.95 (20% Et2O/hexanes, faintly UV active, stains blue in CAM);  
 
[α]20D = –7.8 (c 0.51, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.39 – 7.35 (m, 2 H), 7.34 – 7.30 (m, 2 H), 7.27 – 7.23 (m, 
1 H), 5.52 – 5.48 (m, 1 H), 5.01 (d, J = 11.7 Hz, 1 H), 4.61 (dd, J = 9.7, 2.4 Hz, 1 H), 
4.55 (d, J = 11.4 Hz, 1 H), 3.60 (d, J = 2.3 Hz, 1 H), 3.49 (d, J = 9.4 Hz, 1 H), 3.21 (d, J 
= 9.4 Hz, 1 H), 1.69 (d, J = 1.4 Hz, 3 H), 1.67 (d, J = 1.1 Hz, 3 H), 0.95 (t, J = 7.9 Hz, 9 
H), 0.90 (s, 3 H), 0.90 (s, 9 H), 0.82 (s, 3 H), 0.61 – 0.54 (m, 6 H), 0.07 (s, 1H), 0.01 (s, 
3H);  
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13C NMR (CDCl3, 125 MHz) δ 140.2, 131.5, 128.0, 127.4, 126.9, 126.4, 87.6, 75.3, 70.7, 
70.0, 39.9, 25.9, 21.9, 20.6, 18.8, 18.1, 6.8, 4.5, –4.0, –4.7;  
 
IR (film)  2956, 1462, 1249, 1093, 1040, 834, 774, 730 cm–1;  
 
Exact Mass Calc. for C29H54O3Si2 [M + Na]+ 529.35037, found 529.35032 (ESI) 
 
(2S,3S)-3-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-4,4-dimethyl-5 
(triethylsilyloxy)pentanal (22)28 
TBSO
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OBn OTES
Me Me
9
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9H 7
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Alkene S2 (291 mg, 0.574 mmol, 1.00 equiv) was dissolved in CH2Cl2 (10 mL) and 
cooled to –78 ˚C.  Ozone was passed through the solution until a blue color persisted, and 
then the reaction was sparged with N2. Triphenylphosphine (150 mg, 0.574 mmol, 1.00 
equiv) was added to the colorless solution, which was subsequently allowed to warm to 
rt. After 1 h, the solvent was removed under reduced pressure and the residue was passed 
through a pad of silica (3 × 5 cm) using 5% EtOAc/hexanes (50 mL) as the eluent. 
Removal of the solvent under reduced pressure yielded aldehyde 22 (273 mg, 0.568 
mmol, 99%) as a pale yellow oil that was used immediately in the next step:  
 
Rf = 0.85 (20% Et2O/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +31.5 (c 0.450, CHCl3) 
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1H NMR (CDCl3, 600 MHz) δ 9.70 (d, J = 1.6 Hz, 1 H), 7.35 – 7.30 (m, 4 H), 7.29 – 7.25 
(m, 1 H), 4.85 (d, J = 11.2 Hz, 1 H), 4.52 (d, J = 11.2 Hz, 1 H), 4.42 – 4.40 (m, 1 H), 3.69 
(d, J = 1.4 Hz, 1 H), 3.47 (d, J = 9.6 Hz, 1 H), 3.34 (d, J = 9.6 Hz, 1 H), 0.95 (s, 3 H), 
0.94 (s, 18 H), 0.93 (s, 3 H), 0.62 – 0.53 (m, 6 H), 0.08 (s, 3 H), 0.07 (s, 3 H) 
 
13C NMR (CDCl3, 125 MHz) δ 202.0, 138.7, 128.2, 127.7, 127.4, 87.5, 79.2, 74.3, 69.0, 
40.0, 25.8, 22.2, 21.0, 18.2, 6.8, 4.4, –4.6, –5.0;  
 
IR (film)  2956, 2878, 1738, 1462, 1254, 1087, 1006, 838, 780, 731 cm–1;  
 
Exact Mass Calc. for C26H48O4Si2 [M + H]+ 481.31639, found 481.31596 (ESI) 
 
(4R,5R)-5-(benzyloxy)-2,6,6-trimethyl-7-(triethylsilyloxy)hept-2-en-4-ol (34)  
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Enone (R)- ent-30 (500 mg, 1.28 mmol, 1 eq) was dissolved in 10 mL CH2Cl2 and cooled 
to -78 ºC. A 1.0 M solution of DiBAlH in toluene (2.56 mL, 2.56 mmol, 2 eq) was added 
and the reaction was stirred for 2 hours. After that time, TLC (30% EtOAc/hexanes) 
showed complete consumption of starting material. The reaction was quenched by the 
addition of 8 mL of saturated Rochelle’s salt solution, and the biphasic mixture was 
stirred at ambient temperature for 2 hours. After this time, the layers were separated, the 
aqueous layer was extracted  with 2x 10 mL CH2Cl2 and the combined organic layers 
were concentrated in vacuo. Purification of the residue by flash chromatography (10% 
Et2O/ hexanes) allowed the isolation of 310 mg alcohol 34 (0.789 mmol, 61%) as a clear 
colourless oil.  
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 Rf = 0.85 (30% EtOAc/hexanes, weakly UV active, stains blue in CAM) 
  
[α]20D = -31.8 (c 3.28, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.39- 7.34 (m, 4H), 7.31- 7.27 (m, 1H), 5.36 (d sept. J = 
8.6, 1.3 Hz, 1H), 4.75 (d, J = 11.2 Hz, 1H), 4.67 (d, J = 11.3 Hz, 1H), 4.53 (ddd, J = 8.2, 
5.3, 2.5 Hz, 1H), 3.52- 3.46 (m, 1H), 3.44- 3.40 (m, 1H), 3.33 (d, J = 2.5 Hz, 1H), 1.74 
(d, J = 1.3 Hz, 3H), 1.71 (d, J = 1.3 Hz, 3H), 1.00- 0.95 (m, 9H), 0.63 (ap. q, J = 6.6 Hz, 
6H); 
 
13C NMR (125 MHz, CDCl3) δ 138.7, 133.0, 128.3, 127.9, 127.5, 127.4, 86.6, 75.9, 68.8, 
67.1, 40.7, 25.8, 23.0, 21.3, 18.2, 6.7, 4.3; 
 
IR(film) 3441.5, 2956.5, 2875.9, 1455.2, 1391.5, 1239.5, 1088.9, 1006.4, 815.5 cm-1; 
 
Exact Mass Calc. for C23H40O3Si [M + Na]+ : 415.26389; found: 415.25740 (ESI) 
1-(((3R,4R)-4-(tert-butyldimethylsilyloxy)-2,2,6-trimethyl-1-(triethylsilyloxy)hept-5-
en-3-yloxy)methyl)benzene (S3) 
 
HO
MeMe OBn OTES
Me Me
9
34
TBSO
MeMe OBn OTES
Me Me
9
S3  
Alcohol 34 (310 mg, 0.789 mmol, 1 eq) was dissolved in 2 mL DMF and cooled to 0 ºC. 
Triethylamine (0.331 mL, 2.36 mmol, 3 eq) and DMAP (20 mg, 0.16 mmol, 0.2 eq) were 
added, followed by TBSCl (263 mg, 1.58 mmol, 2 eq). The reaction mixture was stirred 
for 3 hours, until TLC (30% EtOAc/hexanes) showed complete consumption of starting 
material. The reaction was diluted with 50 mL 50% EtOAc/hexanes and washed with 10 
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mL saturated NH4Cl(aq), then 10 mL brine. The organic layer was dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (10% 
EtOAc/hexanes) to yield 365 mg alkene S3 (0.717 mmol, 91%) as a clear colourless oil. 
 
Rf= 0.90 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +3.7 (c 2.53, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.36 (ap. d, J = 8.2 Hz, 2H), 7.31 (ap. t, J = 7.5 Hz, 2H), 
7.24 (ap. t, J = 8.6 Hz, 1H), 5.30 (d. sept., J = 1.5, 9.2 Hz, 1H), 4.78 (d, J = 11.8 Hz, 1H), 
4.61 (dd, J = 9.2, 4.1 Hz, 1H), 4.55 (d, J = 11.7 Hz, 1H), 3.50 (d, J = 9.5 Hz, 1H), 3.31 
(d, J = 4.1 Hz, 1H), 3.26 (d, J = 9.4 Hz, 1H), 1.68 (d, J = 1.2 Hz, 3H), 1.65 (d, J = 1.3 Hz, 
3H), 0.97- 0.92 (m, 9H), 0.87 (s, 9H), 0.56 (ap. q, J = 7.9 Hz, 6H), -0.01 (s, 3H), -0.01 (s, 
3H); 
 
13C NMR (125 MHz, CDCl3) δ 140.0, 130.5, 128.7, 128.0, 127.1, 126.8, 86.0, 75.0, 71.1, 
70.2, 40.7, 26.0, 25.7, 22.0, 21.4, 18.4, 18.2, 6.9, 4.5, -3.9, -4.5; 
 
IR(film) 2955.8, 2876.7, 1471.9, 1388.8, 1251.4, 1083.5, 1005.1, 834.3cm-1; 
 
Exact Mass Calc. for C29H54O3Si2 [M + Na]+ : 529.35037; found: 529.34978 (ESI) 
 
(2S,3R)-3-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-4,4-dimethyl-5-
(triethylsilyloxy)pentanal (35)  
TBSO
MeMe OBn OTES
Me Me
9
S3
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9H
35  
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Alkene S3 (150 mg. 0.296 mmol, 1 eq) was dissolved in 5 mL CH2Cl2 and cooled to -78 
ºC. Ozone was bubbled through the mixture until a blue colour persisted. The reaction 
was then sparged with nitrogen until the blue colour was discharged. Triphenylphosphine 
(78 mg, 0.30 mmol, 1 eq) was added and the reaction was stirred for 30 minutes at 
ambient temperature. The solvent was removed in vacuo and the residue was purified by 
flash chromatography (10% Et2O/hexanes) to yield 120 mg aldehyde 35 (0.25 mmol, 
84%) as a clear colourless oil. 
Rf = 0.85 (20% Et2O/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +7.5 (c 1.5, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 9.77 (d, J = 1.3 Hz, 1H), 7.36- 7.25 (m, 5H), 4.59 (d, J = 
11.4 Hz, 1H), 4.54 (d, J = 11.4 Hz, 1H), 4.24 (dd, J = 14.1, 9.3 Hz, 1H), 3.78 (d, J = 4.1 
Hz, 1H), 3.56 (d, J = 9.6 Hz, 1H), 3.21 (d, J = 9.5 Hz, 1H), 0.97- 0.93 (m, 15H), 0.92 (s, 
9H), 0.61- 0.55 (m, 6H), 0.07 (s, 3H), 0.04 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 203.5, 138.7, 128.2, 127.4, 127.3, 82.9, 78.6, 74.2, 69.7, 
40.7, 25.8, 22.0, 21.0, 18.2, 6.8, 4.4, -4.4, -4.9; 
 
IR(film) 2955.7, 2877.0, 1734.4, 1472.3, 1361.9, 1254.4, 1093.7, 1006.2, 837.2 cm-1; 
 
Exact Mass Calc. for C26H48O4Si2 [M + Na]+ : 503.29833; found: 503.29881 (ESI) 
(6R,7R,8S)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (36a) 
and  
(6S,7R,8S)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (37b) 
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Methyl isobutyl ketone (71.9 µL, 0.576 mmol, 3 eq) was dissolved in 3 mL toluene and 
triethylamine (78 µL, 0.557 mmol, 2.9 eq) was added. The reaction was cooled to -78 ºC 
and dicyclohexylboron chloride (0.122 mL, 0.557 mmol, 2.9 eq) was added. A milky 
white suspension formed. The reaction was stirred for 1.5 hours and then a solution of 
anti aldehyde 22 (92 mg, 0.19 mmol, 1 eq) was added in 1 mL toluene. After 1 hour, the 
reaction was quenched with the addition of  2 mL of a 1:1:1 mixture of pH 7 buffer, 
methanol and 30% H2O2(aq). This was stirred for 2 hours at ambient temperature and then 
diluted with 20 mL 50% EtOAc/hexanes. The aqueous layer was separated, and the 
organic layer was washed with 2x5 mL saturated Na2S2O3(aq) and 5 mL brine. This was 
dried over Na2SO4 and concentrated in vacuo. Analysis of the crude mixture by 1H NMR 
showed a 3:1 ratio of diastereomers. Purification by flash chromatography on silica (2.5% 
EtOAc/hexanes, mixed fractions reflashed with 1% EtOAc/hexanes) allowed the 
seperation of two diastereomers, of which the more polar one was the major diasteromer. 
Analytical data for the two diastereomers is reported below: 
 
When the corresponding reaction was attempted with 9-BBN triflate, very little 
conversion was observed. 
 
(6R,7R,8S)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (36a)  
O
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Rf = 0.50 (10% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
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[α]20D = 12.2 (c 1.10, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.36- 7.27 (m, 5H), 4.91 (d, J = 11.3 Hz, 1H), 4.60 (d, J = 
11.3 Hz, 1H), 4.33 (ap. dd, J = 9.8, 2.2 Hz, 1H), 4.05 (s, 1H), 3.69 (s, 1H), 3.56 (d, J = 
9.6 Hz, 1H), 3.30 (d, J = 3.3 Hz, 1H), 3.21 (d, J = 9.6 Hz, 1H), 2.93 (dd, J = 17.7, 1.8 Hz, 
1H), 2.62 (dd, J = 17.7, 10.0 Hz, 1H), 2.11 (dd, J = 7.3, 3.3 Hz, 2H), 1.96 (sept., J = 6.7 
Hz, 1H), 0.99 (s, 3H), 0.97 (s, 9H), 0.96 (ap. t, J = 8.1 Hz, 9H), 0.90 (s, 3H), 0.82 (d, J = 
6.7 Hz, 3H), 0.80 (d, J = 6.6 Hz, 3H), 0.62- 0.57 (m, 9H), 0.15 (s, 3H), 0.13 (s, 3H)’ 
 
13C NMR (125 MHz, CDCl3) δ 213.8, 139.3, 128.2, 127.3, 86.8, 77.2, 75.5, 69.7, 69.5, 
52.6, 45.4, 40.1, 26.0, 24.6, 22.5, 22.4, 20.8, 18.2, 6.8, 4.4, -4.4, -4.5; 
 
IR(film) 3504.0, 2955.6, 2876.3, 1701.0, 1459.0, 1406.5, 1364.0, 1252.3, 1086.9, 1015.5, 
835.3 cm-1; 
 
Exact Mass Calc. for C32H60O5Si2 [M + Na]+ : 603.38715; found:  603.3902 (ESI) 
 
(6S,7R,8S)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (36b) 
O
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Rf = 0.52 (10% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -1.8 (c 3.76, CHCl3); 
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1H NMR (600 MHz, CDCl3) δ 7.35- 7.27 (m, 5H), 5.08 (d, J = 10.7 Hz, 1H), 4.56 (d, J = 
10.6 Hz, 1H), 4.50 (t, J = 6.6 Hz, 1H), 4.41 (s, 1H), 3.98 (s, 1H), 3.94 (s, 1H), 3.59 (d, J = 
9.7 Hz, 1H), 3.21 (d, J = 10.5 Hz, 1H), 2.73 (dd, J = 17.1, 6.0 Hz, 1H), 2.61 (dd, J = 17.1, 
6.9 Hz, 1H), 2.37 (dd, J = 16.3, 6.8 Hz, 1H), 2.28 (dd, J = 16.3, 6.9 Hz, 1H), 2.14 (sept. 
J= 6.7 Hz, 1H), 1.04 (s, 3H), 1.00 (s, 12H), 0.98 (ap. t, J = 7.9 Hz, 9H), 0.93 (d, J = 6.7 
Hz, 6H), 0.62 (ap. q, J= 8.0 Hz, 6H), 0.19 (s, 3H), 0.06 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 209.8, 138.4, 128.4, 127.6 (2 signals), 88.1, 76.6, 72.6, 
70.0, 69.4, 52.6, 47.4, 39.9, 26.0, 24.2, 22.6, 22.1, 20.7, 18.2, 6.8, 4.4, -3.5, -5.0; 
 
IR(film) 3482.4, 2956.0, 2876.7, 1710.7, 1471.6, 1409.5, 1362.5, 1254.2, 1085.7, 1006.3, 
835.9 cm-1; 
Exact Mass Calc. for C32H60O5Si2 [M + Na]+ : 603.38715; found: 603.3867 (ESI) 
(2S,3R,7R,8R,9S)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-9-(benzyloxy)-8-(tert-
butyldimethylsilyloxy)-7-hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-
11-(triethylsilyloxy)undecane-1,5-dione (37)  
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To a stirring solution of ketone 3 (250 mg, 0.660 mmol, 1.15 equiv), previously 
azeotroped with PhH (5 mL), and PhCH3 (6.6 mL) in a 50 mL flame-dried round-bottom 
flask under an atmosphere of Ar was added Et3N (100 µL, 0.718 mmol, 1.25 equiv) 
dropwise via syringe.  The solution was then cooled to –78 ˚C and 9-BBNOTf (140 µL, 
0.660, 1.15 equiv) was added dropwise over 1 minute. The color of the solution became 
orange and then a deep red coloration developed over 1 h. After 1.5 h, a solution of 22 
(0.574 mmol (assumed)) in PhCH3 (2 mL) was added via cannula dropwise down the 
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inside of the flask. A deep purple solution color was observed. After an additional 1.5 h, 
TLC analysis indicated complete consumption of the aldehyde. The reaction was 
quenched with a 1:1 mixture of methanol and pH 7.0 buffer (2.0 mL) and allowed to 
warm to 0 ˚C. A precooled (0 ˚C) 1:1:1 mixture of methanol/ pH 7 buffer, and 30% 
aqueous H2O2 was added and the mixture was then allowed to warm to ambient 
temperature. After 15 h, the mixture was diluted with 50% EtOAc/hexanes (100 mL). 
The layers were separated and the organic layer was washed with water (20 mL), brine (2 
× 20 mL), dried over Na2SO4, filtered, and then concentrated under reduced pressure. The 
resulting yellow oil was azeotroped with methanol (2 × 10 mL). Purification was 
accomplished with flash column chromatography (3 × 15 cm), eluting with 10% 
acetone/hexanes (200 mL), 20% acetone/hexanes (200 mL), and collecting 10 mL 
fractions. The product containing fractions (20−35) were combined and concentrated 
under reduced pressure to give β-hydroxy ketone 37 (395 mg, 0.460 mmol. 81%), as a 
30:1 mixture of inseperable diasteromers and a viscous pale yellow oil: 
Rf = 0.45 (40% acetone/hexanes, faintly UV active, stains green in Anisaldehyde); 
 
[α]20D = +33.4 (c 0.450, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.39 – 7.21 (m, 10 H), 5.64 (d, J = 5.0 Hz, 1 H), 4.93 (d, J 
= 11.2 Hz, 1 H), 4.74 (d, J = 6.9 Hz, 1 H), 4.65 (d, J = 6.9 Hz, 1 H), 4.69 – 4.60 (m, 1 H), 
4.55 (d, J = 11.4 Hz, 1 H), 4.39 – 4.38 (m, 1 H), 4.41 – 4.36 (m, 1 H), 4.16 (d, J = 4.8 Hz, 
1 H), 4.19 – 4.12 (m, 1 H), 4.05 – 4.02 (m, 1 H), 3.70 – 3.70 (m, 1 H), 3.71 – 3.69 (m, 1 
H), 3.53 (d, J = 9.6 Hz, 1 H), 3.41 – 3.38 (m, 1 H), 3.36 (s, 3 H), 3.32 (s, 3 H), 3.33 – 
3.31 (m, 1 H), 3.19 - 3.13 (m, 1 H), 3.03 – 2.97 (m, 1 H), 2.85 – 2.74 (m, 2 H), 2.63 – 
2.56 (m, 1 H), 0.98 – 0.94 (m, 18 H), 0.93 (s, 3 H), 0.88 (s, 3 H), 0.62 – 0.54 (m, 6 H), 
0.14 (s, 3 H), 0.13 (s, 3 H);  
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13C NMR (CDCl3, 125 MHz) δ 210.6, 170.7, 153.2, 139.2, 135.2, 129.4, 129.0, 128.2, 
127.4, 127.4, 127.2, 97.4, 86.7, 77.2, 77.1, 76.8, 74.2, 69.8, 69.3, 66.3, 59.2, 56.3, 55.7, 
46.1, 43.9, 40.1, 37.6, 26.0, 22.5, 20.8, 18.2, 6.8, 4.4, –4.3, –4.4; 
 
IR (thin film)  3542, 2955, 1783, 1703, 1454, 1391, 1350, 1252, 1212, 1103,1048, 836, 
730, 700 cm–1;  
 
HRMS (ES) calc for C45H73NO11Si2 (M + Na) 882.46144, found 882.46291.  
 
(6R,7R,8R)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (42) 
and 
(6S,7R,8R)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (43) 
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Methyl isobutyl ketone (37 µL, 0.297 mmol, 3.0 eq) was dissolved in 2 mL of toluene. 
Triethylamine (40 µL, 0.287 mmol, 2.9 eq) was added and the mixture was cooled to -78 
ºC. To the solution was added dicyclohexylboron chloride (63 µL, 0.287 mmol, 2.9 eq) 
and a milky white suspension formed immediately. After stirring at -78 ºC for 30 
minutes, a solution of syn aldehyde 35 (47.6 mg, 0.099 mmol, 1 eq) was added and the 
reaction was stirred for 2 hours. TLC analysis (20% EtOAc/hexanes, CAM) showed 
complete consumption of starting material, so the reaction was quenched by the addition 
of 2 mL of a 1:1 mixture of pH 7 buffer and methanol. The reaction was warmed to 0 ºC 
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and 1 mL of 30% H2O2(aq) was added. After 1 hour, the reaction was diluted with 50 mL 
90% EtOAc/hexanes and washed with 5 mL sat Na2SO3(aq) and brine, then dried over 
Na2SO4. Crude 1H NMR showed a 1:1.4 ratio of diastereomers, which were partially 
separated by flash chromatography (5% EtOAc/hexanes). The more polar isomer is the 
major one. 
 
Characterization Data for more polar isomer 13 mg isolated: 
(6S,7R,8R)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (43) 
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Rf = 0.48 (10% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +22.7 (c 0.65, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.35- 7.23 (m, 5H), 4.73 (ap. d, J = 11.7 Hz, 1H), 4.45 (ap. 
d, J = 11.9 Hz, 1H), 4.10- 4.05 (m, 1H), 3.86 (dd, J = 6.0, 2.7 Hz, 1H), 3.57 (ap. d, J = 
6.0 Hz, 1H), 3.49 (d, J = 9.5 Hz, 1H), 3.25 (d, J = 9.5 Hz, 1H), 2.69- 2.65 (m, 2H), 2.58 
(ap. dd, J = 16.2, 4.7 Hz, 1H), 2.30 (dd, J = 7.0, 4.0 Hz, 2H), 2.13 (sept. J = 6.7 Hz, 1H), 
0.96- 0.90 (m, 30H), 0.59- 0.54 (m, 6H), 0.06 (3H), 0.05 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 209.4, 139.3, 128.4, 128.0, 127.3, 127.0, 80.9, 74.1, 73.5, 
69.9, 69.1, 52.6, 48.0, 40.5, 29.7, 26.1, 24.3, 22.6, 21.4, 20.6, 18.2, 6.8, 4.4, -3.5, -4.9; 
 
IR(film) 3541.9, 2955.9, 1712.0, 1471.5, 1362.7, 1254.0, 1090.9, 834.7, 731.0 cm-1; 
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Exact Mass Calc. for C32H60O5Si2 [M + Na]+ : 603.38715; found: 603.38768 (ESI) 
 
Characterization Data for less polar isomer 11 mg isolated: 
(6R,7R,8R)-8-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-6-hydroxy-2,9,9-trimethyl-
10-(triethylsilyloxy)decan-4-one (42) 
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Rf = 0.5 (10% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +24.7 (c 0.55, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.34- 7.33 (m, 4H), 7.29- 7.25 (m, 1H), 4.79 (d, J = 11.3 
Hz, 1H), 4.48 (d, J = 11.2 Hz, 1H), 4.28- 2.19 (m, 1H), 3.91 (t, J = 5.1 Hz, 1H), 3.56 (d, J 
= 9.5 Hz, 1H), 3.51 (d, J = 4.9 Hz, 1H), 3.45 (br. s, 1H), 3.16 (d, J = 9.5 Hz, 1H), 2.71 
(dd, J = 16.3, 2.7 Hz, 1H), 2.60 (dd, J = 16.2, 9.5 Hz, 1H), 2.36 (dd, J = 7.0, 5.0 Hz, 1H), 
2.16 (sept., J = 6.7 Hz, 1H), 0.99 (s, 9H), 0.96 (d, J = 8.0 Hz, 3H), 0.94 (d, J = 7.9 Hz, 
3H), 0.94 (dd, J = 16.6, 2.2 Hz, 2H), 0.89 (s, 15H), 0.09 (s, 3H), 0.07 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 211.2, 138.7, 130.9, 128.2, 127.3, 81.1, 74.1, 74.0, 71.0, 
70.0, 52.7, 46.1, 40.7, 38.7, 30.4, 28.9, 26.1, 26.0, 25.9, 24.5, 22.6, 22.5, 21.7, 20.6, 18.2, 
6.8, 4.4, -3.8, -4.6; 
 
IR(film) 3512.0, 2956.6, 2876.6, 1708.9, 1463.5, 1362.3, 1252.2, 1089.4, 1016.2, 835.5 
cm-1; 
Exact Mass Calc. for C32H60O5Si2 [M + Na]+ : 603.38715; found: 603.38677 (ESI) 
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9-BBN triflate procedure 
Methyl isobutyl ketone (37 µL, 0.297 mmol, 3.0 eq) was dissolved in 2 mL of toluene. 
Triethylamine (40 µL, 0.287 mmol, 2.9 eq) was added and the mixture was cooled to -78 
ºC. To the solution was added 9-BBN triflate (61 µL, 0.287 mmol, 2.9 eq. After stirring 
at -78 ºC for 30 minutes, a solution of syn aldehyde 35 (47.6 mg, 0.099 mmol, 1 eq) was 
added and the reaction was stirred for 2 hours. TLC analysis (20% EtOAc/hexanes, 
CAM) showed complete consumption of starting material, so the reaction was quenched 
by the addition of 2 mL of a 1:1 mixture of pH 7 buffer and methanol. The reaction was 
warmed to 0 ºC and 1 mL of 30% H2O2(aq) was added. After 1 hour, the reaction was 
diluted with 50 mL 90% EtOAc/hexanes and washed with 5 mL sat Na2SO3(aq) and brine, 
then dried over Na2SO4. Crude 1H NMR showed a 1:9 ratio of diastereomers, which were 
separated by flash chromatography (5% EtOAc/hexanes). The more polar isomer 43 is 
the major one. 
 
Analytical data were in accordance with that acquired for the dicyclohexylboron 
mediated aldol. 
 
(S)-4-benzyl-3-((2S,3R,7S,8R,9R)-9-(benzyloxy)-8-(tert-butyldimethylsilyloxy)-7-
hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-5-oxo-11-
(triethylsilyloxy)undecanoyl)oxazolidin-2-one (44) 
and  
(S)-4-benzyl-3-((2S,3R,7R,8R,9R)-9-(benzyloxy)-8-(tert-butyldimethylsilyloxy)-7-
hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-5-oxo-11-
(triethylsilyloxy)undecanoyl)oxazolidin-2-one (45) 
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Oxazolidione ketone 5 (41 mg, 0.109 mmol, 1.1 eq) was dissolved in 2 mL of toluene. 
Triethylamine (15 µL, 0.109mmol, 1.1 eq) was added and the mixture was cooled to -78 
ºC. To the solution was added 9-BBN triflate (23 µL, 0.109 mmol, 1.1 eq. The resulting 
solution turned deep orange. After stirring at -78 ºC for 40 minutes, a solution of syn 
aldehyde 35 (47.6 mg, 0.099 mmol, 1 eq) was added and the deep purple reaction was 
stirred for 1 hour and 40 minutes. TLC analysis (20% EtOAc/hexanes, CAM) showed 
complete consumption of starting material, so the reaction was quenched by the addition 
of 2 mL of a 1:1 mixture of pH 7 buffer and methanol. The reaction was warmed to 0 ºC 
and 1 mL of 30% H2O2(aq) was added. After 1 hour, the reaction was diluted with 50 mL 
90% EtOAc/hexanes and washed with 5 mL sat Na2SO3(aq) and brine, then dried over 
Na2SO4. Crude 1H NMR showed a 1:2 ratio of diastereomers, which were separated by 
flash chromatography (20% to 30% to 40% EtOAc/hexane). The more polar isomer is the 
major one. 
 (S)-4-benzyl-3-((2S,3R,7R,8R,9R)-9-(benzyloxy)-8-(tert-butyldimethylsilyloxy)-7-
hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-5-oxo-11-
(triethylsilyloxy)undecanoyl)oxazolidin-2-one (45) 
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Rf = 0.15 (20% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
 [α]20D = +46.4 (c 0.655, CHCl3); 
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1H NMR (600 MHz, CDCl3) δ 7.36- 7.23 (m, 10H), 5.71 (d, J = 5.1 Hz, 1H), 4.82- 4.77 
(m, 2H), 4.70- 4.64 (m, 2H), 4.46 (d, J = 11.3 Hz, 1H), 4.32- 3.26 (m, 1H), 4.26- 4.21 (m, 
1H), 4.20- 4.15 (m, 2H), 3.89 (t, J =5.3 Hz, 1H), 3.54 (d, J = 9.5 Hz, 1H), 3.51- 3.46 (m, 
1H), 3.44- 3.40 (m, 1H), 3.42 (s, 3H), 3.39 (s, 3H), 3.34 (dd, J = 13.5, 3.4 Hz, 1H), 3.14 
(d, J = 9.5 Hz, 1H), 2.97 (dd, J = 17.3, 3.0 Hz, 1H), 2.84- 2.75 (m, 2H), 2.74- 2.65 (m, 
2H), 0.99 (s, 3H), 0.98 (s, 3H), 0.94 (ap. t, J = 8.0 Hz, 9H), 0.88 (s, 9H), 0.61- 0.55 (m, 
6H), 0.08 (s, 3H), 0.06 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 208.7, 171.0, 153.2, 138.7, 135.2, 129.5, 129.0, 128.2, 
127.4, 97.5, 81.3, 76.8, 74.1 (2 signals), 74.0, 70.9, 70.1, 66.3, 59.5, 56.3, 55.7, 46.7, 
44.5, 40.7, 37.6, 32.0, 29.7, 26.1, 26.0, 21.7, 20.6, 18.2, 6.8, 4.4, -3.8, -4.6; 
 
IR(film)  3527.4, 2955.1, 1783.4, 1709.5, 1455.1, 1389.6, 1251.1, 1109.9, 835.5cm-1; 
 
Exact Mass Calc. for C45H73NO11Si2 [M + Na]+ : 882.46144; found 882.46249 (ESI) 
 
(S)-4-benzyl-3-((2S,3R,7S,8R,9R)-9-(benzyloxy)-8-(tert-butyldimethylsilyloxy)-7-
hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-5-oxo-11-
(triethylsilyloxy)undecanoyl)oxazolidin-2-one (44) 
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Rf = 0.10 (20% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +45.6 (c 1.26, CHCl3); 
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1H NMR (600 MHz, CDCl3) δ 7.37- 7.21 (m, 10H), 5.69 (d, J = 5.0 Hz, 1H), 4.78 (dd, J 
= 11.7, 6.7 Hz, 1H), 4.73 (d, J = 6.8 Hz, 1H), 4.70- 4.65 (m, 2H), 4.25- 4.15 (m, 3H), 
4.09 (br. s, 1H), 3.84 (dd, J = 6.0, 2.8 Hz, 1H), 3.58 (d, J = 6.0 Hz, 1H), 3.49 (d, J = 9.5 
Hz, 1H), 3.38 (s, 3H), 3.38 (s, 3H), 3.33 (dd, J = 13.8, 3.1 Hz, 1H), 3.24 (d, J = 10.0 Hz, 
1H), 2.89 (dd, J = 17.3, 3.2 Hz, 1H), 2.82- 2.78 (m, 2H), 2.76- 2.68 (m, 2H), 2.68- 2.63 
(m, 2H), 0.95 (s, 3H), 0.93 (s, 3H), 0.92- 0.90 (m, 9H), 0.90 (s, 9H), 0.60- 0.54 (m, 6H), 
0.06 (s, 3H), 0.06 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 207.2, 170.8, 153.2, 139.2, 135.2, 129.4, 129.0, 128.1, 
127.4, 127.3, 127.1, 97.5, 80.9, 76.9, 74.1 (2 signals), 73.6, 69.9, 68.9, 66.3, 59.4, 56.3, 
55.7, 48.5, 44.2, 40.5, 37.5, 26.1, 25.9, 21.5, 20.4, 18.2, 6.8, 4.4, -3.6, -4.9; 
 
IR(film) 3527.5, 2955.1, 1783.1, 1710.8, 1463.5, 1390.0, 1252.9, 1109.5 cm-1; 
 
Exact Mass Calc. for C22H42O6Si2 [M + Na]+ : found; (ESI) 
(S)-4-benzyl-3-((2S,3R,5R,7R,8R,9S)-9-(benzyloxy)-5,8-bis(tert-
butyldimethylsilyloxy)-7-hydroxy-3-methoxy-2-(methoxymethoxy)-10,10-dimethyl-
11-(triethylsilyloxy)-undecanoyl)oxazolidin-2-one (S5)30 
                                                
(30) The following characterization data was obtained by Dr. Dennie Welch, and the procedure was 
developed by him. I ran the reaction on the scale reported. 
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To a stirring mixture of CH3CN (28 mL) and Me4N(OAc)3BH (3.05 g , 11.6 mmol, 5.0 
equiv) in a flame-dried 10 mL round-bottom flask under an atmosphere of Ar, at rt, was 
added AcOH (28 mL) dropwise via syringe (solution immediately became 
homogeneous).  The solution was cooled to –30 ˚C and β-hydroxy ketone 37 (2.01 g, 
2.34 mmol, 1.0 equiv) in CH3CN (16 mL) was added dropwise via cannula down the 
inside of the reaction flask.  TLC analysis after 24 h indicated complete consumption of 
starting material. The reaction was quenched by direct transfer to a vigorously stirring 
mixture of 50% EtOAc/hexanes (300 mL), a saturated aqueous solution of potassium 
sodium tartrate (150 mL), and a saturated aqueous solution of NaHCO3 (150 mL).  The 
vigorously stirring mixture was allowed to slowly warm to rt and then solid NaHCO3 was 
added until a neutral pH was achieved.  The mixture was stirred for an additional 30 min, 
and then the layers were separated.  The aqueous layer was extracted with EtOAc (2 × 50 
mL).  The combined organic layers were washed with a saturated aqueous solution of 
NaHCO3 (2 × 30 mL), brine (2 × 20 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure to give the diol  S4 (2.1 g) as a pale yellow oil, and a 95:5 
mixture of diastereomers, that was azeotroped with MeOH (2 × 15 mL) and taken onto 
the next reaction without further manipulation.   
 To a stirring solution of diol S4 (2.34 mmol (assumed), 1.0 equiv), DMF (11 mL), 
and Et3N (0.65 mL, 4.6 mmol, 2.0 equiv) in a flame-dried 10 mL round-bottom flask 
under an atmosphere of Ar, at 0 ˚C, was added TBSCl (0.42 g, 2.8 mmol, 1.2 equiv) in 
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one portion.  TLC analysis after 12 h, during which time the 0 ˚C bath was allowed to 
expire naturally, indicated complete consumption of starting material. The reaction 
solution was diluted with 25% EtOAc/hexanes (200 mL) and then quenched by the 
addition of a saturated aqueous solution of NaHCO3 (5 mL).  The resulting layers were 
separated and the organic layer was washed with water (4 × 30 mL) then dried over 
Na2SO4, filtered, and concentrated under reduced pressure to give a brown oil (2.3 g). It 
was found that the overall yield of the sequence was increased if this intermediate was 
methylated without purification, however purification of a sample of this intermediate for 
characterization was accomplished by flash column chromatography (2.5 × 7 cm), eluting 
with 5% EtOAc/hex (50 mL), 10% EtOAc/hex (50 mL), 15% EtOAc/hex (50 mL), 20% 
EtOAc/hex (50 mL) and collecting 5 mL fractions.  The product containing fractions 
(31−55) were combined and concentrated under reduced pressure to give TBS ether S5 as 
a colorless oil:  
Rf = 0.42 (25% acetone/hexanes, faintly UV active, stains blue in CAM);  
 
[α]20D = +8.2 (c = 1.1, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.38 – 7.21 (m, 10 H), 5.54 (d, J = 5.0 Hz, 1 H), 4.99 (d, J 
= 11.7 Hz, 1 H), 4.76 (d, J = 7.0 Hz, 1 H), 4.65 (d, J = 6.7 Hz, 1 H), 4.59 (td, J = 9.2, 3.8 
Hz, 1 H), 4.54 (d, J = 11.4 Hz, 1 H), 4.21 – 4.11 (m, 3 H), 3.98 (d, J = 1.8 Hz, 1 H), 3.74 
(s, 1 H), 3.63 (br. s., 1 H), 3.58 (d, J = 9.4 Hz, 1 H), 3.50 (ddd, J = 8.1, 2.6, 2.4 Hz, 1 H), 
3.37 (s, 3 H), 3.35 (dd, J = 8.2, 2.1 Hz, 1 H), 3.19 (d, J = 9.7 Hz, 1 H), 3.11 (s, 3 H), 2.77 
(dd, J = 13.3, 9.8 Hz, 1 H), 1.98 (dd, J = 14.6, 5.9 Hz, 1 H), 1.82 – 1.96 (m, 2 H), 1.79 – 
1.67 (m, 2 H), 1.01 (s, 3 H), 0.97 (s, 9 H), 0.96 – 0.93 (m, 12 H), 0.87 (s, 9 H), 0.62 – 
0.54 (m, 6 H), 0.15 (s, 6 H), 0.05 (s, 6 H);  
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13C NMR (CDCl3, 125 MHz) δ 171.2, 153.4, 139.7, 135.6, 129.7, 129.2, 128.3, 127.5, 
127.4, 97.6, 87.4, 78.9, 78.2, 75.7, 75.6, 70.4, 70.3, 68.5, 66.4, 59.3, 56.4, 56.0, 40.3, 
37.7, 37.2, 37.0, 26.2, 26.0, 23.0, 21.1, 18.4, 18.1, 7.0, 4.6, –3.9, –4.1, –4.4, –4.8;  
 
IR (thin film) 3484, 2956, 2957, 1785, 1709, 1472, 1388, 1349, 1253, 1211, 1102, 836, 
777, 734 cm–1;  
 
Exact Mass Calc. for C51H89NO11Si3 [M + Na]+ 998.56356, found 998.56354 (ESI)  
 
 
 
 
(S)-4-benzyl-3-((2S,3R,5S,7R,8R,9S)-9-(benzyloxy)-5,8-bis(tert-
butyldimethylsilyloxy)-3,7-dimethoxy-2-(methoxymethoxy)-10,10-dimethyl-11-
(triethylsilyloxy)undecanoyl)-oxazolidin-2-one (47)30 
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To a stirring solution of crude alcohol S5 (2.3 g, 2.34 mmol (assumed)), Proton Sponge® 
(7.5 g, 35 mmol, 15 equiv), and CH2Cl2 (70 mL) in a flame-dried 200 mL round-bottom 
flask under an atmosphere of Ar, at rt, was added Me3OBF4 (2.6 g, 17 mmol, 7.5 equiv) 
in one portion.  TLC analysis after 14 h indicated complete consumption of starting 
material.  The reaction mixture was diluted with 20% EtOAc/hexanes (200 mL) and 
filtered through celite.  The filtrate was washed with NaHSO4 (pH 1.5, 4 × 20 mL), brine 
(30 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to give a 
dark amber residue.  Purification was accomplished by flash column chromatography 
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eluting with 5% acetone/hexanes and the product containing fractions were combined and 
concentrated under reduced pressure to give methyl ether 47 (1.64 g, 1.66 mmol, 71% 
yield over 3 steps) as a colorless oil: 
Rf = 0.48 (30% EtOAc/hex, faintly UV active, stains blue);  
 
[α]20D = +39.8 (c 0.55, CHCl3); 
 
1H NMR (CDCl3, 600 MHz) δ 7.37 – 7.30 (m, 2 H), 7.30 – 7.19 (m, 3 H), 5.48 (d, J = 4.3 
Hz, 1 H), 4.79 (d, J = 6.9 Hz, 1 H), 4.69 (d, J = 6.9 Hz, 1 H), 4.64 (td, J = 9.2, 3.8 Hz, 1 
H), 4.21 – 4.14 (m, 2 H), 4.09 (t, J = 9.3 Hz, 1 H), 3.95 (d, J = 5.0 Hz, 1 H), 3.72 (d, J = 
4.8 Hz, 1 H), 3.68 (d, J = 10.1 Hz, 1 H), 3.66 – 3.60 (m, 1 H), 3.43 (s, 3 H), 3.49 – 3.41 
(m, 1 H), 3.39 (s, 6 H), 3.37 – 3.41 (m, 1 H), 3.35 (dd, J = 13.7, 3.2 Hz, 1 H), 3.07 (br. s., 
1 H), 2.79 (dd, J = 13.4, 9.7 Hz, 1 H), 1.92 – 1.81 (m, 1 H), 1.77 (br. s., 1 H), 1.68 (d, J = 
10.5 Hz, 1 H), 1.65 (d, J = 11.2 Hz, 1 H), 1.02 (s, 3 H), 0.94 (s, 3 H), 0.89 (s, 9 H), 0.88 
(s, 9 H), 0.12 (s, 3 H), 0.10 (s, 3 H), 0.08 (s, 6 H);  
 
13C NMR (CDCl3, 125 MHz) δ171.2, 153.2, 140.1, 135.6, 129.7, 129.1, 128.2, 127.5, 
127.4, 126.9, 97.4, 86.6, 79.8, 79.3, 76.9, 75.5, 73.2, 70.4, 66.6, 66.4, 59.7, 56.8, 56.3, 
56.0, 40.6, 40.1, 37.7, 37.5, 26.3, 26.2, 22.7, 21.2, 18.5, 18.2, 7.1, 4.6, –3.7, –4.1, –4.3, –
4.5;  
 
IR (thin film) 2955, 2930, 2857, 1786, 1709, 1472, 1388, 1349, 1253, 1210, 1102, 1055, 
1006, 836, 775, 734 cm–1;  
 
LRMS (ES) calcd for C52H91NO11Si3 [M + Na]+ 1012.58, found 1012.58.  
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(S)-4-benzyl-3-((2S,3R,5S,7R,8S,9S)-5,8-bis(tert-butyldimethylsilyloxy)-9,11-
dihydroxy-3,7-dimethoxy-2-(methoxymethoxy)-10,10-
dimethylundecanoyl)oxazolidin-2-one (48)30 
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A 4 mL vial containing a stirring mixture of benzyl ether 47 (173 mg, 0.174 mmol, 1.0 
equiv), 20% Pd(OH)2/C (24 mg, 0.0349 mmol, 0.2 equiv), and EtOAc (1 mL), at rt, was 
equipped with a H2-filled balloon.  TLC analysis after 5 h indicated complete 
consumption of starting material.  The reaction mixture was diluted with EtOAc (10 mL) 
and filtered over a pad of celite.  The celite pad was washed with EtOAc (20 mL).  The 
filtrate was concentrated under reduced pressure to give a colorless residue (140 mg).  
Purification was accomplished by flash column chromatography (2.5 × 8 cm), eluting 
with 5% acetone/hex (100 mL), 7.5% acetone/hex (100 mL), 10% acetone/hex (100 mL), 
12.5% acetone/hex (100 mL), 15% acetone/hex (100 mL), 17.5% acetone/hex (100 mL) 
and collecting 8 mL fractions.  The product containing fractions (13−35) were combined 
and concentrated under reduced pressure to give diol 48 (108 mg, 0.131 mmol, 79% 
yield) as a white foam:  
 
Rf = 0.20 (20% acetone/hex, faintly UV active, stains blue); 
 
[α]20D = +38.4 (c 1.71, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.37 – 7.30 (m, 2 H), 7.30 – 7.19 (m, 3 H), 5.48 (d, J = 4.3 
Hz, 1 H), 4.79 (d, J = 6.9 Hz, 1 H), 4.69 (d, J = 6.9 Hz, 1 H), 4.64 (td, J = 9.2, 3.8 Hz, 1 
H), 4.21 – 4.14 (m, 2 H), 4.09 (t, J = 9.3 Hz, 1 H), 3.95 (d, J = 5.0 Hz, 1 H), 3.72 (d, J = 
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4.8 Hz, 1 H), 3.68 (d, J = 10.1 Hz, 1 H), 3.66 – 3.60 (m, 1 H), 3.43 (s, 3 H), 3.49 – 3.41 
(m, 1 H), 3.39 (s, 6 H), 3.41 – 3.37 (m, 1 H), 3.35 (dd, J = 13.7, 3.2 Hz, 1 H), 3.07 (br. s., 
1 H), 2.79 (dd, J = 13.4, 9.7 Hz, 1 H), 1.92 – 1.81 (m, 1 H), 1.77 (br. s., 1 H), 1.68 (d, J = 
10.5 Hz, 1 H), 1.65 (d, J = 11.2 Hz, 1 H), 1.02 (s, 3 H), 0.94 (s, 3 H), 0.89 (s, 9 H), 0.88 
(s, 9 H), 0.12 (s, 3 H), 0.10 (s, 3 H), 0.08 (s, 6 H); 
 
13C NMR (CDCl3, 125 MHz) δ 171.2, 153.4, 135.5, 129.7, 129.2, 127.6, 97.6, 82.3, 80.7, 
79.1, 76.8, 73.8, 73.4, 66.7, 66.6, 59.7, 58.0, 56.4, 55.9, 39.9, 38.6, 38.1, 37.7, 26.3, 26.2, 
22.5, 19.7, 18.4, 18.2, –3.2, –3.8, –4.2, –4.7;  
 
IR (film) 3502, 2932, 1772, 1716, 1472, 1387, 1252, 1049, 836, 775 cm–1;  
 
Exact Mass Calc. for C39H71NO11Si2 [M + Na]+ 808.44579, found 808.45366 (ESI)  
 
(4R,5R,7S,9R,10S)-11-((S)-4-benzyl-2-oxooxazolidin-3-yl)-4,7-bis(tert-
butyldimethylsilyloxy)-5,9-dimethoxy-10-(methoxymethoxy)-2,2-dimethyl-3,11-
dioxoundecanal (49)30 
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To a stirring solution of diol 48 (420 mg, 0.534mmol, 1.0 equiv), pyridine (2 mL), and 
CH2Cl2 (20 mL) in a 100 mL round-bottom flask under an atmosphere of Ar, at 0 ˚C, was 
added Dess-Martin periodinane (1.3 g, 2.7 mmol, 5.0 equiv) in one portion.  TLC 
analysis after 12 h indicated complete consumption of starting material and formation of 
one product.31 The reaction mixture was diluted with CH2Cl2 (10 mL), hexanes (25 mL), 
                                                
(31)  The eluent employed for TLC analysis of the reaction mixture was 30% EtOAc/hexanes. Under 
these conditions, the product aldehyde has a retention factor of 0.67. A spot presumed to be the β-
hydroxy aldehyde can be observed in the first several h of the reaction and has retention factor of 
0.45.   
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a saturated aqueous solution of NaHCO3 (10 mL), and then cooled to 0 ˚C.  A saturated 
aqueous solution of Na2S2O3 (10 mL) was added dropwise via syringe to the stirring 
reaction mixture.  The mixture was stirred vigorously for 30 min, diluted with 30% 
EtOAc/hexanes (80 mL), and then the layers were separated.  The organic layer was 
washed with a saturated aqueous solution of NaHCO3 (3 × 5 mL), H2O (3 × 5 mL), brine 
(3 × 5 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to give 
a colorless oil that was taken onto the next reaction without further manipulation.  
Characterization data for aldehyde 49:  
Rf = 0.67 (30% EtOAc/hexanes, eluted twice, faintly UV active, stains blue); 
 
1H NMR (CDCl3, 600 MHz) δ 9.74 (s, 1 H), 7.39 – 7.32 (m, 2 H), 7.31 – 7.21 (m, 3 H), 
5.52 (d, J = 4.4 Hz, 1 H), 4.80 (d, J = 6.7 Hz, 1 H), 4.65 (ddd, J = 9.7, 6.4, 2.9 Hz, 1 H), 
4.48 (d, J = 2.6 Hz, 1 H), 4.22 – 4.16 (m, 2 H), 4.03 (t, J = 8.8 Hz, 1 H), 3.70 – 3.63 (m, 2 
H), 3.40 (s, 3 H), 3.40 (s, 6 H), 3.42 – 3.39 (m, 1 H), 3.36 (dd, J = 13.6, 2.8 Hz, 1 H), 
2.80 (dd, J = 13.3, 9.8 Hz, 1 H), 1.86 – 1.77 (m, 2 H), 1.70 (ddd, J = 14.1, 9.0, 2.1 Hz, 1 
H), 1.44 (ddd, J = 14.6, 9.2, 2.3 Hz, 1 H), 1.30 (s, 3 H), 1.28 (s, 3 H), 0.92 (s, 9 H), 0.89 
(s, 9 H), 0.10 (s, 3 H), 0.09 (s, 6 H), 0.07 (s, 3 H);  
 
13C NMR (CDCl3, 125 MHz) δ  210.5, 200.1, 171.2, 153.4, 135.5, 129.7, 129.1, 127.6, 
97.6, 81.1, 79.5, 78.8, 76.3, 66.5, 66.4, 59.5, 58.7, 58.5, 56.5, 56.0, 39.3, 38.5, 37.7, 26.2, 
20.2, 20.2, 18.5, 18.2, –3.6, –4.2, –4.3, –4.4;  
 
Exact Mass Calc. for C39H67NO11Si2 [M + NH4]+ 799.45909, found 799.45868 (ESI)  
2S,3R,5S,7R,8R,11S,15S,18R,Z)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5,8-bis(tert-
butyldimethylsilyloxy)-18-((tert-butyldimethylsilyloxy)methyl)-11-hydroxy-3,7-
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dimethoxy-15-(4-methoxybenzyloxy)-2-(methoxymethoxy)-10,10,16-trimethylicos-
16-ene-1,9,13-trione (50)29 
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To a stirring solution of ketone 5 (464 mg, 1.07 mmol, 2.0 equiv), diisopropylethylamine 
(151 mg, 0.335 mmol, 2.2 equiv), and Et2O (10 mL) in a flame-dried 25 mL round-
bottom flask under an atmosphere of Ar, at –78 ˚C, was added 9-BBN-OTf (290 mg, 1.07 
mmol, 2.0 equiv) dropwise via syringe.  After 1.25 h, the solution was cooled to –115 ˚C 
(EtOH/N2) and aldehyde 49 (0.534 mmol (assumed), 1.0 equiv), in Et2O (3.0 mL), was 
added dropwise via cannula down the inside of the reaction vessel.  The reaction was 
allowed to warm over 20 min to –78 ˚C, and then held at this temperature.  TLC analysis 
after 1.5 h (total) indicated complete consumption of aldehyde 49.  The reaction was 
quenched by the dropwise addition of a 1:1 mixture of MeOH and pH 7.0 buffer (3 mL), 
then warmed to 0 ˚C.  A 30% aqueous solution of H2O2 (1.5 mL) was added dropwise by 
glass pipette to the stirring reaction mixture.  The hydrolysis process was allowed to 
proceed for 1 h. The mixture was diluted with 50% EtOAc/hexanes (100 mL) and the 
layers were separated.  The organic layer was washed with a saturated aqueous solution 
of Na2S2O3 (3 × 5 mL), brine (3 × 5 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure to give a colorless oil.  Purification was accomplished by flash 
column chromatography (2.5 × 11 cm), eluting with 5% acetone/hex (100 mL), 7.5% 
acetone/hex (100 mL), 10% acetone/hex (100 mL), 12.5% acetone/hex (100 mL), 15% 
acetone/hex (100 mL), 17.5% acetone/hex (100 mL) and collecting 8 mL fractions.  The 
product containing fractions (34−53) were combined and concentrated under reduced 
pressure to give aldol adduct 50 (600 mg, 0.493 mmol, 92% yield over two steps) as an 
inseparable 20:1 mixture of diastereomers, and a colorless oil:  
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Rf = 0.23 (20% acetone/hexanes, UV active, stains purple-green in anisaldehyde);  
 
[α]20D = +1.0 (c 0.37, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.39 – 7.32 (m, 2 H), 7.32 – 7.24 (m, 3 H), 7.20 (d, J = 8.3 
Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 5.53 (d, J = 4.4 Hz, 1 H), 5.19 (d, J = 9.8 Hz, 1 H), 
4.98 (d, J = 2.0 Hz, 1 H), 4.79 (d, J = 6.8 Hz, 1 H), 4.77 – 4.83 (m, 1 H), 4.70 (d, J = 6.8 
Hz, 1 H), 4.64 (td, J = 6.5, 3.2 Hz, 1 H), 4.35 (d, J = 10.7 Hz, 1 H), 4.25 (d, J = 10.3 Hz, 
1 H), 4.21 – 4.13 (m, 3 H), 4.05 (t, J = 9.0 Hz, 1 H), 3.79 (s, 3 H), 3.70 (d, J = 10.3 Hz, 1 
H), 3.61 (ddd, J = 10.4, 4.8, 2.4 Hz, 1 H), 3.52 – 3.47 (m, 2 H), 3.40 (s, 3 H), 3.39 (s, 3 
H), 3.40 (s, 3 H), 3.44 – 3.33 (m, 1 H), 2.99 (dd, J = 15.6, 10.3 Hz, 1 H), 2.79 (dd, J = 
13.7, 9.8 Hz, 1 H), 2.58 (dd, 1 H), 2.57 – 2.50 (m, 1 H), 2.48 (dd, J = 17.1, 10.3 Hz, 1 H), 
2.27 (dd, J = 15.6, 2.9 Hz, 1 H), 1.73 (s, 3 H), 1.84 – 1.64 (m, 3 H), 1.60 – 1.50 (m, 1 H), 
1.45 – 1.36 (m, 1 H), 1.23 (s, 3 H), 1.16 – 1.07 (m, 1 H), 1.08 (s, 3 H), 0.90 (s, 9 H), 0.89 
(s, 9 H), 0.86 (s, 9 H), 0.79 (t, J = 7.3 Hz, 3 H), 0.08 (s, 3 H), 0.07 (s, 3 H), 0.05 (s, 3 H), 
0.03 (s, 6 H), 0.03 (s, 3 H);  
 
13C NMR (CDCl3, 125 MHz) δ  213.4, 209.6, 171.2, 159.3, 153.4, 135.6, 134.6, 132.7, 
130.7, 129.7, 129.6, 129.1, 127.5, 113.9, 97.6, 79.1, 78.7, 76.4, 75.5, 73.3, 72.9, 70.2, 
67.0, 66.5, 66.3, 59.7, 57.3, 56.4, 56.0, 55.4, 51.0, 47.9, 45.8, 41.8, 39.5, 37.8, 36.6, 29.1, 
26.2, 26.2, 26.1, 24.8, 22.1, 20.3, 18.7, 18.5, 18.2, 18.1, 12.0, –3.8, –4.3, –4.4, –4.4, –5.1, 
–5.1; 
 
 IR (film) 2955, 2929, 2856, 1785, 1710, 1462, 1385, 1250, 1100, 1050, 836, 776 cm–1;  
 
Exact Mass Calc. for C64H109NO15Si3 [M + Na]+ 1238.6997, found 1238.7020 (ESI)  
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(2S,3R,5S,7R,8R,11S,15S,18R,Z)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5,8-bis(tert-
butyldimethylsilyloxy)-18-((tert-butyldimethylsilyloxy)methyl)-11-
(diisopropylsilyloxy)-3,7-dimethoxy-15-(4-methoxybenzyloxy)-2-(methoxymethoxy)-
10,10,16-trimethylicos-16-ene-1,9,13-trione (54)28 
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To a stirring solution of β-hydroxy ketone 50 (457 mg, 0.376 mmol, 1.0 equiv), DMAP 
(230 mg, 1.88 mmol, 5.0 equiv), Et3N (190 mg, 1.88 mmol, 5.0 equiv), and DMF (10 
mL) in a 25 mL round-bottom flask under an atmosphere of N2, at 0 ˚C, was added 
chlorodiisopropylsilane (0.192 mL, 1.13 mmol, 3 equiv).  TLC analysis after 0.5 h 
indicated complete consumption of starting material.  The reaction mixture was poured 
into a saturated aqueous solution of NaHCO3 (10 mL) and the resulting mixture was 
extracted with 66% EtOAc/hexanes (3 × 100 mL). The combined organic layers were 
washed with brine (30 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure to give a pale yellow residue.  Purification was accomplished by flash column 
chromatography (5 × 6 cm), eluting with 10% EtOAc/hexanes (200 mL) and 20% 
EtOAc/hexanes (300 mL). The product containing fractions were combined and 
concentrated under reduced pressure to give silane 54 (485 mg, 0.364 mmol, 97%) as a 
colorless oil:  
Rf = 0.74 (30% ethyl acetate/hexanes, UV active, stains brown in anisaldehyde); 
 
[α]20D = 6.3 (c 0.57, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.38 – 7.31 (m, 2 H), 7.31 – 7.24 (m, 3 H), 7.19 (d, J = 8.5 
Hz, 2 H), 6.83 (d, J = 8.5 Hz, 2 H), 5.53 (d, J = 4.7 Hz, 1 H), 5.17 (d, J = 10.0 Hz, 1 H), 
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4.93 (d, J = 1.8 Hz, 1 H), 4.83 (dd, J = 9.8, 1.9 Hz, 1 H), 4.79 (d, J = 6.7 Hz, 1 H), 4.69 
(d, J = 6.7 Hz, 1 H), 4.56 – 4.59 (m, 1 H), 4.50 (dd, J = 6.7, 2.9 Hz, 1 H), 4.32 (d, J = 
10.8 Hz, 1 H), 4.20 (d, J = 10.8 Hz, 1 H), 4.18 – 4.15 (m, 2 H), 4.13 (s, 1 H), 4.06 (t, J = 
9.2 Hz, 1 H), 3.78 (s, 3 H), 3.75 (d, J = 10.8 Hz, 1 H), 3.58 (dd, J = 8.9, 4.5 Hz, 1 H), 
3.54 – 3.43 (m, 2 H), 3.39 (s, 3 H), 3.39 (s, 3 H), 3.38 (s, 3 H), 3.35 (d, J = 2.9 Hz, 1 H), 
2.96 (dd, J = 16.4, 10.0 Hz, 1 H), 2.78 (dd, J = 13.3, 9.8 Hz, 1 H), 2.64 – 2.48 (m, 3 H), 
2.25 (dd, J = 16.4, 2.1 Hz, 1 H), 1.84 – 1.71 (m, 2 H), 1.71 (s, 3 H), 1.68 – 1.51 (m, 2 H), 
1.33 (s, 3 H), 1.30 – 1.20 (m, 5 H), 1.07 (s, 3 H), 1.17 – 1.05 (m, 2 H), 1.04 (t, J = 6.4 Hz, 
7 H), 0.98 (d, J = 6.7 Hz, 6 H), 0.89 (br. s., 9 H), 0.89 (s, 9 H), 0.87 (s, 9 H), 0.79 (t, J = 
7.3 Hz, 3 H), 0.08 (s, 3 H), 0.07 (s, 3 H), 0.05 (s, 3 H), 0.03 (s, 9 H);  
 
13C NMR (CDCl3, 125 MHz) δ 211.9, 205.7, 171.0, 158.9, 153.1, 135.4, 134.8, 132.0, 
130.8, 129.5, 129.2, 128.9, 127.3, 113.6, 97.3, 78.9, 78.0, 76.1, 75.8, 74.9, 72.6, 69.9, 
66.7, 66.3, 66.0, 59.5, 56.5, 56.2, 55.8, 55.2, 51.9, 48.3, 47.9, 41.5, 39.4, 37.5, 36.1, 26.0, 
26.0, 25.9, 24.6, 23.1, 20.1, 18.5, 18.4, 18.0, 17.9, 17.7, 17.7, , 17.5, 17.5, 12.4, 12.3, 
11.7, –4.1, –4.3, –4.3, –4.4, –5.3, –5.4;  
 
IR (film) 2954, 2929, 2858, 1784, 1709, 1463, 1386, 1249, 1098, 1048, 834, 731 cm–1;  
Exact Mass Calc. for C70H123NO15Si4 [M + Na]+ 1352.78620, found 1352.78414 (ESI)   
 
(S)-3-((2S,3R,5S,7R,8R,11S,15S,18R,Z)-15-(4-methoxybenzyloxy)-5,8-bis(tert-
butyldimethylsilyloxy)-18-((tert-butyldimethylsilyloxy)methyl)-3,7-dimethoxy-2-
(methoxymethoxy)-10,10,16-trimethyl-9,13-dioxo-11-(triethylsilyloxy)icos-16-enoyl)-
4-benzyloxazolidin-2-one (56) 
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Aldol adduct 50 (170 mg, 0.140 mmol, 1 eq) was dissolved in 6 mL CH2Cl2 and 2,6 
lutidine (0.315 mL, 2.80 mmol, 20 eq) was added. The mixture was cooled to -78 °C and 
triethylsilyl triflate (0.16 mL, 0.70 mmol, 5.0 eq) was added. The reaction was warmed to 
0 C. After 20 minutes, TLC (10% EtOAc/hexanes) showed consumption of starting 
materials. The reaction was quenched with 1 mL NaHCO3(aq). The reaction was diluted 
with 100 mL 50% EtOAc/hexanes, washed with 2 x 25 mL saturated NaHCO3(aq), with 
25 mL brine, then dried over Na2SO4. The solvent was removed in vacuo. The residue 
was purified by flash chromatography to afford 130 mg (0.098 mmol, 70%) TES 
protected aldol 56 adduct as a clear colourless oil. 
 
Rf= 0.85 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -3.0 (c 1.1, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.35- 7.24 (m, 5H), 7.17 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 
8.5 Hz, 2H), 5.52 (d, J = 4.8 Hz, 1H), 5.16 (d, J = 10.1 Hz, 1H), 4.99 (s, 1H), 4.82 (d, J = 
8.1 Hz, 1H), 4.78 (d, J = 6.9 Hz, 1H), 4.68 (d, J = 6.9 Hz, 1H), 4.68- 4.60 (m, 1H), 4.31 
(d, J = 11.0 Hz, 1H), 4.28 (d, J = 7.3 Hz, 1H), 4.18 (d, J = 10.8 Hz, 1H), 4.17- 4.14 (m, 
2H), 4.03 (t, J = 8.9 Hz, 1H), 4.87- 4.82 (m, 1H), 3.78 (s, 3H), 3.71 (d, J = 10.7 Hz, 1H), 
3.57 (ddd, J = 8.7, 4.9, 3.0 Hz, 1H), 3.51- 3.46 (m, 1H), 3.38 (s, 3H), 3.38 (s, 3H), 3.37 
(s, 3H), 2.94 (dd, J = 16.2, 10.0 Hz, 1H), 2.87 (dd, J = 13.5, 10.0 Hz, 1H), 2.69 (d, J = 
16.5 Hz, 1H), 2.58- 2.50 (m, 1H), 2.46 (dd, J = 18.6, 7.6 Hz, 1H), 2.16 (dd, J = 16.0, 2.0 
Hz, 1H), 1.70 (s, 3H), 1.84- 1.67 (m, 2H), 1.57- 1.46 (m, 3H), 1.36 (s, 3H), 0.96 (s, 3H), 
0.92 (ap. t, J = 8.0 Hz, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.97 (t, J = 7.5 Hz, 
3H), 0.64- 0.59 (m, 6H), 0.06 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H), 0.03 (s, 3H), 0.02 (s, 
3H), 0.02 (s, 3H); 
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13C NMR (125 MHz, CDCl3) δ 212.0, 205.9, 171.0, 158.9, 153.1, 135.4, 134.8, 132.0, 
130.8, 129.5, 129.2, 129.0, 127.3, 113.6, 97.3, 78.9, 77.7, 76.1, 75.8, 74.3, 72.6, 72.2, 
69.9, 66.7, 66.3, 66.0, 59.6, 56.4, 56.2, 55.8, 55.2, 51.4, 48.9, 47.9, 41.5, 39.4, 37.6, 35.8, 
34.7, 27.4, 26.0, 25.9, 25.2, 24.6, 23.2, 22.6, 21.1, 18.4 (2 signals), 18.0, 17.9, 11.6, 7.1, 
5.1, -4.0, -4.3 (2 signals), -4.5, -5.3(2 signals); 
 
IR(film) 2955.5, 2856.9, 1785.4, 1709.8, 1514.5, 1463.1, 1387.6, 1250.1, 1100.2, 1049.7, 
1006.2, 836.4, 776.2 cm-1; 
 
Exact Mass Calc. for C70H123NO15Si4 [M + Na]+ : 1347.83080 ; found: 1347.83036 (ESI) 
i292 CSA TES cleave/ DMP oxidation. 20 mg  
(S)-4-benzyl-3-((2S,3R,5S,7R,8R,9S)-9-(benzyloxy)-5,8-bis(tert-
butyldimethylsilyloxy)-11-hydroxy-3,7-dimethoxy-2-(methoxymethoxy)-10,10-
dimethylundecanoyl)oxazolidin-2-one) (S6) 
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Compound 47 (37 mg, 0.037 mmol) was dissolved in 2 mL 1:1 MeOH/ CH2Cl2 and 
cooled to 0 °C. To the mixture was added 0.9 mg CSA (0.004 mmol, 0.1 eq). TLC 
analysis (30% EtOAc/hexanes, CAM) showed consumption of starting material after 20 
minutes. The reaction was diluted with 20 mL 50% EtOAc/hexanes and washed 2x 5mL 
sat NaHCO3(aq) then brine, then dried over Na2SO4. The solvent was removed in vacuo 
and the residue was purified by flash chromatography (20% EtOAc/hexanes) to afford 20 
mg alcohol S6 (0.023 mmol, 62%) as a clear colourless oil. 
 
Rf = 0.60 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
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[α]20D = +26.4 (c 0.25, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.30- 7.22 (m, 10H), 5.45 (d, J = 4.5 Hz, 1H), 5.02 (d, J = 
11.4, 1H), 4.77 (d, J = 6.7 Hz, 1H), 4.68 (d, J = 6.9 Hz, 1H), 4.58- 4.53 (m, 1H), 4.48 (d, 
J = 11.4 Hz, 1H), 4.22- 4.19 (m, 1H), 4.18- 4.08 (m, 3H), 3.74 (ap. d, J = 10.2, 1H), 3.59 
(ddd, J = 10.5, 4.2, 1.7 Hz, 1H), 3.39 (s, 3H), 3.37 (s, 3H), 3.36 (s, 3H), 3.46- 3.40 (m, 
1H), 2.77 (dd, J = 13.3, 9.7 Hz, 1H), 2.58 (br. s, 1H), 1.92- 1.78 (m, 2H), 1.62- 1.50 (m, 
2H), 1.01 (s, 6H), 0.94 (s, 9H), 0.85 (s, 9H), 0.11 (s, 3H), 0.11 (s, 3H), 0.07 (s, 3H), 0.05 
(s, 3H);  
 
13C NMR (125 MHz, CDCl3) δ 170.9, 153.1, 138.6, 135.3, 129.5, 129.0, 128.3, 127.9, 
127.4, 127.3, 97.2, 90.5, 79.3, 79.0, 76.6, 75.6, 73.7, 71.0, 66.4, 66.3, 59.5, 57.2, 56.2, 
55.8, 40.4, 39.6, 38.1, 37.5, 29.7, 26.1, 26.0, 23.9, 21.6, 18.2, 18.0, -3.8, -4.2, -4.4, -4.5;  
 
IR(film) 2927.7, 1786.2, 1463.2, 1254.9, 1111.9, 836.1, 775.2 cm-1; 
 
Exact Mass Calc. for C46H77NO11Si2 [M + Na]+ : 898.4927; found: 898.49100 (ESI) 
 
(3S,4R,5R,7S,9R,10S)-11-((S)-4-benzyl-2-oxooxazolidin-3-yl)-3-(benzyloxy)-4,7-
bis(tert-butyldimethylsilyloxy)-5,9-dimethoxy-10-(methoxymethoxy)-2,2-dimethyl-
11-oxoundecanal (58) 
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Compound S6 (20 mg, 0.023 mmol) was dissolved in 5 mL CH2Cl2 that had been 
saturated with H2O by agitation in a separatory funnel. To the mixture at ambient 
temperature was added Dess- Martin Periodinane (50 mg, 0.118 mmol, 5.1 eq). TLC 
analysis (30% EtOAc/hexanes, CAM) after 1.5 hours shows complete consumption of 
starting material. The reaction was quenched by dilution with 5 mL CH2Cl2 and 2 mL 
Hexanes, and the addition of 1 mL 10% Na2SO3(aq) and 1 mL saturated Na2S2O3(aq). The 
biphasic mixture was stirred until both layers were clear and the layers were separated. 
The aqueous layer was extracted with 2x 10 mL CH2Cl2 and the combined organic layers 
were washed with saturated NaHCO3(aq) and brine then dried over Na2SO4. Concentration 
in vacuo yielded a residue that was purified by flash chromatography (20% 
EtOAc/hexanes) to yield 20 mg aldehyde 58 (0.023 mmol) as a clear colourless oil. 
 
Rf = 0.65 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +19.5 (c 0.22, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 9.75 (s, 1H), 7.39- 7.23 (m, 10H), 5.47 (d, J = 4.6 Hz, 
1H), 4.98 (d, J = 11.4 Hz, 1H), 4.75 (d, J = 6.9 Hz, 1H), 4.67 (d, J = 6.9 Hz, 1H), 4.60- 
4.54 (m, 1H), 4.51 (d, J = 11.5 Hz, 1H), 4.18- 4.06 (m, 3H), 4.00 (d, J = 4.1 Hz, 1H), 
3.70 (d, J = 5.5 Hz, 1H), 3.59 (ap. d, J = 10.5 Hz, 1H), 3.55 (ap. dd, J = 10.5, 4.1 Hz, 
1H), 3.37 (s, 3H), 3.37 (s, 3H), 3.33 (s, 3H), 2.78 (dd, J = 13.3, 9.6 Hz, 1H), 1.90- 1.75 
(m, 2H), 1.72- 1.59 (m, 2H), 1.17 (s, 3H), 1.13 (s, 3H), 0.91 (s, 9H), 0.84 (s, 9H), 0.12 (s, 
3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.02 (s, 3H);  
 
13C NMR (125 MHz, CDCl3) δ 203.9, 170.9, 153.1, 138.4, 135.3, 129.5, 129.0, 128.3, 
128.2, 127.4, 127.3, 127.1, 97.3, 85.8, 79.4, 77.8, 76.2, 75.1, 74.1, 66.3, 59.3, 57.3, 56.2, 
55.8, 50.0, 50.1, 37.9, 37.6, 29.7, 26.3, 26.0, 18.7, 18.4, 18.0, 14.1, -3.5, -4.0, -4.3, -4.4; 
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IR(film) 2927.5, 2855.0, 1789.5, 1714.7, 1257.5, 1104.4 cm-1; 
Exact Mass Calc. for C46H75NO11Si2 [M + Na]+ : 896.47709;  found: 896.4741 (ESI) 
 
i293-i296  Aldol attempts on B benzyloxy aldehyde 
Aldol attempt with 9-BBN triflate 
Ketone 5 (40 mg, 0.092 mmol, 4 eq) was dissolved in 1 mL Et2O and cooled to -78 °C. 
To this solution was added Hunig’s base (18 µL, 0.101 mmol, 4.4 eq) and 9-BBN triflate 
(19.2 µL, 0.090 mmol, 3.9 eq). The reaction was allowed to stir for 1 hour at -78 °C after 
which time β benzyloxy aldehyde 58 (20 mg, 0.023 mmol, 1 eq) was added dropwise in 1 
mL Et2O. TLC (15% EtOAc/hexanes, run 3 times, anisaldehyde) showed no consumption 
of aldehyde after 3 hours. The reaction was quenched with saturated NH4Cl(aq), and 
purfication by flash chromatography (10% to 15% EtOAc/hexanes) allowed recovery of 
Ketone 5 (32 mg, 80%) and aldehyde 58 (20 mg, 100%). 
 
Aldol attempt with Bu2BOTf 
Ketone 5 (16 mg, 0.037 mmol, 3.2 eq) was dissolved in 1 mL Et2O and cooled to -78 °C. 
To this solution was added triethylamine (5.7 µL, 0.045 mmol, 3.9 eq) and dibutylboron 
triflate (8.75 µL, 0.036 mmol, 3.1 eq). The reaction was allowed to stir for 0.5 hour at -78 
°C after which time β benzyloxy aldehyde 58 (10 mg, 0.0115 mmol, 1 eq) was added 
dropwise in 1 mL Et2O. TLC (15% EtOAc/hexanes, run 3 times, anisaldehyde) showed 
no consumption of aldehyde after 3 hours. The reaction was quenched with saturated 
NH4Cl(aq), and 1H NMR spectroscopy showed no new products derived from the 
aldehyde. 
 
Aldol attempt with Cy2BCl 
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Ketone 5 (24 mg, 0.0552 mmol, 4 eq) was dissolved in 1 mL Et2O and cooled to 0 °C. To 
this solution was added triethylamine (9 µL, 0.066 mmol, 4.8 eq) and dicyclohexylboron 
chloride (13 µL, 0.060 mmol, 4.4 eq). A voluminous white precipitate instantly formed. 
The reaction was allowed to stir for 0.5 hour at 0 °C, then was cooled to -78 ºC after 
which time β benzyloxy aldehyde 58 (12 mg, 0.0137 mmol, 1 eq) was added dropwise in 
1 mL Et2O. TLC (15% EtOAc/hexanes, run 3 times, anisaldehyde) showed no 
consumption of aldehyde after 1 hour. The reaction was warmed to 0 ºC for 3 hours, after 
which time TLC showed no progress.  The reaction was quenched with saturated 
NH4Cl(aq), and 1H NMR spectroscopy showed the aldehyde was unconsumed. 
 
 
 
 
(S)-3-((2S,3R,5S,7R,8R,11S,15S,18R,Z)-5,8-bis(tert-butyldimethylsilyloxy)-18-((tert-
butyldimethylsilyloxy)methyl)-11,15-dihydroxy-3,7-dimethoxy-2-
(methoxymethoxy)-10,10,16-trimethyl-9,13-dioxoicos-16-enoyl)-4-benzyloxazolidin-
2-one) (61) 
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Aldol adduct 50 (42 mg, 0.0034 mmol, 1 eq) was dissolved in 4 mL CH2Cl2 and 1 mL pH 
7 phosphate buffer was added. To the vigorously stirring mixture were added 3 7.8 mg 
aliquots of DDQ (0.034 mmol, 1.0 eq each). After 1.5 hours, NMR of an aliquot showed 
complete consumption of the starting material. The reaction was diluted with 50 mL 50% 
EtOAc/hexanes and washed with 3x10 mL saturated NaHCO3(aq), then brine, then dried 
over Na2SO4. Concentration in vacuo yielded a residue that was purified by flash 
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chromatography (10% to 25% to 40% EtOAc/hexanes) to yield 30 mg of seco acid 
precursor 61 (0.027 mmol, 83%) as a clear colourless oil. 
Rf = 0.23 (20% acetone/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +7.4 (c 1.45, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.36- 7.24 (m, 5H), 5.52 (d, J = 4.7 Hz, 1H), 4.98- 4.94 
(m, 3H), 4.79 (d, J = 6.9 Hz, 1H), 4.69 (d, J = 6.9 Hz, 1H), 4.66- 4.62 (m, 1H), 4.33 (d, J 
= 8.6 Hz, 1H), 4.22- 4.16 (m, 2H), 4.08- 4.02 (m, 1H), 3.72 (d, J = 10.4 Hz, 1H), 3.61 
(ddd, J = 10.5, 4.7, 2.2 Hz, 1H), 3.59- 3.55 (m, 2H), 3.42 (s, 3H), 3.40 (s, 3H), 3.39 (s, 
3H), 3.36 (dd, J = 3.2, 13.5 Hz, 1H), 3.30 (t, J = 9.2 Hz, 1H), 3.09 (br. s, 1H), 2.89 (dd, J 
= 16.0, 9.6 Hz, 1H), 2.79 (dd, J = 13.4, 10.0 Hz, 1H), 2.63- 2.53 (m, 2H), 2.44 (dd, J =  
6.0, 3.6 Hz, 1H), 1.83- 1.75 (m, 2H), 1.73 (s, 3H), 1.70- 1.64 (m, 1H), 1.45- 1.34 (m, 2H), 
1.26 (s, 3H), 1.16 (s, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.87- 0.84 (m, 21H), 0.08 (s, 3H), 
0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H), 0.04 (s, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 213.4, 210.7, 138.0, 131.7, 96.6, 78.5, 78.2, 76.2, 75.0, 
72.6, 66.8, 66.2, 65.4, 58.8, 56.9, 56.4, 50.9, 47.3, 45.4, 41.9, 39.3, 36.6, 36.4, 31.6, 26.0, 
25.9, 25.9, 25.8, 24.5, 22.0, 20.1, 18.6, 18.5, 18.3, 17.9, 14.1, 11.8, -4.1, -4.4, -4.5, -4.7 (2 
signals), -5.4, -5.5; 
 
IR(film) 3492.9, 2930.1, 2857.1 1784.9, 1709.9, 1470.0, 1389.3, 1255.2, 1104.3, 1051.5, 
837.0 776.4 cm-1; 
 
Exact Mass Calc. for C56H101NO14Si3 [M + Na]+ : 1118.64221 ; found: 1118.64533 (ESI) 
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(2S,3R,5S,7R,8R,11S,15S,18R,Z)-5,8-bis(tert-butyldimethylsilyloxy)-18-((tert-
butyldimethylsilyloxy)methyl)-11,15-dihydroxy-3-methoxy-7-methoxy)-2-
(methoxymethoxy)-10,10,16-trimethyl-9,13-dioxoicos-16-enoic acid (62) 
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Seco acid precursor 61 (30 mg, 0.027 mmol, 1 eq) was dissolved in 1 mL THF and 0.2 
mL H2O was added. The mixture was cooled to 0 °C and 10 drops 30% H2O2(aq) were 
added, followed by 5 drops 1M LiOH(aq). After 18 hours TLC (30% EtOAc/hexanes) 
showed consumption of the starting material. The reaction was made neutral to 
KI/KIO3/starch peroxide test strips by the addition of 10% Na2SO3(aq) and acidified to pH 
paper by the addition of NaHSO4(aq). The mixture was extracted with 120 mL 75% 
EtOAc/hexanes and concentrated in vacuo. The residue was purified by flash 
chromatography (15% to 20% acetone/hexanes) to afford 19 mg seco acid 62 (0.020 
mmol, 74%) as a clear colourless oil.  
 
Rf = 0.55 (40% acetone/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -21 (c 0.95, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 5.01 (s, 1H), 4.96 (ap.d, J = 9.5 Hz, 2H), 4.78 (d, J = 6.9 
Hz, 1H), 4.69 (d, J = 6.9 Hz, 1H), 4.31 (d, J = 9.8 Hz, 1H), 4.18 (d, J = 2.8 Hz, 1H), 4.04- 
3.99 (m, 1H), 3.73- 3.68 (m, 2H), 3.58 (dd, J = 9.5, 5.0 Hz, 1H), 3.43 (s, 3H), 3.41 (s, 
3H), 3.41- 3.40 (m, 4H), 3.28 (t, J = 9.1 Hz, 1H), 2.90 (dd, J = 16.0, 9.3 Hz, 1H), 2.62 
(ap. d, J = 15.7 Hz, 1H), 2.59- 2.52 (m, 2H), 2.44 (dd, J = 16.1, 3.7 Hz, 1H), 1.87- 1.77 
(m, 2H), 1.72 (s, 3H), 1.70- 1.64 (m, 1H), 1.45- 1.38 (m, 2H), 1.25 (s, 3H), 1.17 (s, 3H), 
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1.16- 1.09 (m, 2H), 0.89 (s, 9H), 0.87 (s, 9H), 0.87- 0.83 (m, 21H), 0.07 (s, 6H), 0.05 (s, 
3H), 0.04 (s, 3H), 0.03 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 213.4, 210.7, 138.0, 131.7, 96.6, 78.5, 78.2, 76.1 72.6, 
66.8, 66.2, 65.4, 58.8, 56.9, 56.4, 50.9, 47.3, 45.3, 41.9, 39.3 36.6, 36.4, 31.6, 26.0, 25.8, 
24.5, 22.0, 20.1, 18.6, 18.5, 18.3, 17.9, 14.1, 11.8, -4.1, -4.4, -4.7 (2 signals), -5.4 (2 
signals); 
 
IR(film) 3468.0, 2956.1, 2857.1, 1710.6, 1472.0, 1254.8, 1100.7, 836.6, 776.1cm-1; 
Exact Mass Calc. for C46H92O13Si3 [M + Na]+ : 959.57379;  found : 959.57364 (ESI) 
 
 
(S)-3-((2S,3R,5S,7R,8R,11S,15S,18R,Z)-5,8-bis(tert-butyldimethylsilyloxy)-18-((tert-
butyldimethylsilyloxy)methyl)-15-hydroxy-3,7-dimethoxy-2-(methoxymethoxy)-
10,10,16-trimethyl-9,13-dioxo-11-(triethylsilyloxy)icos-16-enoyl)-4-benzyloxazolidin-
2-one (64) 
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PMB ether 56 (130 mg, 0.098 mmol, 1 eq) was dissolved in 12 mL CH2Cl2 and 4 mL pH 
7 phosphate buffer was added. To the rapidly stirring biphasic mixture was added 3 22 
mg aliquots of DDQ at 15 minute intervals (0.098 mmol, 1.0 eq each). After one hour, 
TLC showed completion so the reaction was diluted with 50 mL 50% EtOAc/hexanes 
and washed with 2x25 mL saturated NaHCO3(aq), and 25 mL brine, then dried over 
Na2SO4. The solvent was removed in vacuo  and the residue was purified by flash 
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chromatography on silica gel (5% to 10% to 15% to 35% EtOAc/hexanes). Concentration 
yielded 90 mg of seco acid precursor 64  (0.078 mmol, 80 %) as a tan foam. 
 
[α]20D = -5.8 (c 1.5, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.35- 7.23 (m, 5H), 5.52 (d, J = 5.0 Hz, 1H), 5.00- 4.96 
(m, 1H), 4.94 (d, J = 10.8 Hz, 1H), 4.78 (d, J =6.7 Hz, 1H), 4.68 (d, J = 6.7 Hz, 1H), 
4.65- 4.60 (m, 1H), 4.30 (dd, J = 7.3, 2.3 Hz, 1H), 4.17- 4.15 (m, 2H), 4.03 (ap. t, J = 9.3 
Hz, 1H), 3.77 (d, J = 10.7 Hz, 1H), 3.58 (ddd, J = 10.4, 4.7, 2.0 Hz, 1H), 3.51 (dd, J = 
9.7, 5.7 Hz, 1H), 3.38 (s, 6H), 3.37- 3.32 (m, 2H), 2.88 (d, J = 1.3 Hz, 1H), 2.81- 2.74 
(m, 2H), 2.69 (dd, J = 18.1, 2.2 Hz, 1H), 2.54- 2.47 (m, 1H), 2.36 (dd, J = 16.7, 3.2 Hz, 
1H), 1.81- 1.72 (m, 1H), 1.71 (s, 3H), 1.68- 1.62 (m, 1H), 1.50- 1.43 (m, 1H), 1.37 (s, 
3H), 1.27- 1.20 (m, 1H), 1.14 – 1.07 (m, 1H), 1.00 (s, 3H), 0.94 (ap.t, J = 7.9 Hz, 1H), 
0.90 (s, 9H), 0.87 (s, 9H), 0.86 (s, 9H), 0.82 (t, J = 7.5 Hz, 3H), 0.06 (s, 3H), 0.05 (s, 3H), 
0.05 (s, 6H), 0.03 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 212.2, 208.3, 171.0, 153.1, 137.7, 135.4, 130.6, 129.5, 
128.9, 127.3, 97.3, 78.9, 77.9, 76.1, 75.8, 74.0, 66.7, 66.3, 66.0, 65.1, 59.5, 56.5, 56.2, 
55.8, 51.3, 48.5, 47.7, 41.9, 39.3, 37.5, 35.9, 26.0 (2 signals), 25.8, 24.5, 23.4, 20.6, 18.5, 
18.3, 18.2, 17.9, 11.7, 7.1, 5.1, -4.1, -4.4, -4.5, -5.5; 
 
IR(film) 3514.5, 2956.2, 2857.5, 1786.0, 1710.1, 1462.4, 1389.5, 1254.8, 1101.7, 1006.0, 
836.8, 776.4, 736.2 cm-1; 
 
Exact Mass Calc. for C62H115NO14Si4 [M + Na]+ : 1232.72796; found 1232.72796 (ESI) 
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(2S,3R,5S,7R,8R,11S,15S,18R,Z)-5,8-bis(tert-butyldimethylsilyloxy)-18-((tert-
butyldimethylsilyloxy)methyl)-15-hydroxy-3,7-dimethoxy-2-(methoxymethoxy)-
10,10,16-trimethyl-9,13-dioxo-11-(triethylsilyloxy))icos-16-enoic acid (65) 
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Seco acid precursor 64 (45 mg, 0.0391 mmol) was dissolved in 2 mL THF and cooled to 
0 °C. To this reaction were added 10 drops H2O2 and 5 drops 1M LiOH(aq). The reaction 
was stirred at 0 °C for 12 hours after which time TLC showed completion. The reaction 
was made neutral to KI/KIO3/starch peroxide test strips by the addition of saturated 
Na2SO3(aq) and then acidic to pH paper by the addition of NaHSO4(aq). The mixture was 
extracted with 3x 30 mL 90% EtOAc/hexanes and washed with brine, dried over Na2SO4 
then concentrated in vacuo. A sample from an earlier batch was purified for 
characterization by flash chromatography (30% EtOAc/hexanes), and the analytical data 
is given below, but in practice the oxazolidinone containing residue was used directly in 
the next step.  
Rf = 0.15 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -110 (c 0.95, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 5.00 (dd, J = 9.3, 3.2 Hz, 1H), 4.96 (s, 1H), 4.94 (d, J = 
10.7 Hz, 1H), 4.79 (d, J = 6.9 Hz, 1H), 4.69 (d, J = 6.9 Hz, 1H), 4.34 (dd, J = 7.3, 1.9 Hz, 
1H), 4.19 (d, J = 3.2 Hz, 1H), 4.03- 3.99 (m, 1H), 3.71- 3.66 (m, 1H), 3.66 (d, J = 10.6 
Hz, 1H), 3.52 (dd, J = 9.5, 5.6 Hz, 1H), 3.43 (s, 3H), 3.40 (s, 6H), 3.33 (ap. t, J = 8.3 Hz, 
1H), 2.80 (dd, J = 17.0, 9.5 Hz, 1H), 2.65 (dd, J = 18.0, 2.0 Hz, 1H), 2.56- 2.46 (m, 1H), 
2.37 (dd, J = 17.0, 3.2 Hz, 1H), 1.86- 1.75 (m, 1H), 1.71 (s, 3H), 1.71- 1.64 (m, 1H), 
1.49- 1.43 (m, 1H), 1.39- 1.30 (m, 1H), 1.36 (s, 3H), 1.14- 1.07 (m, 1H), 1.02 (s, 3H), 
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0.94 (ap. t, J = 8.2 Hz, 9H), 0.90 (s, 9H), 0.87 (s, 9H), 0.87 (s, 9H), 0.83 (t, J = 7.4 Hz, 
3H), 0.66- 0.59 (m, 6H), 0.07 (s, 6H), 0.06 (s, 6H), 0.04 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 212.5, 208.0, 172.3,137.7, 130.9, 96.6, 78.6, 78.1, 75.9, 
73.7, 66.7, 66.1, 65.1, 58.9, 56.7, 56.4, 51.8, 48.5, 47.6, 41.8, 39.6, 36.4, 26.0, 25.9, 25.8, 
24.5, 23.4, 20.3, 18.5, 18.3 (2 signals), 17.9, 11.7, 7.1, 5.1, -4.1, -4.4(2 signals), -5.4; 
 
IR(film) 3420, 2956.4, 2857.9, 1712.7, 1472.4, 1361.6, 1252.7, 1100.1, 1005.9, 836.6, 
776.3 cm-1; 
 
Exact Mass Calc. for C52H106O13Si4 [M + Na]+ : 1073.66027;  found 1073.65953 (ESI) 
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The residue from the preceding reaction (0.0391 mmol, theory, 1 eq) was dissolved in 2 
mL THF and to this mixture was added  Hunig’s base (20.4 µL, 3 theoretical eq). The 
reaction was stirred for 25 minutes, then 2,4,6-trichlorobenzoylchloride (15.2 µl, 0.0977 
mmol, 2.5 theoretical eq) was added. The reaction was stirred for 1 hour and 40 minutes, 
then diluted with 20 mL toluene. This solution was added to a solution of DMAP (17 mg, 
0.14 mmol, 3.5 theoretical eq) in 5 mL toluene at 60 °C at the rate of 5 mL/hr.  The 
syringe and needle were rinsed with 5 mL toluene. The reaction was stirred for 15 hours 
after completion of the addition. The reaction was concentrated in vacuo and the residue 
was purified by flash chromatography over silica gel (5% EtOAc/hexanes) to afford 21 
mg of macrolactone 66 (0.020 mmol, 51% over 2 steps) as a clear colourless 
 oil. 
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Rf = 0.90 (30% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -26.7 (c 0.355, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.04 (d, J = 10.1 Hz, 1H), 5.09 (d, J = 10.1 Hz, 1H), 4.71 
(d, J = 6.8 Hz, 1H), 4.66 (d, J = 6.8 Hz, 1H), 4.57 (d, J = 6.0 Hz, 1H), 4.50 (br. s, 1H), 
3.96 (d, J = 4.5 Hz, 1H), 3.93- 3.87 (m, 1H), 3.74 (dd, J = 10.1, 3.8 Hz, 1H), 3.67 (d, J = 
10.4 Hz, 1H), 3.54 (s, 3H), 3.39 (s, 3H), 3.37 (s, 3H), 3.43- 3.30 (m, 3H), 3.06 (dd, J = 
16.2, 11.6 Hz, 1H), 2.62- 2.55 (m, 1H), 2.54 (d, J = 7.0 Hz, 1H), 2.50 (ap. d, J = 19.0 Hz, 
1H), 2.10 (dd, J = 16.3, 1.6 Hz, 1H), 1.79- 1.74 (m, 1H), 1.74- 1.69 (m, 1H), 1.65 (br. s, 
3H), 1.59- 1.54 (m, 1H), 1.46 (t, J = 10.6 Hz, 3H), 1.27 (s, 3H), 1.25 (s, 3H), 0.95 (s, 9H), 
0.91 (s, 9H), 0.92- 0.87 (m, 9H), 0.89 (s, 9H), 0.77 (t, J = 7.5 Hz, 3H), 0.62- 0.52 (m, 
6H), 0.11 (s, 6H), 0.09 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 214.4, 203.8, 168.1, 132.2, 131.0, 96.6, 79.8, 78.4, 70.7, 
68.7, 67.5, 65.7, 59.4, 58.3, 56.1, 53.1, 50.8, 45.5, 41.8, 38.7, 38.5, 29.7, 26.2, 26.1, 26.0 
(2 signals), 25.9, 25.7, 24.4, 24.0, 18.4, 18.2, 18.1, 17.8, 16.1, 11.9, 7.2, 5.3, 5.1, -3.7, -
4.2 (2 signals), -4.9, -5.3, -5.4; 
 
IR(film) 3413.8, 2955.7, 2857.0, 1741.5, 1724.0, 1472.0, 1383.9, 1251.6, 1100.9, 836.2  
cm-1; 
 
Exact Mass Calc. for C50H100O12Si4 [M + Na]+ : 1050.7076; found: 1055.6490 (ESI) 
 (2S,3R,5S,7R,8R)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5,8-bis(tert-
butyldimethylsilyloxy)-10-((4S,6R)-6-((2S,5R,Z)-5-((tert-
butyldimethylsilyloxy)methyl)-2-(4-methoxybenzyloxy)-3-methylhept-3-enyl)-2,2-
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diisopropyl-1,3,2-dioxasilinan-4-yl)-3,7-dimethoxy-2-(methoxymethoxy)-10-
methylundecane-1,9-dione (55) 
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To a solution of silane 54 (180 mg, 0.135 mmol, 1.0 equiv) and CH2Cl2 (6.0 mL) in a 25 
mL round-bottom flask, at –78 ˚C, was added a 1.0 M solution (CH2Cl2) of SnCl4 (13.5 
µL). The reaction was allowed to proceed for 2 h and then quenched by the addition of a 
saturated aqueous solution of NaHCO3 (1 mL). The resulting mixture was diluted with 
50% EtOAc/hexanes (45 mL) and then agitated. The resulting mixture was washed with a 
saturated aqueous NaHCO3 (2 × 5 mL), brine (10 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure to give disilyloxane 55 as a clear and  colorless oil 
that could be used without further purification (171 mg, 0.128 mg, 95%).  
 
Rf = 0.74 (30% ethyl acetate/hexanes, UV active, stains blue in CAM);  
 
[α]20D = 11.0  (c 1.8, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.36 – 7.31 (m, 2 H), 7.29 – 7.26 (m, 3 H), 7.25 (d, J = 8.8 
Hz, 2 H), 6.85 (d, J = 8.8 Hz, 2 H), 5.53 (d, J = 5.0 Hz, 1 H), 5.32 (d, J = 9.4 Hz, 1 H), 
4.94 (d, J = 2.1 Hz, 1 H), 4.78 (d, J = 6.7 Hz, 1 H), 4.68 (d, J = 6.7 Hz, 1 H), 4.64 – 4.60 
(m, 1 H), 4.50 (dd, J = 5.0, 9.7 Hz, 1 H), 4.46 (d, J = 10.8 Hz, 1 H), 4.40 (d, J = 11.4 Hz, 
1 H), 4.19 (d, J = 11.1 Hz, 1 H), 4.17 – 4.15 (m, 2 H), 4.10 – 4.05 (m, 2 H), 3.80 (s, 3 H), 
3.80 – 3.75 (m, 2 H), 3.59 – 3.56 (m, J = 2.1 Hz, 1 H), 3.55 – 3.51 (m, 1 H), 3.50 – 3.46 
(m, 1 H), 3.39 (s, 3 H), 3.38 (s, 3 H), 3.38 (s, 3 H), 3.37 – 3.32 (m, 2 H), 2.78 (dd, J = 
13.5, 9.7 Hz, 1 H), 2.61 – 2.53 (m, 1 H), 2.21 – 2.15 (m, 1 H), 1.89 – 1.83 (m, 1 H), 1.81 
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– 1.72 (m, 1 H), 1.66 (s, 3 H), 1.64 – 1.58 (m, 2 H), 1.57 – 1.51 (m, 1 H), 1.35 – 1.30 (m, 
2 H), 1.27 – 1.21 (m, 2 H), 1.18 (s, 3 H), 1.16 (s, 3 H), 1.00 – 0.95 (m, 12 H), 0.88 (m, 18 
H), 0.86 (s, 9 H), 0.84 (t, J = 7.3 Hz, 3 H), 0.07 (s, 3 H), 0.07 (s, 3 H), 0.03 (s, 3 H), 0.02 
(s, 3 H), 0.01 (s, 3 H), 0.01 (s, 3 H);  
 
13C NMR (CDCl3, 125 MHz) δ 212.0, 171.1, 158.9, 153.1, 135.4, 134.0, 133.9, 131.3, 
129.5, 129.0, 128.9, 127.3, 113.7, 97.3, 78.9, 78.1, 76.1, 75.4, 74.2, 72.5, 69.4, 68.2, 66.3, 
66.3, 66.0, 59.5, 56.5, 56.2, 55.8, 55.2, 51.6, 40.7, 40.1, 39.4, 37.5, 36.0, 35.3, 26.0, 25.9, 
25.8, 24.8, 21.7, 18.6, 18.4, 18.0, 17.5, 16.9, 16.9, 16.8, 16.7, 13.6, 13.1, 11.2, –4.1, –4.4, 
–4.5, –5.3, –5.3; 
 
IR (film) 3478, 2954, 2929, 2856, 1783, 1708, 1514, 1301, 1153, 1097, 834, 774 cm–1; 
Exact Mass Calc. for C70H123NO15Si4 [M + Na]+ 1352.78620, found 1352.78414.   
(2S,3R,5S,7R,8R,11S,13S,15S,18R,Z)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5,8-
bis(tert-butyldimethylsilyloxy)-18-((tert-butyldimethylsilyloxy)methyl)-11-hydroxy-
3,7,13-trimethoxy-15-(4-methoxybenzyloxy)-2-(methoxymethoxy)-10,10,16-
trimethylicos-16-ene-1,9-dione (69) 
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To a stirring solution of 55 (116 mg, 0.0871 mmol, 1.0 equiv) and THF (2.0 mL) at  0 ˚C 
was added a 1.0 M solution (THF) of acetic acid (0.52 mL, 0.52 mmol, 6.0 eq), followed 
by 1.0 M solution (THF) of TBAF (0.52 mL, 0.52 mmol, 6.0 eq).  After 1 h and 20 min, 
TLC indicated complete consumption of the starting material. The reaction was quenched 
by the addition of a saturated aqueous layer of NH4Cl (2.0 mL) and the resulting mixture 
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was diluted with 75% EtOAc/hexanes (40 mL). The mixture was washed with a saturate 
aqueous solution of NH4Cl (2 × 10 mL), brine (10 mL), and dried over Na2SO4, filtered, 
and concentrated under reduced pressure (with a PhH azeotrope) to yield a gummy oil 51 
(120 mg) that was immediately subjected to the next reaction. 
 
To a stirring solution of crude diol 51 (0.0871 mmol (assumed), 1.0 equiv) and CH2Cl2 
(3.0 mL) in a foil-wrapped round-bottom flask was added proton sponge® (280 mg, 1.3 
mmol, 15 equiv). Trimethyloxonium tetrafluoroborate (130 mg, 0.87 mmol, 10 equiv) 
were then added to the reaction mixture. The reaction was allowed to proceed at rt for 30 
min, after which time TLC analysis indicated complete consumption of diol 51. The 
reaction was quenched by filtration through a pad of celite into a saturated aqueous 
solution of NaHCO3 (2.0 mL). The celite pad was washed with EtOAc (10 mL). The 
mixture was extracted with 50% EtOAc/hexanes (50 mL).  The organic layer was washed 
with pH 2 buffer (2 × 5 mL), brine (10 mL), dried over Na2SO4, filtered and concentrated 
under reduced pressure to a brown gum.  Purification was accomplished by flash column 
chromatography (1.5 × 12 cm), eluting with 10% EtOAc/hexanes (100 mL), 15% 
EtOAc/hexanes (100 mL), 20% EtOAc/hexanes (100 mL), 25% EtOAc/hexanes (100 
mL) and collecting 10 mL fractions. The product containing fractions were combined and 
concentrated under reduced pressure to give methyl ether 69 (75mg, 0.061mmol, 70% 
over 2 steps) as a clear and colorless oil:  
 
Rf = 0.52 (30% ethyl acetate/hexanes, UV active, stains blue in CAM);  
 
[α]20D = –5.2  (c 0.35, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.36 – 7.30 (m, 3 H), 7.24 (d, J = 8.5 Hz, 2 H), 7.29 – 7.22 
(m, 2 H), 6.85 (d, J = 8.5 Hz, 2 H), 5.52 (d, J = 4.7 Hz, 1 H), 5.17 (d, J = 10.0 Hz, 1 H), 
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4.96 (d, J = 2.1 Hz, 1 H), 4.78 (d, J = 6.7 Hz, 1 H), 4.68 (d, J = 6.7 Hz, 1 H), 4.65 – 4.61 
(m, 1 H), 4.36 (d, J = 11.1 Hz, 1 H), 4.34 (dd, J = 10.0, 2.9 Hz, 1 H), 4.19 – 4.11 (m, 3 
H), 4.08 – 3.99 (m, 2 H), 3.79 (s, 3 H), 3.80 – 3.78 (m, 1 H), 3.71 (d, J = 10.5 Hz, 1 H), 
3.64 – 3.58 (m, 2 H), 3.53 – 3.47 (m, 2 H), 3.39 (s, 3 H), 3.38 (s, 6 H), 3.37 – 3.35 (m, 1 
H), 3.35 – 3.31 (m, 1 H), 3.31 (s, 3 H), 2.78 (dd, J = 13.5, 9.7 Hz, 1 H), 2.50 – 2.43 (m, 1 
H), 2.19 – 2.13 (m, 1 H), 1.81 – 1.78 (m, 2 H), 1.72 (s, 3 H), 1.69 – 1.63 (m, 1 H), 1.62 – 
1.52 (m, 2 H), 1.48 – 1.43 (m, 1 H), 1.42 – 1.36 (m, 1 H), 1.27 – 1.23 (m, 1 H), 1.18 – 
1.13 (m, 1 H), 1.12 (s, 3 H), 1.04 (s, 3 H), 0.89 (s, 9 H), 0.88 (s, 9 H), 0.86 (s, 9 H), 0.83 
(t, J = 7.4 Hz, 3 H), 0.06 (s, 3 H), 0.06 (s, 3 H), 0.04 (s, 6 H), 0.02 (s, 6 H);  
 
13C NMR (CDCl3, 125 MHz) δ  213.7, 171.0, 159.1, 153.1, 135.6, 135.4, 131.7, 130.7, 
129.5, 128.9, 127.3, 113.7, 97.3, 78.9, 78.4, 76.2, 74.9, 73.2, 73.0, 69.6, 66.6, 66.3, 66.1, 
59.5, 56.9, 56.6, 56.2, 55.8, 55.2, 51.6, 41.4, 39.3, 37.5, 36.6, 36.3, 34.1 , 30.6, 26.0, 26.0, 
25.8, 24.7, 21.5, 19.5, 18.4, 18.3, 18.0, 17.9, 11.7, –4.0, –4.5, –4.6, –4.6, –5.3, –5.4;  
 
IR (film) 3533, 2956, 2857, 1729, 1462, 1252, 1100, 938, 836 cm–1;  
 
Exact Mass Calc. for C65H113NO15Si3 [M + Na]+ 1254.7310, found 1254.7360.   
(2S,3R,5S,7R,8R,11S,13R,15S,18R,Z)-1-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5,8-
bis(tert-butyldimethylsilyloxy)-18-((tert-butyldimethylsilyloxy)methyl)-11,15-
dihydroxy-3,7,13-trimethoxy-2-(methoxymethoxy)-10,10,16-trimethylicos-16-ene-
1,9-dione (S7) 
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To a stirring solution of methyl ether 69 (52 mg, 0.043 mmol, 1.0 equiv), CH2Cl2 (2.0 
mL), and pH 7 buffer (0.2 mL) was added a 1.0 M solution (CH2Cl2) solution of  DDQ ( 
172 µL, 0.172 mmol, 4.0 eq) in four portions, separated by 15 min. The reaction was 
allowed to proceed for 2 h, after which time TLC analysis indicated complete 
consumption of starting material. The reaction was diluted with 50% EtOAc/hexanes (40 
mL), washed with a saturated aqueous solution of NaHCO3 (3 × 10 mL), and brine (10 
mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced 
pressure to provide an orange residue. Purification was accomplished with flash 
chromatography (1.5 × 12 cm), eluting with 15% EtOAc/hexanes (100 mL), 25% EtOAc/ 
hexanes (100 mL) and collecting 10 mL fractions. The product containing fractions were 
combined and concentrated under reduced pressure to yield diol S7 (42 mg, 0.038 mmol, 
88% yield) as a clear and colorless oil:  
 
Rf = 0.45 (30% ethyl acetate/hexanes, faintly UV active, stains blue);   
 
[α]20D = +14  (c 0.38, CHCl3);  
 
1H NMR (CDCl3, 600 MHz) δ 7.36 – 7.31 (m, 2 H), 7.29 – 7.23 (m, 3 H), 5.52 (d, J = 5.0 
Hz, 1 H), 4.96 (d, J = 2.3 Hz, 1 H), 4.93 (d, J = 10.3 Hz, 1 H), 4.79 (d, J=6.7 Hz, 1 H), 
4.68 (d, J = 6.7 Hz, 1 H), 4.66 – 4.61 (m, 2 H), 4.20 – 4.14 (m, 2 H), 4.07 – 4.02 (m, 2 
H), 3.73 (d, J = 10.5 Hz, 1 H), 3.62 – 3.57 (m, 3 H), 3.55 (dd, J = 9.7, 5.3 Hz, 1 H), 3.40 
(s, 3 H), 3.38 (s, 6 H), 3.35 (s, 3 H), 3.35 – 3.28 (m, 2 H), 2.94 (br. s., 1 H), 2.77 (dd, J = 
13.3, 9.8 Hz, 1 H), 2.59 – 2.52 (m, 1 H), 2.04 (s, 1 H), 2.06 – 2.00 (m, 2 H), 1.82 – 1.76 
(m, 2 H), 1.73 (s, 3 H), 1.72 – 1.65 (m, 2 H), 1.65 – 1.53 (m, 2 H), 1.22 (s, 3 H), 1.15 (s, 
3 H), 1.14 – 1.07 (m, 1 H), 0.89 (s, 9 H), 0.88 (s, 9 H), 0.86 (s, 9 H), 0.83 (t, J=7.4 Hz, 3 
H), 0.07 (s, 3 H), 0.06 (s, 3 H), 0.05 (s, 6 H), 0.04 (s, 6 H);  
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13C NMR (CDCl3, 125 MHz) δ213.9, 171.0, 153.1, 139.4, 135.4, 130.9, 129.5, 128.9, 
127.3, 97.3, 78.9, 78.5, 76.2, 75.0, 73.3, 66.9, 66.3, 66.3, 66.1, 59.4, 57.0, 57.0, 56.2, 
55.8, 51.6, 41.8, 39.3, 37.5, 37.2, 36.3, 34.3, 26.0, 25.9, 25.8, 24.5, 21.4, 19.8, 18.6, 18.3, 
18.2, 18.0, 11.8, –4.0, –4.5, –4.6, –4.6, –5.4, –5.4; 
 
IR (film) 3473, 2956, 2950, 2857, 1786, 1710, 1462, 1389, 1255, 1104, 1051, 920, 837 
cm–1;  
 
Exact Mass Calc. for C57H105NO14Si3 [M + Na]+ 1134.6741, found 1134.6720 (ESI) 
(3S,4R,8R,9R,12S,14S,16S)-6,9-bis(tert-butyldimethylsilyloxy)-16-((R,Z)-4-((tert-
butyldimethylsilyloxy)methyl)hex-2-en-2-yl)-12-hydroxy-4,8,14-trimethoxy-3-
(methoxymethoxy)-11,11-dimethyloxacyclohexadecane-2,10-dione (71) 
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To a stirring solution of oxazolidinone S7 (30 mg, 0.027 mmol, 1.0 equiv) and a 4:1 
mixture of THF and H2O (2.5 mL), at 0 ˚C, was added a 30% aqueous solution of H2O2 
(160 µL, 1.42 mmol, 50 eq), followed by a 1.0 M aqueous solution of LiOH (108 µL, 
0.108 mmol, 4 equiv.).  TLC analysis after 1 h indicated complete consumption of 
starting material. A saturated aqueous solution of Na2SO3 was cautiously added dropwise 
until complete consumption of H2O2, as judged by KI/starch paper. A 1.0 M aqueous 
solution of NaHSO4 was then added until the mixture was at pH 2.0.  The mixture was 
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extracted with EtOAc (3 × 25 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure (with the aid of a PhH azeotrope) to give a clear and colorless residue 
(30 mg) that was used without further manipulation in the next reaction.32  
 
To a stirring solution of a portion of the residue (21 mg, 0.019 mmol, 1.0 equiv) and THF 
(1 mL) was added Hunig’s base (8.2 µL, 0.048 mmol, 2.5 equiv) followed by 2,4,6-
trichlorobenzoyl chloride (6.2 µL, 0.040 mmol, 2.1 equiv). The reaction was allowed to 
proceed for 5 h, after which time TLC analysis indicated complete consumption of 
starting material. The reaction mixture was diluted with PhCH3 (5 mL) and added over 10 
h to a solution of DMAP (7.0 mg, 0.057 mmol, 3.0 eq) in PhCH3 (15 mL), at 60 ˚C.  The 
reaction was allowed to proceed for 30 h, after which time TLC analysis indicated 
complete consumption of the seco-acid.33 The solvent was removed under reduced 
pressure to yield a yellow residue. Purification was accomplished with flash column 
chromatography (1 × 7 cm), eluting with 10% EtOAc/hexanes. The product containing 
fractions were combined and concentrated to give macrolactone 71 (12 mg, 0.013 mmol, 
68% corrected yield over 2 steps) as a clear and colorless oil:  
 
Rf = 0.74 (30% ethyl acetate/hexanes, not UV active, stains blue);   
 
[α]20D = −53  (c 0.50, CHCl3);  
 
                                                
(32) A single attempt to purify the crude mixture on Davisil® column using an EtOAc/H2O/MeOH/ 
acetone (10:1:1:1) solvent system resulted in cleavage of the MOM group. 
  
(33) A TLC analysis of the intermediate seco-acid shows a retention factor of 0.53 with an eluent of 
25% EtOAc/acetone. During the formation of the mixed anhydride, TLC analysis shows 
disappearance of the spot corresponding to the seco-acid and formation of a less polar spot with a 
retention factor 0.65 in 30% EtOAc/hexanes. Upon injection into the DMAP solution in toluene, 
the spot corresponding to the seco-acid reappears on TLC analysis and gradually disappears as the 
reaction progresses. 
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1H NMR (CDCl3, 600 MHz) δ 5.89 – 5.85 (m, 1 H), 5.08 (d, J = 10.0 Hz, 1 H), 4.72 (s, 1 
H), 4.67 – 4.64 (m, 2 H), 4.16 (d, J = 4.4 Hz, 1 H), 4.00 – 3.95 (m, 1 H), 3.76 – 3.72 (m, 
1 H), 3.72 (dd, J = 10.0, 3.8 Hz, 1 H), 3.67 – 3.60 (m, 2 H), 3.54 – 3.47 (m, 1 H), 3.44 (s, 
3 H), 3.40 – 3.38 (m, 1 H), 3.38 (s, 6 H), 3.37 (s, 3 H), 2.60 – 2.53 (m, 1 H), 2.02 – 1.94 
(m, 2 H), 1.91 – 1.83 (m, 1 H), 1.81 – 1.73 (m, 1 H), 1.72 – 1.66 (m, 1 H), 1.68 (s, 3 H), 
1.65 – 1.59 (m, 1 H), 1.58 – 1.54 (m, 1 H), 1.54 – 1.45 (m, 2 H), 1.40 (s, 3 H), 1.23 (s, 3 
H), 1.23 – 1.15 (m, 2 H), 0.91 (s, 9 H), 0.88 (s, 9 H), 0.88 (s, 9 H), 0.85 (t, J = 7.5 Hz, 3 
H), 0.10 (s, 9 H), 0.06 (s, 3 H), 0.03 (s, 3 H), 0.02 (s, 3 H) ;  
 
13C NMR (CDCl3, 125  MHz) δ 216.5, 168.8, 133.7,130.7, 96.0, 75.3, 70.3, 66.3, 65.4, 
78.5, 76.0, 75.3, 70.3, 66.3, 65.4, 57.5, 57.2, 57.2, 56.1, 50.7, 41.5, 37.4, 37.3, 36.6, 35.9, 
26.0, 25.9, 25.8, 24.4, 22.1, 18.3, 18.3, 18.2, 17.9, 11.8,−4.3, −4.3, −4.5, −5.0, −5.3, −5.4;  
 
IR (film) 353.9, 2956.2, 2857.3, 1729.7, 1462.5, 1384.1, 1252.7, 1154.4, 1099.7, 938.4, 
938.4, 836.2 cm–1;  
 
Exact Mass Calc. for C47H94O12Si3 [M + Na]+ 957.5951, found 957.5947. 
 
Peloruside A (1) 
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To a stirring mixture of macrolactone 71 (4.5 mg, 0.0048 mmol, 1.0 equiv) and MeOH 
(1.5 mL), 0 ˚C, was added an aqueous solution of 4 N HCl (1.5 mL) dropwise over 5 
minutes. The reaction was allowed to proceed at 0 ˚C for 1 h, and then at rt for 2 h. The 
  129 
reaction mixture was neutralized with a saturated aqueous solution of NaHCO3 and the 
extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with brine 
(10 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a 
yellow residue. Purification was accomplished with flash column chromatography, 
eluting with EtOAc (50 mL), 25% acetone/EtOAc (50 mL), 50% EtOAc/acetone (50 
mL), 75% acetone/EtOAc (50 mL), the last of which which eluted the product from the 
column. Concentration of the product containing fractions yielded a light yellow oil 
which was lyophilized using PhH and subsequently triturated with hexanes to yield 
peloruside A  1 as a fluffy white powder (1.7 mg, 0.0032 mmol, 66%);   
 
[α]20D = +16  (c 0.30, CH2Cl2) 
 
 1H NMR (CDCl3, 600 MHz) 6.75 (br s, 1 H), 5.69 (d, J= 10.6 Hz, 1H), 5.05 (d, J = 10.6 
Hz, 1H), 4.85 – 4.95 (m, 1H), 4.53 (br d, J = 8.1 Hz, 1H), 4.43 (s, 1H), 4.29 – 4.21 (m, 
2H),  4.03 (s, 1H), 4.02 – 3.95 (m, 1H), 3.82 (ddd, J = 11.5, 5.1, 3.0 Hz, 1H), 3.69 – 3.61 
(m, 1H), 3.48 (s, 3H), 3.39 (s, 3H), 3.35 (m, 1H), 3.31 (s, 3H), 2.97 (br s, 1H), 2.70 (d, J 
= 9.3 Hz, 1H), 2.55 – 2.65 (m, 1H), 2.27 (br s, 1H), 2.19 – 2.09 (m, 2H), 1.97 – 2.09 (m, 
2H), 1.82 – 1.73 (m, 2H), 1.68 (d, J = 1.0 Hz, 1H), 1.50 – 1.57 (m, 1H), 1.47 – 1.40 (m, 
2H), 1.18- 1.15 (m, 1H), 1.13 (s, 3H), 1.10, (s, 3H), 0.86 (t, J = 7.5 Hz, 3H) 
 
 δ 13C NMR (CDCl3, 125 MHz) 173.9, 136.1, 131.2, 101.9, 78.3, 78.0, 76.0, 73.9, 70.9, 
70.3, 67.0, 63.5, 59.1, 56.1, 55.7, 43.6, 43.4, 35.7, 34.2, 33.9, 32.6, 31.7, 24.7, 20.9, 17.4, 
15.7, 12.3 
 
 δ IR (film) 3441, 2924, 2854, 1739, 1455, 1386, 1155, 1085 cm–1 
 
Exact Mass Calc. for C27H48O11 [M + Na] 571.3094, found 571.3096 (ESI) 
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 Chapter 3 
Introduction to Spiro–prorocentrimine  
 
 
 
I. Isolation and Structural Determination of Spiro–prorocentrimine 
Spiro-prorocentrimine (1) is a spiro-iminium toxin that was isolated from cultures of an 
unknown species of algae, from a strain designated Prorocentrum PM08. Another 
member of the Prorocentrum genus, Prorocentrum lima, has been a rich source of non 
spiro-iminium containing toxins such as okadaic acid. The algal specimens were isolated 
from seaweed from a coral reef in Taiwan.1 
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Figure 3.1 Structure of spiro-prorocentrimine. 
 Extraction and chromatography of 100 L of a culture of Prorocentrum sp. PM08 
provided 3 mg of spiro-prorocentrimine. The structure was determined by a single crystal 
X-ray structure, with a final R-value of 0.0859. Multidimensional NMR studies supported 
the configuration around the spiro-iminium and pyran moieties. The absolute 
configuration of spiro-prorocentrimine is unknown. From the structure in Figure 3.1, 
notable structural features involve an iminium bearing spirocycle, the presence of a 15 
membered lactone, and the presence of a 23 membered macrocyclic ether, a sulfated 
                                                
(1) Lu, C.-K.; Lee, G.-H.; Huang, R.; Chou, H.-N. Tetrahedron Lett. 2001. 42, 1713-1716. 
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pyran moiety and a potentially fragile allylic ester. Because of the presence of the sulfate 
and iminium, the molecule is zwitterionic. Spiro-prorocentrimine is toxic, with an i.p. 
LD99 in mice of 2.5 mg/kg. This is much lower than the toxicity of related compounds.2 
II. Approaches to Other Aza-Spirocyclic Natural Products 
No published approaches other than our own exist to spiro-prorocentrimine. However, 
several elegant and informative approaches to molecules related to spiro-prorocentrimine 
have been made. A detailed summary of these approaches up to 2005 and 2007 may be 
found in the PhD theses of Dr. Anna Chiu and Dr. George Borg respectively. The 
purpose of the following section is to briefly summarize the most important approaches 
relevant to our own approach. Representative molecules in the spiro-iminium family with 
similar aza-spirocyclic regions are shown in figure 3.2.   
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Figure 3.2 Representative members of spiro-iminium family 
Total syntheses of pinnatoxin A (2) have been reported by Kishi, Nagasawa, Hirama, 
Hashimoto and Zakarian. Gymnodimine (3) has been recently synthesized by Romo, 
while Kishi also described an elegant approach. No synthesis of a member of the 
spirolide family, represented above by spirolide A (4) has yet been reported, however 
                                                
(2) Alberto Otero, M.-J. C.; Atanassova, M.; Vieites, J. M.; Cabado, A. G. Chem. Res. Toxicol., 2011, 24, 
1817- 1829. No human intoxications from spiro-imine toxins have been reported: EFSA Panel on 
Contaminants in the Food Chain. EFSA Journal . 2010, 6, 1628- 1667. DOI: 10.2903/j.efsa.2012.1628  
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efforts towards this target have been published by Zakarian, Brimble,  Ishihara, and our 
group. 3 
An approach to the spiro-iminium cores of natural products pioneered by Murai and 
subsequently enhanced and employed our group, the Romo group, and the Brimble group 
involves Diels- Alder reactions of exo-methylene lactams with E dienes. A representative 
example is shown in Equation 3.1. CBz protected caprolactam 5 reacts with diene 6, 
promoted by a cationic copper BOX catalyst. Diels–Alder adduct 7 is obtained in high ee, 
with an excellent exo-endo ratio.4  
NCbz
O
CH2Cl2, rt
NCbz
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OBn
O
 exo/endo = 99:1
+
OBn
OTBS
96% ee
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5 6 7
N
O
N
O
Me Me
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The exo transition state is presumably favoured since it would minimize a steric 
interaction between the diene and the BOX catalyst, which would be bound to the imide 
oxygens. 
A pitfall to this strategy appears to be the elaboration of the lactam adjacent to a 
quaternary centre in the product to a ketone oxidation state (the iminium). While 
unsuccessful attempts employed by our group are described in the next section, the only 
successful strategy that has been reported is a substrate specific Barbier type 
                                                
(3) a) Stivala, C. E.; Zakarian, A. Org. Lett. 2009, 11, 839- 842. b) Brimble, M. A.; Crimmins, D.; Trzoss, 
M. ARKIVOC, 2005, 39- 52. C) Ishihara, J.; Ishizaka, T.; Suzuki, T.; Hatakeyama, S. Tetrahedron. Lett. 
2004, 45, 7855- 7858. 
(4) The structures in this scheme, equation or figure are adapted from ones drawn by Dr. Anna Chiu, with 
her permission. 
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macrocyclization employed by Romo in his total synthesis of gymnodimine (scheme 
3.1).5 
Scheme 3.1 
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Iodide 8, synthesized by a Diels–Alder reaction employing a tosyl-lactam,6 was exposed 
to t-BuLi, which resulted in intramolecular addition of the resulting alkyllithium to the 
tosyl-lactam to form compound 9 in 51- 65% yield. This was subsequently elaborated to 
gymnodimine in 7 steps. This sort of reaction did also work in an intermolecular fashion, 
but a general solution to functionalize neopentyl lactams to iminiums is still unknown as 
this reaction failed on similar substrates in both Romo’s earlier efforts towards 
gymnodimine and our own efforts toward spiro-prorocentrimine.6 
In his original isolation paper for Pinnatoxin A, Uemura proposed that Pinnatoxin A 
arose from an intramolecular Diels–Alder reaction between a diene and an enone in 
compound 10, followed by a condensation on 11 to form the iminium in Pinnatoxin A 
(Figure 3.3).7 An updated biosynthetic proposal is made both in sections III of this 
chapter and in Appendix A. 
                                                
(5) a) Kong, K.; Romo, D.; Lee, C. Angew. Chem. Int. Ed. 2009, 48, 7402- 7405. b) Kong, K.; Moussa, Z.; 
Lee, C.; Romo, D. J. Am. Chem. Soc., 2011, 133, 19844- 19856.  
(6) Kong, K.; Moussa, Z.; Romo, D. Org. Lett., 2005, 7, 5127- 5130. 
(7) Uemura, D.; Chou, T.; Haino, T.; Nagatsu, A.; Fukuzawa, S.; Zheng, S.-Z.; Chen, H.-S. J. Am. Chem. 
Soc., 1995, 117, 1155- 1156.  
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Figure 3.3 Uemura biosynthesis proposal for Pinnatoxins 
This strategy was put into practice by Kishi in his synthesis of ent-pinnatoxin A (Scheme 
3.2). Compound 12 was heated in toluene to afford a mix of products. The desired 
product 13 is shown. Exo selectivity was high (83: 17), but little stereocontrol was noted 
at the C5 stereocentre (53 : 47).  Interestingly, changing the solvent from dodecane to 
toluene and increasing the temperature to 100 °C resulted in an erosion of exo selectivity 
(66: 34). Compound 13 could be deprotected to compound 14 in two steps. Cyclization 
occurred cleanly, at a temperature of 200 °C, followed by a cleavage of the t-Butyl ester 
to yield ent-pinnatoxin A.8 As an illustration of the difficulty in predicting the course of 
these intramolecular Diels–Alder reactions, acetonide containing compound 15 
underwent cycloaddition in good yield to give compound 16 as a single diastereomer. 
Unfortunately the acetonide proved impossible to remove at a later stage in the synthesis. 
 
 
 
 
 
                                                
(8) The enantiomer was not biologically active in a mouse toxicity assay.  
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Scheme 3.2 
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An intramolecular Diels–Alder reaction of lactone 17 bearing an exo- methylene with 
diene 18 was reported by Hashimoto (Equation 3.2). This strategy also provided poor 
diastereoselectivity in the key Diels–Alder reaction, with a 45: 27 : 18 : 10 mixture of 
diastereomers. Desired Diels–Alder adduct 19 was isolated in 35 % yield.9 
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The strategy most pertinent to our current one, involves the use of iminium dienophiles. 
Our efforts using iminium ion dienophiles will be summarized in the next section and are 
also the subject of much of this thesis.  
                                                
(9) Nakamura, S.; Kikuchi, F.; Hashimoto, S. Angew. Chem. Int. Ed., 2008, 47, 7091- 7094.  
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In 2000, MacMillan and coworkers described a series of organocatalytic reactions 
involving Diels–Alder reactions on iminium ions. These reactions were often highly 
enantioselective, but a variety of outcomes regarding endo/exo selectivity, illustrated in 
Figure 3.4, were noted.10 
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Figure 3.4 Endo/exo selective reactions reported by MacMillan.4 
A reaction between cyclopentadiene 20 and enones 21, mediated by catalyst 22 gave 
Diels Alder adducts 23 with moderate to high endo selectivity. A similar reaction 
between 20 and various substituted acroleins 24, mediated by catalyst 25 gave Diels–
Alder adducts 26 with poor endo-exo selectivity. A reaction with isobenzofuran 27, and 
crotonaldehyde, mediated by catalyst 28 gave Diels–Alder adduct 29 with high exo 
selectivity.  
Since all of the spiro-imine natural products appear to result from an exo transition state 
involving an E diene, the exo selectivity observed in this last case deserves further 
                                                
(10) a) Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243- 4244. b) 
Northrup, A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 2458- 2460. 
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comment. A proposal was not made to explain the high exo selectivity of the last case, 
but I believe it may be specific to the isobenzofuran used (Figure 3.5). An interaction 
between one of the phenyls in the diene and the methyl ester of 28 is shown in endo 
transition state 30, while this interaction would be diminished in transition state 31. An 
alternate explanation is that there is a favourable cation π interaction between a phenyl 
group and the iminium cation in transition state 31. 
O
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Me O
E E
Ph
Ph
NE E
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3130  
Figure 3.5 possible explanations for the high exo selectivity with isobenzofuran 27. 
An important take-home message from these studies is that the iminium ions are more 
reactive than the corresponding ketones. This has implications for the Uemura 
biosynthetic proposal, since it may now be envisioned that compound 10 first undergoes 
iminium formation, to form compound 32 followed by a Diels–Alder reaction that would 
directly form pinnatoxin A (Figure 3.6).  
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Figure 3.6 Revised Uemura biosynthesis. 
It is unclear what implications the formation of the cyclic iminium will have on facial 
selectivity. One hint is that computational studies from the Houk group suggest that 
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Diels–Alder reactions on iminium ions might be quite asynchronous.11 Models of endo 
and exo transition states with cyclopentadiene and a dimethyliminium of crotonaldehyde 
suggest  that the leading bond formed is approximately one angstrom closer than the 
lagging bond. This does have implications for the bond disconnections under discussion, 
since the leading bond is often further from stereocentres that impart diastereoselection in 
several of the examples discussed.12 
Our group and the Kishi group concurrently pursued this strategy on different molecules. 
Kishi’s efforts towards the total synthesis of gymnodimine were published in 2005 
(Scheme 3.3).13  
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(11) Gordillo, R.; Houk, K. N. J. Am. Chem. Soc. 2006, 128, 3543- 3553. 
(12) Calculations of Diels–Alder reactions on the corresponding enals showed more synchronous transition 
states, with a leading-following bond difference that was often less than 0.5 angstroms. 
(13) Johannes, J. W.; Wenglowsky, S.; Kishi, Y. Org. Lett. 2005, 7, 3997- 4000. 
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Model enone 33 underwent Teoc deprotection to give compound 34 followed by 
cyclization to form iminium 35 in phosphate buffer.14  In a more elaborate system, 
iminium 36 was held in citrate buffer and a Diels–Alder reaction occurred with 1:1 
endo/exo selectivity to give compound 37 and desired exo compound 38. When the 
reaction was done thermally on intermediate 39, only endo products 40 and 41 were 
observed. Product 41 arises from an attack on the undesired face of the enone. This is 
more evidence that changes in the structure of intramolecular Diels–Alder substrates can 
make dramatic changes to diastereoselectivity. 
 
III.  Summary of Prior Approaches to Spiro-prorocentrimine in the Evans 
Group15 
The purpose of this section is to summarize the prior approaches to spiro-prorocentrimine 
that were pursued in the Evans Group, with a strong emphasis on the findings and 
strategies that have most influenced the current route. It is hoped that this section will 
explain the context in which current decisions about the project were made. 
Dr. Anna Chiu initiated the Spiro-prorocentrimine project in 2002 according to the 
following synthesis plan (Figure 3.7).16 
                                                
(14) Inspection of their NMR spectra and comparison with our own exo methylene imines and iminiums 
revealed that the compound was protonated in the citric acid buffer. 
(15) The work described in this section was carried out by Dr. Anna Chiu, Dr. Trixie Brandl, Dr. George 
Borg, Dr. Joseph Pero and Dr. Martin Juhl and individual parts are noted accordingly.  
(16) Chiu, A. PhD. Thesis, Harvard University, 2005. 
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Figure 3.7 Synthesis plan as envisioned by Dr. Chiu.4 
Spiro-prorocentrimine was envisioned to arise from two fragments of roughly equal 
complexity. Spiro-imine synthon 42 would contain a sulfone at C27, a vinyl halide at C13 
and an amide at C1. Pyran synthon 43 would contain an iodide at C26 alkyl, and an 
aldehyde at C14. The C26–C27 bond construction would involve a sulfone alkylation 
followed by sulfone removal, the C13–C14 bond construction would involve an addition of 
a vinyl metal species into an aldehyde, and a macrolactonization between the alcohol 
formed at C14 and the C1 carboxylate would complete the spiro-prorocentrimine core. 
Significant progress was made towards all of the components, which can be found in Dr. 
Chiu’s thesis. Pyran fragment 44 was constructed via a series of aldol reactions, and it 
was anticipated that the dimethylphenyl silyl group protecting the alcohol at C19 would be 
orthogonal to the other silyl groups to allow selective sulfate installation. 
Most pertinent to the future direction to the project were Dr. Chiu’s efforts to construct 
the spirocyclic iminium core 45 of spiro-prorocentrimine.  
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An initial series of attempts were undertaken in collaboration with a postdoctoral fellow, 
Dr. Trixi Brandl. These involved the Diels–Alder reactions of exo-methylene lactams 
with  E-dienes. A representative example is shown in Equation 3.3. 
NTs
Me O
OTBDPS
TMS
NTs
OMe
TMS
OTBDPS (3.3)
+
TiCl4, CH2Cl2
-78 °C - -10 °C
56 %, 20: 1 dr
46 47 48  
Tosyl-lactam 46 was allowed to react with diene 47 to afford Diels–Alder adduct 48 with 
high exo selectivity. A rationale for the exo selectivity is shown in structure 49 and 50. 
An interaction with the back of the diene and the bound Lewis acid shown in endo 
structure 49 is presumably disfavoured. 
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Figure 3.8 Rationale for exo transition state in lactam Diels–Alder reaction.   
Unfortunately, despite extensive experimentation, no conditions could be found that 
allowed the lactams to be converted to ketones, imines or iminiums. These included 
additions of alkyllithiums that were successful in the Romo case.6 
Given the lack of success in elaborating the lactam to an imine or iminium, Dr Chiu 
decided to attempt a Diels- Alder reaction directly on cyclic iminium 51 bearing an exo-
methylene group (Scheme 3.4). 
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Scheme 3.4 
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A Sakurai allylation on imide 52 followed by alkylation with BOM chloride allowed the 
formation of compound 53 The oxazolidinone was replaced with a Weinreb amide, 
yielding compound 54, which in turn was converted to ketone 55 via the addition of the 
alkyllithium derived from iodide 56.17 Ozonolysis of 55 followed by a selective reduction 
of aldehyde over ketone led to compound 57, which was converted to azide 58 in a 2-step 
sequence.  In practice the compound was stored at this stage. Exposure to 
triphenylphosphine resulted in azide reduction, aza-Wittig reaction, and benzyl alcohol 
elimination to form exo-methylene iminium 51. This compound was both somewhat 
volatile and unstable, and was typically used with minimal purification.  
                                                
(17) For the synthesis of 56 see, Evans, D. A.; Bender, S. L.; Morris, J. J. Am. Chem. Soc. 1988, 110, 2506- 
2526. 
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Dr. Chiu found that imine 51 would react with model E diene 59 under the action of 
either Brønstead acid or metal triflate catalysis to give Diels–Alder adduct 60. She 
identified copper II triflate as the optimal catalyst (Equation 3.4).  
Me
N 33
36
Me
OTBS
51
Me
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9
Me
OTBS
60Me
Me
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Me
Me
Cu(OTf)2
51 %
9: 1 dr
CH3CN/ CH2Cl2
+
(3.4)
 
The diastereoselectivity was high, but unfortunately NMR studies revealed that the 
dominant product of the reactions is via an endo mode on the correct face of the iminium. 
While the correct facial attack results in the correct stereochemistry at C33, the endo 
approach results in the incorrect stereochemistry at C9. It became apparent that a different 
strategy was required to form the spiro-iminium core.18 
In the end of her thesis, Dr. Chiu introduced the idea of constraining the dienes within 
macrocycles. Two optimistic possibilities would arise. One possibility would be that an E 
macrocycle would have a facial bias that would favour exposure of the face that would 
react in an exo fashion anti to the methyl group on the diene, shown in transition state 61. 
The other possibility is that a macrocyclic Z diene would continue to react via an endo 
transition state, and constraining the Z diene within a macrocycle would place the Z diene 
in a reactive planar S-Cis conformation, shown in transition state 62.  
Conversely, there existed the risks that the favoured conformation of the dienes in the 
macrocycles would be a non-reactive S-trans conformation, that the E diene would 
continue to react via an endo transition state, or that the Z diene would prefer to react in 
an exo transition state due to additional steric interactions. 
                                                
(18) Acyclic Z dienes were not reactive with the iminium ion under various conditions explored by Dr. 
Anna Chiu, Dr. George Borg, Dr. Pascal Bindschädler, and myself. Only very electron rich acyclic dienes, 
bearing silyloxy groups were found to react by Dr. David Marcoux. See the work in the following chapters 
for details. 
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Figure 3.9 Dr. Chiu’s concept for macrocyclic dienes. 
Dr. George Borg, Dr. Chiu’s successor on the project, put the synthesis of both Z and E 
macrocycles into practice.19 Dr. Borg employed two generations of approaches to the 
macrocycle, and only the second generation approach, which was carried out in tandem 
with Dr. Joseph Pero, a post-doctoral fellow, is discussed here.20 The initial stages of the 
synthesis are described in detail in Scheme 3.4. 
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(19) Borg, G. PhD. Thesis, Harvard University, 2007. 
(20) Pero, J. E. Postdoctoral Report, Harvard University, 2008.  
(21) The yields in this scheme were obtained by Dr. Pascal Bindschädler in the course of scale-up of this 
route. 
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An aldol reaction between diene 63 and benzyloxyacetaldehyde, mediated by 5 mol % 
copper triflate complexed to ligand 64 set the stereocentre at C5 in aldol adduct 65. This 
stereochemistry was then relayed to C3 by way of a Prasad reduction to give diol 66. 
Differentiation of the alcohols at C3 and C5 was accomplished by cleavage of the C1 ester 
and concomitant cyclization, followed by TBS protection of the C3 alcohol to give 
lactone 67, which was then opened with aniline. The benzyloxy group at C6 was 
deprotected by hydrogenolysis to give diol 68. Diol 68 was then transformed into epoxide 
69 by selective tosylation of the C6 alcohol in the presence of sodium hydride. Opening 
of the epoxide required extensive optimization, but ultimately reaction with an 
organocuprate derived from bromovinyltrimethylsilane 70 was effective. The alcohol at 
C5 was protected to give vinyl iodide 71. Treatment with iodine chloride and TBAF then 
gave vinyl iodide 72a, which could not be separated, from approximately 10-15% of the 
corresponding chloride 72b.22 
Vinyl iodide 72a represented the last common intermediate in the diene synthesis. Dr. 
Borg’s synthesis of the Z-diene is shown in Scheme 3.6. A Sonogashira reaction with 
halides 72 and 4-pentynol provided ene-yne 73. This was subject to reduction with 
Zn(Cu/Ag) to form Z diene alcohol 74 in high yield. Subsequent oxidation gave aldehyde 
75. HWE reaction with keto phosphonate 76 and a Felkin controlled Luche reduction 
gave allylic alcohol 77.23 A 3-step sequence then gave seco acid 78. Cyclization under 
Yamaguchi conditions provided Z-diene 79. 
 
 
                                                
(22) Investigation of other iodonium sources such as I2 or NIS gave inferior yields. 
(23) A Mosher’s ester analysis confirmed the product did not arise from chelate control. It was speculated 
the methanol in the reaction mixture precluded chelate formation. 
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Scheme 3.6 
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Chloride 72b was not entirely consumed in the Sonogashira reaction. Over the course of 
several scale-up reactions conducted by Dr. Bindschädler we accrued several hundred 
milligrams of this compound. I investigated converting this compound to 73. Use of 
Sonogashira conditions reported by Buchwald for aryl halides using X-Phos 80b did not 
yield any product.24 Fortunately, the use of Mor-Dal-Phos ligand 80a with palladium 
source 81 gave an acceptable yield of 73. This ligand was developed and employed by 
the Stradiotto group for a number of challenging aminations, however no previous 
disclosures of this ligand in Sonogashira chemistry have been made.25 This may prove to 
be a useful system for challenging Sonogashira reactions in the future. 
                                                
(24) Gelman, D.; Buchwald, S. L. Angew. Chem. Int. Ed. 2003, 42, 5993- 5996. 
(25) For the use of 80a in the arylation of acetone with relatively unreactive aryl halides, see: Hesp, K. D.; 
Lundgren, R. J.; Stradiotto, M. J. Am. Chem. Soc. 2011, 133, 5194- 5194. I thank Dr. Kevin Hesp for 
suggesting the use of Dal Phos, and Dr. Rylan Lundgren for helpful advice. 
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Dr. Borg had accessed E dienes with C3-C5 acetonide protection via an earlier route. The 
route developed by Dr. Joseph Pero is shown here (Scheme 3.7). Halides 72 are exposed 
to LDA to give alkyne 82, which is then subject to an ene-yne metathesis with alkene 83 
using Grubbs catalyst 84. Diene 85 was obtained in high yield after extensive 
optimization, the most important point being the use of argon as the atmosphere. 
Deprotection and oxidation gave aldehyde 86, which was subject to a similar sequence to 
that of Scheme 3.6 to give E diene macrocycle 87. 
Scheme 3.7 
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With macrocycles 79 and 87 in hand, Dr. Borg attempted some preliminary studies of 
reactions between imine 59 and macrocycle 79 (Equation 3.5). Unfortunately no reaction 
or decomposition was observed with all conditions attempted, which involved a variety 
of Brønstead and Lewis acids. No product 88 or any stereoisomer thereof was obtained. 
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Also worrisome were observations by Dr. Pero that E diene macrocycle 87 was also 
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unreactive with imine 59 under the copper (II) triflate conditions developed by Dr. Chiu. 
No product 88 or any isomer thereof was observed (Equation 3.6).  
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N Me
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Dr. Pero initiated a study on the feasibility of alkylating the iminium. The rationale 
behind this strategy was that the Pauling electronegativity of carbon is 2.5, while that of 
hydrogen is 2.1, and that of copper only 1.9. Dr. Pero was able to successfully alkylate 59 
with methyl triflate to give iminium 89. This did react with 87 to give a Diels–Alder 
adduct whose structure was believed to be 91 on the basis of 2D ROESY experiments 
done at the time (Scheme 3.8). It should be noted that I believe that the configurations at 
C33 and C9 were actually flipped. Evidence for this, and a rationale for this outcome is 
presented in chapter 6. I have drawn all of the Diels–Alder adducts as our understanding 
of the structure was at the time I started the project in this review section. 
Scheme 3.8  
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A different strategy was employed with Z macrocycle 79. Dr. Pero exposed imine 59 to 
benzyl bromide and silver hexafluoroantimonate to produce what was believed to be 
iminium 91 on the basis of 1H NMR and mass spectral studies (Scheme 3.9). This then 
reacted with 79 to afford what was believed to be Diels–Alder adduct 82. This reaction 
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did not proceed at ambient temperature and needed to be run at 40 ºC in DCE to obtain 
conversion. Additionally, there was no benzyl group on the iminium in the product. At 
the time this was attributed to solvolysis. My findings in chapters 5 and 6 showed that an 
alkylation did not occur in this reaction, and the configuration at C33 in this molecule was 
flipped. Again, I have drawn these compounds as they were presented to me when I 
started this project. 
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With what appeared to be a solution to the Diels–Alder reactivity and stereochemical 
problems in hand, attention turned to the rest of the molecule. At this point, a large 
redesign was needed, as having the macrocycle in place before the Diels–Alder reaction 
was not compatible with the previous design. A new plan to target a Uemura type 
intramolecular Diels–Alder reaction was devised. 
In this case, there were 3 variables that could be potentially modulated in an 
intramolecular Diels–Alder reaction. The first variable was if the dienophile reacted as an 
iminium or a enone. While an iminium would be more reactive, the enone would 
potentially present a less sterically demanding environment or have more degrees of 
freedom to participate in the desired cycloaddition. The second variable was if the diene 
needed to be in a Z or an E configuration to achieve reactivity or the proper 
stereochemistry. The third variable was if the 15 membered macrocycle would be present 
in the cycloaddition or would be formed after by macrolactonization. Since there were no 
 
 
 150 
clues from nature about the order of the variables described above, the synthesis required 
enough flexibility to address the 8 scenarios arising from the above variables. 
Representative target molecules are 93 and 94.  
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Figure 3.10 Target for intramolecular Diels–Alder approach. 
Dr Borg explored a mild method for the introduction of the imine at a late stage in the 
synthesis, which was analogous to the method used by Kishi. This involved the 
construction of iodoalkene 95, followed by addition of 95 to aldehyde 96 in a NHK 
reaction. The resulting allylic alcohols were oxidized to enal 97. The Boc group could be 
removed in an exceedingly mild manner, later found to compatible with both a Z diene 
and TBS groups by treatment with TES triflate, then TBAF that resulted in cyclization to 
iminium 98. 
Scheme 3.10 
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Dr. Borg explored elaborating pyran fragment 44, available from Dr. Chiu’s work, to an 
intramolecular Diels–Alder substrate. He made very significant progress in this area, 
which is described in his thesis. Ultimately it was decided that a route based on 
modifying 44, which had been originally designed for a different sequence of 
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disconnects, would take too much effort to deliver sufficient quantities of material for 
proper investigation of intramolecular Diels–Alder reactions.26  
Dr. Borg initiated a new approach to an intramolecular Diels–Alder substrate, the 
majority of which was implemented by post-doctoral fellows Dr. Martin Juhl and Dr. 
Joseph Pero. A number of strategies were investigated, but only the one that was 
successful will be detailed here. 
Dr Juhl and Dr. Borg investigated various approaches using tri-O-acetyl-D- glycal 99 as a 
starting material. This abundant compound contains 6 carbons and 3 stereocentres that 
map on to those of spiro-prorocentrimine and appropriate functional group handles for 
further elaboration. After extensive experimentation, Dr. Juhl developed precedent for a 
key transformation. This involved epoxidation of Tri- O TBS glycal 100 , followed by an 
anti- opening of the glycal epoxide 101 using a Grignard/ cuprate combination derived 
from iodide 102. This allowed the formation of the C17–C18 bond, and set all of the 
stereocentres of the pyran ring on compound 103. The diastereoselectivity of both the 
epoxidation and epoxide opening on this model system were high, and the sense of the 
induction is well precedented in the literature.27 While silyl migration was somewhat 
problematic during efforts to protect this intermediate, Dr. Juhl found that BOM chloride 
enabled the protection of the C19 alcohol on 103 to give compound 104 under conditions 
mild enough to preclude silyl migration.  
 
 
                                                
(26) At this point in the synthesis, it was estimated that the longest linear sequence of the synthesis would 
be over 50 steps. 
(27) Klein, L. L.; McWhorter, W. W.; Ko, S. S.; Pfaff, K.-P.; Kishi, Y. Uemura, D.; Hirata, Y. J. Am. 
Chem. Soc. 1982, 104, 7362- 7364.  
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Scheme 3.11 
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A second important disconnection explored by Dr. Juhl involved setting the stereocentre 
at C23 by an A1,3 strain controlled hydrogenation, a strategy well known in our group.28 
The most convergent strategy would involve doing this hydrogenation before the 
epoxidation/ opening sequence. The synthesis of the hydrogenation substrate is described 
in scheme 3.12. 
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-78 °C; d) n-BuLi, 106, then 107, THF, -78 °C; e) Bu3SnH, LDA, then CuCN, then 108, THF, -78 °C; f) MeI, Pd2(dba)3,
(o-tol)3P, K2CO3, THF/NMP; g) (S)-CBS, HBCat, tol, -78 °C  
                                                
(28) Evans, D. A.; Morrissey, M. M. J. Am. Chem. Soc. 1984, 106, 3866- 3868. 
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Compound 100 was subject to a selective deprotection to produce alcohol 105.29 This was 
oxidized and subject to a Corey-Fuchs reaction to produce alkyne 106. The anion of 106 
was added to aldehyde 107, prepared from citronellol, giving an inconsequential mixture 
of diastereomers, which was oxidized to ynone 108. Elaboration of the ynone to a 
trisubstituted olefin was challenging, but ultimately a 2-step procedure was employed. 
Addition of a stannyl anion gave stannane 109 with high Z –selectivity.30 A Stille reaction 
then gave enoate 110. A notably high loading of palladium needed to be used in this 
transformation. CBS/Itsuno reduction resulted in the synthesis of hydrogenation substrate 
111. 
The envisioned hydrogenation is shown in Figure 3.11. A1,3 strain was expected to give 
112 in high diastereoselectivity. 
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111 112  
Figure 3.11 Envisioned Hydrogenation 
Unfortunately the hydrogenation of the allylic alcohol in the presence of the enol to 
produce compound 112 proved to be difficult (Table 3.1). The Brown catalyst (113) was 
not reactive, while chiral DuPhos based catalyst 114 gave poor olefin site selectivity. 
After extensive optimization, Dr. Juhl was able to obtain 112 in high yield using 
Crabtree’s catalyst (115) in THF. He attributed the divergent reactivity compared with 
CH2Cl2 as a consequence of the attenuation of the Lewis acidity of 115 by THF. In 
general, rhodium catalyst 114 gave varying ratios of enol reduction product 116 or 
                                                
(29) Anquetin, G.; Rawe, S. L.; McMahon, K.; Murphy, E. P.; Murphy, P. V. Chem. Eur. J. 2008, 14, 
1592- 1600. 
(30) Nielsen, T. E.; de Dios, M. A. C.; Tanner, D. J. Org. Chem. 2002, 67, 7309-7313. 
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overreduction product 117 depending on the pressure employed. This transformation will 
be revisited extensively in chapter 4. 
Table 3.1 Selected Hydrogenation conditions explored by Dr. Juhl. 
O
OTBS
OTBS
MeOH
Me
TBSO
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O
OTBS
OTBS
MeOH
Me
TBSO
112
O
OTBS
OTBS
MeOH
Me
TBSO
117
O
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MeOH
Me
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116
113a
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Catalyst
600 psig
400 psig
Pressure Solvent
CH2Cl2
CH2Cl2
entry
1
2
3 114b 900 psig
112: 113 : 114
115a
115a
1 atm
1 atm
CH2Cl2
THF
4
5
1:0:2
0:0:1
1:0:0
4:1:4
1:0:0
% Conversion
0 %
40 %
CH2Cl2 100 %
100 %
86 %
Ir
N
PCy3
PF6
Rh
P
Ph2
Ph2P
BF4
113
P P
Et
Et
Et
Et
Rh
COD
BF4
115114
a) 10 mol %, b) 5 mol %
 
The synthesis continued with the fragment coupling. A protecting group modification 
was employed in the synthesis of the iodide used in the epoxide coupling (Scheme 3.13). 
An aldol reaction between oxazolidinone 118 and acrolein gives aldol adduct 119. 
Compound 119 is silylated to give compound 120. A 2 step reductive cleavage of the 
oxazolidinone gave alcohol 121, which was then converted to iodide 122 in an Appel 
reaction. Dr. Joseph Pero prepared compound 122. 
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d) LiBH4, THF/MeOH, 0 °C- r. t.; e) PPh3, I2, im, THF/CH3CN, r.t., then add 121, 0 °C.  
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Compound 112 was silylated to afford compound 123. (Scheme 3.14) Epoxidation of 
123, and opening with the organometallic derived from 122 afforded fragment-coupling 
product 124. Protection of the C19 alcohol afforded PMBM ether 125. PMBM was 
chosen, as it was orthogonal to the silyl groups, and can be removed in the presence of 
isolated alkenes by oxidation. This would potentially allow selective sulfation at an 
appropriate time. Compound 125 was converted to β keto-phosphonate 126 in a three-
step sequence of ozonolysis, lithiophosphonate addition and oxidation that was originally 
developed in work done by Dr. George Borg.  At this point, either the Z or the E olefins 
may be introduced by HWE reaction with the appropriate aldehydes. Only the synthesis 
of the Z macrocycle will be shown here, but that of the E series was entirely analogous. 
HWE reaction with Z aldehyde 75 followed by a Luche reduction afforded allylic alcohol 
127, with the alcohol at C14 formed in high diastereoselectivity. Hydrolysis of the N-
Phenyl amide at C1 was by a 4-step sequence. C14 was transiently protected as a TMS 
ether, the amide was activated by adding a BOC group. Cleavage of the imide was 
followed by TMS cleavage to give seco acid 128. This was cyclized under Shiina 
conditions to form macrocycle 129. E- macrocycle 130 was formed by an analogous 
procedure. 
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Scheme 3.14 
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Elaboration to nitrogen containing compounds was conducted by deprotection of the 
alcohol at C32  followed by oxidation to aldehyde 131 and addition of iodide 95 (Scheme 
3.15). Oxidation formed enone 132. This could then be converted to imine 133. The 
analogous reaction was carried out in the E series to form enone 134 and imine 135. 
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Scheme 3.15 
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Intramolecular Diels–Alder attempts 
With imines 133 and 135 in hand, attempts were made by Dr. Pero to run intramolecular 
Diels–Alder reactions (Figure 3.12). Application of the BnBr/AgSbF6 conditions to imine 
132 resulted in no reaction at lower temperatures, and decomposition at higher 
temperatures. 132 could be protonated using TFA to form salt 136, but no Diels–Alder 
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reaction to form 137 was observed at 40 ºC.31 Decomposition was observed upon heating 
to 70 ºC. In an attempt to avoid decomposition, alkylation with MeOTf formed iminium 
138, but no cycloaddition to form 139 was observed.  
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Figure 3.12 Attempted intramolecular Diels–Alder reactions in the Z diene series. 
Products attributed to isomerization of the Z- diene were observed upon heating. Acyclic 
compound 140 was prepared in anticipation that more degrees of freedom may be 
available to allow proper orbital overlap, but both protonation with TFA and methyl 
triflate failed to afford anything that Dr. Pero believed was a Diels–Alder adduct. A final 
                                                
(31) In-light of the results obtained in chapter 5, revisiting this result with non-coordinating counterions 
would have been desirable. Unfortunately the samples of 127 and 129 prepared by Dr. Pero had 
decomposed over several years of storage. I felt that the failure of 131 to react was enough evidence that it 
was not worth revisiting the entensive chemistry that would be needed to re-prepare compounds 127 and 
129.  
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series of attempt in the Z series was done by Dr. Martin Juhl, and involved conducting 
thermal reactions with enone 132. Enone 132 did not undergo reaction, even upon 
heating to 110 ºC in toluene. Heating to 150 ºC caused decomposition. A Lewis acid 
catalyzed Diels–Alder reaction with Me2AlCl also failed because of extensive 
decomposition of the substrate.32 
With these discouraging results from the Z diene series, attention turned to the E series. 
Only protonation was attempted for activation of compound 135. Attempts were also 
made with acyclic E diene analogous to 140. No Diels–Alder reaction was observed 
despite allowing the reaction to progress for 6 days. 
Unfortunately no reaction was observed. Enone 134 did not react under thermal 
conditions at 110 ºC and decomposition was noted at 140 ºC.  
At this point, Dr. Pero felt that the intramolecular Diels–Alder reaction was not viable 
with these substrates. The rationale was that they could not achieve conformations in 
which proper orbital overlap occurred to promote the Diels–Alder reaction. In the end of 
his post-doctoral report, Dr. Pero designed an intramolecular Diels–Alder route toward 
spiro-prorocentrimine. 
IV.  Considerations for the Intramolecular Diels–Alder Synthesis Plan 
Since a Diels–Alder reaction that produced compound 92 did work in an intermolecular 
fashion, Dr. Pero proposed the following synthesis plan (Figure 3.13). An intramolecular 
Diels–Alder reaction between imine 141 and Z diene 142 would afford Diels–Alder 
adduct 143. This would then be subject to a ring closing metathesis reaction to form the 
                                                
(32) Roush has shown IMDA reactions with Z-dienes employing this Lewis acid: i) Roush, W. R.; Barda, 
D. A. J. Am. Chem. Soc. 1997, 119, 7402- 7403. ii) Yakelis, N. A.; Roush, W. R. Org. Lett. 2001, 3, 957- 
960. In the course of later studies, I observed that SnCl4 apparently does promote intermolecular Diels–
Alder reactions between macrocyclic dienes and enones, but the enone component displayed poor facial 
selectivity. 
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C26–C27 bond in compound 144. In the RCM route, removal of an orthogonal protecting 
group on C25 would produce allylic alcohol 145. It was hoped this alcohol could be 
employed to direct a reduction of the olefin at C26–C27.   
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Figure 3.13 Redesigned synthesis plan for spiro-prorocentrimine. 
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This was ambitious, since there are other olefins in the molecule, however hydrogenation 
of olefins bearing directing groups that spare olefins with no directing groups are 
known.33 
 
In light of the results presented in Chapter 4, it is also worth considering that since the 
olefins in the molecule are in chiral environments, matching and mismatching of chiral 
catalysts may produce olefin selection even in the absence of directing group influences. 
Such interactions would be best determined empirically. If a successful reduction 
occurred, this would produce alcohol 146. This would be only several protecting group 
manipulations away from spiro-prorocentrimine. Other strategies to form that bond, such 
as an HWE reaction could be envisioned, but the RCM is particularly attractive since it 
may be performed with an intact stereocentre at the C25 position. An HWE reaction on a 
molecule such as 147 would result in a product with a ketone at the C25 position, which 
would require a selective reduction on a macrocycle. My own experience with peloruside 
A (albeit a smaller, more crowded, and presumably less flexible molecule) suggested this 
might be a difficult proposition.  
 
At this point I took over the project, and was tasked with implementing this strategy. In 
redesigning the synthesis for this strategy, I decided to keep the best attributes of the prior 
work, while taking the opportunity of the redesign of the synthesis to address several 
inefficiencies. These efforts are described in the next 3 chapters. 
 
Conclusion 
The efforts towards spiro-prorocentrimine by my predecessors on the project were 
summarized. Imine based Diels–Alder reactions were developed. The imine and iminium 
                                                
(33) Burk, M. J.; Gross, M. F.; Martinez,  J. P.  J. Am. Chem. Soc. 1995, 117, 9375- 9376. 
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ion dienophiles were found to be poorly reactive with Z dienes and to give endo selective 
reactions with E dienes in intermolecular reactions. The synthesis of several macrocycles 
containing Z and E dienes  was developed. These did undergo intermolecular Diels–
Alder reactions with dienophiles. The work on spiro-prorocentrimine concluded with the 
synthesis of several substrates designed for intramolecular Diels–Alder reactions. None 
of these underwent Diels–Alder reactions, which was attributed to the molecule failing to 
achieve conformations that enabled proper overlap of the diene and the dienophile. An 
intermolecular Diels-Alder strategy was proposed to continue the synthesis of spiro-
prorocentrimine. 
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 Chapter 4 
Synthesis of the Macrocyclic Diene1 
I. Preparation of the Hydrogenation Substrate 
According to the synthesis plan presented in chapter 3, spiro-prorocentrimine 1 is 
envisioned to arise from a late stage Diels–Alder reaction between imine 2 and elaborate 
Z- macrocycle 3 (Figure 4.1) followed by a ring-closing metathesis and other functional 
group manipulations. The synthesis of 2 and Diels–Alder reaction studies will be the 
subject of chapter 5 and 6, while the synthesis of 3 is the subject of this chapter. 
Compound 3 in turn would be assembled from C1–C12 fragment 4, available from the 
work of Dr. George Borg, and C13–C26 fragment 5, generated from the glycal epoxide 
based coupling used by Dr. Martin Juhl in the preceding chapter. The substrates for the 
epoxide opening would be C14–C17 synthon 6 and C18–C26 synthon 7. 
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Figure 4.1 Synthesis plan for spiro-prorocentrimine. 
                                                
(1) Portions of the work described in this chapter were well precedented by the work conducted by Dr. 
Martin Juhl, Dr. Joseph Pero and Dr. George Borg that was described in Chapter 3. This is noted where 
applicable. Some of the work in this chapter was preformed with Dr. Pascal Bindschädler, and is noted 
where appropriate. 
  164 
Initial efforts focused on the synthesis of the pyran section 7 of the molecule. After 
considering a variety of options, it was decided that keeping tri-O-acetyl-D-glucal 8 as 
the starting material presented the most efficient and precedented approach to this piece 
since 8 possesses the correct stereocentres at C22–C20, as well as handles for 
functionalization at C23 and C18 as shown in Figure 4.2.2  
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Figure 4.2 D-Glycal as mapped on to fragment 7. 
An approach to a trisubstituted alkene was attempted on a model system. The anion 
derived from alkyne 9 was added to propionaldehyde and oxidized to ynone 10 (Scheme 
4.1).  
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Addition of methyl copper to ynone 10 resulted in decomposition, however addition of 
dimethyllithium cuprate led to a mixture of Z and E olefins 11a and 11b, despite a 
cryogenic quench.3,4 This mixture was inseparable, and could not be equilibrated using 
either thiols or DMAP/ DMAP- HCl.5,6 Had this approach worked, acrolein surrogate 12 
would have been used instead of propionaldehyde. 
                                                
(2) The price of Tri-O-Acetyl-D-glucal from VWR is $60.80 for 25 g (92 mmol). The amount of 75 g was 
sufficient for all of the work described herein. 
(3) Nilsson, K.; Andersson, T.; Ullenius, C; Gerold, A. Krause, N. Chem. Eur. J. 1998, 4, 2051- 2058. 
(4) In retrospect, Et2O was a poor choice of solvent. THF is known to favour the formation of syn- 
carbocupration products, which would have led to 10b in this case, while Et2O is known to lead to 
scrambling by formation of allenoates. See reference 3 for details. 
(5) Significant elimination of an OTBS group was observed upon treatment with 4-t-buthiophenol/DMAP. 
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With these discouraging initial results, it was decided in the interests of time to more 
closely follow the result of Dr. Juhl. However, the use of stoichiometric palladium and 
organostannanes at such an early stage in the synthesis required reexamination (Chapter 3 
Scheme 3.12). This was due to both aesthetic and practical reasons. Because of the price 
of precious metals at the time this transformation was under investigation (early 2009), 
ordering such a large quantity of palladium had become unattractive.7 A similar 
stereoarray to the one desired was produced in the course of the Evans synthesis of 
salvinorin A 13,8 where an iron mediated coupling of methyl magnesium chloride with 
enol phosphate 14 gave rise to trisubstituted olefin 15 (Scheme 4.2).9  
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The α, β–unsaturated aldehyde 16, derived from the product of cross coupling, proved to 
be an excellent substrate for a Nagao type acetate aldol with thiazolidinethione 17, giving 
                                                                                                                                            
(6) For DMAP, see Keck, G. E.; Boden, E. P.; Mabury, S. A.; J. Org. Chem. 1985, 50, 710- 712.; For 
Thiols, see Aroyan, C. E.; Miller, S. J.; J. Am. Chem. Soc. 2007, 129, 256- 257. 
(7) The estimated cost was over $5 000 for the amount of palladium dba projected to be required contrasted 
with Juhl’s purchase of approximately the same amount for $1000 2 years prior. 
(8) Scheerer, J. R.; Lawrence, J. F.; Wang, G. C.; Evans, D. A. J. Am. Chem. Soc. 2007, 129, 8968-8969. 
(9) Cahiez, G.; Avedissian, H. Synthesis 1998, 1199-1205. 
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stereoarray 18.10 This maps well on the corresponding C18–C26 target fragment for spiro-
prorocentrimine 19, so such a strategy was implemented for the construction of 19. 
 
Aldehyde 2011 was subjected to a Roskamp reaction with ethyl diazoacetate, mediated by 
niobium pentachloride, forming C23–C24 bond in β-ketoester 21.12 Based on anecdotal 
evidence from the group, the Roskamp reaction was quite sluggish, which was attributed 
to the sterically demanding environment around the aldehyde.13 No products resulting 
from competing chemistry at the enol ether were observed (Scheme 4.3).  
Scheme 4.3  
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The β-ketoester could readily be transformed into enol phosphates 22a or 22b. 
Unfortunately, neither compound was a competent partner for cross coupling with a 
methyl organometallic, either mediated by iron, or using lithium dimethylcuprate.14 
In the lithium dimethylcuprate coupling, trace quantities of the desired trisubstituted 
enoate 23 could be obtained. The predominant product recovered in attempts at these 
transformations was β-ketoester 21. It was presumed that the nucleophillic attack is 
                                                
(10) Nagao, Y.; Fujita, E. J. Org. Chem. 1986, 51, 2391-2393. 
(11) (a) Anquetin, G.; Rawe, S. L.; McMahon, K.; Murphy, E. P.; Murphy, P. V. Chem. Eur. J. 2008, 14, 
1592- 1600. (b) Tius, M. A.; Hagadone, M. R. U. S. Patent 5,292,899, 1994. 
(12) Holmquist, C. R.; Roskamp, E. J. J. Org. Chem. 1989, 54, 3258- 3260. For the use of niobium 
pentachloride in this transformation, which is cleaner than SnCl2, see: Yadav, J. S.; Subba Reddy, B. V.; 
Eeshwaraiah, B.; Reddy, P. N. Tetrahedron 2005, 61, 875- 878. 
(13) Dr. Drew Adams ran a Roskamp reaction on a less hindered aldehyde at ambient temperature for a 
shorter time. See:  Evans, D. A.; Adams, D. J. J. Am. Chem. Soc. 2007, 129, 1048- 1049. 
(14) Sum, F. W.; Weiler, L. Can. J. Chem. 1979, 57, 1431- 1441. 
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occurring at the phosphorus centre, rather than the desired carbon, releasing the β-
ketoester. This can be attributed to the sterically crowded environment around C23. 
 
Attention switched to the use of an enol triflate in the cross coupling, as reported by 
Fürstner.15 Unfortunately, use of the lithium enolate of the β-ketoester to form Z-enol 
triflate 24a was unsuccessful using the conditions of Fürstner (phenyl triflamide 25, 
LiHMDS deprotonation, DMPU as co solvent) (entry 1, Table 4.1). Use of the more 
reactive Comins reagent 26 was also unsuccessful (Entry 2). 16  
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LiHMDS
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26
Tf Source 24a:24b
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entry
1
2
3 NaHMDS 26 6: 1
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KHMDS
LiHMDS
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29
1:1
24a only
4
5
6 NaHMDS 29 24a only
50 %
30 %
N/A
N/A
NaH 29 24a only7
50 %
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Upon switching to more reactive sodium and potassium enolates, formed using the 
respective hexamethyldisilazides, better reactivity with 25 and 26 was obtained, at the 
expense of olefin geometry (Entry 3, 4).17 It is assumed that a greater amount of the non 
chelated E-enolate 27 relative to Z-enolate 28 is formed with the larger sodium and 
                                                
(15) Scheiper, B.; Bonnekessel, M.; Krause, H.; Fürstner, A. J. Org. Chem. 2004, 69, 3943- 3949. 
(16) Comins, D. L.; Dehghani, A. Tetrahedron Lett. 33, 42, 6299- 6302. 
(17) As assessed by 19F NMR of the enol triflates in the crude reaction mixture. 
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potassium cations.18 Additionally, the more reactive E-enolate 27 could be triflated faster, 
in a Curtin–Hammett type scenario. Since only one geometric isomer of the enol 
phosphates had been observed using LiHMDS enolization, it was decided to return to 
lithium bases and employ the more reactive triflating agent triflic anhydride 29. Exposure 
of 21 to LiHMDS, followed by triflic anhydride, resulted in the formation of a 50% yield 
of the desired enol triflate as solely the Z isomer (Entry 5, table 4.1). The balance of the 
material was β-ketoester 21. Now that a route was secured to the enol triflate, an iron 
mediated cross coupling was attempted, which proceeded cleanly to afford enoate 23 
(equation 4.1).  
 
OTf
O
OTBS
OTBS
23
18
O
EtO
24a
Me
O
OTBS
OTBS
23
18
O
EtO
23
(4.1)
a
a) MeMgCl, Fe(acac)3, THF, NMP, -20 °C  
After validating this method of formation of the enoate, attention returned to optimization 
of the triflate formation. Since the near quantitative formation of enol phosphate 22b with 
LiHMDS as a base showed that enolization was complete, it was anticipated that the 
partial triflation was due to a competitive decomposition of the triflic anhydride.19 An 
obvious candidate was hexamethyldisilazane, the conjugate acid of LiHMDS. Evidence 
supporting this was mixing of triflic anhydride and hexamethyldisilazane in CDCl3, albeit 
at room temperature, in an NMR tube, which resulted in instantaneous reaction. 
Accordingly, a base with a conjugate acid unreactive with triflic anhydride, sodium 
hydride, was used for the enolization (entry 7, Table 4.1). Almost complete conversion to 
the enol triflate at -78 °C was observed. An added bonus was that the enol triflate was 
detected as only one geometric isomer. This contrasts to the triflation results found with 
                                                
(18) An area for future investigation would be the addition of 18-crown-6 to selectively favour the E-
enolate. This may permit a geometrically controlled synthesis of trisubstituted olefins from a common 
precursor. 
(19) In retrospect, the low yield for the formation of 22a may be attributed to a similar decomposition 
route. 
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sodium hexamethyldisilazide and the less reactive triflating agent 26 (entry 3). A 
reasonable explanation is the kinetic quench scenario, where the population of the 
undesired but more reactive E sodium enolate is actually very low, and the activation 
barrier for quench of the Z sodium enolate with the powerful triflating reagent triflic 
anhydride is less than the barrier for interconversion of the enolate isomers. An alternate 
explanation is that no mechanism for the interconversion of the enolate isomers exists in 
the absence of the proton source hexamethyldisilazane.  
 
In practice, the enol triflate formation and cross coupling were conducted in one pot.20 
The enoate was readily reduced to the allylic alcohol 30 using DiBAlH (Scheme 4.4). 
Hydroalumination of the enol ether was not a competing reaction at -78 °C, but when the 
reduction was run at higher temperatures, some decomposition was noted that could be 
attributed to this side reaction.  Observation of a nOe enhancement between the protons 
at the C40 methyl and C25 allylic position indicated the desired E olefin geometry.  
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(20) While the enol triflate was stable to chromatography, higher yields were obtained in the one pot 
procedure. 
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A half reduction directly to aldehyde 31 was attempted, but was unsuccessful despite 
slow addition of DiBAlH solution or attempts to run the reaction in a thawing mixture of 
dichloromethane and toluene (approx -95 °C). Use of Red-Al® or lithium borohydride to 
reduce enoate 23 to allylic alcohol 30 were also unsuccessful. 
 
The allylic alcohol could be oxidized to enal 31 using manganese dioxide, but Parikh– 
Doering conditions were more convenient on large scale.21 Careful chromatography of 
enal 31 was required to remove materials such as DMS and DMSO, which could 
potentially serve as ligands, eroding the selectivity of the subsequent Nagao acetate aldol. 
The acetate aldol reaction was uneventful, providing 19 with 20 to 1 diastereoselectivity. 
Commercial stannous triflate (Strem) proved inferior to stannous triflate prepared 
according to a modified procedure of Dr. Ann Weber.22 Auxiliary 32 was removed 
reductively, and the primary alcohol 33 was selectively protected. The reductive removal 
was unremarkable, however the balance of the material from the selective protection to 
form 34 was protection of the secondary alcohol to yield 35.  
II. Hydrogenation Studies 
 
The next challenge revolved around hydrogenation of the trisubstituted olefin in the 
presence of the enol ether to set the stereochemistry at C23 in desired product 36 
(equation 4.2). 
 
OH MeOTBS
34
O
OTBS
OTBS
[H2], catalyst
OH MeOTBS
36
O
OTBS
OTBS
(4.2)23
 
                                                
(21) Parikh, J. R.; Doering, W. v. E. 1967, 89, 5505- 5507.  
(22) The ratio of SnCl2 to triflic acid may be increased to 5 times that in the following publication: Evans, 
D. A.; Weber, A. E. J. Am. Chem. Soc. 1986, 108, 6757-6761. Fine grinding of the SnCl2 is essential to 
ensure complete conversion in the consequently more viscous reaction. Dr. Paulo Vital developed this 
modification. 
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 This reaction was not initially projected to be problematic, given that Juhl had found 
robust conditions for the selective hydrogenation of a trisubstituted olefin in the presence 
of an enol ether in a very closely related system (Chapter 3, Table 3.1). Technical 
considerations for the success of this reaction mainly revolve around the difficulty of 
monitoring high pressure hydrogenations while in progress. The small quantities of 
substrate (often 10 – 50 mg) employed in test runs,23 combined with the relatively large 
volume of even the smallest hydrogenation bombs precludes accurately measuring 
pressure changes as an indicator of the progress of hydrogenation. Obtaining aliquots for 
chromatographic or spectral analysis is infeasible without specialized equipment, as 
depressurizing and opening the hydrogenation bomb would cause exposure to 
atmosphere, spoiling the catalyst. It should be noted most hydrogenation catalysts such as 
37 are supplied as pre-catalysts containing a chelating diolefin such as cyclooctadiene or 
norbornadiene 38 which is hydrogenated off before productive hydrogenation can begin 
(equation 4.3).24  
 
Rh
L
L
X
+ 2 Solv
H2
37
Rh
SolvL
L Solv
X
 38
39
(4.3)
 
The solvate complexes such as 39 that are formed after removal of norbornadiene or 
COD are generally far more sensitive to water and oxygen than the initial precatalysts. 
An ideal procedure is therefore one that reliably hydrogenates the trisubstituted olefin in 
a predictable amount of time, with minimal hydrogenation of the enol ether. Furthermore, 
                                                
(23) While 10-50 mg of an intermediate 11 steps in is generally a very large quantity to use in scouting 
runs, the sensitive nature of the catalysts, coupled with the potential for over reduction if artificially high 
loadings of catalysts are used necessitate the use of relatively large quantities of substrate. Fortunately the 
efficiency of the synthesis of 35 allowed multigram quantities to be prepared. 
(24) The time for the initiation can often be slower than the complete hydrogenation of substrate. 
Differences between norbornadiene precatalysts (generally activated faster) and COD precatalysts can be 
pronounced. For a kinetic study comparing initiation rates of COD with norbornadiene rhodium complexes 
of bidentate phosphines, see: Heller, D.; Borns, S.; Baumann, W.; Selke, R. Chem. Ber. 1996, 129, 85- 89. 
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this procedure must be amenable to scale-up, from the original scale of the test- run to 
procedures on a gram or more of material to allow reasonable material throughput. The 
Juhl procedure offered such a solution, with the use of Crabtree’s catalyst 40 in THF, 
conducted under a balloon of hydrogen. This reaction was ultimately conducted in a 
multigram scale in the course of Juhl’s scale-up. 
 
With the hydrogenation substrate in hand, the Juhl conditions for hydrogenation were 
attempted (Table 4.2, entry 1). Unfortunately extensive screening of a variety of loadings 
of Crabtree’s catalyst in THF met with little success, as conversions were never higher 
than 50%, and conversion fell when the reaction scale was raised above 50 mg (entry 2). 
 
Table 4.2 Attempts to hydrogenate substrate 34.25  
40
40
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THF
THF
entry
1
2
3 40 500 psig
36: 42 : 46
40
41
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5
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0:1:0
2:1:0
1:0:0
1:0:0
43 200 psig CH2Cl27
1:0:0
0:1:0
1:1:0
OH MeOTBS
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OTBS OH MeOTBS
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OTBS
OTBS OH MeOTBS
42 O
OTBS
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THF 35 %
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N/A
0:0:1
0 %
10 %
44
a) 5- 10 mol% catalyst, [cat] < 0.004 M
b) 50 % conversion was on 10 mg 34, 15 % conversion  was on 190 mg 34
c) This yield was not reproducible
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Rh Cl
PPh3
PPh3
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P
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(25) Approximately 90 attempts were made to hydrogenate 34 before reliable conditions were developed 
The variation of pressure, solvent and catalyst identity was done in a manner that attempted to be 
systematic, and the results selected here represent various established boundary conditions. 
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Over reduction to 42 was observed with increased pressure, despite incomplete 
conversion of starting material (entry 3). Over the course of several of these runs, 
approximately 100 mg of the hydrogenation product was obtained, and NMR 
spectroscopy verified that it was being produced as one diastereomer. Use of Crabtree’s 
catalyst in dichloromethane as the solvent resulted in complete hydrogenation, in 
accordance with the observations of Juhl, and one diastereomer, assumed to be 42, was 
obtained (entry 4). Some of the Juhl hydrogenation substrate was available, and I was 
able to reproduce his procedure with his substrate, showing that the issue lay with my 
substrate rather than the batch of the catalyst or my technique. 
 
A slight improvement was noted in some runs with the use of Crabtree’s catalyst with a 
BArF ion 41 rather than hexafluorophosphate.26 However, use of catalyst 41 proved very 
capricious, in that scale up to a moderate scale resulted in reduced and non-reproducible 
yields (entry 5). Unlike 40, 41 is soluble in diethyl ether, so this solvent was attempted in 
anticipation that the attenuation of reactivity would be less than in the stronger 
coordinating THF. Unfortunately complete conversion to 42 was noted (entry 6).27  
 
Attention switched to a wider range of catalysts. Unfortunately neither the Brown 
cationic rhodium catalyst 43 nor Wilkinson’s catalyst 44 proved reactive at lower 
pressures (200 psig) (entries 7 and 8).28 These catalysts were tested on both the alcohols 
                                                
(26) Wüstenberg, B.; Pfaltz, A. Adv. Synth. Catal. 2008, 350, 174- 178. 
(27) The lack of reproducibility and scalability in these hydrogenation reactions was attributed to physical 
properties related to hydrogen transport. Scaling a reaction up results in an increase in the volume to 
surface area ratio of the reaction, until larger size glassware is used. The depth of the reaction, and 
consequent size of the vortex created by stirring are possibly also factors, and vortex character is 
impossible to monitor in the non-transparent bomb. A mechanism for scale- related decline in yield might 
involve decomposition pathways through hydride-poor iridium species, which would increase in 
concentration if the reaction were starved of hydrogen.  
(28) For the use of 43 in directed hydrogenations of allylic alcohols, see a) Brown, J. M.; Naik, R G. J. 
Chem. Soc., Chem. Commun. 1982,  348- 352. b) Evans, D. A.; Morrissey, M. M. J. Am. Chem. Soc. 1984, 
106, 3866- 3868. 
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and the sodium alkoxides.29 Some over hydrogenated product was noted in both cases.  
Complex 45, bearing an achiral PHOX ligand was prepared, but appeared to hydrogenate 
only the enol ether leading to product 46.26 It is believed that the divergence in reactivity 
compared to the Juhl case is because of the presence of the potentially coordinating 
OTBS group at C26’. While coordination to silyl groups is not typically invoked, the very 
electrophillic nature of the iridium catalyst, combined with the formation of a 6 
membered ring 47 could make chelation favourable (Figure 4.3). 
 
O MeTBSO
47 O
OTBS
OTBS
Ir
L L
H
 
Figure 4.3 Proposed iridium chelate. 
This chelate could suppress catalyst turnover, while leaving the catalyst open to non- 
productive decomposition.30 A TIPS group at C26’ was tried, but this appeared to suppress 
activity in hydrogenation altogether. 
 
At this point, it was decided to attempt the hydrogenation at an earlier stage of the 
synthesis, on either enoate 23 or allylic alcohol 30. In 34, direction from the secondary 
alcohol at C25 introduces the possibility of forming chelate 47 and the alcohol at C25 is 
also sterically hindered. Truncating the molecule at C25 would preclude the formation of a 
chelate, and also lower the steric hindrance at the directing group. This steric reduction 
might mean that the catalyst would more selectively interact with the directing group 
over the enol ether.  
 
                                                
(29) For the use of sodium alkoxide with 44, see a) Thompson, H. W.; McPherson, E. J. Am. Chem. Soc. 
1974, 96, 6232- 6233. For the use of sodium alkoxide with 43 on a substrate of comparable complexity, 
see: b) Paquette, L. A.; Peng, X.; Bondar, D. Org. Lett. 2002, 4, 937- 940.  
(30) A chelate may also be formed with products 36 or 42, involving the endocyclic ring of the pyran. 
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 Selective hydrogenation of the trisubstituted olefin in 23 without hydrogenating the enol 
ether was unsuccessful.31 The most noteworthy result was that catalyst 48 effected 
complete hydrogenation to compound 49 with high diastereoselectivity at C23. (equation 
4.4) The assignment of the stereochemistry is based solely on the Pfaltz model for similar 
substrates.32 The enantiomer of 48 shown was the only one commercially available at the 
time, so this is why a catalyst predicted to produce the incorrect diastereomer was used. 
The other enantiomer of 48 is also readily available in a 5 step synthesis. This result is 
notable since it suggests that control of the configuration at C23 is possible.33 Use of this 
strategy in the synthesis would result in a less convergent synthesis, since fragment 
coupling at the enol ether would now have to occur before the hydrogenation, or possibly 
even before the olefin introduction. Consequently such an approach was held in reserve 
until all other options were explored.  
Me
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EtO
Me
49 O
OTBS
OTBSO
EtO 23
N
O
Ph
Me
O
PCy2
BnBn
Ir
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(4.4)
H2 , 48
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Attention turned to alcohol 30, with the thought that an alcohol would be a better 
directing group than an ester, and the trisubstituted olefin may also be a better 
backbonder than the enoate, allowing better selection between the olefins. 
Allylic alcohol 30 was readily hydrogenated at ambient pressure using  cationic rhodium 
catalyst 43 to yield a 1.2: 1 mixture of separable diastereomers at C23, 50 and 51, while 
                                                
(31) As well as the catalysts in table 4.2, use of a chiral iridium t-Bu-PHOX catalyst and Rhodium 
DuPHOS based catalysts were attempted. Either no reduction or no olefin selectivity was observed. 
Stryker’s reagent was also used in an attempt to do a conjugate reduction, but the reaction was 
unsuccessful.  
(32) Manges, F.; Pfaltz, A. Adv. Synth. Catal. 2002, 344, 40- 44. 
(33) Catalyst 40 did not hydrogenate either olefin of enoate 34 so the intrinsic diastereoselectivity could not 
be directly determined. The results in the next section suggest that the enoate does not have a strong facial 
bias, since alcohol 30 does not have a significant facial bias. Therefore hydrogenation of 23 with 
enantiomeric catalysts was not predicted to have matched and mismatched combinations. 
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preserving the enol ether (equation 4.5). This result contrasts with the low activity of 
catalyst 43 with substrate 34 even at higher pressure, suggesting that steric factors are 
important for this catalyst’s reactivity.  
Rh
P
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43
Me
30 O
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OTBS Me
50 and 51
O
OTBS
OTBS
23 (4.5)
H2 ,43
1 atm
CH2Cl2
HOHO
 
Encouraged by this result, chiral catalysts were screened, but these resulted in no 
hydrogenation at ambient pressure, and over hydrogenation at increased pressure.34  
Accordingly, one final hypothesis was investigated. In screening, Dr. Juhl had noted that 
chiral rhodium DuPHOS complexes appeared more reactive in his hydrogenation than 
Brown catalyst 43, so the decision was made to retry the reduction of 34 using Rhodium 
R,R-Ethyl DuPHOS 52 (Table 4.3).   
Table 4.3 Conditions for selective hydrogenation of 34.  
52a
52a
Catalysta
200 psig
800 psig
Pressure Solvent
CH2Cl2
CH2Cl2
entry
1
2
3 55b 100 psig
36: 42
ent 55 100 psig CH2Cl24 n/a
1:0
1:0
0:1
OH MeOTBS
34 O
OTBS
OTBS OH MeOTBS
36 O
OTBS
OTBS OH MeOTBS
42 O
OTBS
OTBS
% Conversion
60 %
100 %
CH2Cl2 99 %
0 %
a) 15 mol % catalyst
b) 2 mol% catalyst on 1.1 g scale
P P
Et
Et
Et
Et
Rh
COD
BF4
52
P P
Me
Me
Me
Me
Rh
COD
BF4
55  
An initial experiment using 15 mol % loading of catalyst at 200 psig gave 60% 
conversion to the desired product with good selectivity (entry 1). Attempts to increase the 
conversion by increasing the pressure resulted in over reduction (entry 2). Inspection of 
                                                
(34) Catalysts included: [Rh(nbd)(R,R-MeDuPHOS)]BF4 (55), [Rh(COD)((-)-Binap)]ClO4, Ru(OAc)2((-)-
Binap), 48, [Ir(COD)(t-BuPhox)][3,5-BArF] and [Rh(nbd)((+)-DIOP)]BF4. Only the last catalyst was 
active at ambient pressure, and no significant perturbation in diastereoselectivity was observed. Only one 
enantiomer of each catalyst was used, for reason of cost, and the enantiomer of the catalysts was chosen 
arbitrarily, with the exception of the Binap containing catalysts. For these, the enantiomer was chosen for 
which precedent existed that hydrogenation of geraniol would give the desired diastereomer. See: Takaya, 
H.; Ohta, T.; Sayo, N.; Kumobayashi, S. A.; Inouye, S.; Kasahara, I.; Noyori, R. J. Am. Chem. Soc. 1987, 
109, 1596- 1597. 
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the hydrogenation literature revealed that while the ethyl DuPHOS containing complexes 
are well suited to the hydrogenation of dehydroamino acids, they perform quite poorly in 
the hydrogenation of dehydro amino acids bearing tetrasubstituted double bonds, such as 
the hydrogenation of dehydrovaline 53 to valine 54 (equation 4.6). In cases such as this, 
R,R-Me DuPHOS catalyst 55 is superior.35 
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 In the hydrogenation currently under consideration, the tri-substituted olefin in 34 has 2 
substituents on the carbon of the olefin distal to the directing group, in analogy to the 
tetrasubstituted dehydroamino acids. Accordingly, R,R-Me DuPHOS catalyst 55 was 
employed in a hydrogenation reaction of 34, which on the first attempt resulted in 
quantitative conversion and near perfect selectivity according to the crude proton NMR 
spectrum.  
 
Upon scale- up, it was noted that some completely hydrogenated material was obtained. 
Typically each time the scale of hydrogenation increased, the loading of catalyst and 
pressure needed to be lowered to ensure good selectivity. The largest single batch 
hydrogenated was 1.5 g (out of a total of 10g of hydrogenation substrate prepared). No 
attempts to run the reaction on larger batches were made because at this point, a 
reproducible procedure had been found involving 2 mol% catalyst and there was no 
desire to consume further material in optimization (entry 3).36  
                                                
(35)  a) Burk, M. J.; Gross, M. F.; Martinez,  J. P.  J. Am. Chem. Soc. 1995, 117, 9375- 9376. b) Burk, M. 
Acc. Chem. Res. 2000, 33, 363- 372. 
(36) Despite the 2 mol% loading, catalyst 55 was the single largest chemical expense in the course of this 
project. For larger reactions, investigation of the corresponding BPE catalysts, with a more flexible 
backbone, and higher reactivity may be warranted (see reference 35b). The cost of 500 mg of 55 is $432 
from Strem as of May 2nd 2012. At the time of the hydrogenation studies, it would have been difficult to 
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One final note is on the stereochemistry of the hydrogenation product. Use of the S, S-Me 
DuPHOS catalyst ent-55 under the same conditions resulted in no hydrogenation, 
indicating a substrate catalyst mismatch (entry 4). The product of the hydrogenation 
procedure using catalyst 55 was spectrally identical to that obtained in low yield using the 
achiral Crabtree’s catalyst. The enol ether in hydrogenation product 36 could also be 
hydrogenated using Crabtree’s catalyst 40, or R,R-Me DuPHOS catalyst 55 at higher 
loading and pressure, to obtain 42, the same product as when substrate 34 is exhaustively 
hydrogenated using Crabtree’s catalyst in dichloromethane (Scheme 4.5).  
Scheme 4.5  
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These results show that catalyst 55 hydrogenates from the same face that the substrate has 
a natural preference for.  Employing the quadrant model for DuPHOS corroborates this, 
as shown in figure 4.4. Model 56 represents a matched case with R,R-DuPHOS, while 
model 57 represents the mismatched case with S,S-DuPHOS.  It can be seen in model 56 
that only the methyl group protrudes into the blocked quadrant, while in case 57 the large 
pyranyl group would protrude into the blocked quadrant.37 
 
                                                                                                                                            
make 55 from DuPHOS ligand and a rhodium source on this small scale for a much lower price.  With the 
recent decline in the price of rhodium salts, this approach may be warranted. 
(37) This model makes the assumption that a Halpern type scenario, where the minor substrate-catalyst 
complex is more reactive and leads to the dominant hydrogenation product, is not active. See: Halpern, J. 
Science. 1982, 217, 401- 407. A number of examples suggest this Curtin-Hammet scenario is not operative 
in the directed hydrogenation of allylic alcohols. See: Hoveyda, A. H.; Evans, D. A.; Fu, G. C. Chem. Rev. 
1993, 93, 1307- 1370 and references therein.  
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Figure 4.4 Rationalization of the ligand effect in the hydrogenation. 
Final definitive proof of the stereochemistry of 36 was obtained by the analysis of a 
byproduct found in the sequence shown in scheme 4.3. Hydrogenation of 34 to 42 with 
Crabtree’s catalyst in CH2Cl2 always produced trace amounts of bicycle 58, while 
hydrogenation of pure 36 with Crabtree’s catalyst produced up to 20% of bicycle 58 
(Scheme 4.6.) 
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Bicycle 58 may be generated from 36 by loss of the OTBS group at C20, ether formation 
between C18 and the alcohol at C25, and hydrogenation to produce a saturated structure. 
The structure of 58 was assigned from NMR, MS and IR data. The stereochemistry at C23 
was assigned by observation of nOe enhancements between the protons on C23 and C25, 
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and between the methyl group at C23 and the proton at C21. Since 58 is generated from 
pure 36, the stereochemistry at C23 on 36 may be inferred from this result. Two 
suggestions for the mechanism of formation of 58 are presented in scheme 4.6. In the first 
scheme, the enol ether in 36 complexes with an iridium (I) complex to form 
iridacyclopropane 59, which in a ring-flipped all axial form may undergo an attack from 
the alcohol at C25 to C18, producing compound 60. Compound 60 is poised to undergo an 
anti- β silyloxide elimination, with concomitant proton transfer to generate alkene 61. 
Hydrogenation of 61  would result in the formation of 58.  
 
In an alternate mechanism, an iridium (III) hydride complex 62 protonates the OTBS 
group at C20, resulting in the formation of oxocarbenium ion 63 and iridium (I) complex 
64. An intramolecular ether formation would result in the formation of alkene 61. The 
proton from the alcohol at C25 could protonate iridium (I) complex 64 at the metal, 
regenerating 62, or it could protonate off a hydride, resulting in an iridium (I) cationic 
complex that would be poised to react with hydrogen again to regenerate 62. Burgess has 
reported that iridium hydride complexes such as those intermediate in hydrogenations 
mediated by Crabtree’s catalyst are acidic, and will react with enol ethers under certain 
conditions.38  
 
III. The First Fragment Coupling 
The C25 alcohol of the hydrogenation product now had to be protected using a protecting 
group orthogonal to the TBS groups employed elsewhere in the synthesis. It is anticipated 
this alcohol will serve as a directing group for a hydrogenation a second time, after the 
ring closing metathesis reaction.  It was decided to use a DMB group, which would be 
more readily removed than the PMBM group masking the alcohol at C19 (the point of 
                                                
(38) Zhu, Y.; Fan, Y.; Burgess, K. J. Am. Chem. Soc. 2010, 132, 6249- 6253. 
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installation of the sulfate). Unfortunately, efforts to install the DMB group using either 
DMB bromide or DMB trifluoroacetimidate were unsuccessful. Gratifyingly, the more 
reactive DMBM chloride allowed the installation of a DMBM group to afford 65, which 
should have the same oxidative advantage over the PMBM group (Scheme 4.7).39  
 
With the protected hydrogenation product 65 in hand, the next major reaction was 
applying the coupling of an organocuprate to the glycal epoxide as used by Juhl in the 
prior route. DMDO was used to oxidize compound 65, which produced epoxide 66 very 
cleanly, allaying fears that the electron rich DMBM group would be oxidized. 40,41 It was 
noted that batches of DMDO that were wet did not have any detrimental effect on the 
yield (the glycal epoxide is dried via benzene azeotrope, and any droplets of water were 
removed manually from the benzene solution by pipette). Accordingly, molecular sieves 
were not used to dry the DMDO.  
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d
 
                                                
(39) Trost, B. M.; Frederiksen, M. U.; Papillon, J. P. N.; Harrington, P. E.; Shin, S.; Shireman, B. T. J. Am. 
Chem. Soc. 2005, 127, 3666- 3667. 
(40) For the preparation of DMDO, see Adam, W.; Bialas, J.; Hadjiarapoglou, L.  Chem. Ber. 1991, 2377. 
(41) The seminal preparation of anhydrosugars by DMDO oxidation: (a) Halcomb, R. L.; Danishefsky, S. J. 
J. Am. Chem. Soc. 1989, 111, 6661-6666. For studies on the facial selectivity of this reaction: (b) Alberch, 
L.; Cheng, G.; Seo, S.-K.; Li, X, Boulineau, F. P.; Wei, A. J. Org. Chem. 2011, 76, 2532- 2547. 
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More crucially standing the DMDO over sodium carbonate was obligatory. Omission of 
this step resulted in complete decomposition of the glycal epoxide. In-situ preparations of 
DMDO did not give a clean reaction.42 
 
Adaptation of the epoxide opening procedure of Juhl to glycal epoxide 66 was 
completely uneventful.43 Iodide 67 , available from work on the project by Dr. Juhl and 
Dr. Pero was employed as the coupling partner to provide fragment coupling product 68. 
Glycal 65 was noted as a minor byproduct, despite complete oxidation by DMDO in the 
earlier step. An equal amount of alcohol 69 was noted, and it seems a reasonable 
explanation is a reduction of the epoxide by either the Grignard reagent or organocuprate 
during the course of the reaction. The product of the ring opening was protected as the 
PMBM ether according to the precedent of Juhl. This totally protected compound 70 
provided a good place to store material along the route, as the absence of any alcohols 
precluded protecting group migration, and no epimerizable stereocentres are present.  
 
IV. Elaboration to β-Ketophosphonate 
Elaboration of this compound to a β-ketophosphonate was enabled by a 3 step procedure, 
according to the precedent of Borg and Juhl. Exposure of compound 70 to ozone proved 
problematic, as decomposition of the DMBM group was noted even in the presence of 
Sudan III or Sudan black dyes (Scheme 4.8).44 Fortunately acceptable yields were 
obtained upon addition of pyridine to the ozonolysis mixture.45 The quantity of pyridine 
                                                
(42) Cheshev, P.; Marra, A.; Dondoni, A. Carbohydrate Res. 2006, 341, 2714- 2716. 
(43) Klein, L. L.; McWhorter, W. W.; Ko, S. S.; Pfaff, K.-P.; Kishi, Y. Uemura, D.; Hirata, Y. J. Am. 
Chem. Soc. 1982, 104, 7362- 7364. 
(44) Incompatibility of methoxybenzyl groups with ozonolysis has been noted: Yu, W.; Mei, Y.; Kang, Y.; 
Hua, Z.; Jin, Z. Org. Lett., 2004, 6, 3217- 3219. 
(45) For the seminal report of adding pyridine to ozonolysis reactions of sensitive substrates: Slomp Jr., G.; 
Johnson, J. L.; J. Am. Chem. Soc. 1958, 80, 915- 921. 
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was important, with too much being detrimental to yield.46 Besides behaving as a base, it 
is possible that pyridine may π stack with the electron rich DMBM and PMBM groups, 
reducing their richness and propensity to react with ozone. The sensitive aldehyde 71 was 
used without further purification in the next step, the addition of an excess of the lithium 
anion of dimethyl methyl phosphonate.47 The next step was the oxidation of the 
inconsequential mixture of diastereomers with Dess–Martin periodinane to form the β− 
ketophosphonate 72. It was noted the Parikh–Doering conditions result in no oxidation of 
this substrate. 
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Since the alkene formerly in the molecule had been exploited as a latent aldehyde at this 
point, it was now possible to reveal the latent alkene, which will participate in the ring 
closing metathesis. The silyloxy ether at C26’ of compound 72 was accordingly 
deprotected to yield alcohol 73. This alcohol/ phosphonate was found to be extremely 
                                                
(46) Pyridine is resistant to oxidation by ozone, however allowing ozonides to warm in the presence of 
pyridine without adding a reductant may be detrimental to yield: Griesbaum, K. Chem. Comm. 1966, 24, 
920- 921. For a recent exploitation of pyridine as an agent to disproportionate ozonides catalytically, see: 
Willand-Charnley, R.; Fisher, T. J.; Johnson, B. M.; Dussault, P. H.; Org. Lett. 2012, 14, 2242-2245. It is 
possible this disproportionation is responsible for the lower yield above when a larger percentage of 
pyridine is used in the solvent mixture. 
(47) Corey, E. J.; Kwiatkowski, G. T. J. Am. Chem. Soc. 1966, 88, 5654- 5656. 
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polar, and was usually carried on to the next reaction without any further purification. A 
one pot Grieco elimination provides alkene 5, which also proved to be stable to long term 
storage.48 
 
V. Elaboration of the Borg/ Bindschädler Diene Fragment 
In the key fragment coupling developed over several iterations by Borg, Juhl and Pero,  
and described in chapter 3, fragment 74, containing the diene and terminated with an 
aldehyde, was reacted with a pyran containing phosphonate in a HWE reaction to form 
C12–C13 bond. The resulting enone was reduced using Luche conditions under Felkin 
control. The allylic alcohol was transiently protected as a TMS ether so that the N-Phenyl 
amide can be Boc protected to activate it for cleavage. It was envisioned that the 
convergency of this approach could be improved by BOC protection of the N-phenyl 
amide before the HWE reaction. This would obviate the need for transient protection of 
the Luche product. The diene containing fragment 4 used in these studies was prepared 
by Dr. Pascal Bindschädler by the route developed by Dr. George Borg, and I carried out 
the initial studies for functionalization of the N-phenyl amide shown in scheme 4.9. 
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(48) Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem., 1976, 41, 1485- 1486. 
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Initial attempts to Boc protect aldehyde 74  to produce aldehyde 75 led to decomposition. 
Moving to free alcohol 4, attempts to introduce a Boc group also led to decomposition 
rather than Boc amide 76. Alcohol 4 was silylated to give compound 77. This could be 
Boc protected cleanly. Attempts to nitrosate the N-phenyl amide on compound 77, which 
would lead to a functionally equivalent N-nitrosoamide 78  led to decomposition of the 
diene moiety.49 The initial sequence was performed using a TBS group as the transient 
protection. This sequence was subsequently scaled up and optimized by Dr. 
Bindschadler, who employed a TES group to form intermediate 80. The removal of the 
TES group from intermediate 81 is much more efficient (Scheme 4.10). I also conducted 
oxidation of alcohol 76 aldehyde to aldehyde 75.  
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VI. The Second Fragment Coupling and Elaboration to Macrolactone 3 
The aldehyde containing fragment 75 was coupled with phosphonate 5 in an uneventful 
HWE reaction to yield enone 82 (Scheme 4.11). The E to Z ratio was higher than 20: 1. 
Both n-butyllithium and cesium carbonate could be employed as bases with similar 
outcome of olefin geometry, though the presence of more uncharacterized polar 
compounds was noted with the use of cesium carbonate. Initially, an excess of the 
aldehyde was used, as only small quantities of the phosphonate had been prepared. After 
the large scale preparation of the phosphonate, it was employed in excess since the 
                                                
(49) Evans, D. A.; Carter, P. H.; Dinsmore, C. J.; Barrow, J. C.; Katz, J. L.; Kung, D. W. Tetrahedron. Lett. 
1997, 38, 4535- 4538. 
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aldehyde was deemed more precious despite the shorter step count. Fortunately excess 
phosphonate or aldehyde could cleanly be recovered from either stoichiometry.  
 
The subsequent Luche reduction required some optimization. Use of the conditions 
initially employed by Juhl at 0 ºC resulted in clean reduction of both the C14 ketone, and 
the N-Phenyl Boc protected imide at C1 to the corresponding alcohols. 
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Reduction at -20 ºC resulted in the formation of a new product that initially did not 
contain free Boc aniline, but released that compound and contained an aldehyde after 
chromatography. It was speculated that a stable hemiaminal was formed. Finally, 
conditions were found where the reaction was allowed to proceed at -60 ºC for one hour, 
with a subsequent acetone quench at -78 ºC, giving alcohol 83 cleanly. Optimization of 
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this reaction was complicated by the fact that the enone and allylic alcohol had the same 
Rf in a variety of solvents, and that the reaction readily proceeded to exhaustive reduction 
in the TLC spotter.  The cleavage of the imide was uneventful. The seco acid 84 was 
quite non polar, especially in comparison to the peloruside A seco acid, and could be 
readily purified by column chromatography. Macrolactonization proceeded readily under 
the Shiina conditions used by Dr. Juhl to give macrolactone 3.50  
VII. Conclusion 
An approach to fragment 3 which contains a Z diene macrolactone, an appropriately 
protected pyran and a handle for olefin metathesis was completed. The approach was able 
to conserve key disconnections developed in previous work on the project, namely a 
diastereoselective hydrogenation, a glycal epoxide opening by an organocuprate and a 
HWE reaction. Notable accomplishments involved the replacement of a Stille coupling 
using stoichiometric palladium with an iron mediated cross coupling, and the 
optimization of a difficult hydrogenation of a trisubstituted double bond in the presence 
of an enol ether.  
                                                
(50) Shiina, I.; Kubota, M.; Ibuka, R. Tetrahedron. Lett. 2002, 43, 7535- 7539. 
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VIII. Graphical Summary 
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IX. Experimental Section 
 ((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)methanol (S2)  
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While higher yields were reported in the literature for the preparation of this starting 
material, the indicated conditions were chosen to avoid the use of copious quantities of 
HF-Pyridine at an early stage in the synthesis. 
 
A solution of S1 (42.0g, 85.9 mmol)11a in 120 mL MeOH and 36 mL CH2Cl2 at room 
temperature was treated with PPTS (1.08g, 4.29 mmol, 0.05 eq). The reaction was stirred 
for 45 hours, then quenched by addition of 10 mL saturated NaHCO3. The solution was 
diluted with 500 mL of 90% EtOAc/hexanes, and washed with 100 mL water. The 
aqueous layer was extracted 2x with 100 mL of 90% EtOAc and hexanes. The combined 
organic extracts were washed with brine, dried over Na2SO4, and concentrated in vacuo. 
Purification by flash chromatography over silica gel (5% to 10% EtOAc/ Hexanes) 
afforded 13.1 g (37.6 mmol, 44%) of alcohol S2 as a white waxy solid. This material was 
judged to be of >95 % purity by 1H NMR analysis. Analytical data was in accordance 
with literature values.11a 
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(2S,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
carbaldehyde (20)  
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Alcohol S2 (12.2g, 32.6 mmol) was dissolved in 108 mL CH2Cl2 and Hunig’s base (17 
mL, 98 mmol, 3.0 eq) and dimethyl sulfoxide (14 mL, 200 mmol, 6.0 eq) were added 
sequentially. The resulting pale yellow mixture was cooled to 0 °C. SO3- Pyridine (10.4g, 
65.1 mmol, 2.0 eq) was added, briefly removing the septum. After 15 minutes, TLC 
analysis showed completion. Volatiles were removed in vacuo and the resulting residue 
was taken up in a minimal amount of CH2Cl2 and loaded on a pre-equilbrated column 
which was eluted using 5% EtOAc/hexanes to afford 11.6g (31.1 mmol, 95% ) of 
aldehyde 20 as a free flowing tan powder. This material was judged to be of >95 % purity 
by 1H NMR analysis. Analytical data was in accordance with literature.11b 
ethyl 3-((2S,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-yl)-
3-oxopropanoate (21)  
O
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Note: The following procedure was conducted behind a blast shield out of an abundance 
of caution. This reaction was conducted 6 times on scales larger than 1g without incident. 
The following represents the largest batch we prepared. Stannous chloride may also be 
used as the catalyst, with a slight decrease in yield. It is essential that the starting 
aldehyde be free of DMS or DMSO for this reaction to initiate properly. Niobium 
pentachloride (71 mg, 0.266 mmol, 0.01 eq) was quickly ground into a fine powder and 
placed in a dry 250 mL round bottom flask, equipped with a large egg shaped stirbar, 
with no septum but with a stream of nitrogen blowing through the neck of the flask. The 
  192 
rate of nitrogen flow is such that the dichloromethane used in the reaction solvent is 
removed. Ethyl diazoacetate (5.60 mL, 53.2 mmol, 2.0 eq) was added to the flask. 
Bubbling ensued for several seconds then ceased and a reddish suspension formed. A 
digital thermocouple was immersed in the ethyl diazoacetate to allow monitoring of the 
internal temperature. Aldehyde 20 (9.90 g, 26.6 mmol) was dissolved in a minimal 
amount of CH2Cl2 (10 mL). Using a glass pipette, 1 mL of this solution was added to the 
suspension. Depending on the ambient temperature, the reaction may initiate 
spontaneously, or may require heating. In this case, no reaction spontaneously occurred 
after 5 minutes, so the flask was cautiously heated with a heat gun on its lowest setting 
until the internal temperature reached 35 °C. At this point bubbling was observed, and the 
internal temperature rose to 40 °C. The remaining solution of aldehyde 20 was added at a 
rate such that this temperature was not exceeded (over approximately 15 minutes). After 
approximately half the aldehyde had been added, the bubbling slowed, so another sample 
of powdered Niobium pentachloride (71 mg, 0.27 mmol, 0.01 eq) was added. This caused 
vigorous foaming, that was readily contained in the 250 mL flask. After completion of 
the aldehyde addition, the reaction was stirred until bubbling ceased (approximately 45 
minutes). TLC (10% EtOAc/ hexanes, product stains brownish/yellow by anisaldehyde 
visualization) showed complete consumption of starting material. The reaction was 
quenched by dilution with 100 mL CH2Cl2 and the addition of 25 mL saturated 
NaHCO3(aq). The layers were separated and the aqueous layer was washed with 50 mL of 
CH2Cl2. The combined organic extracts were washed with brine, dried over Na2SO4, and 
concentrated in vacuo on a rotavap contained within a fumehood. Purification by flash 
chromatography over silica gel (0.5% –> 1% –-> 2% EtOAc/ hexanes) afforded 10.0 g 
(21.8 mmol, 82%) of β-ketoester 21 as a pale yellow liquid. β-ketoester 21 conveniently 
eluted before the yellow band of the excess ethyldiazoacetate . This material was judged 
to be of >95 % purity by 1H NMR analysis, some signals attributed to enol content were 
observed.  
  193 
 
Rf = 0.20 (5% EtOAc/hexanes, UV active, stains brown in anisaldehyde) 
 
[α]20D = -42.2 (c 2.00, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.49 (d, J = 6.30 Hz, 1H), 4.39 (td, J = 4.8, 1.0 Hz, 1H), 
4.49 (s, 1H), 4.20- 4.15 (m, 3 H), 3.84 (app. d, J = 16.4 Hz, 1H), 3.77- 3.74 (m, 1H), 3.31 
(app. d, J = 16.4 Hz, 1H), 1.26 (td, J = 7.2, 0.6 Hz, 3H), 0.87 (s, 9H), 0.83 (s, 9H), 0.12 
(s, 3H), 0.10 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 201.3, 167.5, 143.4, 102.0, 82.5, 70.8, 63.7, 61.4, 46.4, 
25.9 (2 signals), 18.2 (2 signals), 14.3, -4.4, -4.5, -4.6, -4.9; 
 
IR(film) 2954.9, 1747.9, 1724.8, 1650.2, 1472.0,1252.2, 1098.0, 1061.8 cm-1; 
 
Exact Mass Calc. for C22H42O6Si2 [M + Na]+ : 481.24121 found; 481.24107 (ESI) 
 
 (E)-ethyl 3-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-
2-yl)but-2-enoate (23)  
O
O
OTBS
OTBSO
EtO
Me
O
OTBS
OTBSO
EtO
21 23  
Sodium hydride (95%, mineral oil free, 0.619g, 25.8 mmol, 1.5 eq ) was suspended in 10 
mL THF in a 500 mL RBF under nitrogen. A digital thermocouple was placed through 
the septum to monitor the internal temperature. β-ketoester 21 (7.9 g, 17.2 mmol) was 
dissolved in 25 mL THF under nitrogen and transferred to the sodium hydride suspension 
using a syringe and needle. An additional 5 mL + 5 mL THF were used to quantitate the 
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transfer. The pale brown suspension was stirred for fifteen minutes until bubbling ceased. 
At this point, an additional 20 mL of THF were added, and the flask was cooled to -78 
°C. Freshly distilled triflic anhydride (2.9 mL, 17.2 mmol, 1.0 eq) was added dropwise 
such that the internal temperature did not rise above -55 °C. After 20 minutes, TLC 
analysis (10% EtOAc/ toluene, triflate stains blue by anisaldehyde visualization, Rf 
=0.85) shows complete consumption of the beta keto ester (Rf = 0.7). To the reaction 
mixture is added an additional 100 mL of THF, followed by a solution of iron (III) 
acetylacetonate (607 mg,  1.72 mmol, 0.10 eq) in 15 mL NMP. The resulting orange 
solution is warmed to an internal temperature of -30 °C (using acetone with dry ice added 
to maintain the appropriate temperature). Methylmagnesium chloride (3.0 M in THF, 
11.4 mL, 24.4 mmol, 2.0 eq) is added dropwise at such a rate to maintain the temperature 
below -20 °C (brief excursions to -10 °C have not been detrimental to yield). The 
resulting deep green suspension is stirred at -30 °C until TLC shows the consumption of 
the enol triflate intermediate (10 % EtOAc/ toluene, product stains blue/purple by 
anisaldehyde visualization, Rf =0.90). Note that eluants based on hexanes as the non-
polar phase to not allow seperation of the enol triflate and the product, potentially 
resulting in a premature quench. The reaction typically is complete in under 20 minutes. 
The reaction was quenched by the addition of 50 mL saturated NH4Cl(aq), briefly stirred, 
and transferred to a separatory funnel containing an additional 50 mL of water and 250 
mL of  90% EtOAc/ hexanes. This was immediately shaken, restoring an orange colour to 
the solution. The layers were separated and the aqueous layer was washed with 2x 100 
mL of 90% EtOAc/hex. The combined organic extracts were washed with brine, dried 
over Na2SO4, and concentrated in vacuo. Purification by flash chromatography over silica 
gel (5% EtOAc/ hexanes) afforded 7.23 g (15.8 mmol, 92%) of enoate 23 as a viscous 
colourless liquid. 
 
Rf = 0.55 (10 % EtOAc/hexanes, UV active, stains blue/purple with anisaldehyde) 
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Rf = 0.90 (10 % EtOAc/toluene) 
 
 [α]20D = -28.6 (c 2.28, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.43 (d, J = 6.2 Hz, 1H), 5.83 (s, 1H), 4.74 (apt. t, J = 4.2 
Hz, 1H), 4.34 (d, J = 4.1 Hz, 1H), 4.13 (q, J = 7.1 Hz, 2H), 3.99- 3.95 (m, 2H), 2.15 (s, 
3H), 1.25 (t, J = 7.1, 3H), 0.88 (s, 9H), 0.84 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H), 0.05 (s, 
3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 166.5, 152.9, 143.2, 116.5, 102.1, 82.2, 70.8, 67.3, 59.6, 
25.8, 25.7, 18.1, 18.0, 16.0, 14.3, -4.2 (3 signals), -4.7 
 
IR(film) 2930.0, 2857.7, 1720.1, 1649.2, 1472.0, 1251.0, 1096.6, 836.7, 776.8 cm-1; 
 
Exact Mass Calc. for C23H44O5Si2 [M + Na]+ : 479.26195 ; found : 479.26353 (ESI) 
 
 (E)-3-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)but-2-en-1-ol (30)  
Me
O
OTBS
OTBSO
EtO
23
Me
O
OTBS
OTBS
HO
30  
Enoate 23 (4.43g, 9.69 mmol ) was dissolved in 60 mL CH2Cl2 in a 250 mL flask 
equipped with a thermocouple and an egg shaped stirbar under nitrogen. The resulting 
solution was cooled to -78 C and DiBAlH (1.0 M in toluene, 20.4 mL, 20.4 mmol, 2.1 eq 
) was added over 10 minutes at such a rate as to keep the internal temperature below -70 
°C. After 10 minutes, TLC analysis (20 % EtOAc, SM and product visualize as blue in 
CAM) showed complete consumption of starting material. The reaction was quenched at 
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-78 °C with a mixture of 60 mL saturated Rochelle’s salt and 10 mL MeOH and allowed 
to warm to room temperature. The resulting biphasic mixture was stirred for 3 hours, 
until both layers were clear. The layers were separated, and the aqueous layer was 
extracted with 2x 100 mL CH2Cl2. The combined organic extracts were washed with 
brine, dried over Na2SO4, and concentrated in vacuo. Purification by flash 
chromatography over silica gel (5% to 20%  to 40% EtOAc/ hexanes) afforded 3.570g 
(8.60 mmol, 89%) of allylic alcohol 30 as a very viscous colourless liquid.  
 
Rf = 0.60 (30% EtOAc/hexanes, stains blue in CAM) 
 
[α]20D = -62.3 (c 1.80, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.35 (d, J =6.2 Hz, 1H), 5.67 (t, J = 6.4 Hz, 1H), 4.68 (dd, 
J = 6.2, 3.1 Hz, 1H), 4.22 (td, J = 12.4, 3.3 Hz, 1H), 4.19- 4.14 (m, 2H), 3.81 (dd J = 7.2, 
5.1 Hz, 1H), 1.69 (s, 3H), 0.59 (s, 9H), 0.86 (s, 9H), 0.11 (s, 3H), 0.09 (s, 6H), 0.04 (s, 
3H); 
 
13C NMR (125 MHz, CDCl3) δ 143.6, 134.4, 128.0, 103.1, 83.6, 71.8, 70.2, 59.6, 26.3, 
26.1, 18.5, 18.4, 13.3, -3.4 (2 signals), -2.6, -4.4; 
 
IR(film)  3366.2, 2930.0, 2857.9, 2360.1, 1635.6, 1472.9, 1257.7, 1112.6, 1006.2, 836.6, 
777.0 cm-1; 
 
Exact Mass Calc. for C21H42O4Si2 [M + Na]+ : 437.25138  ; found : 437.25241(ESI) 
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(E)-3-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)but-2-enal (31)  
Me
O
OTBS
OTBSO
H
31
Me
O
OTBS
OTBS
HO
30  
Allylic alcohol 30 (3.57 g, 8.60 mmol) was dissolved in 30 mL CH2Cl2 under nitrogen 
and Hunig’s base (4.65 mL, 25.9 mmol, 3.0 eq) and dimethyl sulfoxide (3.6 mL, 51.7 
mmol, 6.0 eq) were added sequentially. The resulting pale yellow mixture was cooled to 
0 °C. SO3- Pyridine (2.26 g, 17.2 mmol, 2.0 eq) was added, briefly removing the septum. 
After 15 minutes, TLC analysis showed completion. Volatiles were removed in vacuo 
and the resulting residue was taken up in a minimal amount of CH2Cl2 and loaded on a 
pre-equilbrated column which was eluted using 5% EtOAc/hexanes to afford 3.36g (8.14 
mmol, 95% ) of aldehyde 31 as viscous off yellow liquid. This material was judged to be 
of >95 % purity by 1H NMR analysis. Aldehyde 31 was not particularly stable, and was 
typically prepared during the enolization step of the next reaction and used immediately. 
In order to achieve a high diastereoselectivity in the acetate aldol reaction, aldehyde 31 
must be free of ligating impurities such as DMS or DMSO. 
 
Partial Characterization Data:  
 
Rf = 0.95 (30 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
1H NMR (600 MHz, CDCl3) δ 10.02 (d, J = 7.9 Hz, 1H), 6.46 (d, J = 6.1 Hz), 6.03 (dt, J 
= 7.9, 1.3 Hz, 1H), 4.76 (td, J = 4.7, 1.2 Hz, 1H), 4.58- 4.47 (m, 1H), 4.02 (ap. t, J = 4.4 
Hz, 1H), 3.94 (ap. t, J = 4.4 Hz, 1H), 2.20 (s, 3H), 0.90 (s, 9H), 0.84 (s, 9H), 0.13 (s, 3H), 
0.11 (s, 3H), 0.06 (s, 3H), 0.06 (s, 3H); 
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 (R,E)-5-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)-3-hydroxy-1-((S)-4-isopropyl-2-thioxothiazolidin-3-yl)hex-4-en-1-one (19)  
OH MeO
S N
S
Me
Me
19
O
OTBS
OTBS
25 23
18
Me
O
OTBS
OTBSO
H
31  
Sn(OTf)2 (3.74g, 8.97 mmol, 1.1 eq), prepared according to a modified procedure of 
Weber, was placed in a 250 mL flask and suspended in 30 mL CH2Cl2. The suspension 
was cooled to -30 °C in a cryocool and N-ethylpiperidine (1.23 mL, 8.97 mmol, 1.1 eq) 
was added. The resulting light yellow turbid solution was stirred for 5 minutes, then a 
solution of thiazolidinethione 17 (1.99g, 9.79 mmol, 1.2 eq) in 10 mL CH2Cl2 was added 
dropwise by syringe. An additional 5 mL CH2Cl2 was used to rinse the flask and syringe 
containing thiazolidinethione 17. After one hour, the resulting orange suspension was 
cooled to -78 C and aldehyde 31 (3.36g, 8.14 mmol) dissolved in 10 mL CH2Cl2 is added 
dropwise. A futher 5 mL DCM is used to rinse the flask and syringe containing aldehyde 
31. After 1 h, TLC appears to show no further conversion so the reaction is quenched by 
the addition of 30 mL saturated NH4Cl(aq). The resulting suspension is stirred for 10 
minutes, and the resulting tin oxide is removed by filtration through Celite® .  The 
Celite® and tin oxide are washed with 100 mL CH2Cl2. The layers are separated, and the 
aqueous layers are extracted 2x 50 mL CH2Cl2. . The combined yellow organic extracts 
were washed with brine, dried over Na2SO4, and concentrated in vacuo. Purification by 
flash chromatography over silica gel (5% to 20 % to 50 % EtOAc) enabled the recovery 
of 300 mg (0.73 mmol, 9%) of the starting aldehyde. Unreacted acetylthiazolidinethione 
could also be recovered, eluting between the aldehyde and the aldol adduct.  Aldol adduct 
19 4.61 g (7.5 mmol, 91%, ) was obtained as a bright yellow foam, collapsing to a tacky 
solid. 1H NMR shows the aldol adduct to be a 13: 1 mixture of diastereomers, which were 
not separable by chromatography. 
 
  199 
Rf = 0.40 (30% EtOAc/hexanes, UV active, stains dark purple with Anisaldehyde) 
 
[α]20D = +140.3 (c 2.18, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.34 (dd, J = 6.2, 1.2 Hz, 1H), 5.55 (dd, J = 8.4, 1.2 Hz, 
1H), 5.14 (td, J = 6.3, 0.9 Hz, 1H), 4.96- 4.91 (m, 1H), 4.67 (dd, J = 6.2, 2.9 Hz, 1H), 
4.17- 4.15 (m, 1H), 4.14 (d, J = 7.3 Hz, 1H), 3.81 (dd, J = 7.5, 5.3 Hz, 1H), 3.55 – 3.36 
(m, 3H), 3.03 (dd, J = 11.6, 1.0 Hz, 1H), 2.77 (s, 1H), 2.54 (d, J = 4.3 Hz, 1H), 2.37 (app. 
septet, J = 6.4 Hz, 1H), 1.73 (d, J = 1.2 Hz, 3H), 1.07 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 7.0 
Hz, 3H), 0.89 (s, 9H), 0.87 (s, 9H), 0.11 (s, 3H), 0.09 (s, 6H), 0.06 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 203.0, 172.8, 143.6, 134.6, 130.0, 103.3, 83.8, 71.9, 71.7, 
70.5, 65.1, 45.5, 31.1, 31.0, 26.4, 26.2, 19.3, 18.5, 18.4, 16.1, 13.7, -3.3, -3.4, -3.5, -4.3; 
 
IR(film) 3508.3, 2955.7, 1691.8, 1650.1, 1471.4, 1361.7, 1253.4, 1159.8, 1120.8, 1093.8, 
836.6, 778.0 cm-1; 
 
Exact Mass Calc. for C29H53NO5S2Si2 [M + Na]+ : 638.27959  ; found : 638.27982 (ESI) 
 
 (R,E)-5-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)hex-4-ene-1,3-diol (33)  
OH MeO
S N
S
Me
Me
19
O
OTBS
OTBS
25 23
18
OH MeOH
O
OTBS
OTBS
33  
Aldol adduct 19  (4.61g, 7.48 mmol) was dissolved in a mixture of 75 mL THF and 7.5 
mL H2O. The resulting yellow solution was cooled to an internal temperature of -18 °C 
(ice/acetone bath). Lithium borohydride (2.0 M solution in THF, 3.74 mL, 7.48 mmol, 1 
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eq) was added. After 30 minutes, the yellow colour had faded and TLC  (30 % EtOAc/ 
hex, CAM visualizes SM as purple, product as blue, product Rf 0.15) showed complete 
consumption of starting material. The reaction was quenched with 50 mL saturated 
NH4Cl (aq). The layers were separated, and the aqueous layer was extracted with 2x 100 
mL 90% EtOAc/hexanes. The combined organic extracts were washed with brine, dried 
over Na2SO4, and concentrated in vacuo. . Purification by flash chromatography over 
silica gel (20% to 50% EtOAc/ Hexanes) afforded 1.20 g (7.44 mmol, 99%) of 
thiazoldinethione 32 as a white crystalline solid. The desired product  33 was obtained as 
a very viscous colourless oil (3.180g, 6.93 mmol, 93% )This material was judged to be of 
>95 % purity by 1H NMR analysis as the diol could be separated from the minor 
diastereomer carried in from the previous reaction.  
 
Rf = 0.15 (30% EtOAc/hexanes, not UV active, stains blue in anisaldehyde) 
 
[α]20D = -47.7 (c 1.52, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.37 (d, J = 6.2, 1.0 Hz, 1 H), 5.56 (d, J = 8.5, 1.3 Hz, 
1H), 4.69 (dd, J = 6.2, 0.3 Hz, 1H), 4.67- 4.63 (m, 1H), 4.18 (d, J = 6.6 Hz, 1H), 4.11 (t, J 
= 2.6 Hz, 1H), 3.86 (app. t, J = 4.7 Hz, 1H), 3.85- 3.77 (m, 2H), 2.40 (m, 1H), 1.97 (br. s, 
1H), 1.81 (m, 1H), 1.74 (m, 1H), 1.71 (s, 3H), 0.89 (s, 9H), 0.87 (s, 9H), 0.11 (s, 3H), 
0.09 (s, 6H), 0.07 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ143.6, 133.5, 131.0, 102.9, 83.3, 71.7, 69.8, 68.6, 61.3, 
38.8, 26.4, 26.1, 18.6, 18.4, 13.7, -3.4, -3.5, -3.6, -4.4; 
 
IR(film) 3353.8, 2929.4, 2857.3, 1649.8, 1471.4, 1252.3, 1120.6, 835.7, 777.2 cm-1; 
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Exact Mass Calc. for C23H46O5Si2 [M + Na]+ : 481.2776  ; found : 481.2766(ESI) 
 
(R,E)-5-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)-1-((tert-butyldimethylsilyl)oxy)hex-4-en-3-ol (34)  
OH MeOH
O
OTBS
OTBS
33
OH MeOTBS
O
OTBS
OTBS
34  
Diol 33 (2.90g, 6.32 mmol) was dissolved in 32 mL CH2Cl2 under nitrogen. 
Triethylamine (1.77 mL, 12.6 mmol, 2.0 eq) was added. The resulting mixture was 
cooled to 0 °C. The septum was briefly removed and DMAP (77 mg, 0.63 mmol, 0.10 eq) 
and TBSCl (1.05g, 6.95mmol, 1.1 eq) were added. The ice bath was allowed to decay 
over 4 hours. The reaction was quenched by the addition of 1 mL MeOH, followed by 
dilution with 50 mL CH2Cl2. The organic layer was washed with 20 mL of water then 
washed with brine, dried over Na2SO4, and concentrated in vacuo. Purification by flash 
chromatography over silica gel (5% EtOAc/ Hexanes) afforded 3.160 g (5.51 mmol, 
87%) of hydrogenation substrate 34 as a clear colourless oil which was judged to be 
>95% purity by 1H NMR. Flushing the column with 50% EtOAc/ hexanes yielded 
recovered diol 33 (137 mg, 0.299 mmol, 5 % ). A product attributed to protection of the 
secondary alcohol represented the balance of the material, unfortunately attempts to 
selectively deprotect this to regenerate diol 33 led to inconsequential recovery.  
 
Rf = 0.45 (10% EtOAc/hexanes, stains blue in CAM) 
 
[α]20D = -43.6 (c 1.76, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.36 (d, J = 6.2 Hz, 1H), 5.54 (d, J = 8.2 Hz, 1H), 4.67 
(dd, J =  6.2, 3.2 Hz, 1H), 4.64 – 4.58 (apt. septet, J = 3.9, 1H), 4.17 (d, J = 6.7 Hz, 1H), 
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4.13 (apt. t, J = 3.8 Hz, 1H), 3.90 - 3.83 (m, 2H), 3.80 – 3.75 (m, 1H), 1.78 – 1.69 (m, 
2H), 1.69 (s, 3H), 0.90 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H), 0.08 
(s, 3H), 0.07 (s, 3H), 0.07 (s, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 143.7, 132.5, 131.9, 102.9, 83.6, 71.8, 68.0, 61.8, 39.0, 
26.4, 26.2 (2 signals), 26.1, 18.5, 18.4 (2 signals), 13.6, -3.4, -3.5, -3.6, -4.3, -5.2 (2 
signals) 
 
IR(film) 3510.7, 2955.5, 2858.4, 1652.3, 1472.6, 1388.8, 1361.9, 1254.6, 1093.1, 836.1, 
776.7 cm-1; 
 
Exact Mass Calc. for C29H60O5Si3 [M + Na]+ : 595.3641  ; found : 595.2642 (ESI) 
 
(3S,5S)-5-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-2-
yl)-1-((tert-butyldimethylsilyl)oxy)hexan-3-ol (36) 
 
OH MeOTBS
O
OTBS
OTBS
34
OH MeOTBS
36
O
OTBS
OTBS
23
 
A 25 mL scintillation vial equipped with the largest size stirbar that would fit was oven 
dried at 100 °C for 24 hours. The vial was transferred to a glovebox. Hydrogenation 
catalyst 55 (23 mg, 0.038 mmol, 0.02 eq) was loaded into the vial, which was then sealed 
with a suba® septum and removed from the glovebox. Separately, hydrogenation 
substrate 34 (1.10 g, 1.92 mmol, 1 eq) was dissolved in 5 mL CH2Cl2. The septum on the 
vial containing hydrogenation catalyst 55 was vented with a needle, and the solution of 
substrate was transferred to the vial using a syringe and needle to produce an orange 
solution. The septum was removed and the scintillation vial was transferred to a 40 mL 
stainless steel autoclave. The pressure head was screwed on the autoclave and the 
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autoclave was pressurized to 200 psig, then vented to 20 psig 3 times. The autoclave was 
pressurized to 200 psig a fourth time, then the pressure was reduced to 100 psig. After 1 
hour, it was observed the pressure had decreased to 84 psig and remained static. The 
autoclave was vented, and the top removed to reveal a pale yellow solution. This solution 
was concentrated in vacuo and subsequently taken up in diethyl ether and filtered through 
Celite®, with several washings. The ether was removed in vacuo to give a pale yellow oil 
which was purified by flash chromatography over silica gel (3% EtOAc/ Hexanes) to 
afford 1.10g (1.91 mmol, 99% yield) of hydrogenation product 36 as a clear colourless 
oil.  
 
Rf = 0.50 (10% EtOAc/hexanes, stains violet in anisaldehyde) 
 
[α]20D = -33.4 (c 3.33, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.29 (dd, J = 6.0, 1.2 Hz, 1H), 4.64 (dd, J = 6.1, 2.8 Hz, 
1H), 4.21- 4.18 (m, 1H), 3.92- 3.88 (m, 1H), 3.87 (q, J = 5.1 Hz, 1H), 3.82- 3.79 (m, 1H), 
3.78- 3.75 (m, 1H), 3.60 (dd, J = 8.0, 4.0 Hz, 1H), 2.93 (d, J = 3.2 Hz, 1H), 2.42- 2.34 
(m, 1H), 1.67- 1.63 (m, 2H), 1.63- 1.58 (m, 1H), 1.36 (ddd, J =13.3, 8.8, 4.1 Hz, 1H), 
0.93 (d, J = 6.0, 3H), 0.92 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H), 
0.11 (s, 6H), 0.07 (s, 6H); 
 
1H NMR (600 MHz, C6D6) δ 6.27 (d, J = 6.1 Hz, 1H), 4.67 (dd, J = 6.1, 2.8 Hz, 1H), 
4.39- 4.37 (m, 1H), 4.00 (dd, J = 8.3, 5.5 Hz, 1H), 3.98- 3.93 (m, 1H), 3.85 (dd, J = 8.3, 
3.3, 1H), 3.68- 3.64 (m, 1H), 3.61- 3.56 (m, 1H), 2.78- 2.70 (m, 1H), 2.68 (d, J = 3.2 Hz, 
1H), 1.73 (ddd, J = 14.0, 9.8, 4.5 Hz, 1H), 1.62- 1.55 (m, 1H), 1.52 – 1.43 (m, 2H), 1.10 
(d, J = 6.7 Hz, 3H), 1.05 (s, 9H), 1.02 (s, 9H), 0.91 (s, 9H), 0.26 (s, 3H), 0.22 (s, 3H), 
0.17 (s, 3H), -0.01 (s, 3H), -0.01 (s, 3H); 
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13C NMR (125 MHz, CDCl3) δ 143.6, 103.1, 82.3, 71.7, 71.4, 69.3, 62.3, 41.8, 39.3, 27.8, 
26.3, 26.0, 25.9, 18.4, 18.2, 18.1, 13.6, -3.2, -3.4, -3.6, -4.6, -5.5 (2 signals); 
 
IR(film) 3529.3, 2930.1, 2857.9, 1653.9, 1472.2, 1389.5, 1254.5, 1119.5, 1045.6, 836.2, 
777.2 cm-1; 
 
Exact Mass Calc. for C29H62O5Si3 [M + Na]+ : 597.3797 ; found : 597.3805 (ESI) 
 
Overhydrogenation Product (42)  
OH MeOTBS
42
O
OTBS
OTBS
23
 
A 25 mL scintillation vial equipped with the largest size stirbar that would fit was oven 
dried at 100 °C for 24 hours. The vial was transferred to a glovebox. Crabtree’s catalyst  
40 (10.1 mg, 0.0126 mmol, 0.05 eq) was loaded into the vial, which was then sealed with 
a suba® septum and removed from the glovebox. Separately, hydrogenation substrate 34 
(145 mg, 0.253 mmol, 1 eq) was dissolved in 2 mL CH2Cl2. The septum on the vial 
containing the Crabtree’s catalyst 40 was vented with a needle, and the solution of 
substrate was transferred to the vial using a syringe and needle to produce a bright orange 
solution. The septum was removed and the scintillation vial was transferred to a 40 mL 
stainless steel autoclave. The pressure head was screwed on the autoclave and the 
autoclave was pressurized to 200 psig, then vented to 20 psig 3 times. The autoclave was 
pressurized to 200 psig a fourth time, then the pressure was reduced to 100 psig. After 70 
minutes the bomb was vented and disassembled and the vial containing a straw yellow 
solution was removed. The solvent was removed in vacuo and the residue was taken up in 
diethyl ether and filtered through Celite®. The ether was removed in vacuo to give a pale 
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yellow oil which was purified by flash chromatography over silica gel (3% EtOAc/ 
Hexanes) to afford 10 mg of bicycle 58 (0.022 mmol, 9%) and 120 mg of a single 
diastereomer of overhydrogenation product 42 (0.209 mmol, 83%) as a clear colourless 
oil. 
 
Characterization Data for the overhydrogenation product 42: 
 
Rf = 0.40 (10% EtOAc/hexanes, not UV active, stains brown in anisaldehyde) 
 
[α]20D = -8.8 (c 3.9, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 3.90 – 3.82 (m, 2H), 3.81 – 3.76 (m, 1H), 3.66 – 3.61 (m, 
1H), 3.33 (t, J = 7.8 Hz, 1H), 3.32 – 3.29 (m, 1H), 2.99 (dd, J = 8.8, 1.8 Hz, 1H), 2.93 (d, 
J = 3.5, 1H), 2.22 (apt. septet, J = 6.6, 1H), 1.92 – 1.87 (m, 1H), 1.72 – 1.66 (m, 1H), 
1.65 – 1.56 (m, 3H), 1.45 – 1.40 (m, 1H), 0.92 (s, 9H), 0.90 (s, 9H), 0.88 (s, 9H), 0.87 (d, 
J = 6.5 Hz, 3H), 0.11 (s, 3H), 0.10 (s, 3H), 0.09 (s, 6H), 0.07 (s, 3H); 
 
1H NMR (600 MHz, C6D6) δ 4.02- 3.95 (m, 1H), 3.70- 3.64 (m, 2H), 3.63- 3.57 (m, 2H), 
3.50 (t, J = 8.8 Hz, 1H), 3.14 (ap. dd, J = 7.8, 1.0 Hz, 1H), 3.09 (ap. dd, J = 11.7, 1.5 Hz, 
1H), 2.70 (d, J = 3.4 Hz, 1H), 2.61- 2.53 (m, 1H), 1.77 – 1.71 (m, 1H), 1.69- 1.61 (m, 
2H), 1.61- 1.55 (m, 1H), 1.54- 1.47 (m, 2H), 1.14 (d, J = 6.8 Hz, 3H), 1.08 (s, 9H), 0.97 
(s, 9H), 0.90 (s, 9H), 0.27 (s, 3H), 0.21 (s, 3H), 0.13 (s, 3H), 0.05 (s, 3H), -0.02 (s, 6H) 
 
13C NMR (100 MHz, CDCl3) δ 84.0, 75.7, 73.9, 69.5, 65.0, 62.2, 42.6, 39.0, 35.4, 28.1, 
26.5, 26.2, 25.8, 18.5, 18.2, 18.1, 13.2, -2.5, -2.8, -3.7, -4.4, -5.5(2 signals); 
 
IR(film) 3528.8, 2955.4, 2857.2, 1463.1, 1388.0, 1255.3, 1113.3, 834.7, 776.6 cm-1; 
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Exact Mass Calc. for C29H64O5Si3 [M + H]+ : 577.4134  ; found : 577.4032  (ESI) 
 
Characterization Data for the Bicycle 58: 
 
Bicycle 58 
O
O Me
OTBS
OTBS
25
22
58
 
Rf = 0.70 (10% EtOAc/hexanes, not UV active, stains light brown in anisaldehyde) 
 
[α]20D = -18.7 (c 3.76, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 4.92 (d, J = 5.3 Hz, 1H), 4.27- 4.22 (m, 1H), 3.96- 3.91 
(m, 1H), 3.70- 3.62 (m, 2H), 2.07- 1.99 (m, 1H), 1.96- 1.91 (m, 1H), 1.84- 1.79 (m, 1H), 
1.69- 1.60 (m, 2H), 1.59- 1.47 (m, 3H), 1.39 (ap. q, J = 10.7 Hz, 1H), 0.95 (d, J = 9.3 Hz, 
3H), 0.88 (s, 9H), 0.87 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H), 0.04 (s, 6H); 
 
1H NMR (500 MHz, CDCl3) δ 5.09 (d, J = 4.9 Hz, 1H), 4.37 (ap. pentet, J = 6.3 Hz, 1H), 
4.09 (td, J = 10.2, 3.9 Hz, 1Hz), 3.88 (ap. t, J = 4.4 Hz, 1H), 3.79- 3.73 (m, 1H), 3.67- 
3.63 (m, 1H), 2.04 (m, 1H), 1.83- 1.70 (m, 2H), 1.68 – 1.52 (m, 2H), 1.48- 1.32 (m, 2H), 
1.09- 0.97 (m, 2H), 0.99 (s, 9H), 0.95 (s, 9H), 0.94 (d, peak occluded, 3H), 0.07 (s, 3H), 
0.06 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 94.8, 83.5, 70.5, 64.9, 59.7, 41.8, 39.4, 37.2, 27.9, 26.2, 
25.9, 18.3, 18.0, 17.9, -3.2, -4.4, -5.3 (2 signals) 
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IR(film) 2955.6, 2857.5, 1462.7, 1255.4, 1132.6, 1087.5, 836.7, 773.9 cm-1; 
 
Exact Mass Calc. for C23H48O4Si2 [M + H]+ : 445.3164  ; found : 445.3156 (ESI) 
Alternative Overhydrogenation: 
 
The above reaction was conducted with clean, diastereomerically pure hydrogenated 
substrate 36 (167 mg, 0.290 mmol) as the substrate and 40 as the catalyst. The substrate 
was exposed to 100 psi of hydrogen for 35 minutes. The work-up was as above. 
Purification with 2% EtOAc/hexanes yielded 78 mg ( 0.175 mmol, 60%) of Bicycle 58 
with characterization data in accordance with that given above. Overhydrogenation 
product 42 was also obtained. The factors controlling the ratio of the two products are not 
understood, as this reaction gave a varying yield of Bicycle 58 from 10% to 40% over 3 
attempts, with efforts made to reproduce the above conditions.  
 
 
tert-butyl(((3R,4S)-5-iodo-4-methylpent-1-en-3-yl)oxy)dimethylsilane (67)  
I
Me
TBSOOH
Me
TBSO
6769  
Triphenylphosphine (5.46 g, 20.8 mmol, 1.2 eq) and imidazole (1.48 g, 21.7 mmol, 1.25 
eq) were dissolved in 60 mL CH2Cl2 and cooled to 0 ºC. To the stirring solution was 
added iodine (5.29 g, 20.8 mmol, 1.2 eq) and the resulting yellow suspension was stirred 
for 25 minutes.  Alcohol 69 (4.01 g, 17.4 mmol, 1 eq) was dissolved in 10 + 5 mL 
CH2Cl2 and added dropwise. The cooling bath was removed. The reaction was stirred for 
4 hours, until 2 D TLC (20% EtOAc/hexanes, Anisaldehyde) showed completion of the 
reaction. It should be noted that formation of the activated phosphonium and complete 
consumption of alcohol 69 is rapid. Conversion of the activated intermediate to iodide 67 
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is slow. When conversion of the activated intermediate to the iodide is complete, the 
baseline no longer contains a blue spot, and 2 D TLC no longer shows streaking.  
 
The reaction is concentrated in vacuo and the residue is purified by flash chromatography 
(1 % Et2O in pentane) to afford 4.30 g (12.6 mmol, 73 %) of iodide 67 as a clear 
colourless oil.  
 
Rf = 0.95 (20% EtOAc/hexanes, faintly UV active, stains blue in Anisaldehyde) 
 
 (S)-5-((S)-2-((2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-
2-yl)propyl)-1-(3,4-dimethoxyphenyl)-9,9,10,10-tetramethyl-2,4,8-trioxa-9-
silaundecane (65)  
OH MeOTBS
36
O
OTBS
OTBS
23
O MeOTBS
65 O
OTBS
OTBS
DMBM
 
((3,4-dimethoxybenzyloxy)methyl)(methyl)sulfane (1.20 g, 5.27 mmol, 1.7 eq) was 
dissolved in 5.27 mL CH2Cl2. The pale yellow solution was cooled to -78 °C. To this 
solution was added SO2Cl2 (1.0 M solution in CH2Cl2, 5.72 mL, 5.72 mmol, 1.87 eq). 
The resulting dark yellow solution was stirred at -78 °C for one hour, then the cooling 
bath was removed and the solution was stirred at ambient temperature for one hour. The 
solution was concentrated in vacuo on a rotavap within a fumehood, with no external 
heating. The resulting crude DMBM chloride was stirred under vacuum for 20 minutes. 
Meanwhile, TBAI (67mg, 0.263 mmol, 0.086 eq) was dissolved in 0.5 ml CH2Cl2 in a  50 
mL flame dried Schlenk tube under nitrogen. Hydrogenation product 36 (1.78g, 3.1 
mmol) in 1 mL CH2Cl2 was added using a needle and syringe, and the flask was rinsed 
with a further 3 x 1mL CH2Cl2. Freshly distilled Hunig’s base (1.41 mL,  7.90 mmol, 2.6 
eq) was added. The crude DMBMCl was dissolved in 1 mL of CH2Cl2 and transferred to 
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the Schlenk flask, and 2 x 1 mL of CH2Cl2 were used to quantitate the transfer. The 
resulting golden yellow solution was lowered into a preheated 40 °C oil bath and the 
Schlenk tube was allowed to thermally equilibrate and then was sealed. The reaction was 
protected from light and stirred for 23 hours. After 23 hours, the bright orange reaction 
mixture was quenched by dilution with 20 mL CH2Cl2 and the addition of 4 mL saturated 
NaHCO3 (aq). The mixture was transferred to a separatory funnel, an additional 20 mL of 
water was added and the layers were separated. The aqueous layer was washed with 4x 
20 mL of CH2Cl2. The combined organic layers were washed with brine, dried over 
Na2SO4, and concentrated in vacuo. Purification by flash chromatography over silica gel 
(5% –> 10% EtOAc/ Hexanes) afforded 2.20 g (2.94 mmol, 95 %) of DMBM ether 65 as 
a clear colourless oil which was judged to be >95% purity by 1H NMR. 
 
Rf = 0.45 (10% EtOAc/hexanes, faintly UV active, stains purple in CAM) 
 
[α]20D = -25.0 (c 2.85, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.89 (s, 1H), 6.88 (d, J = 7.3 Hz, 1H), 6.83 (d, J = 8.2 Hz, 
1H), 6.28 (d, J = 6.0 Hz, 1H), 4.78 (AB d, J = 7.0 Hz, 1H), 4.73 (AB d, J = 7.0 Hz, 1H), 
4.64 (dd, J = 5.9, 2.7 Hz, 1H), 4.57- 4.51 (m, 2H), 4.25- 4.22 (m, 1H), 3.88 (s, 3H), 3.87 
(s, 3H), 3.87- 3.82 (m, 1H), 3.74- 3.70 (m, 3H), 3.57 (dd, J = 8.8, 3.1 Hz, 1H), 2.36- 3.29 
(m, 1H), 1.87- 1.79 (m, 1H), 1.78- 1.67 (m, 2H), 1.50 (ddd, J = 13.8, 8.7, 5.0 Hz, 1H), 
0.93- 0.91 (m, 12H), 0.88 (s, 9H), 0.87 (s, 9H), 0.13 (s, 3H), 0.11 (br. s, 9H), 0.03 (s, 3H), 
0.03 (s, 3H); 
 
1H NMR (600 MHz, C6D6) δ 6.97 (dd, J = 8.0, 1.9 Hz, 1H), 6.94 (d, J = 1.9 Hz, 1H), 6.63 
(d, J = 8.0 Hz, 1H), 6.24 (dd, J = 6.2, 1.0 Hz, 1H), 4.91 (AB d, J = 6.9 Hz, 1H), 4.86 (AB 
d, J = 6.9 Hz, 1H), 4.72- 4.64 (m, 3H), 4.41- 4.39 (m, 1H), 4.10- 4.05 (m, 1H), 3.95 (dd, 
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J = 8.9, 5.9 Hz, 1H), 3.82- 3.78 (m, 2H), 3.76- 3.72 (m, 1H), 3.47 (s, 3H), 3.40 (s, 3H), 
2.65- 2.57 (m, 1H), 2.04- 1.94 (m, 2H), 1.91- 1.83 (m, 1H), 1.74 (ddd, J = 13.8, 8.8, 4.9 
Hz, 1H), 1.09 (d, J = 6.7 Hz, 3H), 1.03 (s, 9H), 1.01 (s, 9H), 0.98 (s, 9H), 0.27 (s, 3H), 
0.20 (s, 3H), 0.17 (s, 3H), 0.14 (s, 3H), 0.07 (s, 6H);  
 
13C NMR (125 MHz, CDCl3) δ 149.0, 148.5, 143.8, 130.6, 120.4, 111.2, 110.9, 103.4, 
93.8, 81.9, 73.5, 72.1, 71.9, 69.5, 59.7, 55.9, 55.8, 39.4, 38.2, 27.8, 26.4, 26.0, 25.9, 18.4, 
18.1 (2 signals), 13.3, -3.0, -3.2, -3.5, -4.7, -5.4;  
 
IR(film) 2930.1, 1857.1, 1651.3, 1517.3, 1463.6, 1255.5, 1104.3, 1036.2, 836.1, 777.0 
cm-1; 
 
Exact Mass Calc. for C39H74O8Si3 [M + Na]+ : 777.4584  ; found : 777.4583 (ESI) 
 
DMDO oxidation (66)  
O MeOTBS
65 O
OTBS
OTBS
DMBM O MeOTBS
65 O
OTBS
OTBS
DMBM
O  
Glycal 65 (1.19g, 1.58 mmol, 1 eq) was dissolved in 20 mL CH2Cl2 and cooled to 0 °C. 
DMDO in acetone, that was stood over solid K2CO3 at -20 °C for 24 hours, but not dried 
in any other way (20 mL, an excess) was added dropwise using a glass pipette. Use of 
DMDO that is stood over K2CO3 is required to avoid decomposition, but exhaustive 
drying is not necessary, and is wasteful of DMDO solution. After 1 hour, TLC (20% 
EtOAc/hex, anisaldehyde, product decomposes on TLC plate) showed that the starting 
material was consumed. The volatiles were removed in vacuo and the residue was taken 
up in 10 mL benzene. Any droplets of water were removed using a pipette. The benzene 
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was removed, and the azeotroping was repeated twice more. The resulting clear 
colourless oil 66 was used without any further purification in the next step.  
Partial Characterization: 
 
Rf = 0.10, 0.20 (two spots, not UV active, stain brown in Anisaldehyde) 
 
1H NMR (600 MHz, CDCl3) δ 
Fragment Coupling Product (68)  
O MeOTBS
65 O
OTBS
OTBS
DMBM
O
O MeOTBS
O
OTBS
OTBS
DMBM
OH
Me
TBSO
68  
Magnesium turnings (460 mg, 18.9 mmol, 1.5 eq. relative to 1,2 dibromoethane) were 
placed in a 2 neck flask equipped with a condenser, under argon. To the flask are added 
12 mL Et2O and 6 mL toluene. 1,2 Dibromoethane (1.09 mL, 12.5 mmol) was added 
dropwise at such a rate that the vigorous reflux did not overwhelm the condenser. The 
resulting approximately 0.7 M solution of MgBr2 was used directly in the next step.  
 
A freshly titrated solution of tBuLi in pentanes (1.63 M, 5.81 mL, 9.48 mmol, 6.0 eq) 
was was placed in a 100 mL RBF, equipped with a thermocouple to measure the internal 
temperature, under argon. The flask was cooled to -78 °C A solution of iodide 67 (1.62g, 
4.74 mmol, 3.0 eq) in 6 mL Et2O was swiftly added, and the internal temperature rose to -
35 °C. A milky white precipate instantly formed. After 2 minutes, when the temperature 
had returned to below -70 °C, 6 mL of THF was added, followed by the MgBr2 solution 
(6.8 mL, 4.5 mmol, 3.0 eq). After 5 minutes, Li2CuCl4 (0.1 M in Et2O, 3.16 mL, 0.316 
mmol, 0.2 eq) is added and the solution is warmed to an internal temperature of -54 °C 
for 20 minutes. The resulting light brown suspension is cooled back to -78 °C. The 
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epoxide 66 is dissolved in 4 mL of THF, and this is added dropwise to the cuprate 
reaction. An additional 2 mL of THF are used to quantitate the reaction. After 30 
minutes, the reaction is removed from the cooling bath. After an additional half hour of 
stirring the orange solution is quenched with 5 mL of a 1:1 mixture of saturated NH4Cl(aq) 
and 28- 30 % NH3(aq) and stirred for 5 minutes. The resulting mixture is transferred to a 
separatory funnel and diluted with 100 mL of a 90% EtOAc/hexanes mixture and 20 mL 
of water. The layers are separated and the aqueous layer is washed with 2 x 50 mL of 
90% EtOAc/hexanes. The organic layers are washed with brine, dried over Na2SO4, 
filtered and concentrated in vacuo. Purification by flash chromatography over silica gel 
(5% EtOAc/ Hexanes) afforded 1.24 g of  coupling product 68  (1.26 mmol, 80% over 2 
steps) as a clear colourless oil which was judged to be >95% purity by 1H NMR. 
 
Rf = 0.70 (20% EtOAc/hexanes, faintly UV active, stains purple in anisaldehyde) 
 
[α]20D = +7.30 (c 2.91, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.89 (s, 1H), 6.89 (ap. d, J = 9.2 Hz, 1H), 6.83 (ap. d, J = 
8.5 Hz, 1H), 5.81 (ddd, J =16.8, 10.4, 6.3 Hz, 1H), 5.14 (dt, J = 17.2, 1.3 Hz,  1H), 5.07 
(dt, J = 10.4, 1.1 Hz, 1H), 4.79 (d, J = 6.7 Hz, 1H), 4.72 (d, J = 6.9 Hz, 1H), 4.58 (d, J = 
11.5 Hz, 1H), 4.52 (d, J = 11.7 Hz, 1H), 4.01 (dd, J = 6.3, 4.1 Hz, 1H), 3.89 (s, 3H), 3.89 
(s, 3H), 3.84 (ap. pent., J = 6.1 Hz, 1H), 3.74- 3.67 (m, 2H), 3.57 (t, J = 7.3 Hz, 1H), 3.55 
(t, J = 7.6 Hz, 1H), 3.19 (td, J = 8.5, 3.1 Hz, 1H), 3.15- 3.11 (m, 1H), 3.06 (dd, J = 10.2, 
2.1 Hz, 1H), 2.15 (ap. sext. J =7.0 Hz, 1H), 1.97 (ddd, J = 14.1, 6.2, 3.1 Hz, 1H), 1.93 (d, 
J = 5.1 Hz, 1H), 1.90 (pent., J = 6.7 Hz, 1H), 1.81- 1.76 (m, 1H), 1.73 (ap. sext., J = 6.6 
Hz, 1H), 1.58 (t, J =7.4 Hz, 1H), 1.17 (ddd, J = 9.1, 8.9, 7.3 Hz, 1H), 0.93- 0.91 (m, 
12H), 0.90 (s, 9H), 0.90 (s, 9H), 0.89- 0.88 (m, 12H), 0.15 (s, 6H), 0.14 (s, 3H), 0.12 (s, 
3H), 0.05 (s, 3H), 0.04 (s, 6H), 0.02 (s, 3H); 
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1H NMR (600 MHz, C6D6) δ 6.99 (dd, J = 8.1, 1.9 Hz, 1H), 6.96 (d, J = 1.8 Hz, 1H), 6.65 
(d, J = 8.2 Hz, 1H), 5.91 (ddd, J = 16.8, 10.4, 6.3 Hz, 1H), 5.24 (dt, J = 17.2, 1.3 Hz, 1H), 
5.08 (dt, J = 0.8, 10.6 Hz, 1H), 4.94 (d, J = 6.7 Hz, 1H), 4.88 (d, J = 6.9 Hz, 1H), 4.73 (d, 
J = 11.7 Hz, 1H), 4.63 (d, J = 11.7 Hz, 1H), 4.14- 4.14 (m, 1H), 4.10- 4.06 (m, 1H), 3.88- 
3.84 (m, 1H), 3.83- 3.79 (m, 1H), 3.71 (t, J = 7.9 Hz, 1H), 3.66 (t, J = 8.7 Hz, 1H), 3.51 
(s, 3H), 3.41 (s, 3H), 3.30 (td, J = 3.0, 9.0 Hz, 1H), 3.24 (dd, J =  8.8, 1.6 Hz, 1H), 3.20- 
3.15 (m, 1H), 2.71- 2.41 (m, 1H), 2.18 (ddd, J = 14.0, 6.5, 2.9 Hz, 1H), 2.10 (ap. sext., J 
= 6.3 Hz, 1H), 2.06- 2.01 (m, 1H), 1.94- 1.86 (m, 2H), 1.86- 1.80 (m, 1H), 1.65 (d, J = 
5.1 Hz, 1H), 1.32- 1.26 (m, 1H), 1.14 (d, J = 6.9 Hz, 3H), 1.09 (d, J = 6.8 Hz, 3H), 1.08 
(s, 9H), 1.05 (s, 9H), 1.04 (s, 9H), 1.01 (s, 9H), 0.28 (s, 3H), 0.27 (s, 3H), 0.25 (s, 3H), 
0.21 (s, 3H), 0.16 (s, 3H), 0.12 (s, 3H), 0.11 (s, 3H), 0.10 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 149.0, 148.5, 140.2, 130.6, 120.3, 114.6, 111.1, 110.9, 
93.6, 83.9, 80.5, 78.9, 76.6, 75.9, 73.4, 73.3, 69.4, 59.7, 55.9, 55.8, 40.5, 38.5, 37.0, 35.7, 
29.1, 26.4, 26.2, 25.9, 18.6, 18.2 (2 signals), 16.0, 12.9, -2.3 (2 signals), -2.9, -3.4, -4.1, -
4.8, -5.4; 
 
IR(film) 3532.1, 2954.7, 2893.9, 2856.6, 1728.0, 1594.3, 1517.2, 1471.8, 1387.7, 1360.7, 
1255.5, 1093.1, 1033.6, 938.4, 837.0, 775.2, 671.6 cm-1; 
 
Exact Mass Calc. for C51H100O10Si4 [M + Na]+ : 1007.6285  ; found : 1007.6272 (ESI) 
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PMBM Ether (70)  
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((4-methoxybenzyloxy)methyl)(methyl)sulfane, (1.41 g, 7.10 mmol, 5 eq) was dissolved 
in 7.10 mL CH2Cl2. The pale yellow solution was cooled to -78 °C. To this solution was 
added SO2Cl2 (1.0 M solution in CH2Cl2, 7.10 mL, 7.10 mmol, 5 eq). The resulting dark 
yellow solution was stirred at -78 C for one hour, then the cooling bath was removed and 
the solution was stirred at ambient temperature for one hour. The solution was 
concentrated in vacuo on a rotavap within a fumehood, with no external heating. The 
resulting crude PMBM chloride was stirred under vacuum for 20 minutes. Meanwhile, 
TBAI (36 mg, 0.142 mmol, 0.10 eq) was dissolved in 0.5 ml CH2Cl2 in a  50 mL flame 
dried Schlenk tube under nitrogen. Fragment coupling product 68 (1.40 g, 1.42 mmol) in 
1 mL CH2Cl2 was added using a needle and syringe, and the flask was rinsed with a 
further 3 x 1mL CH2Cl2. Freshly distilled Hunig’s base (2.5 mL,  14.2 mmol, 10 eq) was 
added. The crude PMBMCl was dissolved in 1 mL of CH2Cl2 and transferred to the 
Schlenk flask, and 2 x 1 mL of CH2Cl2 were used to quantitate the transfer. The resulting 
pinkish solution was lowered into a preheated 40 °C oil bath and the Schlenk tube was 
allowed to thermally equilibrate and then was sealed. The reaction was protected from 
light and stirred for 36 hours. After 36 hours, the reaction was poured on a column, 
prequilibrated 5% NEt3 in 50% EtOAc/hexanes. The material is eluted with more of the 
same eluent, and the product containing fractions are concentrated in vacuo to yield a 
brown oil. Purification by flash chromatography over silica gel (5% –> 10% EtOAc/ 
Hexanes) afforded 1.53 g of PMBM ether 70 as a clear colourless oil (1.35 mmol, 95 %) 
which was judged to be >95% purity by 1H NMR. Quenching the reaction with saturated 
NaHCO3(aq) followed by a standard aqueous extraction results in large quantities of what 
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is believed to be the paramethoxybenzyl acetal of formaldehyde (Rf = 0.55 in 20% 
EtOAc/hexanes, UV active, stains bright pink in CAM) which is stubbornly inseparable 
from the desired product (though not detrimental to the subsequent 
ozonolysis/phosphonate addition reaction, after which it is readily separable). 
 
Rf = 0.65 (20% EtOAc/hexanes, faintly UV active, stains blue/purple in CAM) 
 
[α]20D = -8.5 (c 2.52, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 9.6 Hz, 2H), 6.89- 6.86 (m, 4H), 6.82 (d, J = 
8.0 Hz, 1H), 5.79 (ddd, J = 16.8, 10.4, 6.3 Hz, 1H), 5.10 (dt, J = 17.2, 1.7 Hz, 1H), 5.02 
(dt, J = 10.4, 1.0 Hz, 1H), 4.81 (d, J =6.9 Hz, 1H), 4.79 (d, J = 8.2 Hz, 1H), 4.71 (d, J = 
7.1 Hz, 1H), 4.68 (d, J =6.9 Hz, 1H), 4.61 (d, J = 11.5 Hz, 1H), 4.56 (d, J = 11.5 Hz, 1H), 
4.53 (d, J = 11.6 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 4.01- 3.99 (m, 1H), 3.88 (s, 3H), 
3.87 (s, 3H), 3.87- 3.84 (m, 1H), 3.81 (s, 3H), 3.73- 3.67 (m, 2H), 3.67- 3.64 (m, 1H), 
3.51- 3.47 (m, 1H), 3.38 (ap. t, J = 5.1 Hz, 1H), 3.15 (dd, J = 6.7, 3.2 Hz, 1H), 2.07- 2.01 
(m, 1H), 1.92- 1.87 (m, 2H), 1.80- 1.69 (m, 2H), 1.66- 1.60 (m, 1H), 1.54- 1.49 (m, 1H), 
1.38- 1.31 (m, 1H), 0.92 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.88 
(s, 9H), 0.88 (s, 18H), 0.11 (s, 3H), 0.10 (s, 6H) 0.08 (s, 3H, 0.03 (s, 3H), 0.03 (s, 6H), 
0.00 (s, 3H); 
 
1H NMR (600 MHz, C6D6) δ 7.35 (d, J = 8.2 Hz, 2H), 7.00 (d, J = 8.2 Hz, 1H), 6.97 (s, 
1H), 6.83 (d, J = 8.3 Hz, 2H), 6.65 (d, J = 8.0 Hz, 1H), 5.69 (ddd, J = 17.0, 10.3, 6.2 Hz, 
1H), 5.42 (d, J = 17.1 Hz, 1H), 5.06 (d, J = 10.4 Hz, 1H), 5.01 (d, J = 6.7 Hz, 1H), 4.95 
(d, J = 6.9 Hz, 1H), 4.87 (d, J = 6.9 Hz, 1H), 4.85 (d, J = 6.7 Hz, 1H), 4.76 (d, J = 11.7 
Hz, 1H), 4.73 (d, J = 11.7 Hz, 1H), 4.69 (d, J = 11.8 Hz, 1H), 4.58 (d, J = 11.5 Hz, 1H), 
4.22- 4.19 (m, 1H), 4.15- 4.10 (m, 1H), 4.07 (t, J = 4.4 Hz, 1H), 3.90 (dd, J = 6.6, 6.0 Hz, 
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1H) 3.85- 3.77 (m, 2H), 3.66 (ap. t, J = 5.5 Hz, 1H), 3.51 (s, 3H), 3.51- 3.48 (m, 1H), 
3.41 (s, 3H), 3.29 (s, 3H), 2.43- 2.37 (m, 1H), 2.26 (ddd, J = 13.6, 6.5, 3.1 Hz, 1H), 2.12- 
2.05 (m, 2H), 1.98- 1.92 (m, 1H), 1.91- 1.86 (m, 1H), 1.82- 1.76 (m, 1H), 1.68- 1.62 (m, 
1H), 1.21 (d, J = 6.6 Hz, 3H), 1.18 (d, J = 6.7 Hz, 3H), 1.08 (s, 9H), 1.04 (s, 18H), 1.00 
(s, 9H), 0.27 (s, 3H), 0.25 (s, 3H), 0.25 (s, 3H), 0.23 (s, 3H), 0.18 (s, 3H), 0.13 (s, 3H), 
0.10 (s, 6H); 
 
13C NMR (125 MHz, CDCl3) 159.1, 150.0, 148.5, 140.5, 130.6, 129.9, 129.3, 120.3, 
114.4, 113.7, 111.1, 110.9, 93.7, 93.5, 84.2, 79.9, 78.2, 76.5, 75.9, 73.1, 72.9, 69.4, 69.2, 
59.8, 55.9, 55.8, 55.2, 40.3, 38.5, 37.4, 37.3, 26.1, 26.0, 25.9, 18.2, 18.0 (2 signals), 15.8, 
13.3, -3.1, -3.7 (2 signals), -4.0, -4.1, -4.7, -5.3; δ 
 
IR(film) 2954.0, 2856.5, 1612.2, 1515.4, 1463.5, 1387.7, 1250.8, 1097.0, 1034.8, 836.5, 
774.4 cm-1; 
 
Exact Mass Calc. for C60H110O12Si4 [M + Na]+ : 1157.6966  ; found : 1157.6970 (ESI) 
 
Pyran Keto-Phosphonate (72)  
O MeOTBS
O
OTBS
OTBS
DMBM
OPMBM
Me
TBSO
70
O MeOTBS
O
OTBS
OTBS
DMBM
OPMBM
O
Me
TBSO
72
PO
OMeMeO  
Alkene 70 (900 mg, 0.792 mmol, 1 eq) was dissolved in 20 mL CH2Cl2 and 2 mL 
pyridine was added. A pipette tip of Sudan III indicator was added. The reaction was 
cooled to -78 °C for 10 minutes with stirring to ensure it was thermally equilibrated. 
Ozone was sparged through until the colour faded from red to peachy orange. The 
reaction was then sparged with nitrogen for one minute. Triphenylphosphine (415 mg, 
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0.546 mmol, 2 eq) was added and the cooling bath was removed. After 50 minutes the 
solvent was removed in vacuo and the residue was employed directly in the next step. 
 
TLC data for intermediate aldehyde: 
Rf = 0.60 (20% EtOAc/hexanes, faintly UV active, stains purple/blue in CAM) 
 
Dimethyl methyl phosphonate (0.490 mL, 4.75 mmol, 6 eq) was dissolved in 10 mL THF 
under nitrogen and cooled to -78 °C.  To the stirring reaction was added 2.94 M n-BuLi 
in hexanes (0.81 mL, 2.38 mmol, 3 eq) and the reaction was stirred for one hour. The 
aldehyde/ triphenylphosphine/ triphenylphosphine oxide mixture was dissolved in 5 mL 
THF and added dropwise to the phosphonate mixture. Another 3 + 2 mL of THF was 
used to quantitate the transfer.  The reaction was stirred for 40 minutes at -78 °C until 
TLC (30% EtOAc/hexanes, CAM) showed consumption of starting material. The 
reaction was quenched with NH4Cl(aq) and diluted with 50 mL 90% EtOAc/hexanes. An 
emulsion typically results from this reaction, so shaking is done gently. The reaction 
mixture was washed with brine, then dried over Na2SO4 solvent was removed in vacuo. 
Flash chromatography (20% to 50% EtOAc/hexanes) afforded 800 mg (0.635 mmol, 
80% over 2 steps) of an inconsequential mixture of diastereomers that was used directly 
in the next step.  
 
TLC data for intermediate alcohols: 
Rf= 0.30 (50 % EtOAc/hexanes, faintly UV active, stains purple in CAM) 
 
This residue dissolved in 15 mL CH2Cl2 and Dess-Martin periodinane (348 mg, 0.826 
mmol, 1.3 eq) was added. TLC after 1 hour showed complete conversion to pyran beta 
ketoester 72. The reaction was diluted with 15 mL CH2Cl2, 3 mL hexanes and cooled to 0 
°C. 6 mL saturated NaS2O3(aq) and 6 mL saturated NaHCO3(aq) were added and the 
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biphasic reaction mixture was stirred until the layers became clear. The layers were 
separated, the aqueous layer was extracted with 60 mL 90% EtOAc/hexanes and the 
combined organic layers were washed with saturated NaHCO3(aq), brine, then dried over 
Na2SO4. Concentration of the residue in vacuo yielded a tacky solid that was purified by 
flash chromatography on silica (30% EtOAc/hexanes) to yield 795 mg Pyran 
phosphonate (0.632 mmol, 79% over 3 steps) as a clear colourless oil. 
 
Rf = 0.45 (50 % EtOAc/hexanes, UV active, stains purple in CAM) 
 
[α]20D = -1.0 (c 2.49, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 9.70 Hz, 2H), 6.89- 6.86 (m, 4H), 6.82 (d, J = 
7.90 Hz, 1H), 4.81 (d, J = 9.5 Hz, 1H), 4.80 (d, J = 9.6 Hz, 1H), 4.71 (d, J = 6.9 Hz, 1H), 
4.67 (d, J = 6.9 Hz, 1H), 4.60 (d, J = 11.6 Hz, 1H), 4.56 (d, J =11.4 Hz, 1H), 4.52 (d, J = 
11.5 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1H), 4.14 (d, J = 3.4 Hz, 1H), 3.88 (s, 3H), 3.87 (s, 
3H), 3.83 (ap. t, J = 3.8 Hz, 1H), 3.80 (s, 3H), 3.77 (br. s, 3H), 3.75 (br. s, 3H), 3.72- 3.67 
(m, 3H), 3.49 (ddd, J = 10.2, 6.3, 3.2 Hz, 1H), 3.39 (dd, J = 5.6, 4.4 Hz, 1H), 3.21- 3.14 
(m, 2H), 3.02 (dd, J = 21.5, 15.5 Hz, 1H), 2.20- 2.14 (m, 1H), 2.09- 2.01 (m, 1H), 1.94- 
1.84 (m, 2H), 1.75- 1.70 (m, 1H), 1.68- 1.62 (m, 1H), 1.51- 1.43 (m, 1H), 0.94 (d, J = 6.6 
Hz, 3H), 0.91 (s, 9H), 0.89 (s, 9H), 0.89 (s, 9H), 0.88- 0.87 (m, 12H), 0.11 (s, 3H), 0.10 
(s, 6H), 0.08 (s, 3H), 0.05 (s, 3H), 0.03- 0.02 (m, 9H); 
 
1H NMR (600 MHz, C6D6) δ 7.37 (d, J = 8.6 Hz, 2H), 7.00 (dd, J = 8.0, 1.9 Hz, 1H), 6.98 
(d, J = 1.9 Hz, 1H), 6.86- 6.83 (m, 3H), 5.02 (d, J = 6.8 Hz, 1H), 4.98 (d, J = 6.8 Hz, 1H), 
4.90 (d, J = 6.9 Hz, 1H), 4.83 (d, J = 6.8 Hz, 1H), 4.77 (d, J = 11.6 Hz, 1H), 4.73 (d, J = 
11.8 Hz, 1H), 4.70 (d, J = 11.8 Hz, 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.54 (d, J = 3.2 Hz, 
1H), 4.19- 4.13 (m, 1H), 4.08 (t, J = 4.4 Hz, 1H), 3.92 (dd, J = 5.7, 4.4 Hz, 1H), 3.90 - 
  219 
3.81 (m, 3H), 3.67 (dd, J = 6.0, 4.5 Hz, 1H), 3.56 (dd, J = 6.3, 3.8 Hz, 1H), 3.52 (s, 3H), 
3.52 (d, J = 11.1 Hz, 3H), 3.47 (d, J = 11.2 Hz, 3H), 3.41 (s, 3H), 3.31 (s, 3H), 3.28- 3.20 
(m, 1H), 2.93 (dd, J = 14.6, 22.1 Hz, 1H), 2.51- 2.45 (m, 1H), 2.45- 2.39 (m, 1H), 2.24 
(ddd, J = 13.9, 8.2, 3.9 Hz, 1H), 2.14 (ap. sext., J = 7.5 Hz, 1H), 1.99 (ddd, J = 13.3, 8.9, 
3.6 Hz, 1H), 1.95 (ap. sext., J = 7.5 Hz, 1H), 1.81 (ddd, J = 13.6 9.9, 3.7Hz, 1H), 1.75 
(ddd, J = 15.0, 11.2, 5.7 Hz, 1H), 1.25 (d, J = 6.7 Hz, 3H), 1.08- 1.07 (m, 12H), 1.06 (s, 
9H), 1.04 (s, 9H), 1.00 (s, 9H), 0.27 (s, 3H), 0.26 (s, 3H), 0.25 (s, 3H), 0.23 (s, 3H), 0.20 
(s, 3H), 0.10 (s, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 203.7 (d, J = 7.4 Hz), 159.1, 148.9, 148.5, 130.6, 129.8, 
129.2, 120.2, 113.7, 111.0, 110.9, 110.3, 93.7, 93.5, 84.8, 80.6 (2 signals), 80.1, 76.7, 
75.4, 73.1, 72.7, 69.4, 69.2, 59.8, 55.9, 55.8, 55.7, 55.2, 52.8 (2 signals), 52.7, 40.1, 38.4, 
38.0, 36.7, 35.6, 33.7, 31.1, 29.6, 26.1, 25.9 (2 signals), 25.8, 18.2, 18.1, 18.0, 14.9, 13.7, 
-3.2, -3.8, -3.9, -4.1, -4.7, -5.0, -5.4; 
 
IR(film) 2930.3, 2856.1, 1727.4, 1612.6, 1515.3, 1463.5, 1387.5, 1255.2, 1093.0, 1031.1, 
939.7, 837.1, 776.1, 669.2 cm-1; 
 
Exact Mass Calc. for C62H115O16PSi4 [M + Na]+ : 1281.6892  ; found : 1281.6922 (ESI) 
 
Elaborated Pyran Ketophosphonate (73)  
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Pyran ketophosphonate 72 (201 mg, 0.160 mmol, 1 eq) was dissolved in a mixture of 3 
mL MeOH and 3 mL CH2Cl2 and cooled to 0 °C. To the stirring mixture under air was 
added 4 mg (0.016 mmol, 0.1 eq) camphorsulfonic acid. After 1 hour, TLC (50% 
EtOAc/hexanes, CAM) showed complete consumption of starting material, so the 
reaction was quenched by the addition of 1 mL saturated NaHCO3(aq). The mixture was 
diluted with 50 mL 90% EtOAc/hexanes and the organic layer was separated. The 
organic layer was washed with brine, dried over Na2SO4 and concentrated in vacuo. The 
polar phosphonate alcohol was held under high vacuum to remove all methanol which 
would interfere with the next step, but no other purification was required. 
Characterization Data: 
 
Rf = Baseline (50% EtOAc/hexanes, UV active, stains purple in CAM) 
 
[α]20D = +8.70 (c 1.45, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.24 (d, J = 8.7 Hz, 2H), 6.90- 6.86 (m, 4H), 6.83 (d, J = 
8.0 Hz, 1H), 4.82 (dd, J = 6.9, 1.6 Hz, 1H), 4.73 (d, J = 6.9 Hz, 1H), 4.67 (d, J = 6.9 Hz, 
1H), 4.61 (d, J = 5.9 Hz, 1H), 4.59 (d, J = 6.0 Hz, 1H), 4.51 (d, J = 11.4 Hz, 1H), 4.47 (d, 
J = 11.6 Hz, 1H), 4.23 (d, J = 2.5 Hz, 1H), 3.94- 3.89 (m, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 
3.83 (ap. t, J = 4.1 Hz, 1H), 3.80 (s, 3H), 3.79 (d, J = 6.9 Hz, 3H), 3.77 (d, J = 6.9 Hz, 
3H), 3.77- 3.74 (m, 2H), 3.72 (dd, J = 11.1, 5.6 Hz, 1H), 3.65 (dd, J = 6.9, 3.9 Hz, 1H), 
3.53- 3.49 (m, 1H), 3.39 (ap. t, J = 5.0 Hz, 1H), 3.22 (dd, J = 6.9, 2.8 Hz, 1H), 3.17 (dd, J 
= 20.4, 15.7 Hz, 1H), 2.99 (dd, J = 21.9, 15.5 Hz, 1H), 2.28- 2.21 (m, 1H), 2.09- 2.03 (m, 
1H), 1.91- 1.82 (m, 3H), 1.79- 1.69 (m, 2H), 1.61- 1.50 (m, 2H), 0.93 (d, J = 7.9 Hz, 3H), 
0.92 (s, 9H), 0.89 (s, 18H), 0.80 (d, J = 6.9 Hz, 3H), 0.11 (s, 3H), 0.10 (s, 3H), 0.10 (s, 
3H), 0.08 (s, 3H), 0.06 (s, 3H), 0.04 (s, 3H); 
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1H NMR (600 MHz, C6D6) δ 7.35 (d, J = 8.6 Hz, 2H), 6.99- 6.97 (m, 2H), 6.83 (d, J = 
8.6 Hz, 2H), 6.63 (d, J = 7.9 Hz, 1H), 5.04 (d, J = 6.8 Hz, 1H), 4.94 (d, J = 6.7 Hz, 1H), 
4.85 (d, J = 6.8 Hz, 1H), 4.83 (d, J = 6.8 Hz, 1H), 4.73 (d, J = 11.7 Hz, 1H), 4.71 (d, J = 
11.6 Hz, 1H), 4.63 (d, J = 11.6 Hz, 1H), 4.58 (s, 1H), 4.57 (d, J = 11.5 Hz, 1H), 4.18- 
4.14 (m, 1H), 4.06 (ap. t, J = 4.8 Hz, 1H), 3.93 (ap. t, J = 6.3 Hz, 1H), 3.86 (dd, J = 7.5, 
4.5 Hz, 1H), 3.82- 3.79 (m, 1H), 3.68 (ap. t, J = 5.6 Hz, 1H), 3.54 (dd, J = 7.5, 2.3 Hz, 
1H), 3.52 (s, 3H), 3.46 (d, J = 11.1 Hz, 3H), 3.40 (s, 3H), 3.38 (d, J = 11.3 Hz, 3H), 3.29 
(s, 3H), 3.17 (dd, J = 20.4, 14.4 Hz, 1H), 2.74 (dd, J = 22.7, 14.8 Hz, 1H), 2.52- 2.46 (m, 
1H), 2.46- 2.41 (m, 1H), 2.19 (ddd, J = 13.5, 10.1, 2.8 Hz, 1H), 2.15- 2.05 (m, 2H), 2.05- 
1.99 (m, 1H), 1.95- 1.89 (m, 1H), 1.80 (ddd, J = 15.0, 11.1, 4.0 Hz, 1H), 1.18 (d, J = 6.7 
Hz, 3H), 1.07 (s, 9H) 1.07 (s, 9H), 1.03 (s, 9H), 0.92 (d, J = 6.7 Hz, 3H), 0.27 (s, 3H), 
0.26 (s, 3H), 0.25 (s, 3H), 0.25 (s, 3H), 0.22 (s, 3H), 0.19 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 203.5, 159.1, 148.9, 148.6, 130.2, 129.7, 129.1, 120.3, 
113.7, 111.1, 110.9, 93.9, 93.7, 84.2, 79.7, 79.5 (2 signals), 76.3, 75.7, 74.1, 72.8, 69.7, 
69.2, 59.2, 55.8, 55.7, 55.1, 52.9 (2 signals), 52.8, 40.8, 38.1, 37.8, 36.6, 35.5, 32.5, 30.4, 
29.6, 26.1, 25.9, 25.8, 18.2, 18.0, 17.9, 14.7, 13.1, -3.1, -3.8 (2 signals), -4.1, -4.6, -5.1; 
 
IR(film) 3442.2, 2954.0, 2856.5, 1728.1, 1613.3, 1515.5, 1463.6, 1385.5, 1251.5, 1098.3, 
1032.7, 837.5, 776.3, 666.90 cm-1; 
 
Exact Mass Calc. for C56H101O16PSi3 [M + Na]+ : 1167.6021  ; found : 1167.6026 (ESI) 
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To the residue of 73 was added o-nitrophenylselenocyanate (109 mg, 0.477 mmol, 3 
theoretical equivalents) and the mixture was dissolved in 4 mL of THF under nitrogen. 
To the light brown solution was added PBu3 (0.119 mL, 0.477 mmol, 3 theoretical 
equivalents) which resulted in the formation of a dark brown solution. This was allowed 
to stir for 1 hour, at which time TLC showed complete consumption of the starting 
material. To the brown mixture was added 4 mL of 30% H2O2 and the resulting biphasic 
mixture was stirred for 12 hours. TLC during this time shows oxidation to the selenoxide 
(Rf = 0, stains dark purple) followed by formation of the Elaborated Pyran 
Ketophosphonate 5 (Rf = 0.60 in 50% EtOAc/hexanes). The reaction is judged complete 
when no more material that stains blue is present on the baseline of the TLC. The 
reaction is diluted with 50 mL 90% EtOAc/hexanes and washed with saturated NaHSO3 
until the washings were neutral to KI/KIO3/Starch peroxide test strips. This was washed 
with brine and dried over Na2SO4. Concentration in vacuo yielded a vile smelling orange 
residue which was purified by flash chromatography to yield 145 mg elaborate 
β−ketophosphonate  (0.129 mmol, 81 %) as a dark yellow coloured oil that was > 95% 
pure by 1H NMR. Judging from the colour and the odour, selenium containing 
byproducts were present, which were not removed by chromatography. These do not 
appear to be detrimental to the next step. 
 
Rf = 0.60 (50% EtOAc/hexanes, UV active, stains blue-black in CAM) 
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[α]20D –20.3 (c = 3.21, CHCl3);  
 
1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 9.6 Hz, 2H), 6.89- 6.86 (m, 4H), 6.83 (d, J = 
8.0 Hz, 1H), 5.73 (ddd, J = 17.7, 10.4, 7.7 Hz, 1H), 5.23 (dd, J = 17.7, 0.7 Hz, 1H), 5.17 
(dd, J = 10.4, 1.4 Hz, 1H), 4.82 (d, J = 6.9 Hz, 1H), 4.79 (d, J = 7.0 Hz, 1H), 4.68 (d, J = 
6.9 Hz, 1H), 4.65 (d, J = 7.0 Hz, 1H), 4.62 (d, J = 4.6 Hz, 1H), 4.60 (d, J = 4.7 Hz, 1H), 
4.47 (d, J = 16.3 Hz, 1H), 4.45 (d, J = 16.0 Hz, 1H), 4.23- 4.19 (m, 1H), 4.19 (d, J = 2.9 
Hz, 1H), 3.88 (s, 3H) 3.87 (s, 3H), 3.83 (t, J = 4.0 Hz, 1H), 3.80 (s, 3H), 3.78 (d, J = 1.2 
Hz, 3H), 3.76 (d, J = 1.3 Hz, 3H), 3.71- 3.69 (m, 1H), 3.51 (ddd, J = 9.5, 6.2, 3.0 Hz, 
1H), 3.39 (dd, J = 5.7, 4.1 Hz, 1H), 3.22 (dd, J = 6.0, 4.2 Hz, 1H), 3.15 (dd, J = 20.6, 
10.5 Hz, 1H), 3.01 Hz, (dd, J = 21.6, 15.5 Hz, 1H), 2.22- 2.14 (m, 2H), 1.87 (qd, J = 7.0, 
2.0 Hz, 1H), 1.75 (ddd, J = 13.6, 10.0, 3.4 Hz, 1H), 1.51- 1.45 (m, 2H), 0.98 (d, J = 6.7 
Hz, 3H), 0.92 (s, 9H), 0.90 (s, 9H), 0.89 (s, 9H), 0.85 (d, J = 6.9 Hz, 3H), 0.12 (s, 3H), 
0.11 (s, 3H), 0.10 (s, 3H), 0.10 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 203.5, 159.1, 149.0, 148.6, 139.0, 130.9, 130.5, 129.8, 
129.2, 120.4, 117.0, 113.7, 111.1, 110.9, 93.8, 91.7, 84.8, 80.2 (2 signals), 80.1, 76.4, 
75.6, 75.2, 72.7, 69.5, 69.2, 55.9, 55.8, 55.2, 52.8 (broad signal), 41.0, 38.0, 36.8, 35.7, 
33.2, 30.8, 29.6, 26.1, 26.0, 25.8, 18.2, 18.0 (2 signals), 14.9, 13.4, -3.1, -3.8, -3.9, -4.0, -
4.6, -5.0; 
 
IR (film) 2954.6, 2856.4, 1727.8, 1612.8, 1515.5, 1463.7, 1252.4, 1098.8, 1032.9, 837.7, 
776.6; 
 
Exact Mass Calc. for C56H99O15PSi3 [M + Na]+ : 1149.5922  ; found : 1149.5927 (ESI) 
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(3S,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-12-hydroxy-7-methylene-N-
phenyldodec-8-ynamide 
PhHN
O OTBSOTBS
S4
1PhHN
O OTBSOTBS
S3
1 Cl
OH  
In a 25 mL Schlenk tube under nitrogen equipped with a stirbar were placed Palladium 
cinnamyl chloride dimer (40.5 mg, 0.078 mmol, 0.1 eq), 4-(2-(di(adamantan-1-
yl)phosphino)phenyl)morpholine (Mor-Dalphos) (72.3 mg, 0.156 mmol, 0.2 eq) and 
Cesium carbonate (254 mg, 0.781 mmol, 1 eq). The flask was evacuated and backfilled 4 
times with nitrogen. It was useful to place the Cesium carbonate on top of the other 
reagents to minimize their blowing around during this step. Separately, vinyl chloride S3 
(400 mg, 0.781 mmol, 1 eq) was mixed with 4-pentyl-1-ol (0.22 mL, 2.34 mmol, 3 eq) in 
6 ml of THF under nitrogen. The THF mixture was transferred into the Schlenk tube and 
the orange mixture was heated to 65 °C and sealed. After 7 hours, TLC (10% 
EtOAc/hexanes, KMnO4, starting material Rf= 0.85, product Rf=0.25, pentynol Rf=0.10, 
pentynol ene-yne dimer Rf=0.05) showed consumption of pentynol due to head to tail 
dimerization, but presence of starting material. An additional 0.2 mL of 4-pentyl-1-ol was 
added and the reaction was stirred for 20 more hours until TLC showed consumption of 
starting material. The reaction was quenched with 10 mL saturated NH4Cl(aq) and diluted 
with 30 mL 90% EtOAc/hexanes. The layers were separated and the aqueous layer was 
extracted with 2x 20 mL 90% EtOAc/hexanes. The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated in vacuo. Purification of the 
residue by flash chromatography on silica (10% to 20% EtOAc/hexanes) gave 295 mg of 
ene-yne S4 (0.527 mmol, 67%) as a clear colorless oil. Characterization data were in 
agreement with ene-yne S4 prepared from vinyl iodide   with palladium chloride 
benzonitrile complex (see George Borg’s thesis for the data and Chapter 3 for an 
explanation of the necessity of using separate conditions for Sonogashira coupling on the 
vinyl chloride). 
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(3S,5S,Z)-3,5-bis((tert-butyldimethylsilyl)oxy)-7-methylene-N-phenyl-12-
((triethylsilyl)oxy)dodec-8-enamide (80)51 
 
PhHN
O OHOTBSOTBS
4
1
PhHN
O OTESOTBSOTBS 12
1
80  
To a solution of alcohol 4 (472 mg, 0.84 mmol) in CH2Cl2 (10 mL) at 0 °C was added 
imidazole (172 mg, 2.52 mmol) and TESCl (211 µL, 1.26 mmol). The reaction was 
stirred at 0 °C for 20 min, then quenched with saturated NaHCO3, diluted with EtOAc 
and extracted. The aqueous layer was back-extracted with EtOAc (2x). The organic 
layers were mixed, washed with saturated NH4Cl (2x), saturated NaHCO3 and brine, 
dried over Na2SO4, filtered, and concentrated in vacuo. Purification by chromatography 
on silica gel using EtOAc in hexanes (10%) as eluant gave 567 mg ( quant) of amide 80 
as a clear colorless oil. Yield: quant. (567 mg);  
 
Rf = 0.36 (90:10 hexanes/EtOAc, UV active, stains blue in CAM);  
 
[α]20D –14.7 (c = 1.0, CHCl3);  
 
1H NMR (500 MHz, CDCl3) δ 8.45 (s, 1H), 7.50-7.52 (m, 2H), 7.30-7.33 (m, 2H), 7.07-
7.10 (m, 1H), 5.73 (d, J = 11.6 Hz, 1H), 5.50 (dt, J = 11.7, 7.3 Hz, 1H), 5.02 (s, 1H), 4.91 
(s, 1H), 4.29-4.34 (m, 1H), 3.79-3.87 (m, 1H), 3.58 (t, J = 6.6 Hz, 2H), 2.69 (dd, J = 14.9 
3.7 Hz, 1H), 2.36-2.41 (m, 2H), 2.17-2.23 (m, 3H), 1.80 (ddd, J = 12.7, 9.6 Hz, 2.8, 1H), 
1.69 (ddd,  J = 13.9, 9.2,4.0 Hz, 1H), 1.55-1.61 (m, 2H), 0.97 (t, J = 8.0 Hz, 9H), 0.94 (s, 
9H), 0.91 (s, 9H), 0.61 (q, J = 8.0 Hz, 6H), 0.16 (s, 3H), 0.12 (s, 6H), 0.10 (s, 3H);  
 
                                                
(51) The following characterization data was obtained by Dr. Pascal Bindschädler and the procedure was 
written by him, and adapted from the one I developed for the series with C12 TBS protection. 
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13C NMR (125 MHz, CDCl3) δ 169.4, 141.5, 138.5, 132.7, 129.9, 129.1 (2C), 124.0, 
119.8 (2C), 116.4, 68.8, 67.7, 62.7, 46.9, 44.3, 43.4, 33.4, 26.13 (3C), 26.11 (3C), 25.6, 
18.2 (2C), 7.0, 4.7, –3.8, –4.2, –4.3, –4.6; 
 
 IR (film) 3320, 2955, 2930, 2858, 1686, 1671, 1601, 1542, 1499, 1442, 1256, 1096, 
1005, 836, 776, 749 cm-1;  
Exact mass calcd for C37H69NO4Si3 [M+H]+: 676.4607; found 676.4605 (ESI). 
 
tert-butyl ((3S,5S,Z)-3,5-bis((tert-butyldimethylsilyl)oxy)-7-methylene-12-
((triethylsilyl)oxy)dodec-8-enoyl)(phenyl)carbamate (81)51 
 
PhN
O OTESOTBSOTBS 12
1
Boc
PhHN
O OTESOTBSOTBS 12
1
80 81  
To a solution of 80 (567 mg, 0.84 mmol) in CH3CN (10 mL) at room temperature was 
added DMAP (205 mg, 1.68 mmol) and Boc2O (565 mg, 2.52 mmol). The reaction was 
stirred at room temperature for 30 min, and concentrated under reduced pressure. 
Purification by chromatography on silica gel using 5% EtOAc in hexanes as eluant gave 
title compound 81 as a clear colorless oil. Yield: 99% (643 mg);  
 
Rf = 0.45 (90:10 hexanes/EtOAc, UV active, stains blue in CAM);  
 
[α]20D +6.2 (c = 1.0, CHCl3);  
 
1H NMR (500 MHz, CDCl3) δ 7.37-7.40 (m, 2H), 7.31-7.34 (m, 1H), 7.06-7.08 (m, 2H), 
5.78 (d, 1H, J = 11.7 Hz), 5.51 (dt, J = 11.7, 7.3 Hz, 1H), 5.04 (s, 1H), 4.95 (s, 1H), 4.40-
4.45 (m, 1H), 3.81-3.86 (m, 1H), 3.64 (t, J = 6.5 Hz, 2H), 3.10 (dd, J = 16.7, 7.5 Hz, 1H), 
2.99 (dd, J = 16.7, 4.4 Hz, 1H), 2.22-2.35 (m, 4H), 1.62-1.71 (m, 4H), 1.38 (s, 9H), 0.98 
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(t, J = 7.9 Hz, 9H), 0.89 (s, 9H), 0.89 (s, 9H), 0.61 (q, J = 8.0 Hz, 6H), 0.09 (s, 3H), 0.06 
(s, 3H), 0.05 (s, 3H), 0.05 (s, 3H);  
 
13C NMR (125 MHz, CDCl3) δ 173.7, 152.9, 142.0, 139.3, 132.3, 130.4, 129.1 (2C), 
128.5 (2C), 127.9, 116.2, 83.1, 68.9, 67.0, 62.8, 46.2, 45.8, 45.2, 33.5, 28.1 (3C), 26.23 
(3C), 26.19 (3C), 25.6, 18.25, 18.23, 7.0, 4.7, –4.10, –4.13, –4.18, –4.24;  
 
 
IR (film) 2955, 2856, 1736, 1704, 1459, 1370, 1294, 1255, 1154, 1091, 1005, 836, 775, 
746 cm-1;  
 
Exact mass calcd for C42H77NO6Si3 [M+Na]+: 798.4951; found 798.4955 (ESI). 
 
 
tert-butyl ((3S,5S,Z)-3,5-bis((tert-butyldimethylsilyl)oxy)-12-hydroxy-7-
methylenedodec-8-enoyl)(phenyl)carbamate (76)51 
 
PhN
O OTESOTBSOTBS 12
1
Boc
PhN
O OHOTBSOTBS
76
1
Boc81  
To a solution of 71 (568 mg, 0.73 mmol) in CH2Cl2 (5 mL) and MeOH (5 mL) at 0 °C 
was added PPTS (14.5 mg, 0.058 mmol). The reaction was stirred at 0 °C for 2.5 h, then 
quenched with saturated NaHCO3, diluted with Et2O and extracted. The aqueous layer 
was back-extracted with Et2O (2x). The organic layers were mixed, washed with brine, 
dried over Na2SO4, filtered, and concentrated under reduced pressure. Purification by 
chromatography on silica gel using hexanes:EtOAc (90:10 to 80:20) as eluant gave title 
compound 76 as a clear colorless oil. Yield: 94% (455 mg);  
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Rf = 0.26 (80:20 hexanes/EtOAc, UV active, stains blue in CAM);  
 
[α]20D +10.8 (c = 1.0, CHCl3); 
 
 1H NMR (500 MHz, CDCl3) δ 7.37-7.40 (m, 2H), 7.31-7.34 (m, 1H), 7.06-7.07 (m, 2H), 
5.81 (d, J = 11.6 Hz, 1H), 5.51 (dt, J = 11.7 Hz, 7.2 Hz, 1H), 5.06 (s, 1H), 4.94 (s, 1H), 
4.42-4.47 (m, 1H), 3.76-3.81 (m, 1H), 3.64 (td, J = 6.1, 6.0 Hz, 2H), 3.16 (dd, J = 16.6, 
7.8 Hz, 1H), 2.96 (dd, J = 16.6, 4.0 Hz, 1H), 2.24-2.42 (m, 4H), 1.64-1.78 (m, 5H), 1.37 
(s, 9H), 0.90 (s, 9H), 0.89 (s, 9H), 0.10 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H);  
 
13C NMR (125 MHz, CDCl3) δ 173.8, 153.1, 141.9, 139.3, 132.1, 130.8, 129.1 (2C), 
128.5 (2C), 127.9, 116.5, 83.2, 68.9, 67.1, 62.6, 46.4, 45.5, 45.1, 33.2, 28.1 (3C), 26.3 
(3C), 26.2 (3C), 25.4, 18.24, 18.22, –4.06, –4.14, –4.18, –4.22;  
 
IR (film) 2930, 2857, 1736, 1459, 1370, 1294, 1255, 1154, 1090, 836, 775 cm-1;  
 
Exact mass calcd for C36H63NO6Si2 [M+Na]+: 684.4086; found 684.4077 (ESI). 
 
tert-butyl ((3S,5S,Z)-3,5-bis((tert-butyldimethylsilyl)oxy)-7-methylene-12-oxododec-
8-enoyl)(phenyl)carbamate (75)  
PhN
O OHOTBSOTBS
76
1
Boc
PhN
O OOTBSOTBS
75
12
1
Boc
H
 
Alcohol 76, (528 mg, 0.780 mmol, 1 eq) was dissolved in 3 mL CH2Cl2. Hunig’s base 
(0.429 mL, 2.39 mmol, 3 eq) and DMSO (0.340 mL, 4.78 mmol, 6 eq) were added and 
the reaction was cooled to 0 °C. SO3-Py (253 mg, 1.59 mmol, 2 eq) was added. After 15 
minutes, TLC showed completion (TLC conditions). The volatiles were removed in 
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vacuo and the residue was taken up in a minimal amount of CH2Cl2 and loaded on a pre-
equilbrated column which was eluted using 10% EtOAc/hexanes to afford 528 mg (0.780 
mmol, 100% ) of aldehyde 75 as a clear colourless oil. This material was judged to be of 
>95 % purity by 1H NMR analysis. 
 
Rf =  0.80 (20 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D +6.6 (c = 2.5, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 9.77 (t, J = 1.6 Hz, 1H), 7.37 (ap. t, J = 7.3 Hz, 2H), 7.31 
(ap. t, J = 7.5 Hz, 1H), 7.05 (ap. d, J = 7.5 Hz, 2H), 5.84 (dd, J = 11.6, 1.3 Hz, 1H), 5.44 
(dt, J = 11.5, 6.8 Hz, 1H), 5.07 (s, 1H), 4.92 (s, 1H) 4.43- 4.38 (m, 1H), 3.81 (ap. pent, J 
= 6.1 Hz, 1H), 3.09 (dd, J = 16.6, 7.3 Hz, 1H) 2.98 (dd, J = 16.7, 4.4 Hz, 1H), 2.60- 2.55 
(m, 2H), 2.54- 2.50 (m, 2H), 2.27 (ap. d, J = 6.3 Hz, 2H), 1.68 (ap. t, J =  6.2 Hz, 2H), 
1.36- 1.35 (m, 11H), 0.88 (s, 9H), 0.87 (s, 9H), 0.08 (s, 3H), 0.05 (s, 3H), 0.04 (s, 3H), 
0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 201.8, 173.4, 152.6, 141.5, 139.0, 131.6, 129.6, 128.8, 
128.2, 127.6, 116.5, 82.8, 68.5, 66.7, 45.7, 45.4, 44.9, 44.0, 27.7, 25.9, 21.5, 18.0, 17.9, -
4.4, -4.5, -4.6; 
 
IR (film) 2961.4, 2856.2, 1736.1, 1597.3, 1472.1, 1369.9, 1294.0, 1255.1, 1154.1, 
1090.4, 836.4, 775.3 cm-1; 
 
Exact mass calcd for C36H61NO6Si2 [M+Na]+: 682.3930; found 682.3960 (ESI). 
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Elaborate HWE Product (82)  
DMBMO Me
O
OTBS
OTBS
OPMBM
O
Me
TBSO
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OMeMeO
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O OTBSOTBS
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1
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O
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TBSO
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Phosphonate 5 (80 mg, 0.064 mmol, 1 eq) was mixed with aldehyde 75 (85mg, 0.129 
mmol, 2 eq) in a minimal amount of CH2Cl2. The CH2Cl2 was removed in vacuo and the 
residue was dissolved in 4 mL THF under nitrogen. Cesium carbonate (23 mg, 0.067 
mmol, 1.05 eq) was added and the reaction was stirred at room temperature. After 15 
hours, the resulting turbid mixture was filtered through Celite® and concentrated in 
vacuo. The residue was purified by flash chromatography on silica (5% to 50% 
EtOAc/hexanes) to afford 102 mg (0.057 mmol, 89%) of enone 82 as a viscous clear 
colourless oil. 1H N NMR indicated a greater than 20:1 ratio of E: Z double bond 
isomers. The excess aldehyde was also recovered. 
 
Characterization Data: 
 
Rf = 0.60 (25 % EtOAc/hexanes, highly UV active, stains blue in CAM) 
 
[α]20D = -15.8 (c 3.69, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.39- 7.35 (m, 2H), 7.33- 7.29 (m, 1H), 7.26 (d, J = 6.7 
Hz, 2H), 7.07- 7.04 (m, 2H), 6.93 (dt, J = 15.7, 6.9 Hz, 1H), 6.90- 6.86 (m, 4H), 6.84- 
6.81 (m, 1H), 6.48 (dd, J = 15.5, 1.3, 1H), 5.80 (d, J = 11.5 Hz, 1H), 5.76- 5.69 (m, 1H), 
5.47- 5.41 (m, 1H), 5.24 (d, J = 17.3 Hz, 1H), 5.17 (d, J = 10.3 Hz, 1H), 5.03 (s, 1H), 
4.88 (s, 1H), 4.83- 4.78 (m, 2H), 4.68 (d, J = 5.9 Hz, 1H), 4.66 (d, J = 6.0 Hz, 1H), 4.62 
(d, J = 5.4 Hz, 1H), 4.60 (d, J = 4.3 Hz, 1H), 4.47 (d, J = 10.8 Hz, 1H), 4.45 (d, J = 11.3 
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Hz, 1H), 4.42- 4.37 (m, 1H), 4.23- 4.19 (m, 1H), 4.10- 4.07 (m, 1H), 3.88 (s, 3H), 3.87 (s, 
3H), 3.84- 3.81 (m, 2H), 3.80 (m, 3H), 3.70- 3.69 (m, 1H), 3.53- 3.49 (m, 1H), 3.42- 3.38 
(m, 1H), 3.23- 3.20 (m, 1H), 3.09 (dd, J = 16.7, 7.3 Hz, 1H), 2.98 (dd, J = 16.8, 4.5 Hz, 
1H), 2.40- 2.33 (m, 2H), 2.29- 2.22 (m, 3H), 2.19- 2.12 (m, 2H), 1.90- 1.84 (m, 1H), 
1.79- 1.74 (m, 1H), 1.71- 1.66 (m, 2H), 1.62- 1.50 (m, 3H), 1.49- 1.44 (m, 1H), 1.39 (s, 
9H), 0.98 (d, J = 6.6 Hz, 3H), 0.93- 0.91 (m, 12H), 0.90- 0.89 (m, 18H), 0.88- 0.86 (m, 
18H), 0.12-  0.09 (m, 9H), 0.12- 0.09 (m, 9H), 0.07 (m, 3H), 0.05- 0.03 (m, 9H), 0.02 (s, 
6H), 0.00 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 201.3, 173.4, 159.1, 152.6, 148.9, 148.5, 146.5, 141.5, 
139.0, 138.9, 131.0, 130.5, 130.3, 129.8, 129.3, 128.8, 128.2, 127.6, 125.7, 120.4, 120.4, 
117.0, 116.2, 113.7, 111.1, 110.9, 93.7, 91.6, 84.4, 82.8, 80.0, 79.9, 76.8, 75.7, 75.2, 72.8, 
69.4, 69.2, 68.5, 66.7, 55.8, 55.7, 55.1, 45.8, 45.5, 45.0, 41.0, 38.1, 34.2, 32.9, 30.6, 29.6, 
27.7, 27.3, 26.1, 26.0, 25.9 (2 signals), 18.2, 18.0 (2 signals), 17.9 (2 signals), 15.1, 13.3, 
-3.2, -3.8 (2 signals), -4.0, -4.4 (2 signals), -4.5 (2 signals), -4.6, -4.9; 
 
IR(film) 2954.0, 2856.4, 1736.2, 1708.0, 1618.1, 1515.4, 1471.8, 1369.7, 1293.9, 1254.2, 
1155.6, 1093.7, 1033.9, 836.9, 775.7 cm-1; 
 
Exact mass calcd for C90H153NO17Si5 [M+Na]+: 1682.9877; found 1682.9560(ESI). 
 
Elaborate Luche Product (83)  
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Enone 82 (90 mg, 0.054 mmol, 1 eq) was dissolved in 3 mL THF and 1.5 mL MeOH. 
Cerium trichloride heptahydrate (40 mg, 0.108 mmol, 2 eq) was added and the reaction 
was stirred until this dissolved. The reaction was then cooled to -78 °C and NaBH4 (6.1 
mg, 0.162 mmol 3 eq) was added as a solid. After 1 hour the reaction was quenched by 
the addition of 0.3 mL acetone and 3 mL saturated NH4Cl(aq). The mixture was quickly 
diluted with 30 mL 90 % EtOAc/hexanes and washed with H2O. The aqueous layers was 
extracted with 20 mL 90 % EtOAc/hexanes and the combined organic layers were 
washed with brine and dried over Na2SO4, then concentrated in vacuo. The residue was 
purified by flash chromatography to yield elaborate Luche product 83 (80 mg, 0.048 
mmol, 89 %) as a clear colourless oil. 
 
Characterization Data: 
 
Rf = 0.60 (25 % EtOAc/hexanes, highly UV active, stains blue in CAM) 
 
[α]20D = -15.3 (c 3.05, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.37 (ap. t, J = 7.3 Hz, 2 H), 7.31 (ap. t, J = 7.3 Hz, 1H), 
7.24 (ap d, J = 8.8 Hz, 2H), 7.07- 7.04 (m, 2H), 6.89- 6.85 (m, 4H), 6.83 (d, J = 7.8 Hz, 
1H), 5.76 (ap. d, J = 12.7 Hz, 1H), 5.73- 5.68 (m, 2H), 5.49- 5.40 (m, 2H), 5.23 (d, J = 
12.7 Hz, 1H), 5.18 (d, J = 11.2 Hz, 1H), 5.01 (s, 1H), 4.90 (s, 1H), 4.81- 4.78 (m, 2H), 
4.68 (d, J = 6.8 Hz, 1H), 4.65 (d, J = 6.8 Hz, 1H), 4.61 (d, J = 7.3 Hz, H), 4.59 (d, J = 7.8 
Hz, 1H), 4.48 (d, J = 11.7 Hz, 1H), 4.46 (d, J = 11.2 Hz, 1H), 4.42- 4.37 (m, 1H), 4.03- 
3.99 (m, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 3.85- 3.83 (m, 1H), 3.83- 3.80 (m, 1H), 3.80 (s, 
3H), 3.70- 3.67 (m, 1H), 3.55- 3.49 (m, 1H), 3.43- 3.40 (m, 1H), 3.20 (dd, J = 6.3, 3.4 
Hz, 1H), 3.08 (dd, J = 16.6, 7.3 Hz, 1H), 2.97 (dd, J = 16.6, 4.4, 1H), 2.32- 2.27 (m, 2H), 
2.26- 2.22 (m, 2H), 2.14- 2.08 (m, 2H), 1.93- 1.83 (m, 2H), 1.79- 1.72 (m, 1H), 1.69- 
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1.66 (t, J = 5.8 Hz, 2H), 1.60- 1.46 (m, 4H), 1.36 (s, 9H), 0.96 (d, J = 6.4 Hz, 3H), 0.93 
(d, J = 4.5 Hz, 3H), 0.90 (s, 27H) 0.87 (s, 9H), 0.86 (s, 9H), 0.11 (s, 3H), 0.11 (s, 6H), 
0.09 (s, 3H), 0.08 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.04 (s, 3H), 0.04 (s, 3H), 0.03 (s, 
3H); 
 
13C NMR (125 MHz, CDCl3) δ 173.4, 159.1, 152.6, 149.0, 148.6, 141.7, 139.0, 138.9, 
131.6, 131.5, 131.2, 130.5, 130.3, 129.8, 129.2, 128.8, 128.2, 127.6, 120.4, 117.1, 116.0, 
113.7, 111.2, 110.9, 93.6, 91.6, 84.3, 82.8, 80.1, 78.0, 77.6, 75.5, 75.3, 73.7, 72.8, 69.4, 
69.1, 68.6, 66.7, 55.9, 55.7, 55.1, 45.9, 45.5, 44.9, 41.1, 38.2, 36.6, 34.0, 32.7, 30.6, 28.4, 
27.8, 26.1, 25.9 (2 signals), 18.4, 18.0, 17.9 (2 signals), 15.8, 13.3, -3.3, -3.9  
(3 signals), -4.0, -4.1, -4.4, -4.5 (2 signals); 
 
IR (film) 2930.0, 2856.0, 1737.8, 1515.2, 1463.0, 1369.9, 1253.0, 1155.5, 1093.5, 
1033.2, 836.2, 774.9 cm-1; 
 
Exact mass calcd for C90H155NO17Si5 [M+Na]+: 1685.0033; found 1685.0001 (ESI). 
 
Elaborate Seco Acid (84)   
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Elaborate Luche product 83 (80 mg, 0.048 mmol, 1 eq) was dissolved in 3 mL THF and 
cooled to -20 °C. To this solution were added 15 drops of 30 % aqueous hydrogen 
peroxide. To the homogenous solution were added 7 drops of 1 M LiOH(aq) (an excess) . 
The reaction was held at -5 °C for 15 hours at which time TLC showed complete 
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consumption of starting material. To the solution at 0 °C was added saturated Na2SO3(aq) 
until a KI/KIO3/Starch peroxide test strip shows the absence of peroxides. The reaction 
was made acidic to pH paper by the addition of 1 M NaHSO4. The reaction was diluted 
with 20 mL 90 % EtOAc/hexanes and the aqueous layer was extracted with a further 50 
mL of 90 % EtOAc/hexanes. The combined organic layers were washed with brine, dried 
over Na2SO4 and concentrated in vacuo. Purification of the residue by flash 
chromatography on silica (30 % to 40 % EtOAc/hexanes) yielded 59 mg of elaborate 
seco acid 84 (0.0396 mmol, 82 %) as a clear colourless very viscous oil. 
 
Rf = 0.20 (50% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -9.6 (c 0.32, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 6.90- 6.86 (m, 4H), 6.83 (d, J = 
8.0 H, 1H), 5.76- 5.66 (m, 3H), 5.53- 5.46 (m, 1H), 5.44 (dd, J = 15.3, 6.6 Hz, 1H), 5.24 
(d, J = 17.1 Hz, 1H), 5.19 (d, J = 10.3 Hz, 1H), 5.02 (s, 1H), 4.92 (s, 1H), 4.82- 4.79 (m, 
2H), 4.69 (d, J = 6.9 Hz, 1H), 4.67 (d, J = 6.9 Hz, 1H), 4.62 (d, J = 11.3 Hz, 1H), 4.60 (d, 
J = 11.3, 1H), 4.50 (d, J = 11.6, 1H), 4.46 (d, J = 11.4 Hz, 1H) 4.27 (ap. sext., J = 4.5 Hz, 
1H), 4.23- 4.18 (m, 1H), 4.03 (ap. t, J = 5.7 Hz, 1H), 3.89 (s, 3H), 3.88 (s, 3H), 3.86 (ap. 
t, J = 3.7 Hz, 1H), 3.81 (s, 9H), 3.74 (ap. sext. J = 4.0 Hz, 1H), 3.70 (dd, J = 6.3, 3.7 Hz, 
1H), 3.55- 3.51 (m, 2H), 3.43 (ap. t, J = 4.5 Hz, 1H), 3.21 (dd, J = 6.3, 3.6 Hz, 1H), 2.56 
(dd, J = 15.2, 4.7 Hz, 1H), 2.36 (dd, J = 13.5, 4.2 Hz, 1H), 2.33- 2.27 (m, 1H), 2.20 (dd, J 
= 13.3, 8.2 Hz, 1H), 2.15- 2.09 (m, 2H), 1.94 – 1.89 (m, 1H), 1.88- 1.83 (m, 1H), 1.79- 
1.71 (m, 2H), 1.67- 1.61 (m, 1H), 1.59- 1.53 (m, 1H), 1.53- 1.46 (m, 1H), 0.97 (d, J = 6.7 
Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H), 0.90 (s, 27 H), 0.90 (s, 9H), 0.89 (s, 9H), 0.12 (s, 3H), 
0.12 (s, 3H), 0.l1 (s, 6H), 0.10 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 
3H), 0.06 (s, 3H); 
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1H NMR (600 MHz, C6D6) δ 7.36 (d, J = 8.6 Hz, 2H), 7.03- 7.00 (m, 2H), 6.85 (d, J = 
8.8 Hz, 2H), 6.65 (d, J = 7.9 Hz, 1H), 5.87 (d, J = 11.6 Hz, 1H), 5.82- 5.70 (m, 2H), 5.64 
(dd, J = 15.5, 7.6 Hz, 1H), 5.55- 5.49 (m, 1H), 5.27 (d, J = 17.2 Hz, 1H), 5.11 (d, J = 10.2 
Hz, 1H), 5.08 (s, 1H), 5.03 (s, 1H), 5.01 (d, J = 6.8 Hz, 1H), 4.95 (d, J = 6.7 Hz, 1H), 
4.86- 4.81 (m, 2H), 4.79 (d, J = 6.7 Hz, 1H), 4.76 (d, J = 11.7 Hz, 1H), 4.63 (d, J = 6.6 
Hz, 1H), 4.61 (d, J = 6.6 Hz, 1H), 4.51- 4.43 (m, 2H), 4.19 (t, J = 6.1 Hz, 1H), 4.10 (t, J = 
4.1 Hz, 1H), 3.94 (dd, J = 6.0, 4.2 Hz, 1H), 3.87 (ap. sept., J = 3.6 Hz, 1H), 3.85- 3.81 
(m, 1H), 3.79 (dd, J = 5.7, 2.6 Hz, 1H), 3.69 (dd, J = 4.7, 4.4 Hz, 1H), 3.54- 3.50 (m, 
1H), 3.52 (s, 3H), 3.42 (s, 3H), 3.31 (s, 3H), 2.58 (dd, J = 15.0, 4.6 Hz, 1H), 2.51 (dd, J = 
15.0, 7.0 Hz, 1H), 2.49- 2.45 (m, 1H), 2.43 (dd, J = 13.3, 4.5 Hz, 1H), 2.39- 2.34 (m, 
1H), 2.32 (dd, J = 13.5, 8.2 Hz, 1H), 2.25- 2.20 (m, 1H), 2.16- 2.10 (m, 1H), 2.08- 2.02 
(m, 1H), 1.99- 1.93 (m, 1H), 1.89- 1.80 (m, 2H), 1.78- 1.72 (m, 1H), 1.27 (d, J = 6.7 Hz, 
3H), 1.14 (d, J = 6.3 Hz, 3H), 1.08 (s, 9H), 1.05 (s, 18H), 1.01 (s, 9H), 1.00 (s, 9H), 0.28 
(s, 3H), 0.27 (s, 3H), 0.26 (s, 3H), 0.25 (s, 3H), 0.25 (s, 3H), 0.24 (s, 3H), 0.19 (s, 6H), 
0.14 (s, 3H), 0.11 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 174.2 (broad signal), 159.2, 149.0, 148.6, 141.3, 139.0, 
132.0, 131.8, 131.7, 131.1, 130.5, 129.9, 129.8, 129.3 (2 signals), 120.5, 117.2, 116.3, 
113.8, 111.2, 110.9, 93.6, 91.6, 84.4, 80.1, 78.0, 77.7, 75.5, 75.4, 73.8, 72.8, 69.5, 69.3, 
69.1, 68.5, 66.9, 55.9, 55.8, 55.2, 46.2, 43.8, 41.3, 41.1, 38.2, 34.0, 32.7, 30.6, 29.7, 28.5, 
26.1, 26.0, 25.8, 25.7, 18.4, 18.3, 18.0, 17.9 (2 signals), 17.7, 15.8, 13.3, -3.3, -3.8, -3.9, -
4.0, -4.1, -4.2, -4.5, -4.6, -4.9; 
 
IR(film) 3200 (broad), 2928.3 2855.8, 1711.8, 1612.3, 1515.4, 1463.5, 1251.6, 1097.8, 
1033.4, 836.5, 775.2 cm-1; 
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Exact Mass Calc. for C79H142O16Si5 [M + Na]+ : 1509.9036; found : 1509.8856 (ESI) 
 
Elaborate Z- Diene (3)  
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In a flame dried 5 mL flask were placed DMAP (24 mg, 0.198 mmol, 5 eq) and 1-methyl-
6-nitro-benzoic anhydride (34 mg, 0.099 mmol, 2.5 eq) under nitrogen. These were 
dissolved in 1 mL CH2Cl2. In a separate flask, elaborate seco acid 84 (59 mg, 0.040 
mmol, 1.0 eq) was dissolved in 5 mL CH2Cl2 and added at the rate of 0.5 mL/hr by 
syringe pump. The syringe and needle were washed with an additional 1 mL of CH2Cl2. 
The reaction was stirred an additional 8 hours after the addition was complete. The 
solvent was removed in vacuo and the residue was purified by flash chromatography 
(10% EtOAc/hex) to yield 59 mg of elaborate Z macrocycle (0.04 mmol,  quant) as a 
clear colourless oil. 
 
Rf = 0.50 (20% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = -25.2 (c 1.98, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.24 (d, J = 8.5 Hz, 2H), 6.89- 6.86 (m, 4H), 6.83 (d, J = 
7.9 Hz, 1H), 5.76 (d, J = 11.3 Hz, 1H), 5.71 (ddd, J = 17.9, 10.1, 7.9 Hz, 1H), 5.63- 5.57 
(m, 1H), 5.38- 5.28 (m, 2H), 5.23 (d, J = 17.0 Hz, 1H), 5.19 (d, J =10.3 Hz, 1H), 5.02 (s, 
1H), 5.00 (t, J = 7.7 Hz, 1H), 4.82- 4.79 (m, 3H), 4.66- 4.64 (m, 2H), 4.61 (d, J = 11.4 
Hz, 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.49 (d, J = 11.7 Hz, 1H), 4.44 (d, J = 11.4 Hz, 1H), 
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4.20- 4.17 (m, 2H), 4.16- 4.12 (m, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 3.87- 3.86 (m, 1H), 
3.81 (s, 3H), 3.73- 3.70 (m, 1H), 3.68 (ap. d, J = 8.4 Hz, 1H), 3.52- 3.48 (m, 1H), 3.43- 
3.41 (m, 1H), 3.17 (t, J = 4.8 Hz, 1H), 2.60 (dd, J =14.5, 8.3 Hz, 1H), 2.49 (dd, J = 14.6, 
3.2 Hz, 1H), 2.35 (dd, J = 13.6, 3.5 Hz, 1H), 2.31- 2.26 (m, 1H), 2.18 (dd, J = 12.9, 7.6 
Hz, 1H), 2.15- 2.11 (m, 1H), 2.10- 2.04 (m, 1H), 1.96- 1.90 (m, 1H), 1.83- 1.77 (m, 1H), 
1.77- 1.71 (m, 1H), 1.54- 1.49 (m, 1H), 1.48- 1.39 (m, 2H), 0.96 (d, J = 6.6 Hz, 3H), 0.90 
(s, 18H), 0.89 (s, 18H), 0.87 (d, J = 6.9 Hz, 3H), 0.84 (s, 9H), 0.11 (s, 3H), 0.11- 0.10 (m, 
12H), 0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.02 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 170.5, 159.1, 149.0, 148.6, 141.2, 139.0, 133.3, 132.0, 
130.9, 130.5, 129.9, 129.2, 126.7, 120.4, 117.1, 113.7, 111.2, 110.9, 93.4, 91.6, 84.8, 
80.2, 77.9, 75.9, 75.1, 75.1, 75.0, 72.8, 69.5, 69.1, 67.4, 66.9, 55.9, 55.7, 55.2, 46.0, 43.5, 
43.3, 40.8, 39.4, 32.2, 31.5, 31.0, 29.7, 28.6, 26.0 (3 signals), 25.9, 18.4, 18.0 (3 signals), 
13.8, 13.5, -3.4, -3.8, -3.9, -4.0 (2 signals), -4.1, -4.2, -4.5, -4.7, -4.8; 
 
IR(film) 2953.5, 2959.7, 1731.7, 1515.0, 1470.7, 1251.0, 1098.3, 1034.3, 836.4, 774.5 
cm-1; 
 
Exact Mass Calc. for C79H140O15Si5 [M + Na]+ : 1491.8930; found : 1491.8777 (ESI) 
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 Chapter 5 
Diels–Alder Studies: Iminium Synthesis and Activation1,2 
I. Efficent Preparation of Dienophiles 
According to the synthesis plan described in the end of chapter 3, spiro-prorocentrimine 1 
would arise from a late-stage Diels–Alder reaction of imine 2 and macrocyclic Z- diene 3 
followed by subsequent transformations (Figure 1). This chapter describes the synthesis 
of derivatives of 2 and studies of their use in Diels–Alder reactions. 
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Figure 5.1 Targeted disconnection of spiro-prorocentrimine. 
Initial efforts focused upon the feasibility of elaborating intermediate 4, prepared by Dr. 
Anna Chiu as I had inherited 5 g of this material. A sequence of reactions to prepare 2 
was run once on a trial scale  (Scheme 5.1).  
 
 
                                                
(1) Portions of the work discussed in this chapter were conducted in conjunction with Dr. Pascal 
Bindschadler and Dr David Marcoux. This is indicated in the appropriate sections. 
(2) Adapted in part with permission from Marcoux, D.; Bindschädler, P.; Speed, A. W. H.; Chiu, A.; Pero, 
J. E.; Borg, G. A.; Evans, D. A.; “Effect of Counterion Structure on Rates and Diastereoselectivities in α,β-
Unsaturated Iminium-Ion Diels–Alder reactions” Org Lett. 2011, 13, 3758- 3761. © 2011 by The American 
Chemical Society. 
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Scheme 5.1  
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Intermediate 4 could be elaborated to azide 5 in the four step sequence developed by Dr. 
Anna Chiu. Selective deprotection of the TBS protecting group at the C26’ alcohol was 
followed by oxidation to afford aldehyde 6. This could be exposed to 
methylidenetriphenylphosphorane to afford olefin 7, with concomitant and desired 
elimination of the benzyloxy at C37. Exposure to triphenylphosphine in benzene did result 
in Staudinger reduction and an aza-Wittig reaction, to afford what was tentatively 
assigned as desired fragment 2. Compound 2 proved to be unstable, surprisingly volatile, 
and possessed an appalling odour. I did not regard compound 2 as a viable synthon for 
several reasons. Preparation of 2 on a large scale was envisoned to be difficult, due to 
scalability issues I encountered with the transformation from 4 to 5.3 It was also feared 
that any epimerization that occurred on aldehyde 6 may not be detectable since the two 
stereocentres are quite far apart.4 As cyclic iminiums are postulated to be the centre of 
biological activity in these toxins, and as 2 is a Michael acceptor, I also wished to 
minimize handling of such a compound. 
 
                                                
(3) These transformations involve the selective reduction of an aldehyde at C36 in the presence of a ketone 
at C32, which I found did not scale well in my hands. 
(4) See section VI of this chapter for validation of this fear. 
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Since the target dienophile contained a benzyl group on the iminium, it was decided to 
investigate a new synthesis of the dienophile incorporating the benzyl group at an early 
stage, synthesizing a compound such as 8 bearing both a secondary amine and a ketone, 
and cyclizing the secondary aminine on the ketone of the enone to form benzyl iminium  
9 directly (equation 5.1). 
Me
O Me
8
NHBn
37
27
27' HX
- H2O Me
NBn Me
937
27
27' (5.1)
X
 
In order to test this principle rapidly, I synthesized a racemic model system.  Glutaric 
anhydride 10 was opened by benzylamine, and the resulting amide acid rac-11 was 
reduced to  amino alcohol rac-12 by the action of LiAlH4 (Scheme 5.2). The nitrogen 
could be selectively Boc protected to give rac-13.  
Scheme 5.2 
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CF3COO CF3COO
rac-16rac-17rac-18
a) BnNH2, CH2Cl2; b) LiAlH4, THF, 66 °C; c) Boc2O, CH3CN, 40 °C; d) SO3•py, i-Pr2NEt, DMSO, CH2Cl2; e) Me2NH2Cl,
CH2O(aq), 70 °C f) C14H29MgCl, THF, 0 °C; g) TFA, CH2Cl2; h) CDCl3, 4 days  
At this point, NMR analysis was complicated by the signifigant broadening and 
multiplying of signals in the spectra, which persisted in all compounds until the removal 
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of the Boc group. The alcohol was oxidized to aldehyde rac-14, and the exo methylene 
group was installed by a Mannich reaction to give enal rac-15.5 
Addition of a Grignard reagent in the 1,2 sense to the enal, followed by oxidation allowed 
the preparation of enone rac-16.6 Exposure of this compound to TFA, resulted in the 
removal of the Boc group, and the formation of ammonium salt rac-17. The cyclization 
of this compound to iminium rac-18 occurred spontaneously over several days in 
chloroform-d. Alternatively, the reaction could be accelerated by the addition of 
molecular sieves.  In working with a related series of compounds, Dr. David Marcoux 
developed the most efficient cyclization protocol, which involved adding a drop of TFA 
to a solution of the salt in chloroform, and refluxing until cyclization was complete 
(typically around 2 hours for the benzylamines). 
With this proof of principle in hand, we needed to develop a non-racemic synthesis, and 
use the actual side chain. This was carried out primarily by Dr. Pascal Bindschädler 
(Scheme 5.3) 
Scheme 5.3 
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(5) Ragoussis, V.; Giannikopoulos, A.; Skoka, E.; Grivas, P. J. Agric. Food. Chem. 2007, 55, 5050-5052. 
(6) This Grignard reagent was chosen to mitigate potential volatility of any intermediates. 
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The stereocentre at C34 was set by desymmetrization of glutaric anhydride 10 using an 
enzymatic method desymmetrization.7 The resulting acid ester 19 was obtained in 94% ee 
as determined by chromatography of the benzyl amide derivative on a Chriacel OD 
column. Benzyl amide 20 was formed by forming an acid chloride, and subsequent 
reaction with 2 equivalents of benzylamine. An initial attempt to reduce the amide ester 
resulted in the formation of achrial benzyl piperidine 21.8 Accordingly the ester was 
hydrolyzed using lithium hydroxide to form the amide acid 11. It should be noted that 
this step resulted in a signifigant degredation of the enantiomeric ratio of these 
compounds, which was undetected to by us at the time.9 Section IV of this chapter 
contains both the rationalization for and solution to this problem. Several important 
findings were made with this material despite the low enantiomeric ratio, so this is why 
these results are included. All steps up to the formation of the enal were conducted 
identically with the racemic series, ultimately yielding enal 15. Dr. Bindschadler prepared 
sidechain iodide 22 from (S)- Citronellol using a known procedure.10 We initially 
encountered difficulty with the lithium halogen exchange due to the propensity of this 
substrate to undergo a 5-exo trig cyclization, as also reported by Bailey.11  A solution to 
this problem was found by Dr. Bindschädler by running the reaction in small batches, 
which presumably allowed for a much more rapid dispersal of the heat generated in the 
lithium halogen exchange to the surrounding cryostat. Oxidation to 23 was followed by 
                                                
(7) Ito, H.; Inoue, T.; Iguchi, K. Org. Lett. 2008, 10, 3873-3876. 
(8) For an analogous transformation mediated by BH3•SMe2 see: Venuti, M. C.; Ort, O. Synthesis. 1988, 
985-988. 
(9) As described in section VI I estimate the e.r. of this material dropped to approximately 65:35. 
(10) Mori, K.; Masuda, S.; Suguro, T. Tetrahedron, 1981, 37, 1329-1340. The ee of the citronellol, 
obtained from Sigma Aldrich, was determined to be greater than 99% by comparison with racemic 
citronellol. Conditions were injection of 1 µl of a 10mg/mL ether solution of citronellol, with a 100: 1 split 
on a Beta Dex 225 column, 30 minutes at 90 °C, followed by a 4 °C/ minute ramp to 170 °C. I thank Ms. 
Naomi Rajapaksa for her assistance with this determination. The (S) configuration was confirmed by 
optical rotation measurements. 
(11) Bailey, W. F.; Khanolkar, A. D.; Gavaskar, K.; Ovaska, T. V.; Rossi, K.; Thiel, Y.; Wiberg, K. B. J. 
Am. Chem. Soc. 1991, 113, 5720-5727. 
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Boc removal and cyclization to iminium 24 occurred in a similar fashion to the racemic 
model system. It should be noted in retrospect that despite the fact that integrity of the 
stereocentre at C34 had been compromised, compounds 23  and 24  appeared homogenous 
by 1H and 13C NMR. This means the stereocentres were too distant to show the 
epimerization that will be explained in section VI. 
 
II.  Reevaluation of Mode of Activation of Dienophiles 
Dr. Pero had observed that some decomposition of the diene in the course of his 
experiments with methyl triflate (Chapter 3, Scheme 3.8). He blamed this decomposition 
on adventitious triflic acid.12 Since superstoichiometric TFA had been used in the 
iminium formation, it seemed prudent to develop a method of purifying the iminium of 
any unwanted Bronstead acids. The 3,5-BArF counterion was initially developed as a 
phase transfer reagent,13 before achieving its current prominence as a less coordinating 
counterion in organometallic chemistry and I knew from my preparation of some 
hydrogenation catalysts in chapter 4 that some 3,5-BArF metal salts could be purified by 
chromatography with dichloromethane. It was envisioned that iminium BArFates could 
be used to chromatographically separate the iminium ions from more polar bronstead 
acids, without using protic (and nucleophillic) eluants such as methanol in 
chromatography.14 Accordingly, iminium BArFate 25 was prepared from iminium 18 by 
counterion exchange with sodium BArFate 26 in ether, and purified by chromatography 
                                                
(12) Generation of triflic acids from metal triflates has frequently caused confusion in the studies of 
reactions mediated by metal triflates. The analogy may be extended to alkyl triflates.  See: Dang, T. T.; 
Boeck, F.; Hintermann, L. J. Org. Chem. 2011, 76, 9353-9361. The term Hidden BrØnsted Acid catalysis 
was used in this paper. 
(13) Nishida, H.; Takada, N.; Yoshimura, M.; Sonoda, T.; Kobayashi, H. Bull. Chem. Soc. Jpn. 1984, 57, 
2600- 2604. The preparation of the BArFate in the above paper may lead to explosion. For a safe 
preparation of sodium 3,5-BArFate, see: Yakelis, N. A.; Bergman, R. G. Organometallics, 2005, 24, 3579- 
3581. 
(14) This fear ultimately turned out to be unfounded, as the iminium ions are stable even as methanol 
solutions.  
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on silica gel using dichloromethane as eluent (Scheme 5.4). 19F NMR studies verified the 
absence of any residual TFA. This procedure was repeated with iminium 24 to afford 
BArfate 27. 
Scheme 5.4 
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With the model system in hand, I attempted some Diels–Alder studies using diene 28, 
available from the work of Dr. George Borg (Equation 5.2). I made the observation was 
that in the Diels–Alder reactions with 18 and 25, the iminium BARFates were consumed 
faster than the trifluoroacetate in reactions with otherwise similar concentrations of 
reagents. Product rac-28 was generated in a 7:1 dr with the endo isomer being dominant. 
It appeared that the reaction with BArF reached the halfway point in about a third of the 
time as the trifluoroacetate. No quantitative studies were performed, however this rate 
acceleration reinforced the value of using the BARFate as the counterion.   
OTBDPS
TMS
18 or 25
NBn
Me OTBDPS
C14H29
X
TMS
28
(5.2)
 
A more pressing observation in these reactions was that the benzyl group remained on the 
iminium in both the TFA and BArFate cases on adduct 28. I believed that this may have 
been a consequence of different steric demand between the model system and the real 
system. Accordingly, the actual Z Macrocyclic diene 3 was allowed to react with benzyl 
iminium 27. Because of the small quantity of macrocyclic diene 3 available at the time, a 
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concentration above 0.05 M could not be achieved, and the reaction had to be heated to 
60 °C for several days in chloroform-d. Regardless of this pitfall, some product 29 was 
isolated with very similar chemical shifts to those of Pero’s Diels–Alder adducts 
(Equation 3). It should be noted that since 27 was not diastereomerically pure, 29 was 
presumably not formed as a diastereomerically pure compound. This fact was not 
appreciated at the time, but will be elaborated on in section VI.15  
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At the time I believed the stereochemistry had the desired configuration at C33, but the 
results in Chapter 6, Section I suggest the configuration was as drawn, with the opposite 
configuration at C33. Regardless of stereochemical matters, it was clearly evident that the 
benzyl group was still present in these systems. It was speculated that the 
hexafluoroantimonate used by Dr. Pero had some special property in accelerating the 
solvolysis of the reaction. Another  iminium, 30a, had been prepared from 15 with a butyl 
side chain to simplify NMR interpretation. Hexafluoroantimonate 30b was prepared from 
counterion exchange with TFA salt 30a, exploiting the pKa difference between 
hydronium hexafluoroantimonate and TFA and driving the reaction to completion via 
azetropic reomoval of the TFA. The addition of methanol during the counterion exchange 
was necessary to dissolve the hexafluoroantimonic acid during the counterion exchange. 
This did not result in decomposition of the iminium, emphasizing its stability.  The 
                                                
(15) The results in section I of chapter 6 suggest that the undesired enantiomer of 27 may react faster with 
E-macrocyclic dienes, which are formed under the conditions noted. Consequently the stereocentre at C33 
may be flipped from what is shown. Insufficent material was prepared to allow full characterization. A full 
explaination and solution to this problem, which was not appreciated when this Diels–Alder reaction was 
first carried out is found in Chapter 6. 
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iminium hexafluoroantimonate could not be purified by chromatography using 
dichloromethane alone, however, chromatography with 10% methanol in 
dichloromethane worked well and no decomposition resulted. No macrocycle 3 was 
available at this point, so 30b was allowed to react with isoprene to afford 31.  
Compound 31 also retained the benzyl group, even after chromatography in the presence 
of methanol (Scheme 5.5). 
Scheme 5.5 
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 At this point, I felt I had overestimated the ease of solvolysis of the benzyl group from 
the iminium, since compounds 30 and 31 were both stable towards chromatography. I 
began to question if the benzyl group had actually been installed in the alkylation done by 
Dr. Pero. Inspection of Dr. Pero’s NMR data and mass spectral data for the alkylation of 
32 to form 33 indeed showed that only very small quantities of the benzyl iminium 33 
had been formed, and the dominant product was the protonated iminium 34 with 
hexafluoroantimonate as the counterion (Scheme 5.6).16 This result was surprising at first, 
as Dr. Borg had demonstrated even the more reactive E macrocyclic diene 35 did not 
react with a protonated iminium 36 that had TFA as the counterion.17 No cycloadduct 37 
was detected. A logical explaination was that the counterion effect was responsible for 
the reactions in the Pero examples, and that the enhanced electonegativity of alkylation 
was not in fact necessary for the Diels–Alder reaction to proceed. 
                                                
(16) Dr. Pero had attributed the base peak corresponding to the mass of 34 in his mass spectral data as 
indicating ease of solvolysis. A small peak corresponding to the mass of 33 was observed. Since Dr. Pero 
used crude material in the Diels–Alder reaction after the alkylation, the presence of the benzyl group was 
inferred by 1H NMR from peaks that actually arose from benzyl bromide and benzyl alcohol. I had the 
advantage of comparison with an authentic benzylated iminium. 
(17) Borg, G. PhD. Thesis., Harvard University, 2007. Page 70. Scheme 3.10. 
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Scheme 5.6 
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It is postulated that the conditions Pero used may form an insoluble silver/benzyl bromide 
complex, which is not a competent alkylating agent. Upon filtration of the reaction, 
adventitious water reacts with this complex, releasing hexafluoroantimonic acid which 
protonates the iminium.18  Dr. Pero’s observation of reaction with this iminium was not 
due to the presence of an electronegative group, but was because of the counterion effect, 
that had first inadvertently been recognized with the BArF salt.  As described in the next 
two sections, a rational synthesis of protonated iminium hexafluoroantimonates was 
developed, and they were found to be excellent dienophiles.  Later work by Dr. 
Marxcoux and Dr. Bindschädler resulted in a quantitative analysis of the counterion 
effects in protonated iminiums using a variety of counterions. Importantly it was 
demonstrated that hexafluoroantimonate was as effective as promoting the Diels- Alder 
reaction as BArFate. Triflate was similar in reactivity to these “ate” ions. Dr. Marcoux 
also conducted an important competition study, where he found that the alkylated 
iminiums actually react at a slower rate than the protonated iminiums. The results of 
                                                
(18) The mixture of silver hexafluoroantimonate and benzyl bromide in the presence of an imine results in 
the immediate formation of a thick precipitate. The intermedicy of tropylium salts may be possible. 
Tropylium salts are not soluble in non-polar organic solvents, but are also not known to react with water. It 
is not clear what effect an imine base would have. See: Garfunkel, E.; Reingold, D. J. Org. Chem. 1979, 44, 
3725-3725. 
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these studies have been published.2 It can therefore be reasoned that the methylated 
iminium triflate  also showed a rate acceleration relative to Borg’s examples because of 
this counterion effect and not because of the electronegativity of the methyl substituent. 
 
III. Further Exploration of the Counterion Effect 
With the reinterpretation of Pero’s results in hand, the preparation of the dienophile was 
altered to contain a more readily removable PMB group instead of the benzyl group with 
the aim of synthesizing protonated iminiums. I first carried out the synthesis of a racemic 
model to scope out the viability of the route, in complete analogy to scheme 5.2. Dr. 
Bindschädler prepared the chiral material with the elaborate side chain. Synthesis of the 
chiral compound is shown in Scheme 5.7.  
Scheme 5.7  
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Removal of the PMB with DDQ proved to be infeasible, presumably due to the electron 
withdrawing nature of the BOC group. Fortunately the stronger oxidant CAN was able to 
cleanly remove the PMB group. Cyclization occurred more rapidly than with the benzyl 
iminiums, and it should be noted cyclization occurred even in the course of the removal 
of the BOC group. PMB acid 38 had a degraded enantiomeric excess that was not known 
at the time, as with the prior benzylated species. Enal 40 could be elaborated to model 
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enone 41 and finally iminium 42, or elaborate enone 43 (which at the time we did not 
appreciate existed as a mixture of diastereomers) which was transformed to iminium 44. 
 
Both 42 and 44 were more polar than the corresponding N-benzyl iminiums, but could 
still be purified by flash chromatography on silica gel with 10% MeOH in CH2Cl2, with 
either trifluoroacetate or 3,5-BArF counterions. 
 
Unfortunately, reaction of BArF iminium 44 with Z macrocycle 3 resulted in 
decomposition of 3 (equation 5.4). Nothing attributable to desired adduct 45 could be 
isolated. It was decided to construct a simpler model macrocycle to attempt to 
deconvolute the Diels–Alder reaction on less precious material. 
O
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IV. Preparation of a Simplified Macrocyclic Diene Model 
A simpler model macrocycle 46 was available from the work of Borg, that had been 
employed by Pero in the course of his Diels–Alder studies. However this model bore an 
earlier and defunct protecting group strategy (with a benzyl group at the C15 alcohol), so 
it was decided to update the synthesis of the model to reflect the most current protecting 
group strategy. Macrocycle 47 was targeted and its synthesis is described in Scheme 5.8. 
Alcohol 48 was protected with a TBDPS group, and the olefin in compound 49 was 
transformed to to β-keto phosphonate 50 in a three step sequence. HWE reaction with 
aldehyde 51 was uneventful, and Luche reduction of 52 produced compound 53. In this 
case, 52 and 53 could be resolved by TLC, simplifying analysis of the the reaction. Imide 
cleavage gave seco acid 54 and Shiina macrolactonization gave model macrocycle  47. 
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V. Optimization of the Dienophile Activation  
Reaction of this model macrocycle with proton iminium BArFate 42b also resulted in 
decomposition (Equation 5.5).  Produt 55a was not apparent.  
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Since similar conditions to Pero were being used, and a clean reaction was not obtained, I 
made a final attempt to switch the counterion back to hexafluoroantimonate, which was 
used in Dr. Pero’s system.19 Gratifyingly cycloadduct 55b was obtained in modest yield 
after chromatography (Scheme 5.9). As before, it should be noted that at the time I 
                                                
(19) Again, since 42 was employed as a scalemic mixture, 55 may have been obtained as a diastereomeric 
mixture that was not readily apparent by 1H NMR. See footnote 17. 
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conducted the reaction, I believed I had accessed the desired stereochemistry at C33. The 
product is shown with what is currently believed to be the obtained stereochemistry at 
C33. Chapter 6 will contain further details on the stereochemistry of the Diels–Alder 
adducts. There are a several possible rationales for the divergent outcome between 
hexafluoroantimonate 42c and BArFate 42b. One possibility is that the 3,5- BArFate is 
more dissociated from the iminium, and the proton is more free to be transferred to diene 
47, ultimately resulting in destructive reactions. It should be noted that 42c and 42b have 
similar NMR spectra, but it is unclear to what extent counterion association would peturb 
NMR spectra. Another possibility is that the BArFate engages in some sort of π stacking 
interaction with 47, changing the electronic environment around the diene and opening a 
possibility for a distructive interaction. The third possibility is that 43b contains some 
sort of impurity that was not detected, that catalyzes the decomposition of 47. This line of 
thought will be revisited in Chapter 6. 
Scheme 5.9  
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Concurrently to the efforts described above, Dr. Bidschädler and I had investigated the 
fesability of actually conducting the Diels–Alder reaction with a benzyl group or 
derivative in place, and subsequently removing it. We were ultimately unsuccessful at 
this, and it appeared that the reactivity problem was solved with the use of 
hexafluoroantimonate counterions. However, in  chapter 6 it is disclosed that the proton 
on the iminium  may be detrimental to the stereochemical course of the reaction. Had a 
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method of removing a substituent on the nitrogen been feasible, it would have been 
valuable.  The attempted N-dealkylations were mainly conducted by Dr. Bindschädler. 
Attacks by nucleophiles on adducts such as 31 to effect an SN2 reaction at the benzyl 
group were mainly thwarted by deprotonation at C31 to form an enamine. Attempts to 
oxidatively remove a PMB group from the nitrogen at the iminium stage did not proceed, 
presumably due to the difficulty of oxidizing an aryl group with a neighbouring iminium 
cation attached. Oxidative removal of the PMB from the deprotonated enamine tautomer 
resulted in destruction of the enamine. The only partially successful debenzylation 
conditions involved hydrogenolysis of the benzyl group, but it was judged that such 
conditions would not be compatible with the disubstituted olefin at C12-C13 in spiro-
prorocentrimine. 
 
VI. Revision of the Dienophile Synthesis 
The dienophiles prepared by Dr. Bindschädler’s route from compound 19  had provided 
very useful in the course of experiments to determine the mode of activation of the Diels–
Alder reaction as described above. However, in later stages of the work on this project, a 
problem with the preparation of the dienophile was detected in a scale-up campaign. 
Notably, during the hydrolysis of the ester in compound 38, signifigant quantites of very 
non polar intermediates were detected by TLC. The resultant products did not contain any 
of these impurities, and were very clean by 1H NMR analysis. It was hypothesized that 
during the hydrolysis, some achiral imide 56 was being formed, which could be 
anticipated to be much less polar than both the starting material and desired product 
(Equation 5.6). Since the intermediates prepared by Dr. Bindschädler were non-racemic 
(as evidenced by their optical rotation), intermediacy of the imide is not thought to be the 
sole pathway to produce the acid amide 57.  
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It was decided to investigate a new route for scale up that precluded the possibility of the 
formation of achiral intermediates, and subsequent racemization. It was also decided to 
attempt to intercept the intermediates on the route to the dienophile that Dr. Bindschädler 
used, to minimize the amount of peturbation in the synthesis. 
In Dr. Chiu’s route, product 58 of a Sakurai addition to an oxazolidinone bearing a 
crotonate was used to set the initial stereocentre.20 Rather than following her route, which 
necessitated the use of stoichiometric amounts of BOM chloride, and a sensitive 
reduction of an aldehyde in the presence of the ketone, a reversal of the ends in a 
diastereomeric conjugation allylation product was envisioned. In this case, the imide in 
compound 59 would be elaborated to a protected amine at C36, while the allyl group 
would serve as an aldehyde surrogate at C32 (Scheme 5.10). This also had the advantage 
that the use of the natural series of the oxazolidinone could be maintained by switching 
the Sakurai method of allylation to a conjugate addition of allylcopper as reported by 
Williams, which is documented to have the opposite stereochemical outcome.21  
Compound 59 is available in greater than 40: 1 dr, which is important since the 
diastereomers are not readily separated, and this ratio becomes the enantiomer ratio in the 
next step. PMB amide 60 was prepared by an AlMe3 mediated transamidation of 59 with 
PMBNH2. This amide could be cleanly reduced to amine 61 by the action of LiAlH4 in 
THF. The amine is then protected to give Boc amide 62, and ozonolysis reveals aldehyde 
                                                
(20) Wu, M.-J.; Wu, C.-C.; Lee, P..-C. Tetrahderon Lett. 1992, 33, 2547-2548. Note that the 
stereochemistry of the Sakurai conjugate addition product in the above reference is misassigned. For the 
correct stereochemistry see: Williams, D. R.; Mullins, R. J.; Miller, N. A. Chem. Commun. 2003, 2220-
2221.  
(21) Williams, D. R.; Kissel, W. S.; Li, J. J. Tetrahedron Lett. 1998, 39, 8593- 8596. 
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62. A Mannich reaction,22 using modified conditions and aminobenzoic acid 64 provided 
enal 40, which was identical to that prepared earlier in all respects except optical rotation. 
Scheme 5.10 
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CH2Cl2 , -78 °C, then PPh3; e) 64, C4H8NH, CH2Cl2, 63, CH2O(aq).  
This 5 step sequence intercepted enal 40 on the prior route, and favourably compares in 
step count. Comparison of optical rotations of the enal 40 prepared in both the current 
and previous route showed that the use of this sequence was justified, as the optical 
rotation measured for enal 40 was of the same sign, but over four times as much as that 
prepared from the enzymatic desymmetrization. Compound 40 was elaborated to both 
butyl containing model system 42c and side chain containing iminium 44c (Scheme 
5.11). The hexafluorophosphates have very similar reactivity, properties and spectra to 
the hexafluoroantimonates, with the exception that the counterions can be observed by 
19F NMR. As explained in the next chapter, it became important to quantify the extent of 
counterion exchange, and antimony containing counterions do not have well behaved 19F 
spectra. A more efficient method than alkyllithium addition was also employed to 
introduce the methyl-hexenyl side chain. Alcohol 65 was converted to bromide 66. 
Examination of the literature showed that Mulzer had prepared a Grignard reagent of the 
corresponding bromide without observation of cyclization.23 
 
                                                
(22) Erkkilä, A.; Pihko, P. M. J. Org. Chem. 2006, 71, 2538-2541. 
(23) Martin, H. J.; Pojarliev, P.; Kählig, H.; Mulzer, J. Chem. Eur. J. 2001, 7, 2261- 2271. 
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Scheme 5.11  
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The desired Grignard reagent was prepared with a large excess of magnesium turnings 
entrained with 1 eq of magnesium bromide in THF. The addition of this side chain to the 
enal could be conducted on gram scale, at room temperature with only minor amounts of 
side products. The main side product that corresponded to a 1,2 reduction of the Enal (a 
common side reaction of Grignard additions to compounds that are able to form 
stabilized radicals). The new dienophile, of cetain stereochemical integrity was employed 
in the reactions described in the next chapter. Dienophile 67 could also be prepared from 
enone 41. 
VII. Conclusion 
An efficient synthesis of several chiral iminium dienophiles allowing a higher material 
throughput than previous routes was developed in conjunction with Dr. Pascal 
Bindschadler. An even more efficient route was later developed which absolutely 
precluded stereochemical scrambling by removing the mechanistic possibility of forming 
meso intermediates. During the course of Diels–Alder reactions involving these iminium 
dienophiles it was observed that non-coordinating counterions resulted in faster Diels- 
Alder reactions than coordinating counterions. The success of the reactions of iminium 
dienophiles on macrocyclic dienes conducted by Dr. Joseph Pero is now attributed to this 
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counterion effect rather than a rate acceleration provided by the more electronegative 
alkylation of the iminiums. Alkylated iminiums were shown to not be viable candidates 
for the construction of spiro-prorocentrimine as no reliable method could be found to 
effect dealkylation. A model system was synthesized to study the Diels–Alder reactions 
on Z-dienes without consuming expensive 3. 
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VIII. Graphical Summary 
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IX. Experimental Section 
 (5R,6R)-2,2,3,3,6,10,10-heptamethyl-9,9-diphenyl-5-vinyl-4,8-dioxa-3,9-
disilaundecane (49)  
OH
Me
TBSO
48 49
OTBDPS
Me
TBSO
 
Alcohol 48 (910 mg, 3.94 mmol, 1 eq) was dissolved in 5 mL CH2Cl2 and imidazole (402 
mg, 5.91 mmol, 1.5 eq) was added. The reaction was cooled to 0 °C and TBDPSCl (1.44 
mL, 5.53 mmol, 1.4 eq) was added dropwise by syringe. A thick white precipitate 
immediately formed. TLC after 2 hours (5% EtOAc/hex, 48 is baseline and stains faint 
grey in CAM) showed complete consumption of 48. The reaction was quenched by the 
addition of 1 mL of saturated NH4Cl(aq) and diluted with 20 mL 90% hexanes/ EtOAc. 
This was washed with 5 mL of brine, then dried over Na2SO4, and concentrated in vacuo. 
. Purification by flash chromatography over silica gel (0.5% Et2O/ Hexanes) afforded 1.8 
g (3.86 mmol, 98%) of TBDPS ether 49 as a clear colourless oil.  
 
Rf = 0.80 (5% EtOAc/hexanes, UV active, stains blue CAM) 
 
[α]20D = +1.8 (c 1.80, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.74- 7.71 (m, 4H), 7.49- 7.45 (m, 2H), 7.45- 7.41 (m, 
4H), 5.85 (ddd, J = 16.9, 10.4, 6.1 Hz, 1H), 5.18 (dt, J = 16.9, 1.5 Hz, 1H), 5.09 (dt, J = 
10.4, 1.1 Hz, 1H), 4.36 (ap. t, J = 5.1 Hz, 1H), 3.72 (AB dd, J = 10.0, 6.6 Hz, 1H), 3.54 
(AB dd, J = 10.0, 6.2 Hz, 1H), 1.80- 1.73 (m, 1H), 1.11 (s, 9H), 0.93 (s, 9H), 0.92 (d, J = 
6.9 Hz, 3H), 0.08 (s, 3H), 0.06 (s, 3H); 
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13C NMR (125 MHz, CDCl3) δ 140.7, 135.6 (broad signal), 134.0, 129.5, 127.6 (broad 
signal), 114.2, 73.6, 65.8, 42.4, 26.9, 25.9, 19.3, 18.2, 11.1, -4.2, -5.0 
 
IR(film)  2957.3, 2857.5, 1472.0, 1427.8, 1251.6, 1112.2, 1074.8, 1027.9, 835.6 cm-1; 
 
Exact Mass Calc. for C28H44O2Si2 [M + Na]+ : 491.27720  ; found : 491.27632 (ESI) 
 
 
dimethyl ((3S,4R)-3-((tert-butyldimethylsilyl)oxy)-5-((tert-butyldiphenylsilyl)oxy)-4-
methyl-2-oxopentyl)phosphonate (50)  
49
OTBDPS
Me
TBSO OTBDPS
Me
TBSO
O
P
O
MeO
MeO
50  
Alkene 49 (680 mg, 1.45 mmol, 1 eq) was dissolved in 10 mL CH2Cl2 and cooled to -78 
°C. Ozone was bubbled through the reaction until a blue colour persisted. The reaction 
was then sparged with nitrogen until the blue colour was discharged. Triphenylphosphine 
(380 mg, 1.45 mmol, 1 eq) was added and the cooling bath was removed. After 45 
minutes, the volatiles were removed in vacuo, the residue was azeotroped with 2x 10 mL 
of benzene and the material was carried on crude to the next reaction. 
 
TLC analysis of intermediate aldehyde: 
Rf = 0.75 (5 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
Dimethyl methyl phosphonate (0.775 mL, 7.25 mmol, 5.0 theory eq) was dissolved in 8 
mL THF and cooled to -78 C. Freshly titrated nBuLi (3.16M in hexanes, 1.15 mL, 3.62 
mmol, 2.5 eq) was added dropwise and the resulting clear colourless solution was stirred 
for 1 hour. After 1 hour, a solution of crude aldehyde in 5 mL THF was added dropwise 
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and the transfer was quantitated with an additional 2 mL THF. The reaction turned 
slightly tan in colour. After 15 minutes, TLC (20 % EtOAc/hexanes) showed complete 
consumption of the aldehyde, so the reaction was quenched with addition of 3 mL of 
saturated NH4Cl(aq) and diluted with 20 mL 90% EtOAc/hexanes and 5 ml of water. The 
layers were separated and the aqueous layer was washed with 2 x 20 mL 90% 
EtOAc/hexanes. The combined organic extracts were washed with 5 mL of brine, then 
dried over Na2SO4, and concentrated in vacuo. Purification by flash chromatography over 
silica gel (75 % EtOAc/ Hexanes) afforded 600 mg ( 1.01 mmol, 69%) of  an alcohol as a 
clear colourless oil and inconsequential mixture of diastereomers that was used 
immediately in the next step. 
 
TLC analysis of intemediate alcohols: 
Rf = 0.15 (75% EtOAc/hexanes, UV active, stains purple in CAM) 
 
The mixture of alcohols (600 mg, 1.01 mmol, 1 eq) was dissolved in 10 mL of CH2Cl2 
that had been shaken with water in a separatory funnel. The solution was cooled to 0 °C 
and Dess–Martin periodinane (556 mg, 1.3 mmol, 1.3 eq) was added. The reaction 
immediately became turbid. After 1 hour, TLC showed complete consumption of starting 
material (50 % EtOAc/hex, product and SM visualize purple by CAM). To quench the 
reaction, 5 mL hexanes, 10 mL CH2Cl2, 10 mL saturated NaHCO3(aq) and 10 mL 
saturated Na2S2O3(aq) were added. The reaction was stirred until the biphasic layers were 
clear. The layers were separated and the aqueous layer was washed with 2 x 20 mL 90% 
EtOAc/hexanes. The combined organic extracts were washed with 10 mL of saturated 
NaHCO3(aq), then with  5 mL of brine, then dried over Na2SO4, and concentrated in 
vacuo. Purification by flash chromatography over silica gel (50 % EtOAc/ Hexanes) 
afforded 530 mg ( 0.892 mmol, 55% over 3 steps) of  beta ketophosphonate 50 as a clear 
colourless oil. 
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Rf = 0.50 (75% EtOAc/hexanes, UV active, stains blue-purple in CAM) 
 
[α]20D = +16.7 (c 2.03, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.66 (ap. d, J = 7.0 Hz, 4H), 7.45- 7.41 (m, 2H), 7.39 (ap. 
t, J = 7.9 Hz, 4H), 3.78 (d, J = 5.2 Hz, 3H), 3.76 (d, J = 5.0 Hz, 3H), 3.59 (dd, J = 10.1, 
8.5 Hz, 1H), 3.48 (dd, J = 10.1, 5.5 Hz, 1H), 3.20 (dd, J = 21.8, 15.4 Hz, 1H), 3.01 (dd, J 
= 21.8, 15.4 Hz), 2.07- 2.00 (m, 1H), 1.07 (s, 9H), 0.90 (s, 9H), 0.72 (d, J = 6.9 Hz, 3H), 
0.07 (s, 3H), 0.03 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 203.8 (d, 2JPC= 7.25 Hz), 135.5 (broad signal), 133.5, 
129.7 (2 signals), 127.7 (broad signal), 77.9 (d, 3JPC= 4.5 Hz), 65.1, 52.8 (broad signal), 
39.2, 36.2 (d, 1JPC= 134 Hz), 26.9, 25.8, 19.2, 18.2, 10.1, -4.7, -5.3; 
 
IR(film) 2930.4, 2856.8, 1726.1, 1472.0, 1258.1, 1111.9, 1035.2 cm-1; 
 
Exact Mass Calc. for C30H49O6PSi2 [M + Na]+ : 615.26975 ; found : 615.27141 (ESI) 
 
tert-butyl phenyl((3S,5S,8Z,12E,15S,16R)-3,5,15-tris((tert-butyldimethylsilyl)oxy)-17-
((tert-butyldiphenylsilyl)oxy)-16-methyl-7-methylene-14-oxoheptadeca-8,12-
dienoyl)carbamate  
OTBDPS
Me
TBSO
O
P
O
MeO
MeO
50
PhBocN
O OTBSOTBS
51
12
1
H
O
PhBocN
O OTBSOTBS
O
TBSO
Me
OTBDPS
52
 
Phosphonate 50 (640 mg, 0.969 mmol, 1.24 eq) was dissolved in 4 mL THF and cooled 
to 0 °C. To the reaction was added dropwise 3.16 M nBuLi in hexanes (0.284 mL, 0.897 
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mmol, 1.15 eq). The resulting mixture was stirred for 10 minutes, then aldehyde 51 (515 
mg, 0.780 mmol, 1.0 eq)  as a solution in 2 mL THF was added dropwise. The transfer 
was quantitated with a further 1 + 1 mL THF. The reaction was stirred for 15 hours, over 
which time it became turbid. TLC showed the reaction was not complete or progressing. 
The reaction was quenched with NH4Cl(aq) and the aqueous layer was washed with 2 x 50 
mL 90% EtOAc/hexanes. The combined organic layers were washed with brine, and 
dried over Na2SO4. Purification by flash chromatography (5% to 15% to 50% 
EtOAc/hexanes) allowed the recovery of 600 mg desired product 52 (0.533 mmol, 68%), 
164 mg of recovered aldehyde 51 (0.248 mmol, 32%) and 260 mg of recovered 
phosphonate 50 (0.438 mmol, 45%). The recovered aldehyde and phosphonate were 
recycled under the same reaction conditions, and the desired project was combined with 
that from the prior reaction to yield a total of 790 mg (0.702 mmol, 90%) of enone 52 as 
a very viscous colourless oil. 
 
Rf = 0.55 (10% EtOAc/hexanes, strongly UV active, stains blue in CAM) 
 
[α]20D = -5.10 (c 2.05, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.73 (d, J = 7.9 Hz, 4H), 7.50- 7.42 (m, 8H), 7.39- 7.34 
(m, 1H), 7.12 (ap. d, J = 7.3 Hz, 2H), 7.01 (dt, J = 15.7, 6.7, 1H), 6.53 (dd, J = 15.7, 1.3 
Hz, 1H), 5.88 (d, J = 11.7 Hz, 1H), 5.54- 4.49 (m, 1H), 5.10 (s, 1H), 4.95 (s, 1H), 4.52 
(ap. d, J = 3.2 Hz, 1H), 4.46 (ap. pentet, J = 4.8 Hz, 1H), 3.88 (ap. pentet, J = 6.0 Hz, 
1H), 3.68 (t, J = 8.3, 1H), 3.51 (dd, J = 10.2, 6.0 Hz, 1H), 3.16 (AB dd, J = 16.7, 7.3 Hz, 
1H), 3.07 (AB dd, J = 16.7, 4.5 Hz, 1H), 2.45 (ap. q, J = 6.7, 2H), 2.38- 2.30 (m, 4H), 
2.14- 2.06 (m, 1H), 1.75 (ap. t, J = 6.0 Hz, 2H), 1.42 (s, 9H), 1.13 (s, 9H), 0.97 (s, 9H), 
0.94 (s, 9H), 0.94 (s, 9H), 0.82 (d, J = 6.9 Hz, 3H), 0.14 (s, 3H), 0.11 (s, 3H), 0.11 (s, 
3H), 0.09 (s, 3H), 0.08 (s, 6H); 
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13C NMR (125 MHz, CDCl3) δ 201.7, 173.5, 152.6, 146.7, 141.6, 139.0, 135.6 (broad 
signal), 133.7 (2 signals), 131.1, 130.4, 129.6 (2 signals), 128.9, 128.3, 127.7, 127.6 
(broad signal), 125.9, 116.2, 82.9, 76.7, 68.6, 66.7, 65.5, 45.8, 45.6, 45.1, 40.4, 33.0, 
27.8, 27.3, 26.9, 26.0, 25.9, 25.8, 19.2, 18.2, 18.0 (2 signals), 10.4, -4.3, -4.4 (2 signals), -
4.5, -4.6, -5.2; 
 
IR(film) 2955.5, 2857.2, 1737.7, 1709.7, 1472.1, 1254.8, 1154.2, 1090.8, 836.8 cm-1; 
 
Exact Mass Calc. for C64H104NO8Si4 [M + H]+ : 1126.6833  ; found : 1126.6472 (ESI) 
 
tert-butyl phenyl((3S,5S,8Z,12E,14S,15S,16R)-3,5,15-tris((tert-
butyldimethylsilyl)oxy)-17-((tert-butyldiphenylsilyl)oxy)-14-hydroxy-16-methyl-7-
methyleneheptadeca-8,12-dienoyl)carbamate (53)   
PhBocN
O OTBSOTBS
O
TBSO
Me
OTBDPS
PhBocN
O OTBSOTBS
OH
TBSO
Me
OTBDPS
52 53  
Enone 52 (570 mg, 0.506 mmol) was dissolved in 12 mL THF and 6 mL MeOH in a 
round bottom flask equipped with an internal thermocouple. To this mixture was added 
cerium trichloride heptahydrate (302 mg, 0.810 mmol, 1.6 eq) and the reaction was 
stirred until this dissolved. The reaction was cooled to an internal temperature of -60 °C 
and NaBH4 was added as a solid. After 30 minutes TLC (10% EtOAc/Hexanes, Cam 
visualization) showed complete consumption of the starting material. The mixture was 
cooled to -78 °C and 0.2 mL of acetone was added dropwise. Saturated NH4Cl(aq) was 
added and the reaction was rapidly diluted with 35 mL of a 85% EtOAc/Hexanes 
mixture. The bubbling mixture was shaken and washed with 10 mL saturated NH4Cl(aq) 
and brine. This was dried over Na2SO4 and concentrated in vacuo. The residue was taken 
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up in CH2Cl2, filtered through Celite® to remove any residual cerium salts and 
reconcentrated. The allylic alcohol 53 (570 mg, 0.506 mmol, quant.) was of sufficient 
purity to be used directly in the next step. 
 
Rf = 0.50 (10% EtOAc/hexanes, faintly UV active, stains blue in CAM) 
 
[α]20D = +1.6 (c 1.83, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.65 (ap. t, J = 7.9, 1.1 Hz, 4H), 7.44-7.39 (m, 2H), 7.39- 
7.34 (m, 6H), 7.31 (ap. t, J = 7.4 Hz, 1H), 7.06 (d, J = 7.7 Hz, 2H), 5.78 (d, J =11.5 Hz, 
1H), 5.71 (dt, J = 15.2, 6.6 Hz, 1H), 5.52- 5.44 (m, 2H), 5.02 (s, 1H), 4.92 (s, 1H), 4.43- 
4.39 (m, 1H), 4.00 (t, J = 6.1 Hz, 1H), 3.82 (sextet, J = 6.1 Hz, 1H), 3.77 (dd, J = 5.4, 3.2 
Hz, 1H), 3.59 (AB dd, J = 10.1, 7.3 Hz, 1H), 3.53 (AB dd, J = 10.1, 6.1 Hz, 1H), 3.09 
(AB dd, J = 16.7, 7.3 Hz, 1H), 2.89 (AB dd, J =16.7, 4.5 Hz, 1H), 2.52 (br. s, 1H), 2.38- 
2.27 (m, 2H), 2.25 (ap. t, J = 5.5 Hz, 2H), 2.14 (ap. q, J = 7.2 Hz, 2H), 1.86 (qd, J = 6.7, 
3.1 Hz, 1H), 1.68 (t, J = 6.1 Hz, 2H), 1.36 (s, 9H), 1.05 (s, 9H), 0.88 (s, 18H), 0.87 (s, 
9H), 0.83 (d, J = 6.8 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.05 (s, 3H), 0.04 (s, 6H), 0.03 
(s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 173.5, 152.6, 141.7, 139.1, 135.6 (broad signal), 133.7, 
133.6, 132.4, 131.5, 130.9, 130.4, 129.6, 128.9, 128.3, 127.7, 127.6 (broad signal), 116.1, 
75.7, 73.7, 68.6, 66.8, 65.9, 46.0, 45.6, 45.0, 39.0, 32.8, 29.7, 28.4, 27.8, 26.9, 26.0 (2 
signals), 25.9, 19.2, 18.3, 18.0, 11.4, -4.0, -4.4 (2 signals), -4.5; 
 
IR(film)  3546.6, 2929.1, 2856.4, 1736.6, 1254.4, 1154.1, 1090.2, 835.8 cm-1; 
 
Exact Mass Calc. for C64H105NO8Si4 [M + Na]+ : 1150.6810 ; found : 1150.6439 (ESI) 
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 (3S,5S,8Z,12E,14S,15S,16R)-3,5,15-tris((tert-butyldimethylsilyl)oxy)-17-((tert-
butyldiphenylsilyl)oxy)-14-hydroxy-16-methyl-7-methyleneheptadeca-8,12-dienoic 
acid (54)  
PhBocN
O OTBSOTBS
OH
TBSO
Me
OTBDPS
53 HO
O OTBSOTBS
OH
TBSO
Me
OTBDPS
54  
Allylic alcohol 53 (560 mg, 0.496 mmol, 1 eq) was dissolved in 10 mL THF and cooled 
to -20 °C. To this solution was added 0.5 mL of 30 % aqueous hydrogen peroxide. To the 
homogenous solution was added 1 mL of 1 M LiOH(aq) (1 mmol, 2 eq) and 1 mL of 
deionized water. Crystals were observed to form which redissolved upon warming the 
reaction to 0 °C. The reaction was held at 0 °C for 18 hours at which time TLC showed 
complete consumption of starting material. The TLC analysis indicated the presence of 
both seco acid 54 and peracid (10% EtOAc/hexanes, CAM stain, Rf sm=0.50, stains blue; 
Rf BocAniline=0.47, stains yellow; Rf Peracid = 0.45, stains blue; Rf seco acid= 0.05, 
stains black ). To the solution at 0 °C are added 3 mL of saturated Na2SO3(aq). After 5 
minutes a KI/KIO3/Starch peroxide test strip shows the absence of peroxides and TLC 
shows convergence of the peracid to the seco acid. The reaction was made acidic to pH 
paper by the addition of 1 M NaHSO4. The reaction was diluted with 50 mL 95% 
EtOAc/hexanes and the aqueous layer was extracted with a further 50 mL of 95% 
EtOAc/hexanes. The combined organic layers were washed with brine, dried over 
Na2SO4 and concentrated in vacuo. Purification of the residue by flash chromatography 
on silica (10% to 50% EtOAc/hexanes) yielded 430 mg of seco acid 54 (0.451 mmol, 
91% over 2 steps) as a clear colourless very viscous oil. 
 
Rf = 0.3 (30% EtOAc/hexanes, UV active, stains black in CAM) 
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[α]20D = -9.6 (c 1.01, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.65 (ap. t, J = 6.6 Hz, 4H), 7.44- 7.39 (m, 2H), 7.39- 7.35 
(m, 4H), 5.74 (d, J = 10.2 Hz, 1H), 5.73- 5.69 (m, 1H), 5.54- 5.44 (m, 2H), 5.02 (s, 1H), 
4.93 (s, 1H), 4.32- 4.26 (m, 1H), 4.01 (t, J = 6.9 Hz, 1H), 3.80- 3.72 (m, 2H), 3.58 (AB 
dd, 10.3, 7.5 Hz, 1H), 3.53 (AB dd, 10.3, 6.2 Hz, 1H), 2.58 (AB dd, 15.2, 4.5 Hz, 1H), 
2.42 (AB dd, 15.2, 6.0 Hz, 1H), 2.38 – 2.27 (m, 3H), 2.22- 2.12 (m, 3H), 1.89- 1.83 (m, 
1H), 1.75- 1.68 (m, 1H), 1.68- 1.61 (m, 1H), 1.05 (s, 9H), 0.88 (s, 18H), 0.88 (s, 9H), 
0.83 (d, J = 7.0 Hz, 3H), 0.11 (s, 3H), 0.09 (s, 6H), 0.06 (s, 3H), 0.06 (s, 3H), 0.04 (s, 
3H); 
 
13C NMR (125 MHz, CDCl3) δ 176.1, 141.1, 135.6 (broad signal), 133.7, 132.4, 131.9, 
130.8, 130.0, 129.6 (2 signals), 127.6 (broad signal), 116.3, 75.6, 73.7, 68.5, 66.8, 65.9, 
46.2, 44.1, 41.8, 40.0, 39.0, 32.8, 28.4, 26.9, 26.0, 25.9, 25.8, 19.2, 18.3, 17.9 (2 signals), 
11.4, -4.1 (2 signals), -4.3, -4.4, -4.6, -4.9; 
 
IR(film) 2955.0, 2856.9, 1713.0, 1471.8, 1254.5, 1106.5, 835.7 cm-1; 
 
Exact Mass Calc. for C53H92O7Si4 [M - H]- : 951.58473  ; found : 951.57660 (ESI) 
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(Z) – TBDPS Truncated Model Macrocycle (47)  
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DMAP (269 mg, 2.20 mmol, 5.0 eq) and 2-methyl-6-nitro-benzoic anhydride (378 mg, 
1.10 mmol, 2.5 eq) were dissolved in 5 mL CH2Cl2 in a 100 mL round bottom flask under 
nitrogen. Separately seco acid 54 (420 mg, 0.440 mmol, 1 eq) was dissolved in 39 mL 
CH2Cl2 and added to the DMAP/ MNBA mixture by syringe pump at the rate of 3 mL/ 
hour. When the addition was complete, the reaction was stirred for a further 6 hours. The 
solvent was removed and the residue was purified by flash chromatography on silica 
(10% EtOAc/hexanes) to yield 405 mg of macrocycle 47 (0.433 mmol, 98%) as a very 
viscous clear colourless oil. 
 
Rf = 0.85 (10 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -0.7 (c 1.13, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.67- 7.61 (m, 4H), 7.44- 7.40 (m, 2H), 7.40- 7.34 (m, 
4H), 5.79 (d, J = 11.5 Hz, 1H), 5.56 (ap. pentet, J = 7.3 Hz, 1H), 5.39 (dd, J = 11.5, 6.1 
Hz, 1H), 5.36- 5.31 (m, 1H), 5.03 (d, J = 2.0 Hz, 1H), 5.00 (dd, J= 8.4, 6.6 Hz, 1H), 4.84 
(d, J = 1.8 Hz, 1H), 4.23- 4.14 (m, 2H), 4.03 (dd, J  = 8.5, 1.3 Hz, 1H), 3.57 (t, J = 10.0 
Hz, 1H), 3.36 (dd, J = 10.2, 6.1 Hz, 1H), 2.65 (AB dd, J = 14.2, 8.5, 1H), 2.47 (AB dd, J 
= 14.2, 3.3 Hz, 1H), 2.48- 2.43 (m, 1H), 2.35 (dd, J = 13.3, 3.6 Hz, 2H), 2.24- 2.14 (m, 
3H), 1.75 (sextet, J = 7.3 Hz, 1H), 1.58- 1.51 (m, 2H), 1.47- 1.41 (m, 1H), 1.05 (s, 9H), 
0.92 (s, 9H), 0.92 (s, 9H), 0.82 (s, 9H), 0.69 (d, J = 6.8 Hz, 3H), 0.11 (s, 6H), 0.08 (s, 
3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H); 
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13C NMR (125 MHz, CDCl3) δ 170.6, 141.3, 135.6 (broad signal), 133.9, 133.8, 133.1, 
131.9, 131.1, 129.6, 129.5, 127.6 (broad signal), 127.0, 117.3, 77.1, 72.6, 67.4, 67.0, 
66.0, 46.0, 43.1, 37.7, 32.5, 29.7, 28.4, 26.9, 26.1, 25.9, 25.8, 19.2, 18.3, 18.0 (2 signals), 
9.3, -3.8 (2 signals), -4.5, -4.6, -4.7, -4.8; 
 
IR(film) 2955.3, 2856.8, 1734.3, 1472.1, 1255.2, 1109.9, 836.2 cm-1; 
 
Exact Mass Calc. for C53H90O6Si4 [M + Na]+ : 957.57067 ; found : 957.57151 (ESI) 
 
 (S)-N-(4-methoxybenzyl)-3-methylhex-5-enamide (60)  
ON
OO
Ph
Me 32
34
36
59
NHPMB
O
Me 36
32
60  
In a 500 mL flask equipped with a reflux condenser and the largest egg shaped stirbar 
that would fit through the neck, PMBM amine (5.63 mL, 43 mmol, 1.25 eq) was 
dissolved in 20 mL CH2Cl2. Trimethylaluminum (2.0 M in toluene, 20.7 mL, 41.4 mmol, 
1.2 eq) was added dropwise through the reflux condenser. The resulting light yellow 
solution was stirred for 15 minutes, then a solution of the conjugate addition product 59 
(9.43g, 34.5 mmol, 1 eq) in 30 mL CH2Cl2 was added. The transfer was quantitated with 
2x 10 mL CH2Cl2. The reaction was stirred for 24 hours. TLC analysis (30% EtOAc/hex, 
starting material Rf= 0.55, visualizes light grey, product Rf= 0.20, visualized purple by 
CAM, CAUTION: TLC had extremely offensive odour and was kept in fumehood until 
cool) did not show complete consumption of starting material, but after this amount of 
time, baseline impurities were beginning to form. Water was allowed to flow through the 
reflux condenser, and the reaction was quenched by the cautious and dropwise addition of 
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60 mL of saturated aqueous Rochelle’s salt solution. CAUTION: It should be noted a 
several second induction period was noted between the addition of the aqueous solution 
of Rochelle’s salt and gas evolution, so the addition was done cautiously. After the 
addition of the Rochelle’s salt solution was complete, an additional 120 mL of CH2Cl2 
were added, and the reaction was vigorously stirred for 18 hours. The resulting biphasic 
mixture was filtered through a medium frit and the layers were separated. The aqueous 
layer was washed with 2 x 100 mL 90% EtOAc/hexanes. The combined organic extracts 
were washed with brine, dried over Na2SO4, and concentrated in vacuo. . Purification by 
flash chromatography over silica gel (30% to 50% EtOAc/ Hexanes) afforded 2.30g (8.41 
mmol, 24%) of recovered starting material 59 as a white crystalline solid. The desired 
product was obtained as a white crystalline solid (4.95g, 20.0 mmol, 58% ). The 
recovered starting material was recycled under the same stoichiometry and combined 
with amide 60 (overall yield, 6.26g, 25.3 mmol, 73%). It should be noted that the 
recovery of oxazolidine  from this reaction was less than 30% in smaller batches, and in 
practice was not performed on this scale.  
 
Rf = 0.20 (30% EtOAc/hexanes, UV active, stains purple in CAM, CAUTION: TLC is 
accompanied by extremely offensive smell) 
 
[α]20D = -4.8 (c 0.80, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.20 (ap. d, J = 6.3 Hz, 2H), 6.86 (ap. d, J = 6.3 Hz, 2H), 
5.81- 5.73 (m, 1H), 5.60 (br. s, 1H), 5.03- 5.00 (m, 1H), 4.99 (ap. d, J = 5.4 Hz, 1H), 
4.40- 4.35 (m, 2H), 3.80 (s, 3H), 2.22 (dd, J = 13.9, 6.7 Hz, 1H), 2.15- 2.06 (m, 2H), 
2.15- 2.06 (m, 2H), 1.95 (dd, J = 13.9, 7.8 Hz, 1H), 0.96 (d, J = 6.6 Hz, 3H); 
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13C NMR (125 MHz, CDCl3) δ 172.0, 159.0, 136.5, 130.5, 129.2, 116.5, 114.0, 55.3, 
43.6, 43.0, 41.0, 30.5, 19.5; 
 
IR(film) 3257.5, 3072.8, 2957.9, 1637.0, 1544.4, 1513.6, 1458.6, 1248.6, 1028.5 cm-1; 
 
Exact Mass Calc. for C15H21NO2 [M + H]+ : 248.1645  ; found : 248.1647 (ESI) 
 
 (S)-N-(4-methoxybenzyl)-3-methylhex-5-en-1-amine (61)  
NHPMB
O
Me 36
32
Me 36
32
NHPMB
60 61  
Lithium aluminum hydride (1.37g, 36.1 mmol, 2.0 eq) was placed in a 500 mL flask 
equipped with an egg shaped stir bar and a reflux condenser under nitrogen. The lithium 
aluminum hydride was suspended in 10 mL of THF, and amide 60, dissolved in 20 mL 
THF was added dropwise with a needle and syringe, with considerable gas evolution. The 
transfer was quantitated using 6 mL of THF. The solution was heated to reflux, and held 
at that temperature for 9 hours. The reaction was removed from the heating bath, allowed 
to cool until bubbling just stopped. A solution of 1g of KOH in 4.5 mL H2O was added 
through the reflux condenser with great caution. CAUTION: it is imperative that the 
work-up be done drop-wise with extreme caution due to an exotherm in a solution near 
its boiling point. Doing the work-up on a cooler reaction results in poor granulation and a 
much inferior yield on work-up. After the addition of the KOH solution, the reaction was 
returned to the heating bath and allowed to reflux for another 15 minutes. The reaction 
was then poured hot through a pad of Celite®, and the granular white suspension was 
rinsed with 100 mL of EtOAc. Concentration yielded amine 61 as a clear colourless oil. 
No further purification was required. Due to the volatile nature of the amine, EtOAc was 
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not completely removed from the bulk sample using high vacuum, but an aliquot was 
freed of EtOAc for characterization by exposure to high vacuum for 5 hours. 
 
Rf = 0.1 (streaks, 30% EtOAc/hexanes, not UV active, stains in cold KMnO4) 
 
[α]20D = -3.0 (c 0.70, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.23 (ap. d, J = 8.2 Hz, 2H), 6.87 (ap. d, J = 8.2 Hz, 2H), 
5.77 (ap. sextet, J = 4.7 Hz, 1H), 4.99 (ap. d, J = 7.7 Hz, 1H), 4.97 (s, 1H), 3.80 (s, 3H), 
3.72 (s, 2H), 2.70 – 2.58 (m, 2H), 2.09- 2.03 (m, 1H), 1.93- 1.87 (m, 1H), 1.62- 1.52 (m, 
2H), 1.37- 1.29 (m, 1H), 0.88 (d, J = 6.1  
13C NMR (125 MHz, CDCl3) δ 158.5, 137.3, 132.7, 129.2, 115.7, 113.7, 55.2, 53.5, 47.3, 
41.5, 36.8, 30.9, 19.5; 
 
IR(film) 2954.3, 2834.2, 1612.0, 1512.4, 1461.5, 1300.7, 1246.7, 1174.0, 1105.6, 1037.6, 
911.1, 821.1 cm-1; 
 
Exact Mass Calc. for C15H23NO [M + H]+ : 234.1852  ; found : 234.1840 (ESI) 
 
 (S)-tert-butyl 4-methoxybenzyl(3-methylhex-5-en-1-yl)carbamate (62)  
Me 36
32
NHPMB
61
Me 36
32
BocNPMB
62  
The crude amine 61 was dissolved in 36 mL CH3CN in a 250 mL RBF equipped with an 
egg shaped stir bar. Boc2O (3.9g, 18 mmol, 1.0 theory eq.) was added. The flask, open to 
air was immersed in an oil bath preheated to 40 °C. Bubbling commenced immediately. 
After 1 hour, volatiles were removed in vacuo and the residue was purified by flash 
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chromatography on silica (6% EtOAc/hexanes). Boc amide 62 (5.94 g, 99% over 2 steps) 
was obtained as a clear colourless oil. Rotamers were observed in a wide variety of NMR 
solvents, but CD3CN proved ideal for characterization. 
Rf = 0.55 (20% EtOAc/hexanes, faintly UV active, stains in KMnO4 when heated) 
 
[α]20D = +1.9 (c 2.1, CHCl3); 
 
1H NMR (600 MHz, CD3CN) δ 7.11 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 2H), 5.78- 
5.69 (m, 1H), 5.00- 4.91 (m, 2H), 4.31 (br. s, 2H), 3.76 (s, 3H), 3.13 (br. s, 2H), 2.01 (br. 
s, 1H), 1.91- 1.84 (m, 2H), 1.53- 1.46 (m, 1H), 1.43 (br. s, 9H), 1.28- 1.20 (m, 1H), 0.84 
(d, J = 6.6 Hz, 3H); 
 
13C NMR (125 MHz, CD3CN) δ 159.8, 156.6 (broad signal), 138.3, 132.0, 129.7, 116.27, 
114.7, 79.8, 55.8, 50.2 (broad signal), 45.2 (broad signal), 41.8, 35.1 (broad signal), 31.3, 
28.6, 19.7; 
 
IR(film) 2973.3, 2928.6 1693.3, 1513.2, 1247.6, 1171.2 cm-1; 
 
Exact Mass Calc. for C20H31NO3 [M + Na]+ : 356.21961  ; found : 356.2219 (ESI) 
 
(R)-tert-butyl 4-methoxybenzyl(3-methyl-5-oxopentyl)carbamate (63)  
Me 36
32
BocNPMB
62
Me
BocNPMB
O
H
63  
Alkene 62 (3.77g, 11.3 mmol 1 eq) was dissolved in 38 mL CH2Cl2 in a 100 mL flask. A 
pipette tip of Sudan III dye was added. The red mixture was cooled to -78 °C and sparged 
with ozone until the colour of the mixture faded to a peach colour. The reaction mixture 
  273 
was sparged with nitrogen for one minute. Triphenylphosphine (2.96g, 11.3 mmol, 1 eq) 
was added, and the cooling bath was removed. The reaction mixture was stirred under 
nitrogen for 2 hours, then the solvent was removed in vacuo and the residue was purified 
by flash chromatography on silica (10% EtOAc/hexanes to 30% EtOAc/hexanes). 
Aldehyde 63 (2.92g, 8.70 mmol, 77%) was obtained as a pink viscous oil (the aldehyde 
co-elutes with a residue from the Sudan III dye which is not detrimental to the subsequent 
reaction.) 
 
Rf = 0.50 (20% EtOAc/hexanes, faintly UV active, stains in KMnO4 when heated) 
 
[α]20D = +11.6 (c 4.14, CHCl3); 
 
1H NMR (600 MHz, CD3CN) δ 9.62 (br. s, 1H), 7.16 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 
Hz, 2H), 4.31 (br. s, 2H), 3.76 (s, 3H), 3.15 (br. s, 3H), 2.43- 2.29 (m, 1H), 2.23- 2.14 (m, 
1H), 1.52- 1.30 (m, 12H), 0.89 (d, J = 6.7 Hz, 3H); 
 
13C NMR (125 MHz, CD3CN) δ 203.8, 159.8, 156.5 (broad signal), 131.9, 129.8, 114.7, 
80.0, 55.8, 51.2, 49.8 (broad signal), 45.1 (broad signal), 35.7 (broad signal), 28.6, 26.4, 
20.1; 
 
IR(film) 2931.3, 1724.1, 1689.8, 1513.3, 1464.1, 1413.2, 1354.4, 1247.7, 1170.0 cm-1; 
 
Exact Mass Calc. for C19H29NO4 [M + Na]+ : 358.19888  ; found : 358.2014 (ESI) 
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 (R)-tert-butyl (4-formyl-3-methylpent-4-en-1-yl)(4-methoxybenzyl)carbamate (40)  
Me
BocNPMB
O
H Me
BocNPMB
O
H
63
40  
Aldehyde 63 (2.92g, 8.70 mmol, 1 eq) was dissolved in 22 mL CH2Cl2 in a 100 mL flask 
equipped with the largest football shaped stirbar that would fit. To the resulting solution 
was added 3.5 mL of a 37 wt % aqueous solution of formaldehyde (43 mmol, 5.0 eq). 
Para-dimethylaminobenzoic acid (0.718g, 4.35 mmol, 0.5 eq) was added, followed by 
pyrrolidine (0.363 mL, 4.35 mmol, 0.5 eq). Upon the addition of pyrrolidine, the PDABA 
went into solution. The biphasic solution was stirred vigorously under air for 4 hours 
(disappearance of the starting material by TLC is rapid, but full conversion to the 
Mannich product requires additional time). The reaction was quenched by the addition of 
10 mL of a 1 M aqueous solution of citric acid, and the layers were separated. The 
aqueous layer was washed with 2 x 50 mL CH2Cl2 and the combined organic layers were 
washed with brine. A suspension of para-dimethylaminobenzoic acid is carried in the 
organic layer through these steps, but is not detrimental to the product upon 
concentration. The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The resulting residue was purified by flash chromatography on silica (20 % 
EtOAc/ hexanes) to yield 2.69g of enal 40 (7.63 mmol, 88%) as a thick pale yellow oil. 
 
Rf = 0.45 (20% EtOAc/hexanes, strongly UV active, stains in cold KMnO4) 
 
[α]20D = -4.5 (c 2.18, CHCl3); 
 
1H NMR (600 MHz, CD3CN) δ 9.48 (s, 1H), 7.14 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 
Hz, 2H), 6.28 (br. s, 1H), 6.04 (s, 1H), 4.36- 4.29 (m, 1H), 4.24 (AB d, J = 5.4 Hz, 1H), 
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3.74 (s, 3H), 3.14- 2.93 (m, 2H), 2.56 (q, J = 6.7 Hz, 1H), 1.69- 1.63 (m, 1H), 1.55- 1.48 
(m, 1H), 1.42 (br. s, 9H), 1.01 (d, J = 7.0 Hz, 3H); 
 
13C NMR (125 MHz, CD3CN) δ 195.6, 159.8, 156.1, 155.6, 134.2, 131.9, 129.8, 114.7, 
79.9, 55.8, 50.0 (broad signal), 45.3 (broad signal), 34.0 (broad signal), 29.8, 28.6, 20.0;  
 
IR(film) 2972.3, 1693.9, 1612.7, 1513.5, 1463.5, 1413.5, 1365.7, 1247.6, 1169.3, 1035.7, 
949.5, 883.1 cm-1; 
 
Exact Mass Calc. for C20H29NO4 [M + Na]+ : 370.1989  ; found : 270.2015 (ESI) 
 
(R)-tert-butyl 4-methoxybenzyl(3-methyl-4-methylene-5-oxononyl)carbamate (41)  
Me
BocNPMB
O
H
40
Me Bu
41
BocNPMB
O
 
Enal 40 (901 mg, 2.59 mmol, 1 eq) was dissolved in 8.6 mL THF and cooled to -78 °C 
under nitrogen. To this solution was added a 3.3 M solution of nBuLi in hexanes (0.864 
mL, 2.84 mmol, 1.1 eq). Upon completion of the addition of one equivalent, a bright 
yellow colour formed. TLC (20% EtOAc/hexanes, KMnO4 visualization) shows 
complete consumption of the starting material. The reaction was quenched with saturated 
NH4Cl(aq) and extracted using CH2Cl2. The combined organic layers were washed with 
brine and dried over Na2SO4. The resulting oil was azeotroped with benzene and used 
directly in the next step. The azeotroped oil was dissolved in 8.6 mL DCM and cooled to 
0 °C. To this mixture was added Hunig’s base (1.4 mL, 7.8 mmol, 3.0 theoretical eq.) and 
DMSO (1.1 mL, 15 mmol, 6.0 theoretical eq.). SO3-Py  (824 mg, 5.2 mmol, 2.0 
theoretical eq.) was added as a solid and the reaction mixture was stirred until TLC 
showed complete consumption of the diastereomeric alcohols (20% EtOAc/hex, KMnO4 
  276 
visualization). The volatiles were removed in vacuo and the residue was purified by flash 
chromatography to yield 765 mg of enone 41 (1.89 mmol, 73% yield over 2 steps). 
 
Rf = 0.50 (20% EtOAc/hexanes, strongly UV active, stains in cold KMnO4) 
 
[α]20D = -4.5 (c 2.16, CHCl3); 
 
1H NMR (600 MHz, CD3CN) δ 7.13 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 6.05 
(s, 1H), 5.70 (s, 1H), 4.35- 4.28 (m, 1H), 4.24 (AB d, J = 15.4 Hz, 1H), 3.75 (s, 3H), 
3.10- 2.91 (m, 2H), 1.93 (pentet, J = 2.5 Hz, 2H), 1.58 (ap. septet, J = 6.6 Hz, 1H), 1.50 
(pentet, J = 7.6 Hz, 2H), 1.42 (br. s, 9H), 1.32- 1.25 (m, 2H), 0.97 (d, J = 6.6 Hz, 3H), 
0.88 (t, J = 7.6 Hz, 3H); 
 
13C NMR (125 MHz, CD3CN) δ 203.0, 159.8, 156.0 (broad signal), 154.3, 131.9, 129.8, 
122.9, 114.7, 79.9, 55.8, 49.7 (broad signal), 45.5 (broad signal), 38.5, 35.2 (broad 
signal), 31.5, 28.6, 27.6, 26.9, 23.1, 20.6, 14.2; 
 
IR(film) 2860.4, 1872.4, 1691.4, 1612.8, 1513.2, 1463.9, 1412.7, 1365.5, 1302.3, 1247.9, 
1169.5, 1036.0 cm-1; 
 
Exact Mass Calc. for C24H37NO4 [M + Na]+ : 426.2615  ; found : 426.2609 (ESI) 
 (R)-tert-butyl (3-methyl-4-methylene-5-oxononyl)carbamate (S1)  
Me Bu
41
BocNPMB
O
Me Bu
S1
BocHN
O
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PMB amide 41 (502 mg, 1.24 mmol, 1 eq) was dissolved in 10 mL CH3CN at ambient 
temperature. To the stirring solution was added 1 mL H2O, then CAN (1.7 g, 3.1 mmol, 
2.5 eq). The cloudy orange solution was stirred for 1.5 hours, until TLC (20% 
EtOAc/hexanes) showed complete consumption of starting material. The reaction was 
diluted with 60 mL 90% EtOAc/hexanes and washed with 2x 10 mL saturated NH4Cl(aq). 
The aqueous layers were extracted with 50 mL 90 % EtOAc/hexanes. The combined 
organic layers were washed with brine, then dried over Na2SO4. Concentration in vacuo 
yielded a chalky yellow residue that was purified by flash chromatography (5% 
EtOAc/hexanes, it should be noted the order of elution of anisaldehyde and product is 
opposite that shown on the TLC, with anisaldehyde eluting first from the column). The 
product Boc amide S1 , (180 mg, 0.635 mmol, 51% was obtained as a clear colourless 
oil. 
 
Rf = 0.40 (20% EtOAc/hexanes, weakly UV active, stains in cold KMnO4) 
 
[α]20D = -22.1 (c 1.57, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 6.07 (s, 1H), 5.75 (s, 1H), 4.72 (br. s, 1H), 3.17- 3.11 (m, 
1H), 2.95 (ap. septet, J = 5.8 Hz, 1H), 2.86 (ap. sextet, J = 7.5 Hz, 1H), 2.69 (t, J = 7.5 
Hz, 2H), 1.62- 1.51 (m, 4H), 1.43 (br. s, 9H), 1.34 (sextet, J = 7.3 Hz, 2H), 1.05 (d, J = 
6.9 Hz, 3H), 0.92 (t, J = 7.5 Hz, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 202.6, 155.9, 153.4, 122.7, 78.9, 38.5, 37.8, 36.8, 30.1, 
28.4, 26.8, 22.4, 20.1, 13.9; 
 
IR(film) 3389.8, 2961.6, 2932.5, 1713.9, 1704.2, 1694.0, 1514.6, 1366.1, 1249.5, 1173.3 
cm-1; 
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Exact Mass Calc. for C16H29NO3 [M + Na]+ : 306.2039  ; found : 306.2039 (ESI) 
 
 
 (R)-6-butyl-4-methyl-5-methylene-2,3,4,5-tetrahydropyridin-1-ium 2,2,2-
trifluoroacetate (42a)  
Me Bu
S1
BocHN
O
Me
NH
Bu
42a
CF3COO
 
Boc amide S1 (180 mg, 0.635 mmol, 1 eq) was dissolved in 1 mL CH2Cl2 and 1 mL TFA 
was added. After 5 minutes at ambient temperature, the volatiles were removed, and the 
yellowish residue was azeotroped 2x 5 mL CH2Cl2. The residue was taken up in 5 mL  
CHCl3 and refluxed for 1 hour. Removal of volatiles in vacuo yielded 273 mg of TFA 
iminium 42a as a brownish oil. Estimation of the yield was complicated by the presence 
of approximately 2 equivalents of TFA that could not be removed despite extensive 
pumping. 
 
Partial Characterization Data (Proton NMR): 
 
1H NMR (600 MHz, CDCl3) δ 13.62- 13.27 (broad bump, 1H), 6.35 (s, 1H), 6.16 (s, 1H), 
3.90 – 3.83 (m, 1H), 3.83- 3.76 (m, 1H), 2.93- 2.86 (m, 2H), 2.72- 2.66 (m, 1H), 2.11- 
2.05 (m, 1H), 1.78- 1.70 (m, 1H), 1.65 (pentet, J = 8.2 Hz, 2H), 1.41 (ap. sextet, J = 6.9 
Hz, 2H), 1.27 (d, J = 6.9 Hz, 3H), 0.94 (t, J = 7.3 Hz, 3H); 
 
Exact Mass Calc. for C20H29NO4 [M + Na]+ : 370.1989  ; found : 270.2015 (ESI) 
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(R)-6-butyl-4-methyl-5-methylene-2,3,4,5-tetrahydropyridin-1-ium 
hexafluorophosphate(V) (42c)  
Me
NH
Bu
42a
CF3COO
Me
NH
Bu
42c
PF6
 
The TFA iminium 42a / TFA mixture (100 mg, 0.232 mmol based on 100% yield for 
preceding step) was dissolved in 5 mL CH2Cl2. A solution of KPF6 (650 mg, 3.58 mmol, 
15 eq) was dissolved in 3 mL water and the two solutions were mixed vigorously with a 
pipette in a test-tube for 2 minutes. The organic layer was removed with a pipette and the 
aqueous layer was washed with a further 5 mL CH2Cl2. The organic layers were dried 
over Na2SO4 and the solvent was removed in vacuo to yield iminium 
hexafluorophosphate 42c (70.3 mg, 0.226 mmol, 97% ) as a greasy solid melting at 
around ambient temperature. Analysis by 19F NMR indicated removal of the 
trifluoroacetic acid, and greater than 95% conversion to the PF6 salt. This compound was 
not > 95 % pure by NMR, but attempts at chromatography did not improve the quality of 
the material, and what was obtained was satisfactory for subsequent steps. 
 
Rf = 0.3 (10% MeOH/ CH2Cl2, strongly UV active, stains white/yellow in CAM) 
 
[α]20D = +15.7 (c 1.71, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 11.30- 10.95 (broad bump, 1H), 6.41 (s, 1H), 6.19 (s, 1H), 
3.96 – 3.84 (m, 2H), 2.92- 2.88 (m, 2H), 2.74- 2.67 (m, 1H), 2.13- 2.07 (m, 1H), 1.80- 
1.73 (m, 1H), 1.68 (pentet, J = 7.9 Hz, 2H), 1.44 (ap. sextet, J = 7.6 Hz, 2H), 1.28 (d, J = 
6.8 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H); 
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13C NMR (125 MHz, CDCl3) δ 181.6, 140.0, 132.8, 44.3, 34.0, 30.3, 30.0, 27.1, 22.4, 
18.5, 13.4; 
 
IR(film) 3651.6, 333.3, 2920.1, 1655.3, 1459.6, 968.5, 8400.9 cm-1; 
 
Exact Mass Calc. for C11H20N [M]+ : 166.1590  ; found : 166.1530 (ESI) 
 
(S)-6-bromo-3-methylhex-1-ene (66)  
Me
HO
Me
Br
6665  
Alcohol 65 (1.62g, 14.2 mmol, 1.0 eq) was dissolved in 47 mL CH2Cl2 and imidazole 
(1.16g, 17.0 mmol, 1.20 eq.) was added. The mixture was cooled to 0 °C and 
triphenylphosphine dibromide (6.59g, 15.6 mmol, 1.1 eq) was added. The reaction was 
stirred at 0 °C for 10 minutes, then the cooling bath was removed, and the reaction was 
stirred for an hour. TLC (10% EtOAc/hexanes, KMnO4) showed complete consumption 
of starting material. The solvent was removed at 200 torr and the residue was purified by 
flash chromatography (pure pentane). The product containing fractions were concentrated 
at 250 torr, and the residue was briefly held at 150 torr to yield 2.31 g of bromide 66 
(13.0 mmol, 92%) as a clear colourless oil. Spectral data were in accordance with the 
literature.10 
tert-butyl ((3R,9S)-3,9-dimethyl-4-methylene-5-oxoundec-10-en-1-yl)(4-
methoxybenzyl)carbamate (43)  
Me
BocNPMB
O
H
40
Me
BocNPMB
O
43
Me
 
Enal 40 (2.65g, 7.63 mmol) was azeotroped with benzene and held under vacuum. 
Meanwhile a 3 neck flask equipped with a water cooled reflux condenser was flame dried 
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and cooled under argon. To the flask were added 2.46 g magnesium turnings (125 mmol, 
17.0 eq) which were vigorously stirred under argon for 2 hours. THF (4 mL) was added 
to the turnings, and 0.150 mL 1,2-dibromoethane was added. A vigorous reaction ensued 
almost immediately. A solution of bromide 66 (2.21g, 12.5 mmol, 1.6 eq) in 4 mL THF 
was added at a rate sufficient to maintain reflux (approximately 10 minutes for complete 
addition). Alternating addition of 0.420 mL 1,2-dibromoethane (6.67 mmol total, 0.87 eq) 
was also performed to continually activate the magnesium. An additional 7 mL THF was 
added, and the grey solution was stirred and allowed to cool for 0.5 hours. Upon cooling, 
a grey precipate, assumed to be MgBr2 formed. The enal was dissolved in 5 mL THF and 
cooled to -78 °C under argon. The Grignard reagent was transferred to the enal by 
syringe, with washing of the magnesium turnings with an additional 6 + 5 mL THF. A 
substantial amount of the MgBr2 suspension remained in the flask. After 10 minutes, the 
Grignard reaction was warmed to 0 °C. TLC (20% EtOAc/hexanes , KMnO4) showed 
complete consumption of the enal. The reaction was quenched with 10 mL saturated 
NH4Cl(aq) and extracted with 3 x 50 mL (90% EtOAc/hexanes). The organic layers were 
washed with brine and dried over Na2SO4. Concentration yielded 3.4 g of a viscous oil 
that was used directly in the next step. The resulting oil was azeotroped with benzene and 
dissolved in 25 mL CH2Cl2 and cooled to 0 °C. To this mixture was added Hunig’s base 
(4.10 mL, 22.9 mmol, 3.0 theoretical eq.) and DMSO (3.25 mL, 45.8 mmol, 6.0 
theoretical eq.). SO3-Py  (2.43 g, 15.3 mmol, 2.0 theoretical eq.) was added as a solid and 
the reaction mixture was stirred until TLC showed complete consumption of the 
diastereomeric alcohols (20% EtOAc/hexanes, KMnO4 visualization). The volatiles were 
removed in vacuo and the residue was purified by flash chromatography (10% EtOAc/ 
hexanes) to yield 2.85 g of enone 43 (6.40 mmol, 84% yield over 2 steps). Eluting after 
the desired product were 300 mg of enal 40 contaminated with pyridine. Since the enal 
was completely consumed in the Grignard reaction it is believed this was the result of a 
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1,2 reduction of the enal by the Grignard, followed by reoxidation of the allylic alcohol in 
the Parikh–Doering reaction. 
 
Rf = 0.55 (20% EtOAc/hexanes, strongly UV active, decolourizes cold KMnO4) 
 
 [α]20D = 2.6 (c 2.6, CHCl3); 
 
1H NMR (500 MHz, CD3CN) δ 7.17 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 6.07 
(s, 1H), 5.77- 5.68 (m, 1H), 5.73 (s, 1H), 5.00 (ap. d, J = 17.1 Hz, 1H), 4.94 (ap. d, J = 
10.2 Hz, 1H), 4.42- 4.31 (m, 1H), 4.27 (AB d, J = 15.6 Hz, 1H), 3.78 (s, 3H), 3.20- 3.91 
(m, 2H), 2.73- 2.64 (m, 3H), 2.17- 2.08 (m, 2H), 1.66- 1.48 (m, 3H), 1.46 (br. s, 9H), 
1.33 (ap. q, J = 7.3 Hz, 1H), 1.00 (d, J = 4.4 Hz, 3H), 0.99 (d, J = 4.5 Hz, 3H); 
 
13C NMR (125 MHz, CD3CN) δ 202.9, 159.8, 156.0 (broad signal), 154.3, 145.6, 131.9, 
129.8, 122.9, 118.2, 113.2, 79.9, 55.8, 50.0 (broad signal), 45.6, 38.7, 38.5, 36.8, 35.1 
(broad signal), 31.5, 28.6, 23.2, 20.6; 
 
IR(film) 2931.1, 1691.4, 1612.4, 1513.1, 1461.3, 1412.6, 1365.5, 1302.2, 1247.8, 1169.8, 
1036.6, 910.3 cm-1; 
 
Exact Mass Calc. for C27H41NO4 [M + Na]+ : 466.2928  ; found : 466.2905 (ESI) 
 
tert-butyl ((3R,9S)-3,9-dimethyl-4-methylene-5-oxoundec-10-en-1-yl)carbamate (S2)  
Me
BocNPMB
O Me
43
Me
BocHN
O Me
S2  
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PMB amide 43 (970 mg, 2.19 mmol, 1 eq) was dissolved in 20 mL CH3CN and 2 mL 
H2O were added. To the mixture was added CAN (3.0g, 5.5 mmol, 2.5 eq) and the 
resulting orange mixture was stirred for 1 hour until TLC (20 % EtOAc/hexanes, product 
Rf= 0.53, anisaldehyde Rf= 0.50), showed complete consumption of starting material. 
The reaction was diluted with 100 mL 90% EtOAc/ hexanes and washed with 3 x 10 ml 
saturated NH4Cl(aq), then brine. The organic layer was dried over Na2SO4 and filtered, 
then concentrated in vacuo. The residue was purified by flash chromatography (5% 
EtOAc/hexanes, the anisaldehyde elutes first, despite the order of elution on TLC) to 
yield 388 mg of BOC amide S2 (1.20 mmol, 55%) as a clear colourless oil. 
 
Rf = 0.53 (20% EtOAc/hexanes, faintly UV active, stains in cold KMnO4) 
 
[α]20D = -12.1 (c 3.44, CHCl3); 
 
1H NMR (500 MHz, CDCl3) δ 6.06 (s, 1H), 5.47 (s, 1H), 5.72- 5.64 (m, 1H), 4.97 (ap. d, 
J = 17.1 Hz, 1H), 4.92 (ap.d, J = 10.2 Hz, 1H), 4.71 (br. s, 1H), 3.14- 3.09 (m, 1H), 2.96 
(sextet, J = 6.9 Hz, 1H), 2.85 (sextet, J = 5.9 Hz, 1H), 2.67 (t, J = 6.8 Hz, 2H), 2.13 
(pentet, J = 7.3 Hz, 1H), 1.64- 1.58 (m, 2H), 1.57- 1.49 (m, 2H), 1.43 (br. s, 9H), 1.30 
(ap. q, J = 6.9 Hz, 1H), 1.04 (d, J = 6.8 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H); 
 
13C NMR (125 MHz, CDCl3) δ  202.4, 155.9, 153.3, 144.3, 122.8, 112.7, 78.9, 38.5, 38.0, 
37.7, 36.7, 36.1, 30.1, 28.4, 22.3, 20.1; 
 
IR(film) 3377.1, 2966.1, 2871.1, 1714.0, 1513.3, 1455.9, 1366.0, 1250.0, 1174.1, 996.6, 
938.7, 911.2 cm-1; 
 
Exact Mass Calc. for C19H33NO3 [M + Na]+ : 346.2353 ; found : 346.2353 (ESI) 
  284 
 
 
 (R)-4-methyl-5-methylene-6-((S)-4-methylhex-5-en-1-yl)-2,3,4,5-tetrahydropyridin-
1-ium 2,2,2-trifluoroacetate (S3)  
Me
BocHN
O Me
S2
Me
NH
S3
Me
CF3COO
 
Amide S2 (320 mg, 0.989 mmol, 1 eq) was dissolved in 2 mL CH2Cl2 and 2 mL TFA 
was added dropwise. Bubbling ensued. After 5 minutes, volatiles were removed in vacuo 
to give a brown oil, which was dissolved in 10 mL CHCl3 and refluxed for 2 hours. 
Volatiles were removed in vacuo to give a brown oil, which has the following partial 
characterization data, and was used without further purification. 
 
1H NMR (600 MHz, CDCl3) δ 13.68- 13.45 (broad bump, 1H), 6.38 (s, 1H), 6.15 (s, 1H), 
5.60 (ddd, J = 14.3, 9.8, 8.3 Hz, 1H), 4.98- 4.93 (m, 2H), 3.91- 3.83 (m, 1H), 3.83- 3.76 
(m, 1H), 2.90- 2.82 (m, 2H), 2.73- 2.65 (m, 1H), 2.16- 2.05 (m, 2H), 1.77- 1.69 (m, 1H), 
1.69- 1.56 (m, 2H), 1.43- 1.31 (m, 2H), 1.27 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 180.4, 160.6 (multiplet), 143.3, 140.0, 132.4, 113.6, 43.5, 
37.4, 35.8, 33.3, 30.5, 27.1, 26.8, 20.1, 18.6; 
 
19F NMR (470 MHz, CDCl3) δ -76.4 ppm 
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 (R)-4-methyl-5-methylene-6-((S)-4-methylhex-5-en-1-yl)-2,3,4,5-tetrahydropyridin-
1-ium hexafluorophosphate(V) (44c) 
Me
NH
44c
Me
PF6
Me
NH
S3
Me
CF3COOH
 
The brown oil from the preceding step was dissolved in 10 mL CH2Cl2 and washed 
vigorously twice with 5 mL saturated NaPF6(aq). The organic layer was dried over 
Na2SO4. Solvent was removed in vacuo to give 44c as a greasy brown solid (344 mg, 
0.981 mmol, 99 % yield) in sufficient purity to be used without further purification. 
Characterization data: 
 
[α]20D = +28.9 (c 2.89, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 10.84- 10.38 (broad bump, 1H), 6.41 (s, 1H), 6.20 (s, 1H), 
5.63 (ddd, J = 17.1, 10.3, 7.9 Hz, 1H), 4.99 (ap. d, J = 17.1 Hz, 1H), 4.95 (ap. d, J = 10.3 
Hz, 1H),  3.97- 3.83 (m, 2H), 2.93- 2.81 (m, 2H), 2.74- 2.69 (m, 1H), 2.17- 2.07 (m, 2H), 
1.80 – 1.72 (m, 1H), 1.72- 1.62 (m, 2H), 1.48- 1.35 (m, 2H), 1.27 (d, J = 6.7 Hz, 3H), 
1.00 (d, J = 6.7 Hz, 3H); 
 
 
13C NMR (125 MHz, CDCl3) δ 181.4, 143.5, 140.0, 132.8, 113.6, 44.3, 37.4, 35.9, 34.2, 
30.4, 27.2, 26.3, 20.2, 18.6; 
 
19F NMR (470 MHz, CDCl3) δ -72.6 (d, 1JPF = 713 Hz); 
 
IR(film): 3649.3, 3329.1, 2965.1, 1654.2, 1458.0, 1418.9, 1334.2, 1202.4, 841.3 cm-1 
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Exact Mass Calc. for C14H24N [M cation]+ : 206.1903 ; found : 206.1874 (ESI) 
 
 (R)-6-butyl-1-(4-methoxybenzyl)-4-methyl-5-methylene-2,3,4,5-tetrahydropyridin-
1-ium hexafluoroantimonate(V) (67)  
Me
NPMB
Bu
67
SbF6
Me Bu
41
BocNPMB
O
 
Enone 41 (456 mg, 1.13 mmol, 1 eq) was dissolved in 3 mL CH2Cl2 and 3 mL 
trifluoroacetic acid was added. After 5 minutes the volatiles were removed in vacuo and 
the residue was redissolved in 5 mL CHCl3. Five drops of TFA were added and the 
mixture was refluxed for 14 hours. The solvent was removed in vacuo and 1H NMR 
analysis showed complete cyclization. The residue was dissolved in 6 mL of a 1:1 
mixture of MeOH and CH2Cl2 and HSbF6-6H2O (427 mg, 1.24 mmol, 1.1 eq) was added 
as a solid. The volatiles were removed in vacuo and the residue was azeotroped 3x 5 mL 
CH2Cl2. The residue was purified by flash chromatography (5% MeOH/ CH2Cl2) to yield 
580 mg of iminium 67 (1.11 mmol, 97%) as a brown oil setting to a brown crystalline 
solid slightly below room temperature. 
 
Rf = 0.30 (10% MeOH in CH2Cl2, strongly UV active, stains yellow/white in CAM) 
 
 [α]20D = +9.1 (c 3.11, CHCl3); 
 
1H NMR (500 MHz, CDCl3) δ 7.16 (d, J = 8.6 Hz, 2H), 6.96 (d, J = 8.6 Hz, 2H), 6.47 (s, 
1H), 6.22 (s, 1H), 5.14 (d, J = 5.2 Hz, 1H), 5.05 (s, J = 5.2 Hz, 1H), 3.89- 3.78 (m, 2H), 
3.83 (s, 3H), 3.10- 3.03 (m, 1H), 3.02- 2.96 (m, 1H), 2.77- 2.70 (m, 1H), 2.77- 2.70 (m, 
1H), 2.12- 2.07 (m, 1H), 1.74- 1.67 (m, 1H), 1.49 (pent. J =7.3 Hz, 2H), 1.25 (d, J = 6.8 
Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H); 
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13C NMR (125 MHz, CDCl3) δ 181.2, 160.5, 141.4, 133.2, 129.1, 122.3, 115.1, 59.6, 
55.4, 52.2, 31.2, 30.4 (2 signals), 27.8, 22.9, 18.9, 13.3; 
 
IR(film) 2964.9, 1610.4, 1515.6, 1463.7, 1254.0, 1181.3, 1029.6, 832.8, 657.6 cm-1; 
Exact Mass Calc. for C19H28NO+ [M]+ : 286.2165  ; found : 286.2153 (ESI) 
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Chapter 6 
Diels Alder Studies: Olefin Isomerization 
I. Reevaluation of the Stereochemistry of the Pero Model 
The studies in the previous chapters culminated in the synthesis of elaborate Z-diene 1 , 
model Z-diene 2, elaborate iminium 3 and model iminium 4 (Figure 6.1). This chapter 
will describe the studies of their respective Diels–Alder reactions.  
O
Me
TBSO OPMBM
OTBSMe
OTBS
DMBMO
O
O
OTBS
OTBS
1 Me
TBSO
O
O
OTBS
OTBS
OTBDPS
2
Me
NH
4
PF6
Me
Me
NH
3
PF6
Me
 
Figure 6.1 Dienes and Dienophiles 
After the development of the viable Diels–Alder reaction with protonated iminium ions, 
this strategy was extended by Dr. David Marcoux in the course of the synthesis of the 
spirolide spiroiminium core. Dr. Marcoux had attempted some Diels–Alder reactions 
between acyclic Z-enolsilane containing diene 5 and iminium 6, and in addition to 
product 7, he recovered some isomerized diene 8. (Equation 6.1)  
NH
Me
Me
Me
SbF6
OBn
Me
OTIPS
NH
Me
Me
Me
SbF6
Me
OTIPS
OBn
(6.1)OBn
Me
OTIPS
75 6
CH2Cl2
85 %
8  
Dr. Pero had also been aware of diene isomerization in the course of some of his 
unsuccessful intramolecular Diels–Alder reactions (Chapter 3 Section III). I had assumed 
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that no isomerization was occurring in my Diels–Alder reactions, based on the spectral 
similarity of my results with Dr. Pero’s. A further piece of data that reassured me was 
that Z-diene 1 and 2 could be observed throughout the Diels–Alder reactions I conducted 
under optimized conditions, and could be recovered intact from reactions that were not 
run to completion. However, this does not preclude a scenario where the E-diene is 
consumed as soon as it is formed and cannot build up in a detectable concentration. Dr. 
Pero had noted that E-diene 9 was consumed at a much faster rate than Z-diene 10.1   
 
Out of an abundance of caution, it was decided to devise an experiment to test if this 
scenario was operative. It was noted that samples of Z-diene 10 prepared by Borg and 
Pero that were anywhere from 3 to 5 years old, and had been stored continuously at -20 
°C, contained various amounts of E-diene 9 (anywhere from 10 to 30 %) (Equation 6.2). 
This E diene 9 directly corresponded with authentic samples prepared from the ene-yne 
metathesis route shown in Chapter 3.  
Me
BnO
O
O
OTBS
OTBS
OTBS
9
Me
BnO
O
O
OTBS
OTBS
OTBS
10
(6.2)
 
I did not want to revisit the ene-yne metathesis route at this point, as the material that Dr. 
Bindschädler had prepared was beyond the point at which the ene-yne metathesis route 
diverged. Based on the hypothesis that the isomerization was mediated by Brønstead 
acids, a sample of macrocycle 2 was dissolved in chloroform-d and taped in a window, 
                                                
(1) Such scenarios have been reported or postulated in the literature: see (a) Borch, R. F.; Evans, A. J.; 
Wade, J. J. J. Am. Chem. Soc. 1975, 97, 6282- 6284. (b) Franzini, M.; Zanoni, G. Angew. Chem. Int. Ed. 
2004, 43, 4837- 4841. 
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exposed to sunlight. Clean isomerization to E-diene 11 was complete within 48 hours 
(Equation 6.3).2 
Me
TBSO
O
O
OTBS
OTBS
OTBDPS
2
Me
TBSO
O
O
OTBS
OTBS
OTBDPS
11
(6.3)
CDCl3, h!
> 90 %
 
Verification that it was not light but photogenerated acid mediating the transformation 
employed the following experiment: three NMR tubes were filled with chloroform-d, 2 
tubes of which contained model macrocycle 2. One tube contained just chloroform. One 
tube containing model macrocycle 2 was wrapped in aluminum foil, and the other tubes 
containing model macrocycle 2 and the tube containing just chloroform were taped in the 
window. When isomerization of 2 to 11 in the tube exposed to light was complete, an 
NMR spectrum was taken of the sample kept in the dark, and no isomerization was 
detected. The chloroform in this sample was removed, and replaced with the chloroform 
from the blank tube that had been exposed to light. The tube was returned to the dark for 
2 days, and after that time an NMR experiment showed complete isomerization of 2 to 
11.  
 
The E-diene 11, obtained by the acid mediated isomerization was subject to a Diels– 
Alder reaction with model iminium 4, and unfortunately the product 12 obtained was 
identical to the product that was obtained from the Diels–Alder reaction of the Z-diene 
under the conditions used in Chapter 5 (Scheme 6.1). The stereochemical assignment will 
be explained shortly, as it also does not follow from the stereochemical model originally 
proposed. 
 
 
                                                
(2) Identification of this compound was based on J couplings of the olefins in the 1H NMR spectrum, and 
similarity of the spectrum to macrocyclic Z-dienes prepared by Dr. Borg. 
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Scheme 6.1  
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c) 2, 4, DCE, > 0.2 M, 40 °C, 2 days
 
This result means that the Diels–Alder reactions described in the preceeding chapter had 
not generated the correct stereochemistry at C33. Unfortunately, this also means that the 
results reported by Pero also provided the incorrect C33 to C9 stereochemical relationship. 
The reason Pero did not catch this was because in his studies he had allowed E-diene 9 to 
react with only the methylated iminium 13 derived from imine 14, to give product 15. Z-
diene 10 was allowed to react only with the protonated iminium 16 derived from imine 
14 to give product 17 (Scheme 6.2). This precluded direct comparison of the NMR 
spectra as 15 and 17 had different iminium structures. In retrospect, the 1H spectra of 15 
and 17 are similar enough that it is almost certain the two products had the same C9–C33 
configurations.3  
 
 
 
                                                
(3) Dr. Pero’s archival samples of 15 and 17 had decomposed after 4.5 years of storage before I reached 
this realization. Inspection of the 2D ROESY spectra that he left almost certainly support my assignment, 
though because of the small quantity of 16 that Dr. Pero obtained, that ROESY spectrum in particular 
contained a lot of ambigious noise. In section II of this chapter, I prepare compounds of the correct C9-C33 
configuration that have markedly different 1H NMR spectra. 
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Scheme 6.24 
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With ample quantities of Diels–Alder adduct 12 in hand, ROESY spectroscopy was 
employed to determine the stereochemistry around the spiro-centre and iminium.5 Upon 
irradiation of the proton at C9 , a strong signal corresponding to the methyl group at C34 
was observed. This is consistent with the stereochemistry shown in Figure 6.2. 
Me
N
O
O
TBSO
TBSO OTBS
Me OTBDPS
H
H
PF6
Me
9 34
 
Figure 6.2 Stereochemistry of Diels–Alder adduct 12. 
                                                
(4) The experiments in this scheme were performed by Dr. Joseph Pero, I made the stereochemical 
assignments indicated. 
(5) nOe spectroscopy is ineffective with these Diels–Alder adducts, extended irradiation results in little to 
no correlation. The molecular weight/shape must be in a regieme where rates of molecular tumbling are not 
averaged out in the timeframe of the NOESY pulse sequence. For a review on selecting the best NMR 
experiments for molecular size, see: Reynolds, W. F.; Enríquez, R. G. J. Nat. Prod. 2002, 65, 221-244. 
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This means that product 12 must have arisen from an endo attack of the diene syn to the 
methyl group on iminium 4. Such an orientation in the transition state is represented by 
structure 18 in Figure 6.3. Up until that point, we had expected that the attack of the 
macrocyclic diene would occur anti to the methyl group on the iminium, represented by 
structure 19, which would lead to product 20. Product 20 would have the correct 
configuration at C33, but the incorrect configuration at C9. In fact, with acyclic E-dienes, 
attack anti to the methyl group had been observed,6 and until the ROESY study we 
believed that products 12 and 15 actually had the configurations at C33 and C9 depicted in 
hypothetical product 20.  
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Figure 6.3 Endo orientations of cycloadditions on E- dienes. 
This stereochemical outcome suggested that the macrocycle itself had a facial bias. In 
Figure 6.4, hypothetical transition state 21 shows how an attack anti to the methyl group 
on 4 by the favoured face would necessarily go through an exo transition state, leading to 
                                                
(6) Marcoux, D.; Bindschädler, P.; Speed, A. W. H.; Chiu, A.; Pero, J. E.; Borg, G.; Evans, D. A. Org. Lett. 
2011, 13, 3758- 3761. 
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product 22, which would possess the desired stereochemistry. A final possibility would 
be an exo reaction of the disfavoured face, syn to the methyl group on 4, depicted in 
transition state 23 which would give product 24, possessing incorrect stereochemistry at 
both C9 and C33. This path was judged very unlikely, as the back of the diene would clash 
with the methyl at C34 in the transition state, and there would be a syn-pentane interaction 
between C10 and the C34 methyl in product 24.  
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Figure 6.4 Unlikley exo orientations of cycloadditions. 
With the new hypothesis that the E-macrocyclic diene has a pronounced facial bias, 
studies were undertaken with the reactive dienophile PTAD 25 to attempt to confirm this. 
PTAD is a reactive dienophile, that reacts via endo transition states and has been used 
before to assess facially biased dienes,7 and simplifies the analysis since both an exo and 
                                                
(7) For use of PTAD to assess facial bias, see: a) Marchand, A. P.; Ganguly, B.; Shukla, R. Tetrahedron, 
1998, 30, 4477-4484. b) Morrison, C. F.; Vaters, J. P.; Miller, D. O.; Burnell, D. J. Org. Biomol. Chem., 
2006, 4, 1160-1165. It should be noted that PTAD does undergo non-concerted reactions with very electron 
rich dienes, but a concerted reaction was assumed for the cases shown above. See: Clennan, E. L.; 
Earlywine, A. D. J. Am. Chem. Soc. 1987, 109, 7104- 7110. A computational study by Houk suggests that 
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endo transition state would give the same product (Scheme 6.3). In the event, E-diene 11 
was mixed with 25, and at room temperature the reaction appeared to be essentially 
instantaneous as judged by the loss of the red colour of the PTAD. PTAD adduct 26 was 
obtained as a single product. The 1H NMR spectrum of PTAD adduct 26 bore close 
resemblance to that of 12, with chemical shifts of the protons at C8 , C12, C13 and C14 
being almost superimposable. On this basis, the structure of 26 was assigned as being 
homologous to 12 at C9.8 This result supports the idea that the E- macrocyclic diene has a 
strong facial bias. When coupled with the strong bias of 4 to react via an endo transition 
state, Diels–Alder adduct 12 is obtained.9 
Scheme 6.3  
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The analogous reaction with Z-diene 2 also proceeded essentially instantaneously, with 
decolorization of the PTAD stock solution occurring immediately upon mixing with a 
solution of 2. In this case, two diastereomers were obtained in approximately a 6:1 ratio, 
with the minor adduct being 26. The 1H NMR spectrum of the major adduct, 27, was very 
different to that of both iminium adduct 12 and PTAD adduct 26, supporting the earlier 
                                                                                                                                            
concerted reactions via an endo transition state are favoured on non-oxygen substituted dienes with PTAD: 
Chen, J. S.; Houk, K. N.; Foote, C. S. J. Am. Chem. Soc. 1998, 120, 12303- 12309.  The endo transition 
state arises since there would be a repulsion between the nitrogen lone pairs and the π system in the exo 
transition state. 
(8) Unfortunately compound 26 was not solid, and attempts to remove TBS groups led to decomposition, 
precluding analysis by X-Ray diffraction.   
(9) For the analogous use of N-phenyl maleimide to probe the endo/exo selectivity of a macrocyclic diene, 
see: Morales, C. A.; Layton, M. E.; Shair, M. D. Proc. Natl. Acad. Sci. 2004, 101, 12036- 12041. 
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assignment of 26 by anaology. 1H and 13C analysis of 27 showed it did not arise from 
modes of reaction other than a 4+2, such as an ene reaction. 
 
These studies suggest that the reaction of Z-diene 2 with iminium 4 to give 12 must be 
occurring through an isomerization. For 12 to arise from a Diels–Alder reaction of 4 and 
2 without isomerization of 2 would involve an exo attack of the minor conformer of the 
Z-diene syn to the methyl group, shown in transition state 28, Figure 6.4.  Such an attack 
would be imagined to have a steric clash between C8 on the back of the diene and the 
methyl at C34. The other reaction syn to the methyl group via an endo mode, shown in 29 
would give syn pentane interaction containing product 24 and is also judged unlikely.   
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Figure 6.5 Modes of reaction of macrocyclic Z-dienes. 
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There are two modes of addition that may occur anti to the methyl group. A exo mode 
anti to the methyl group, shown in transition state 30, would give compound 20. This 
cycloaddition would go through what the PTAD results suggest is the major 
conformation of the diene, however, the exo transition state may be undesirable as the C7-
C8 bond at the back of the diene is placed over the sp3 centre at C34. Transition state 31 
shows the desired orientation of the reactants that would lead to compound 22, bearing 
the desired C34–C33–C9 stereochemical relationship. While this goes through an endo 
transition state, it would also be on the minor conformer of the Z diene, and it is unclear if 
the steric interaction between C10 on the diene (represented as R1) and the sp3 centre at 
C34 would disfavour this transition state more than transition state 30. 
 
To summarize the above observations, it may be said that the Z and E macrocyclic olefins 
are probably in similar conformations and present the same face of the diene (ie the Re 
face of the olefin at C7. What makes the E diene present the correct face and the Z diene 
present the incorrect face with respect to the desired product is the change in 
configuration at C9. This stylized in structures 32 and 33, shown in Figure 6.6.  
7 79
9
open open
blockedblocked
32 33
 
Figure 6.6 The same diene face is presented in each macrocycle. 
It may be anticipated from the results described above that forming the correct 
stereochemistry at C33 and C9, shown in product 22 will be difficult. E-diene 11 must 
react through exo transition state 18, which is disfavoured by dienophile 4, while to 
access the correct stereochemistry with Z diene 2, it must react through the minor 
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conformer in endo transition state 31 which possesses a steric interaction between C10 
and C34. 
 
II. Attempts to Promote an Exo Transition State 
Faced with the setback that the correct stereochemistry had not yet been accessed in the 
Diels–Alder reaction, we were faced with three possible solutions: 
The first, or least motion principle was to find some method of suppressing the 
isomerization of Z-dienes. The second option would be to find some way to force an exo 
transition state on the more reactive E-diene. The third option would be to abandon the 
iminium Diels–Alder reaction and further investigate the elaboration of the lactam Diels–
Alder adducts prepared by Brandl and Chiu (Chapter 3). Efforts initially focused on the 
second option, since the E diene did present the correct face and was more reactive than 
the Z diene. There is no general method to overturn endo/exo selectivity, so this appeared 
to be an attractive research area.  
 
To briefly summarize, three different routes to modify dienophile 4 to become exo 
selective were attempted. Mono or bis halogenation α to the iminium was considered. It 
was postulated steric bulk at this position would disfavour endo transition states 34 and 
35. Unfortunately a number of efforts to halogenate 4 failed.10 To test the principle, tert 
butyl iminium 36 and isopropyl iminium 37 were prepared. These systems were not 
reactive in Diels–Alder reactions with simple dienes, so this approach was abandoned 
(Figure 6.7).  
                                                
(10) Conditions attempted on both iminium 4, freebase 38 and PMB iminium included treatment with NCS, 
NBS, I2, CuBr2 and Barluenga reagent ([SymCollidine2I]+PF6- ). Iminium salts were generally unreactive 
with these reagents, while the freebase was decomposed. 
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Figure 6.7 Attempts to force an exo transition state with α substituents. 
 
Another attempt was made to use bulky Lewis acids to activate the nitrogen, shown in 
Figure 6.8. Imine 38 could be prepared from iminium 4 by a simple aqueous sodium 
hydroxide wash.11 The yield for this deprotonation was high, but could not be measured 
precisely because of the marked volatility of 38. Imine 38 was notably unstable, and was 
typically used immediately after preparation.  Compound 38 could be complexed with 
various Lewis acids to form the corresponding adducts. Gold complex 39 was prepared, 
but was not reactive, even with isoprene.12 Complex 39 was markedly more stable than 
parent imine 38. Mixing 38 with tris-pentafluorophenylborane led to complex 40, as 
ascertained by desymmetrization in the 19F NMR spectrum. This complex was not stable, 
and decomposed on a time scale incompatible with a Diels–Alder reaction.13 Attempts to 
form complex 41, with trityl BArfate salts led to decomposition of 38.14   
                                                
(11) Dr. David Marcoux originally showed that iminium 6 was stable to these conditions. Our previous 
method of forming 38 was chromatography of 4 with 1% Et3N in CH2Cl2, which provides inferior yields 
and product quality. 
(12) The AuCl carbene complex was treated with AgSbF6, then 38. See:  de Frémont, P.; Scott, N. M.; 
Stevens, E. D.; Nolan, S. P. Organometallics, 2005, 24, 2411- 2418. 
(13) Bergquist, C.; Bridgewater, B. M.; Harlan, J. C.; Norton, J. R.; Friesner, R. A.; Parkin, G. J. Am. 
Chem. Soc. 2000, 122, 10581- 10590. 
(14) New peaks on the olefin region of the 1H NMR spectrum were observed, and it is suspected oxidation 
of 38 by hydride abstraction occurred. For trityl borate oxidations, see: Straus, D. A.; Zhang, C.; Tilley, T. 
D. J. Orgmet. Chem. 1989, 369, C13- C17. 
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Figure 6.8 Attempts to employ bulky Lewis pair adducts. 
A final concept was employed, the use of electron rich tetraarylborate complexes. These 
are known to associate with NH cations as shown in structure 42, and it was hoped that 
tetraarylborates with meta substituents may shield areas in which substituents on the 
diene would need to sit in an endo transition state, therefore favouring exo transition state 
43.15  
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H 34 H
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Figure 6.9 Attempts to peturb diastereoselectivity with bulky borates. 
 
Sodium tetraarylborates 44a and 44b with 3,5 methyl and methoxy substituents were 
prepared,16 and it was found that mixing these compounds with the hexafluorophosphates 
                                                
(15) Hydrogen bonds in ammonium tetraphenylborate to the midpoints of the aryl rings have been 
characterized by neutron diffraction. See: Steiner, T.; Mason, S. A. Acta Cryst. 2000, B56, 254- 260. 
(16) For the preparation of the sodium tetraarylborate salts, originally used as aryl sources in rhodium 
mediated aryl conjugate additions, see: Shintani, R.; Tsutsumi, Y.; Nagaosa, M.; Nishimura, T.; Hayashi, T. 
J. Am. Chem. Soc., 2009, 131, 13588- 13589.  
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in acetonitrile resulted in the precipitation of sodium hexafluorophosphate to produce 
iminiums 45a and 45b. NMR spectra of these iminium ions in chloroform revealed an 
association as evidenced by large perturbations in the chemical shifts of various protons 
on the iminium ion, while the same compounds desolved in acetonitrile had spectra that 
were almost superimposable with the hexafluorophosphate salts, indicating a lack of 
association. It was also striking that the acetonitrile solutions were colourless, while 
solutions in chloroform were bright yellow.17 This colour change was reversible upon 
removal and exchange of solvents, as were the changes observed in the NMR spectra. It 
was also observed that the solutions in chloroform were light sensitive, rapidly changing 
to an orange colour under exposure to sunlight. Unfortunately even when protected from 
the light, solutions of the iminium borates in halogenated solvents were not sufficiently 
stable to enable Diels–Alder reactions to be conducted.18   
III. Solution to the Isomerization of the Diene 
With the difficulty encountered in forcing the Diels–Alder reaction to undergo an exo 
transition state on an E diene, it was decided to pursue the first option, that of suppressing 
the isomerization. While no decomposition of the dienophiles had been observed by 1H 
NMR, it is entirely possible that a quantity of acid arising from decomposition below the 
1H NMR detection limits would still be sufficient to conduct isomerization under the 
reaction conditions. It was also possible the solvent itself was decomposing to something 
acidic under the reaction conditions. Modulating the solvent proved to be ineffective. The 
dienophile is not soluble in less polar solvents, while the diene is not soluble in more 
polar solvents. Mixtures of solvents were difficult to employ as volatility differences 
                                                
(17) Coloured complexes have been observed with N-acylammonium tetrafluoroborates: King, J. A. Jr.; 
Bryant, G. L. Jr. J. Org. Chem., 1992, 57, 5136- 5139.  
(18) Hypothesis for the lack of stability are the potential protonation of aryl ligands on the electron rich 
borates, or alternately a Fridel–Crafts reaction between the iminium and the electron rich aryl borate. The 
acetonitrile solutions appear indefinitely stable, so some aspect of the tight association in halogenated 
solvents drives the decomposition. 
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coupled with evaporation into the headspace of the flask often resulted in sufficient 
changes in composition to promote oiling out of one component. Trifluorotoluene was 
explored as a solvent, but any improvement over dichloroethane was marginal.19 The 
addition of some kind of acid scavenger to the Diels–Alder reaction was attempted. Since 
the proton is required for the Diels–Alder reaction, it was initially thought that this could 
not be a stoichiometric base. Accordingly some experiments were carried out where 
solutions of Stang’s base 46, proton sponge 47  or pyridine 48 were titrated into three 
separate lots of iminium ion 4 in an NMR tube. Strikingly different results were obtained. 
Addition of Stang’s base or proton sponge resulted in the precipitation of a solid, and the 
gradual upfield migration of the exo iminium peaks until at the addition of one equivalent 
of the base the spectum was that of the free base imine 38.20 In the pyridine experiment, 
as one eqivalent of pyridine was titrated in in steps of 10%, the iminium peak broadened 
and finally disappeared, but the exomethylene peaks remained unpeturbed. Even if 
substoichiometric amounts of  46 and 47 were used, decomposition of the iminium ion in 
its entirety was observed over 24 hours.   
N N
N N
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
46 47 48  
Figure 6.10 Bases employed in NMR titration. 
Based on the above results, it was judged that pyridine would have least peturbation on 
the reaction, so a Diels–Alder reaction with 2 was prepared with 2 equivalents of 
dienophile 4 and one equivalent of pyridine. After heating to 40 °C for 18 hours, NMR 
studies showed that diene 2 was intact, but the dienophile had completely decomposed. 
This result can be understood as a consequence of the previously observed lack of 
                                                
(19) Curran has championed the use of trifluorotoluene as an environmentally friendly replacement for 
CH2Cl2. Akiya, O.; Curran, D. P. J. Org. Chem. 1997, 62, 450- 451. 
(20) The bases are not present in the NMR spectrum as it appears the hexafluorophosphate salts of the 
conjugate acids are completely insoluble in CDCl3. 
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stability of the free base imine 38. Presumably, the imine decomposes to products that are 
also basic, and so the proton can be transferred from intact iminium to decomposed 
imine, generating more imine to be decomposed. The overall outcome is that a catalytic 
amount of base results in complete decomposition of the iminium.  
 
A possible solution was using a base whose conjugate acid has a pKa much less than that 
of the iminium, but is still insufficiently acidic to effect the isomerization of the diene. 
This would keep the iminium protonated throughout the Diels–Alder reaction. 
Trifluoroacetate is a potential candidate. It had already been documented by Dr. Borg that 
iminium trifluoroacetates do not engage in Diels–Alder reactions with the macrocyclic 
dienes, but also do not decompose them. This is actually the main reason 
hexafluorophosphate was used instead of hexafluoroantimonate as the non-coordinating 
counterion in the final synthesis of 4 described in Chapter 5.21 This change allowed the 
ratio of hexafluorophosphate to trifluoroacetate to be observed by 19F NMR throughout 
the reaction. 
 
A preliminary experiment with a 2 equivalents of a 6: 1 ratio of hexafluorophosphate 
iminium 4 to trifluoroacetate iminium 49 was set up with the macrocyclic diene in DCE 
as the solvent. Gratifyingly, a new product diastereomer, tentatively assigned as 22, was 
present in an approximately 1:1 ratio with the undesired diastereomer. Unfortunately this 
mixture of 12 and 22 was not seperable, so at the time pure 22 for NMR studies could not 
be obtained. This finding bolstered the idea that buffering the reaction mixture could 
improve diastereoselectivity (Equation 6.4). The mixture of 4 and 49 could be held for 
several days under vacuum and the ratio of hexafluorophosphate to trifluoroacetate 
                                                
(21) Phosphorous is S=1/2 and hexafluorophosphate is well behaved in 19F NMR specta (Antimony 
consists of two naturally abundant isotopes, 121Sb is spin 5/2 and 123Sb is spin 7/2. Hexafluoroantimonate 
gives a very broad 19F NMR signal and often can not be observed at all.) 
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remained constant. Interstingly, when the Diels–Alder reaction mixture was pumped 
down, with no other manipulation, the sample was enriched in hexafluorophosphate. It is 
unclear if this supports the idea the iminium is decomposing to something with a weaker 
conjugate base, as I also observed that the Diels–Alder adducts will slowly lose 
trifluoroacetic acid under vacuum.22  
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1:1 12: 22NH
Me Bu
CF3COO
+
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4 (6.4)
Unfortunately, attempts to increase the ratio of trifluoroacetate to hexafluorophosphate 
resulted in unacceptably slow reaction rates, which was not surprising given Dr. Borg’s 
earlier results, and the importance of having non-coordinating counterions shown in 
Chapter 5. 
 
It was decided to investigate neutral buffers that could be added to pure iminium 
hexafluorophosphate. Four possible candidates emerged, triphenylphosphine, 
triphenylphosphine oxide, 2-fluoropyridine and 3- fluoropyridine (Table 6.1).23 
Admixture of triphenylphosphine and iminium 4 resulted in immediate decomposition, 
but the 3 other bases generated mixtures that were completely stable for 24 hours at 40 
ºC. It was decided that the volatile fluoropyridines were the best candidates for further 
investigation because of their ease of removal. 
                                                
(22) A hypothesis for this observation is that the position of the equilibrium between protonated iminiums 
12 and 22 and trifluoroacetic acid and free imine is sufficient to allow the trifluoroacetic acid to be pumped 
away over a several day time scale. It appears iminium 49 does not behave this way, but I did note that 49 
does tend to bind excess trifluoroacetic acid, so it is possible that the time to remove this excess is longer. 
The accurate integration of trifluoroacetic acid in 1H spectra of 49 is difficult because the single proton is 
extremely broad. 
(23) Triphenylphosphine pKa : Streuli, C. A. Anal. Chem., 1960, 32, 985- 987. Fluoropyridine pKas : 
Brown, H. C.; McDaniel, D. H. J. Am. Chem. Soc. 1955, 77, 3752- 3755.  
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Table 6.1 Screening of weak bases in the Diels–Alder reaction  
N N
P P
O
eq. Additivea pKa of BH+ % conversion of 2b 12 : 22
50 51 52 53
FN
48
a) Relative to 2. 3 eq of 4 were used relative to 2  b) After 48 hours reaction, 40 °C,
[2]> 0.1 M in DCE c) On a 40 mg scale. On smaller scales the ratio of 2 to 22
 is higher. d) 2 recovered unchanged, 4 decomposed e) Both 2 and 4 recovered unchanged
0.5 eq. 48 0 n/ad
0.5 eq. 50 0 n/ad
none n/a 50 3:1c
1 eq. 52 30 1: 2
3 eq.  52
F
< 10 n/ de
1 eq. 53 50 1: 6
3 eq. 52 < 10 n/de
entry
5.25
1
2
3
4
5
6
7
-0.44
-0.44
2.97
2.97
2.73
 
The base 3-fluoropyridine was judged to be the most promising, so was used in a 
preperative scale reaction with compounds 4 and 22 (equation 6.5). It is possible any 2-
fluoropyridinium formed is still acidic enough to promote isomerization. 
 
This reaction gave  a 9:1 diastereoselectivity for product 22 in a preperative scale reaction 
(Equation 6.5). The reaction was allowed to go for 6 days, and reached 76 % conversion 
of 12 with a 52 % yield of 22 (67 % based on recovered starting material). Attempting to 
increase the temperature generally led to inferior results in the screening reactions.   
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22
 DCE, 40 °C
[2] = 0.4 M
1 eq  53
76 % conversion
67 % yield BORSM
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O
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With abundant supplies of 22 available, efforts were undertaken to assign the 
stereochemistry. First a pure sample of 22 needed to be obtained. This was best 
accomplished by deprotonation to form freebase 54, followed by chromatography of 54, 
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after which 54 was protonated with TFA and subject to counterion exchange to reform 22 
(Scheme 6.4).24  
Scheme 6.4  
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The 1D ROESY correlations are shown in Figure 6.11. ROESY correlations between the 
allylic proton at C9 and the alpha protons at C31 were observed in each direction in both 
CDCl3 and C6D6.25 This is taken as proof of the desired stereochemistry. The only other 
Diels–Alder adduct that could have these enhancements would be 24, which would arise 
from an attack of the Z diene syn to the methyl group on 4 and would contain a syn 
pentane interaction. A ROESY correlation was also observed between the proton at C9 
and the proton at C12.   
NH
O
O
TBSO
TBSO OTBS
Me OTBDPS
H
PF69
22
Me
34
Pr
31 NH
O
O
TBSO
TBSO OTBS
Me OTBDPS
H
PF69
22
R
Me
34
H 12
H
N
OO
TBSO
TBSO
OTBSMe
OTBDPS
H
24
Me10
34
Bu
PF6
 
Figure 6.11 ROESY correlations for the assignment of 22. 
                                                
(24) Compounds 12 and 22 were not seperable by chromatography using MeOH/CH2Cl2 mixtures. 
Freebase 54 is seperable from the freebase of 12 by chromatography using EtOAc/hexanes, though the 
seperation is only feasible if the product ratio is high because the freebases streak even with Et3N additives. 
The streaking is attributed to tautomerization of the imine. 
(25) The assignments of the protons that were irradiated were made by COSY and confirmed by TOCSY 
irradiations with low mixing times. 
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There was too much overlap in the aliphatic region to determine if there was a ROESY 
correlation between the proton at C34 and the bridge at C10. 
 
IV. Macrolactone Ring Contraction in Deprotection 
Compound 22 could not be crystallized, so attempts to remove the protecting groups were 
undertaken. Exposure of 22 to hexafluorosilic acid resulted in complete removal of the 
silyl protecting groups.26 Unortunately a large upfield peturbation was observed in the 
chemical shift of the proton at C14. This suggested that the ester attachment had been lost. 
The mass spectrum suggested a lactone was still present, and 1H NMR studies suggested 
that structure  55 had formed (Equation 6.6).  
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The analogous ring contraction also occurred with macrolactone 2 to give lactone 56. A 
variety of conditions for the deprotection of macrolactone 2 were screened, and all 
appeared to promote this contraction (Table 6.2).27 This is a problem that will need to be 
addressed for a successful completion of the synthesis. Given the poor results obtained 
with acetonide protection described in the next section, a reasonable possibility would be 
the use of TES groups in place of all of the TBS groups in the molecule. These should not 
peturb comformation too much, and milder conditions may enable deprotection without 
rearrangement. It is unclear if the TES groups could be introduced in the beginning or if a 
later stage protecting group swap would need to be made. 
                                                
(26) a) for hexafluorosilicic acid see: Pilcher, A. S.; DeShong, P. J. Org. Chem. 1993, 58, 5130- 5134. b) 
for TAS-F, see Scheidt, K. A.; Chen, H.; Follows, B. C.; Chemler, S. R.; Coffey, D. S.; Roush, W. R. J. 
Org. Chem. 1998, 63, 6436- 6437. 
(27) Aqueous hydrofluoric acid was potentially promising, and should be investigated further. The 
dominant product was 56, but a small triplet was observed around 5 ppm, which may indicate unisomerized 
material. 
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Table 6.2 Attempts to suppress macrolactone contraction on 2.  
Me
TBSO
O
O
OTBS
OTBS
OTBDPS
2
Me
HO
OH
OH
56
O
O
OH
Reagent Solvent Outcome
1    CSA    MeOH/ CH2Cl2 56
2    HF•py THF 56
3    H2SiF6(aq) CD3CN 56
4    HF•py THF/py 56
5     TAS-F DMF-d7/ D2O 56
6     TBAF THF decomposition
7     TBAF THF/AcOH 56
8     Et3N(HF)3 CD3CN
9      HF(aq) CH3CN
56a
56a
a) Trace quantities of non rearranged macrolactone may be present.
Future investigation warrented
Entry
 
 
V. Studies on C3-C5 Acetonide Macrolactones 
With the finding that a trans-lactonization was occurring, a new protecting group strategy 
was briefly investigated, that is placing an acetonide on the C3 and C5 alcohols to form 
model Z diene 57 (Scheme 6.5). Removal of an acetonide may be done under milder 
conditions than the removal of TBS groups. It was envisioned that the TBS groups could 
be removed using a basic fluoride source, followed by mild acid treatment to remove the 
acetonide.28  
 
 
 
 
 
 
 
                                                
(28) If the conditions to remove the acetonide still promote lactonization, a cyclopentylidene ketal may be 
considered as the rate of hydrolysis is even faster. See: Evans, D. A.; Connell, B. T. 2003, 125, 10899- 
10905. 
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Scheme 6.5  
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c) PPTS, MeOH/CH2Cl2, 0 °C; d) TESCl, Et3N, 
CH2Cl2; e) Boc2O, CH3CN; f) SO3•py, i-Pr2NEt,
DMSO, CH2Cl2, 0 °C; g) 64, n-BuLi, THF, then 63;
h) CeCl3•7H2O, NaBH4, MeOH/THF, -60 °C; 
i) LiOH(aq), H2O2(aq), THF, -5 °C; j) MNBA, DMAP,
CH2Cl2.  
Synthesis of 57 was uneventful. Diene 58, synthesized by Dr. Pascal Bindschädler, was 
desilylated with HF•py. Formation of the C5 lactone was noted as a minor byproduct even 
with a C1 amide, so the compound was protected as the acetonide without further 
purification. Removal of the C12 methoxypropyl group, formed during the acetonide 
protection, gave compound 59. It was noted that approximately 10% isomerization to the 
E diene occurred during the course of these reactions, and this compound was 
inseperable. TES protection at C12 gave 60 which was then Boc protected to give 61. 
Removal of the C12 TES gave alcohol 62, which was then oxidized to aldehyde 63 and 
combined with phosphonate 64, available from the work in Chapter 5, to give HWE 
adduct 65. Compound 65 was subject to a Luche reduction to give allylic alcohol 66, 
which was complicated by the fact that the product and the starting material were 
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indistinguishable by TLC, unlike the Luche reduction on the bis TBS compound. The 
Boc amide on 66 could be hydrolyzed to give seco acid 67, which was cyclized to 57 
under Shiina conditions. The reactions in this sequence were only conducted one time 
each, and it is projected that if they were run again yields would be higher for the Luche 
reduction and amide cleavage. 
 
With compound 57 in hand, the first task was to assess the intrinsic facial selectivity of 
this molecule. Accordingly 57 was allowed to react with PTAD 25 (Scheme  6.6). The 
product of this reaction, 68 was obtained as predominantly one diasteromer. Notably, this 
reaction was slower than the PTAD reactions with compound 2, with the colour of the 
PTAD persisting for up to a minute upon mixing. Unfortunately, the 1H NMR spectrum 
of 68 did not closely resemble those of PTAD adducts 26 or 27, so the stereochemical 
assignment had to be done by a derivatization. Compound 68 was exposed to CSA in 
methanol which removed the acetonide without translacronization to give diol 69.29 
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(29) This possibly represents a solution to the translactonization problem. However removal of the 
acetonide before the TBS groups precludes any assistance in lactone cleavage from hydrogen bonding by a 
free alcohol at C15. More studies would have to be undertaken before this is considered a conclusive 
solution. 
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TBS protection of diol 69 gave a compound with an identical 1H spectrum to 26, which 
suggests the desired face is exposed on the Z diene acetonide macrocycle. Unfortunately, 
compound 57 did not react with dienophile 4. Despite extended reaction times at high 
temperatures, 4 and 57 could be recovered from Diels–Alder reactions unchanged 
(Equation 6.7). None of compound 70 was obtained. Compound 2 would have reacted or 
decomposed under the conditions attempted. It was noted the minor component of the E 
diene was consumed in this reaction, but nothing tractable could be obtained for 
characterization.  
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Given the slow reaction with PTAD, it was suspected that the diene may be more twisted 
out of an s-cis conformation than the diene in 2. Accordinly an attempt was made to 
cleave the acetonide in 57 to make diol 71 with the hopes that an increase in the degrees 
of freedom would produce a more reactive diene (Scheme 6.7). Diol 71 reacted with 
PTAD to give predominantly compound 69, showing that the facial selectivity was 
preserved. A minor compound was also noted, which suggested that comformations 
exposing the other face of the diene were now accessable. Unfortunately diol 71 
decomposed upon reaction with compound 4. Compound 71 was available in a small 
amount, and this experiment may bear repeating.  
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One final manifestation of the reactivity difference between compound 57 and compound 
2 was manifested in the isomerization behaviour. I attempted to isomerize 57 and 71 in 
acidic CDCl3 as I had with compound 2. Compound 57 underwent less than 50 % 
isomerization to compound 72 despite 4 days of continuous exposure to day/night cycles 
in CDCl3, while compound 71 was completely stable under these conditions and none of 
compound 73 was obtained (Scheme 6.8).30 
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I believe the enhanced stability of compounds 57  and 71 relative to 2 is indicative of the 
diene being twisted. A consequence of this is less basic system, less ameniable to 
protonation and subsequent isomerization. 
 
VI. Diels–Alder Application to the Elaborate System and Future Outlook 
Despite trepidation about the overall protecting group strategy, since compounds 1 and 3 
were in-hand, the analogous Diels–Alder was tried to produce elaborate Diels–Alder 
adduct 74. What is believed to be this compound was obtained in modest yield with 9:1 
diastereoselectivity. The 1H NMR spectrum of this compound strongly resembled that of 
22 in various diagnostic regions. (Equation 6.8) 
                                                
(30) The logic of continuous exposure to light was to maximize [HCl]. In retrospect, an intriguing 
possibility is that the reaction is undergoing photoisomerization to a photostationary state (a non- s-cis Z 
diene may be a worse chromophore). For an example of photochemistry on conjugated alkenes in acidic 
solvent see: Roberts, J. C.; Pincock, J. A. J. Org. Chem. 2004, 69, 4279- 4282. 
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Compound 75, the isomer at C33 was also obtained. Both compounds 74 and 75 were 
employed in trial RCM reactions. While these results are very preliminary, they are 
instructive. With this compound available, some ring closing metathesis attempts were 
tried. Exposure of 75, which has undesired C33 chemistry to second generation Hoveyda–
Grubbs catalyst 76 in C6D6 or CDCl3 resulted in the formation of a compound with mass 
corresponding to 77, but the reactions were very unclean by 1H NMR.31  
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(31) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc., 2000, 122, 8168- 
8179.  
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Freebase 78 was prepared, and rapidly reacted to form a compound that did not have a 
mass corresponding to 77. Since the mass obtained represented the loss of CH2, it was 
speculated that a rearrangement followed by a ring-opening reaction had occurred. The 
product of such a reaction could be compound 79. There is no NMR evidence 
corresponding to this structure, but an interesting observation is that 79 does not streak on 
TLC and is far less polar than 75 or 77.32 This could be explained by the reluctance of the 
10 membered ring in a compound such as 79 to form an Z-enamine tautomer (which is E 
relative to the carbon chain of the ring). Tautomerization could provide a mechanism for 
streaking. A mechanism for the loss of CH2 is proposed where alkylidene compound 80 
undergoes a protonation via a 7 membered ring to form alkylruthenium complex 81. This 
could undergo b hydride elimination to form 82.33 A metathesis on 82 could then form 
compound 79 (Figure 6.12).34   
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80 81 82
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Figure 6.12 Proposed mechanism for isomerization leading to loss of a methylene group. 
With these results, attention turned to metathesis on compound 74. Unfortunately, the 
same conditions that had resulted in masses consistent with RCM on compound 75 did 
not lead to mass hits for compound 83. Exposure of 74 to either Hoveyda–Grubbs 
catalyst 76 or rapidly initiating Piers catalyst 84 in refluxing CH2Cl2 resulted in either no 
                                                
(32) 75 and 78 have the same Rf on TLC in EtOAc/hexanes systems, and preperative chromatography of 53 
in this solvent system results in the recovery of 56. No loss of HPF6 is observed with MeOH/CH2Cl2 
systems. 
(33) For a discussion of isomerization during metathesis, see: Hong, S. H.; Sanders, D. P.; Lee, C. W.; 
Grubbs, R. H. J. Am. Chem. Soc. 2005, 127, 17160- 17161.  
(34) Coordination of the Ruthenium to the imine, followed by tautomerization to form a ruthenium η-3 
complex may be operative. 
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reaction or slow decomposition of 74.35 Freebase 85 was prepared. This also did not 
undergo RCM upon exposure to catalyst 76. Interestingly, no mass signals corresponding 
to compound 86  were obtained either, unlike the results obtained in Scheme 6.9. 
Prolonged heating in the presence of 76 resulted in complete decomposition of freebase 
86. 
Scheme 6.10 
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An explaination for this divergent reactivity is proposed in Figure 6.13. In ruthenium 
alkylidene 87, which would arise from compound 85, the chains containing C12 and C28, 
are on the opposite faces of the ring denoted as A, while in alkylidene 88, which arises 
                                                
(35) Romero, P. E.; Piers, W. E.; McDonald, R.  Angew. Chem. Int. Ed. 2004, 43, 6161- 6165.  
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from 78, the chains are on the same face of the ring denoted as A. It could be anticipated 
there would be a much lower barrier to forming the 10 membered ring from 88 than 87.  
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Figure 6.13 Proposal for structural divergence in reactivity in 78 and 85 
The decomposition proposed in figure 6.12 must still happen, accounting for the 
distruction of 85, however now this compound cannot undergo a by-product producing 
metathesis. 
 
Two future avenues for investigation of the ring closing metathesis are proposed in 
Figure 6.14. The first is to synthesize ene-carbamate 89 from Diels–Alder adduct 74.36 
This would contain a Z olefin (E relative to the 23 membered ring) that would disfavour a 
ring opening ring closing event. A potential danger of this substrate would be excision of 
the C26 to C32 segment if an alkylidene at C26 engaged the ene-carbamate in a metathesis, 
however, the quaternary centre at C33 should disfavour this on a steric basis. It is 
anticipated this compound will be more thermally stable than the iminium ions, which 
should allow more heating in an attempt to access conformations that close. Since this 
compound also lacks protic functionality, molybdenum and tungsten based catalysts 
could be screened.   
                                                
(36) Dr. Anna Chiu was able to protect Diels–Alder adducts with the Teoc group. See Equation 1 in 
Appendix B of her thesis for details. 
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Figure 6.14 Proposed substrate for second generation RCM reaction. 
A different strategy would involve attempting to change the order in which the catalyst 
engages the olefins. Hoveyda has shown that the Hoveyda–Grubbs catalyst can undergo 
hydrogen bonding to allylic alcohols which can accelerate the rate of catalysis.37 
Deprotection of the DMBM group at the C25 alcohol would produce compound 90 . RCM 
attempts on this compound would ascertain if any difference in reactivity would be 
present. 
 
Completion of the synthesis would still be dependant on developing a chemoselective 
reduction of the C26-C27 olefin formed in a metathesis, followed by finding global 
deprotection conditions that could thwart the translactonization described above. I believe 
at this point, before embarking on another scale-up, a better strategy to synthesize spiro-
prorocentrimine can be developed based on the observations described in this thesis. This 
is outlined in Appendix A. 
 
VII.  Conclusion 
A procedure was found to isomerize the Z macrocyclic diene to an E macrocyclic diene. 
The E macrocyclic diene was found to give the same product under the standard Diels – 
Alder reaction conditions as the Z macrocyclic diene, revealing that a previously 
undetected olefin isomerization during the Diels–Alder reaction actually resulted in the 
                                                
(37) Hoveyda, A. H.; Lombardi, P. J.; O’Brien, R. V.; Zhugralin, A. R. J. Am. Chem. Soc. 2009, 131, 8378- 
8379. I thank Prof. Amir Hoveyda and Dr. Robert O’Brien for suggesting this idea.  
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incorrect stereochemistry in previous model studies. A method to buffer the Diels–Alder 
reactions to prevent the isomerization based on consideration of the pKas of the 
conjugate acids of the dienophiles was developed and implemented. This chemistry was 
also applied to the elaborate system with success. Unfortunately attempts to deprotect the 
model system in an attempt to access a crystalline compound resulted in a contraction of 
the macrolactone. Protection of the alcohols at C3 and C5 with an acetonide was unfruitful 
because of a lack of reactivity of the acetonide protected Z diene.  While future 
investigations could revolve around global TES protection, a proposal has been 
developed for a different synthesis of spiro-prorocentrimine that is described in the 
subsequent appendix. 
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VII. Graphical Summary 
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(E)- TBDPS Truncated Model Macrocycle (11) 
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A NMR tube containing 1 mL CDCl3 and 29 mg of macrocycle 2 (0.031 mmol) was 
placed in direct sunlight on June 20th 2011 on the roof of the Harvard chemistry building 
in Cambridge Massachusetts from 9.00 am to 2.00 pm. 1H NMR showed approximately 
20 % isomerization had occurred. The tube was then kept in the dark for 3 days, at which 
time 1H NMR showed complete isomerization to 11. The solvent was removed to yield 
29 mg of E macrocycle 11 as a tacky white foam, which was used without further 
purification. 
 
Rf = 0.85 (10 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -2.2 (c 1.24, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.67- 7.62 (m, 4H), 7.45- 7.33 (m, 6H), 6.04 (d, J = 16.2 
Hz, 1H), 5.67 (dt, J = 14.2, 6.3 Hz, 1H), 5.53 (dt, J = 15.7, 6.8 Hz, 1H), 5.22 (dd, J = 
16.6, 8.3 Hz, 1H), 5.04 (ap. t, J = 8.8 Hz, 1H), 4.98 (s, 1H), 4.89 (s, 1H), 4.34- 4.27 (m, 
1H), 4.06 (d, J = 18.8 Hz, 1H), 3.74- 3.67 (m, 1H), 3.56 (t, J = 9.7 Hz, 1H), 3.37 (dd, J = 
9.8, 6.3 Hz, 1H), 2.54 (td, J = 16.6, 2.9 Hz, 1H), 2.46 (dd, J = 12.8, 8.3 Hz, 1H), 2.32- 
2.33 (m, 2H), 2.20- 2.11 (m, 2H), 1.79- 1.69 (m, 1H), 1.60- 1.53 (m, 1H), 1.06 (s, 9H), 
0.92- 0.86 (m, 3H), 0.90 (s, 3H), 0.88 (s, 9H), 0.81 (s, 9H), 0.68 (d, J = 6.8 Hz, 3H), 0.15 
(s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H), 0.05 (s, 3H); 
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13C NMR (125 MHz, CDCl3) δ 170.7, 142.9, 135.6 (broad signal), 135.1, 133.9, 129.9, 
129.6 (2 signals), 127.6 (broad signal), 116.7, 78.4, 71.6, 68.7, 66.4, 66.1, 47.0, 44.7, 
41.8, 37.6, 30.6, 26.9, 26.0, 25.9 (2 signals), 25.8, 19.2, 18.3, 18.1, 9.1, -4.0, -4.2, -4.4, -
4.5, -4.6, -4.8; 
 
IR(film) 2928.7, 2866.1, 1736.6, 1472.6, 1263.1, 1106.6, 836.6, 775.2, 700.9 cm-1; 
 
Exact Mass Calc. for C53H90O6Si4 [M + Na]+ : 957.57067  ; found : 957.5502 (ESI) 
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E Macrocycle 11 (20.5 mg, 0.022 mmol, 1.0 eq) and iminium 4 (12.2 mg, 0.039 mmol, 
1.8 eq) were mixed in 5 mL dry CH2Cl2, which was then removed immediately in vacuo 
to give a homogenous mixture. This was dissolved in 1 ml CDCl3 from a freshly opened 
bottle. This mixture was held in the dark at room temperature. After 17 hours, 1H NMR 
showed almost complete consumption of macrocycle x. The residue was purified by 
chromatography (1% MeOH in CH2Cl2) to afford 28 mg of title compound 12 (0.22 
mmol, quant.) as a tan foam. 
 
Rf = 0.30 (tight spot, 10% MeOH/ CH2Cl2, faintly UV active, stains blue with CAM) 
Rf = 0.30 (streaks heavily, 50% EtOAc/ hexanes) 
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[α]20D =  -23.7 (c 0.61 , CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 11.10 (br. s, 1H), 7.66- 7.61 (m, 4H), 7.45- 7.41 (m, 2H), 
7.40- 7.34 (m, 4H), 5.85 (ddd, J = 9.9, 9.8, 5.0 Hz, 1H), 5.37 (s, 1H), 5.19 (dd, J = 8.2, 
14.7 Hz, 1H), 5.07 (ap. t, J = 8.5 Hz, 1H), 4.10 (d, J = 8.6 Hz, 2H), 4.08- 4.03 (m, 1H), 
3.95- 3.86 (m, 1H), 3.85- 3.77 (m, 1H), 3.56 (t, J = 9.7 Hz, 1H), 3.39 (dd, J = 10.1, 6.0 
Hz, 1H), 2.73- 2.62 (m, 2H), 2.53- 2.46 (m, 3H), 2.35- 2.26 (m, 2H), 2.26- 2.18 (m, 4H), 
2.07- 1.94 (m, 3H), 1.88- 1.77 (m, 3H), 1.74- 1.58 (m, 4H), 1.50 (ap. t, J = 10.7 Hz, 1H), 
1.45- 1.33 (m, 3H), 1.10 (d, J = 6.6 Hz, 3H), 1.07 (s, 9H), 0.94 (t, J = 7.4 Hz, 3H), 0.91 
(s, 9H), 0.89 (s, 9H), 0.83 (s, 9H), 0.66 (d, J = 6.7 Hz, 3H), 0.10 (s, 3H), 0.09 (s, 6H), 
0.07 (s, 6H), 0.06 (s, 3H); 
 
1H NMR (600 MHz, C6D6) δ 11.50 (br. s, 1H), 7.81- 7.77 (m, 4H), 7.39- 7.27 (m, 6H), 
5.91 (ddd, J = 15.0, 10.0, 4.8 Hz, 1H), 5.48 (br. s, 1H), 5.42 (ap. t, J = 8.6 Hz, 1H), 5.32 
(dd, J = 14.9, 8.7 Hz, 1H), 4.43- 4.37 (m, 2H), 4.23- 4.18 (m, 1H), 3.86- 3.80 (m, 1H), 
3.77 (t, J = 9.8 Hz, 1H), 3.74- 3.66 (m, 1H), 3.58 (dd, J = 6.0, 10.1 Hz, 1H), 2.77 (d, J = 
13.8 Hz, 1H), 2.65 (dd, J = 9.7, 15.4 Hz, 1H), 2.62- 2.56 (m, 1H), 2.56- 2.49 (m, 1H), 
2.42- 2.21 (m, 5H), 2.19- 2.14 (m, 1H), 1.98 (ap. t, J = 13.2 Hz, 1H), 1.93- 1.83 (m, 3H), 
1.78- 1.67 (m, 3H), 1.58- 1.51 (m, 2H), 1.49- 1.42 (m, 2H), 1.37- 1.22 (m, 2H), 1.22 (s, 
9H), 1.01 (s, 9H), 1.00 (s, 9H), 0.98 (s, 9H), 0.98- 0.94 (m, 3H), 0.92- 0.82 (m, 2H), 0.74 
(d, J = 6.7 Hz, 3H), 0.50 (d, J = 6.4 Hz, 3H), 0.24 (s, 3H), 0.22 (s, 3H), 0.18 (s, 6H), 0.18 
(s, 3H), 0.14 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ198.5, 171.1, 137.3, 136.3, 135.6 (broad signal), 133.8, 
133.7, 129.7, 129.6, 128.9, 127.6 (broad signal), 126.0, 78.7, 71.1, 68.5, 67.3, 65.8, 48.7, 
44.9, 44.6, 43.3, 41.2, 40.5, 37.5, 35.6, 34.8, 31.1, 29.7, 28.6, 28.1, 26.9, 26.2, 26.0, 25.9, 
23.6, 22.4, 19.2, 18.3, 18.1, 17.9, 16.3, 13.3, 8.9, -4.2, -4.3, -4.4, -4.6, -4.7, -4.8; 
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IR(film) 2929.3, 2856.6, 1727.9, 1664.3, 1471.8, 1387.9, 1254.9, 1109.5, 974.6, 838.7, 
775.0, 702.2 cm-1; 
 
Exact Mass Calc. for C64H110NO6Si4+ [M cation]+ : 1100.7405  ; found : 1100.7374 (ESI) 
 
19F NMR (470 MHz, CDCl3) δ -72.6 (d, 1JPF = 713 Hz); 
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Z macrocycle 2 (78 mg, 0.0833 mmol, 1 eq) and iminium 4 (77 mg, 0.250 mmol, 3.0 eq) 
were mixed in 1 mL DCM in a 5 mL conical flask and the solvent was immediately 
removed in vacuo. The resulting tan foam was held under high vacuum with a stir bar for 
15 minutes. Subsequently, the flask was backfilled with nitrogen and 200 µL of 1,2 
Dichloroethane, freshly passed through a column of 80- 200 mesh Aluminia, Basic 
Brockman activity 1 were added. To the solution were added 7.2 µL 3-fluoropyridine 
(0.0833 mmol, 1 eq). The mixture was swirled to dissolve the foam and then was sealed 
and placed in a 40 °C oil bath. The reaction was stirred for 132 hours, after which time 
the solvent was removed in vacuo. Analysis by 1H NMR indicated a 1: 7 ratio of 
unconsumed Z macrocycle 2 to desired product. The ratio of desired product to undesired 
diastereomer was 9 : 1. The residue was redissolved in 50 mL CH2Cl2 and washed with 
2x 10 mL 1.0 M NaOH(aq). Purification was accomplished by chromatography with 50 % 
EtOAc/hexanes. Macrocycle 2 (18 mg, 0.019 mmol, 23 %) was recovered. All product 
containing fractions were concentrated and re-dissolved in 2 mL CH2Cl2. A drop of TFA 
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was added and volatiles were removed in vacuo. The residue was taken up in 10 mL 
CH2Cl2 and washed 2x with saturated NaPF6(aq). Concentration in vacuo gave 52 mg of 
12  (0.0417 mmol, 50 %) as a tan foam 
 
Rf = 0.30 (tight spot, 10% MeOH in CH2Cl2, stains blue with CAM, faintly UV active) 
Rf = 0.25 (major diastereomer, 50% EtOAc/ hexanes) 
 
1H NMR (600 MHz, CDCl3) δ 10.6 (br. s, 1H), 7.67-7.63 (m, 4H), 7.46- 7.41 (m, 2H), 
7.41- 7.36 (m, 4H), 5.44 (tdd, J = 11.8, 8.5, 2.8 Hz, 1H), 5.36 (br. s, 1H), 5.03 (dd, J = 
15.4, 10.4 Hz, 1H), 4.81 (ap. t, J = 9.0 Hz, 1H), 4.08 (d, J = 8.8 Hz, 1H), 4.04- 3.98 (m, 
1H), 3.97- 3.90 (m, 1H), 3.91- 3.84 (m, 1H), 3.65- 3.60 (m, 1H), 3.58 (ap. t, J = 9.6 Hz,  
1H), 3.41 (dd, J = 10.2, 6.2 Hz, 1H), 3.00- 2.93 (m, 1H), 2.88- 2.79 (m, 2H), 2.47- 2.32 
(m, 4H), 2.26- 2.05 (m, 5H), 1.88- 1.83 (m, 1H), 1.79- 1.69 (m, 5H), 1.65 (t, J = 11.0 Hz, 
1H), 1.56- 1.47 (m, 2H), 1.11 (d, J = 7 Hz, 1H), 1.09 (s, 9H), 0.99 (t, J = 7.3 Hz, 3H), 
0.91 (s, 3H), 0.90 (s, 9H), 0.84 (s, 9H), 0.68 (d, J = 6.7 Hz, 3H), 0.11 (br. s, 6H), 0.10 (s, 
3H), 0.07 (s, 6H).   
 
1H NMR (500 MHz, C6D6) δ 10.95 (br. s, 1H), 7.82- 7.77 (m, 4H), 7.31- 7.26 (m, 6H), 
5.57 (ap. t, J = 14.6 Hz, 1H), 5.14 (br. s, 1H), 5.05 (ap. t, J = 8.8 Hz, 1H), 4.99 (dd, J = 
15.1, 9.3 Hz, 1H), 4.20 (d, J = 8.3 Hz, 1H), 4.15- 4.07 (m, 1H), 4.07- 3.93 (m, 2H), 3.80- 
3.73 (m, 2H), 3.61- 3.58 (m, 1H), 3.05- 2.89 (m, 2H), 2.81- 2.75 (m, 1H), 2.62- 2.58 (m, 
1H), 2.54- 2.49 (m, 1H), 2.43- 2.38 (m, 1H), 2.25- 2.19 (m, 1H), 2.15 (dd, J = 12.2, 9.8 
Hz, 1H), 2.05- 1.83 (m, 7H), 1.83- 1.75 (m, 1H), 1.70- 1.62 (m, 2H), 1.60- 1.52 (m, 2H), 
1.19 (s, 9H), 1.06 (t, J = 7.3 Hz, 3H), 1.04 (s, 9H), 0.98 (s, 9H), 0.91 (s, 9H), 0.80 (d, J = 
6.8 Hz, 3H), 0.70 (d, J = 6.7 Hz, 3H), 0.21 (s, 3H), 0.20 (s, 3H), 0.18 (s, 3H), 0.15 (s, 
3H), 0.13 (s, 3H), 0.12 (s, 3H). 
 
  326 
13C NMR (125 MHz, CDCl3) δ 198.8, 170.5, 135.6 (broad signal), 135.1, 133.8 (broad 
signal), 129.7, 129.6, 128.0, 127.6, 122.6, 80.9, 70.9, 68.8, 67.0, 65.9, 47.3, 46.8, 46.0, 
45.3, 42.7, 39.1, 37.4, 33.3, 29.7, 28.9, 28.5, 28.4, 28.1, 26.9, 26.1, 26.0, 25.9, 25.8, 24.6, 
22.4, 19.2, 18.4, 18.0, 17.2, 13.3, 9.0, -3.9, -4.0, -4.5, -4.6; 
 
IR(film) 3344.8, 3290.4, 2955.6, 2856.9, 1720.7, 1671.8, 1471.8, 1387.2, 1255.2, 1109.9, 
838.7, 775.1, 702.4 cm-1; 
 
Exact Mass Calc. for C64H110NO6Si4+ [M cation]+ : 1100.7405  ; found : 1100.7517 (ESI) 
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E macrocycle 11 (13 mg, 0.014 mmol) was dissolved in 2 mL CH2Cl2. Separately PTAD 
(2.4 mg, 0.014 mmol, 1 eq) was dissolved in 1 mL CH2Cl2. The cherry red PTAD 
solution was added dropwise to the solution of 11 and the red colour was discharged with 
each drop. At the very end of the addition, a faint pink colour persisted. The solvent was 
removed and 1H NMR analysis showed essentially one diastereomer. The residue was 
purified by flash chromatography (10% EtOAc/hexanes) to afford Diels- Alder adduct 26 
(15 mg, 0.013 mmol, 97%) as a clear colourless oil. 
 
Rf = 0.16 (10% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -50.8 (c 0.34, CHCl3); 
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1H NMR (600 MHz, CDCl3) δ 7.64 (ap. t, J = 6.7, 4H), 7.54 (ap d, J = 7.5 Hz, 2H), 7.46 
(ap. t, J = 7.6 Hz, 2H), 7.45- 7.40 (m, 2H), 7.40- 7.34 (m, 5H), 5.89 (ddd, J = 10.4, 10.3, 
4.8 Hz, 1H), 5.49 (br. s, 1H), 5.24 (dd, J = 16.1, 9.2 Hz, 1H), 5.11 (ap. t, J = 9.1 Hz, 1H), 
4.28- 4.23 (m, 2H), 4.17 (ap. t, J = 8.9 Hz, 1H), 4.12 (dd, J = 9.0, 1.0 Hz, 1H), 4.09- 4.04 
(m, 1H), 3.98 (d, J = 16.2 Hz, 1H), 3.57 (t, J = 9.8 Hz, 1H), 3.39 (dd, J = 10.2, 5.1 Hz, 
1H), 2.59- 2.49 (m, 2H), 2.45- 2.23 (m, 4H), 1.81- 1.70 (m, 2H), 1.65- 1.56 (m, 2H), 1.07 
(s, 9H), 0.91 (s, 9H), 0.90 (s, 9H), 0.84 (s, 9H), 0.64 (d, J = 6.4 Hz, 3H), 0.10 (br. s, 9H), 
0.09 (s, 3H), 0.07 (s, 3H), 0.07 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 171.5, 152.1, 137.7, 135.6, 133.8, 131.4, 129.8, 129.6, 
129.1, 127.9, 127.7, 127.6, 127.1, 126.7, 125.3, 124.6, 79.2, 70.9, 68.4, 67.0, 65.7, 55.5, 
47.5, 44.3, 43.3, 38.5, 37.4, 36.6, 31.6, 31.4, 29.7, 26.9, 26.0, 25.9, 25.8, 25.7, 24.7, 19.2, 
18.3, 18.1, 17.9, 8.7, -4.2, -4.3, -4.5, -4.7 (2 signals); 
 
IR(film) 2954.9, 2956.4, 1775.4, 1720.5, 1503.6, 1471.5, 1415.7, 1255.9, 1090.3, 836.7, 
775.2, 702.0 cm-1; 
 
Exact Mass Calc. for C61H95N3O8Si4 [M + Na]+ : 1132.6088  ; found : 1132.5877 (ESI) 
 
 
PTAD Diels- Alder with Z diene  
Me
TBSO
O
O
OTBS
OTBS
OTBDPS
2
Me
TBSO
ON
O
OTBS
OTBS
9
OTBDPS
N
N
O
O
Ph
27
 
The integrity of the Z diene in the sample of macrocycle used in this experiment was 
investigated by 1H NMR immediately prior to the experiment and a 33: 1 ratio of Z to E 
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dienes was observed. Z macrocycle 2 (9 mg, 0.01 mmol, 1 eq) was dissolved in 1 mL 
CH2Cl2 and a solution of PTAD (1.7 mg, 0.01 mmol, 1 eq) was added dropwise until a 
faint pink colour persisted. The solvent was removed in vacuo and 1H NMR analysis 
showed a 6:1 ratio of disastereomers where the minor distereomer corresponds to 
compound 26 . The diastereomers can be separated by gradient chromatography (5% to 
10% EtOAc/ hexanes).  Characterization data for the major diastereomer 27: 
 
Rf = 0.13 (10% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = +73 (c 0.66, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.66- 7.62 (m, 4H), 7.55 (ap. d, J = 9.4 Hz, 2H), 7.49- 
7.34 (m, 9H), 5.79 (ap. dt, J = 15.4, 7.0 Hz, 1H), 5.71 (ap. d, J = 4.8 Hz, 1H), 5.41 (dd, J 
= 15.4, 6.9 Hz, 1H), 5.09 (ap. t, J = 7.8 Hz, 1H), 4.71 (d, J = 16.4 Hz, 1H), 4.42- 4.37 (m, 
1H), 4.14- 4.10 (m, 1H), 4.08 (d, J = 8.5 Hz, 1H), 3.80 (d, J = 16.4 Hz, 1H), 3.58 (ap. t, J 
= 9.4 Hz, 1H), 3.40 (dd, J = 10.2, 6.1 Hz, 1H), 2.58 (AB dd, J = 15.2, 2.9 Hz, 1H), 2.51 
(AB dd, J = 15.2, 10.3 Hz, 1H), 2.39 (d, J = 13.8 Hz, 1H), 2.38- 2.30 (m, 2H), 2.26 (dd, J 
= 13.9, 5.6 Hz, 1H), 2.16- 2.11 (m, 1H), 1.95 – 1.87 (m, 1H), 1.79- 1.68 (m, 2H), 1.62- 
1.56 (m, 2H), 1.07 (s, 9H), 0.94 (s, 9H), 0.92 (s, 9H), 0.85 (s, 9H), 0.72 (d, J = 6.8 Hz, 
3H), 0.13 (s, 3H), 0.13 (s, 3H), 0.12 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 170.8, 152.4, 151.5, 135.6, 134.1, 133.8 (2 signals), 
131.4, 129.7, 129.6, 129.0, 128.6, 127.9, 127.6, 126.8, 125.3, 124.6, 77.8, 71.9, 68.5, 
67.3, 65.8, 54.8, 47.9, 44.0, 43.4, 37.7, 37.6, 36.6, 34.3, 30.1, 26.9, 26.0, 25.9, 25.8, 24.7, 
19.2, 18.3, 18.1, 17.9, -4.2, -4.4, -4.5, -4.6 (2 signals), -4.7; 
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IR(film) 2928.7, 2856.1, 1772.4, 1719.0, 1502.4, 1471.9, 1412.9, 1255.1, 1091.5, 836.9, 
775.2, 702.0 cm-1; 
 
Exact Mass Calc. for C61H95N3O8Si4 [M + Na]+ : 1132.6088  ; found : 1132.5980 (ESI) 
 
2-((4S,6S)-6-((Z)-7-hydroxy-2-methylenehept-3-en-1-yl)-2,2-dimethyl-1,3-dioxan-4-
yl)-N-phenylacetamide 
PhHN
O OTBSOTBS OH O OHOO
PhHN
Me Me
58 59  
The following telescoping sequence was found to give optimum throughput. The terminal 
MOP group is not entirely stable to chromatography, but relying on chromatography for 
its removal proved detrimental to yields. Accordingly the following 3 step procedure is 
implemented: 
 
Z diene 58 (156 mg, 0.278 mmol) was dissolved in 5 mL THF in a Falcon® tube and 0.6 
mL pyridine were added followed by 0.8 mL HF-pyridine. The mixture was stirred for 18 
hours, until no species that stained in CAM with an Rf greater than 0.05 in 70% 
EtOAc/hexanes were present. The reaction was quenched by the addition of solid 
NaHCO3 and stirred until bubbling ceased (approximately 15 minutes). The mixture was 
filtered through Celite®, and washed with 40 mL EtOAc. The solvent was removed in 
vacuo and the residue was held under high vacuum for 2 hours to remove residual 
pyridine. The residue was used directly in the next step without any further purification. 
 
TLC characterization of intermediate triol: 
 
Rf = 0.05 (70% EtOAc/hexanes, faintly UV active, stains dark blue in CAM) 
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The crude triol was dissolved in 3 mL CH2Cl2 and 1.5 ml dimethoxypropane were added. 
To the stirring solution at room temperature was added a crystal of PPTS. After several 
minutes, an spot with Rf = 0.4 in 70% EtOAc/hexanes was observed. This was attributed 
to methoxypropyl protection of the primary alcohol. Over the next hour, this turned into a 
spot with Rf = 0.95 in 70% EtOAc/hexanes, which was attributed to the addition of the 
acetonide group. After 1.5 hours, when the lower spot vanished, the reaction was 
quenched with 2 mL saturated NaHCO3(aq) and the aqueous layer was extracted with 10 
mL DCM. The combined organic layers were dried with brine and Na2SO4 then 
concentrated to yield a crude MOP acetonide that was used directly in the next step.  
 
TLC characterization of intermediate MOP acetonide: 
Rf = 0.95 (70% EtOAc/hexanes. UV active, stains blue in CAM) 
The crude acetonide was dissolved in a mixture of 3 mL CH2Cl2 and 0.6 mL MeOH and 
cooled to 0 °C. A crystal of PPTS was added. After 2.5 hours, TLC (70% 
EtOAc/hexanes) showed consumption of the starting material, so the reaction was 
quenched with saturated NaHCO3(aq) and diluted with 40 mL 90% EtOAc/hexanes. This 
was dried with brine, then over Na2SO4, then concentrated in vacuo. The residue was 
purified by flash chromatography (50% EtOAc/hexanes) to yield 59.4 mg of alcohol 59 
(0.159 mmol, 57% ) as a clear colourless oil. 
 
Rf = 0.60 (70% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -5.5 (c 2.97, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 8.39 (br. s, 1H), 7.48 (d, J = 8.7 Hz, 2H), 7.32 (t, J = 7.5 
Hz, 2H), 7.10 (t, J = 7.3 Hz, 1H), 5.80 (dd, J = 11.7, 1.3 Hz, 1H), 5.50 (dt, J = 11.6, 7.4 
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Hz, 1H), 5.05 (s, 1H), 4.94 (s, 1H), 4.30- 4.25 (m, 1H), 4.00- 3.95 (m, 1H), 3.65 (AB d, J 
= 6.0 Hz, 1H), 3.63 (AB d, J = 6.1 Hz, 1H), 2.58- 2.50 (m, 2H), 2.40 (dd, J = 13.8, 6.0 
Hz, 1H), 2.33 (pent. d, J = 7.8, 1.5 Hz, 1H), 2.29 (pent. d, J = 6.7, 1.4 Hz, 1H), 2.15 (dd, 
J = 13.7, 7.2 Hz, 1H), 1.69- 1.62 (m, 2H), 1.53- 1.48 (m, 2H), 1.49 (s, 6H), 1.28 (dd, J = 
11.6, 14.5 Hz, 1H); 
 
13C NMR (125 MHz, CDCl3) δ 169.0, 140.6, 137.9, 132.0, 130.1, 128.9, 124.0, 119.6, 
116.4, 99.1, 67.7, 66.6, 62.0, 43.9 (2 signals), 35.6, 32.8, 30.1, 24.9, 19.8; 
 
IR(film) 3458.1, 3310.7, 3138.8, 2993.1, 2939.2, 1665.3, 1600.1, 1548.1, 1499.3, 1444.2, 
1380.3, 1259.8, 1200.3, 1167.1, 1063.0, 984.7, 900.8, 756.3, 692.6 cm-1 ; 
 
Exact Mass Calc. for C22H31NO4 [M + Na]+ : 374.2326  ; found : 374.2336 (ESI) 
 
 
2-((4S,6S)-2,2-dimethyl-6-((Z)-2-methylene-7-((triethylsilyl)oxy)hept-3-en-1-yl)-1,3-
dioxan-4-yl)-N-phenylacetamide 
 
O OHOO
PhHN
Me Me
59
O OTESOO
PhHN
Me Me
60  
Alcohol 59 (59 mg, 0.158 mmol, 1 eq) was dissolved in 3 mL CH2Cl2 and DMAP (4 mg, 
0.2 eq) and triethylamine (0.110 mL, 0.790 mmol, 5 eq) were added. To the solution were 
added 0.080 mL (0.474 mmol, 3 eq) of chlorotriethylsilane. After 5 minutes, TLC 
analysis (20% EtOAc/hexanes) showed completion. The reaction was quenched with 
saturated NaHCO3(aq), diluted with 50 mL CH2Cl2 and washed with 10 ml saturated 
NaHCO3(aq). The organic layer was washed with brine, dried over Na2SO4 and 
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concentrated in vacuo. Purification of the residue by flash chromatography afforded 67.2 
mg of TES ether 60 (0.137 mmol, 87%) as a clear colourless oil. 
 
Rf = 0.30 (20% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -1.9 (c 3.36, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 8.46 (br. s, 1H), 7.49 (d, J = 7.6 Hz, 2H), 7.32 (t, J = 7.4 
Hz, 2H), 7.09 (t, J = 7.3 Hz, 1H), 5.77 (dd, J = 11.6, 1.0 Hz, 1H), 5.51 (dt, J = 11.7, 7.3 
Hz, 1H), 5.04 (s, 1H), 4.94 (s, 1H), 4.30- 4.25 (m, 1H), 3.99- 3.95 (m, 1H), 3.62 (t, J = 
6.3 Hz, 2H), 2.58- 2.49 (m, 2H), 2.40 (dd, J = 13.6, 6.2 Hz, 1H), 2.26 (qd, J = 7.6, 1.6 
Hz, 2H), 2.15 (dd, J = 13.8, 6.8 Hz, 1H), 1.61 (ap. pent., J = 7.8 Hz, 2H), 1.59- 1.54 (dt, J 
= 13.2, 2.3 Hz, 1H), 1.50 (s, 3H), 1.49 (s, 3H), 1.29 (q, J = 12.8 Hz, 1H), 0.96 (t, J = 8.0 
Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 168.8, 140.7, 138.1, 132.4, 129.6, 128.9, 123.9, 119.5, 
116.2, 99.1, 67.7, 66.6, 62.3, 44.0, 35.6, 33.2, 30.2, 25.2, 19.8, 6.7, 4.4; 
 
IR(film) 3313.3, 2992.3, 2952.3. 2942.3, 2875.8, 1654.3, 1600.5, 1546.4, 1499.4, 1443.6, 
1380.0, 1258.5, 1200.2, 1167.7, 1099.7, 1016.3, 898.7, 810.7, 746.9 cm-1 ; 
 
Exact Mass Calc. for C28H45NO4Si [M + Na]+ : 510.30101  ; found : 510.3017 (ESI) 
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tert-butyl (2-((4S,6S)-2,2-dimethyl-6-((Z)-2-methylene-7-((triethylsilyl)oxy)hept-3-
en-1-yl)-1,3-dioxan-4-yl)acetyl)(phenyl)carbamate  
O OTESOO
PhHN
Me Me
60
O OTESOO
PhN
Me Me
Boc 61  
Amide 60 (67 mg, 0.137 mmol, 1 eq) was dissolved in 3 mL CH2Cl2 and DMAP (84 mg, 
0.687 mmol, 5 eq) and BOC2O (149 mg, 0.687 mmol, 5 eq) were added. After 2 hours, 
TLC (20% EtOAc/hexanes, CAM) showed complete consumption of the starting 
material. The solvent was removed in vacuo and the residue was purified by flash 
chromatography (10% EtOAc/hexanes) to yield 78.8 mg of Boc amide 61 (0.134 mmol, 
98%) as a clear colourless oil.  
 
Rf = 0.60 (20% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = +3.5 (c 3.94, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.39 (ap. t, J = 8.7 Hz, 2H), 7.33 (ap.t, J = 7.5 Hz, 1H), 
7.08 (ap. d, J = 7.3 Hz, 2H), 5.78 (dd, J = 11.6, 1.0 Hz, 1H), 5.50 (dt, J = 11.7, 7.3 Hz, 
1H), 5.04 (s, 1H), 4.93 (s, 1H), 4.45- 4.40 (m, 1H), 3.99- 3.94 (m, 1H), 3.62 (t, J = 6.6 
Hz, 2H), 3.20 (dd, J = 17.0, 7.3 Hz, 1H), 2.95 (dd, J = 17.1, 4.8 Hz, 1H), 2.40 (dd, J = 
13.6, 6.0 Hz, 1H), 2.27 (qd, J = 7.5, 1.6 Hz, 2H), 2.14 (dd, J = 13.7, 7.0 Hz, 1H), 1.65- 
1.59 (m, 3H), 1.44 (s, 3H), 1.38 (s, 3H), 1.38 (s, 9H), 1.21 (q, J = 12.5 Hz, 1H), 0.97 (t, J 
= 7.9 Hz, 9H), 0.60 (q, J = 7.9 Hz, 6H); 
 
13C NMR (125 MHz, CDCl3) δ173.0, 152.6, 141.1, 138.8, 132.1, 129.8, 128.9, 128.1, 
127.7, 115.9, 98.7, 83.0, 67.7, 66.0, 62.4, 44.6, 44.2, 36.4, 33.3, 30.1, 27.7, 25.1, 19.6, 
6.7, 4.4; 
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IR(film) 2952.7, 2876.2, 1737.4, 1707.8, 1457.4, 1369.9, 1294.0, 1256.1, 1090.1, 745.8 
cm-1 ; 
 
Exact Mass Calc. for C33H43NO6Si4 [M + Na]+ : 610.35344  ; found : 610.3551 (ESI) 
 
 
 
tert-butyl (2-((4S,6S)-6-((Z)-7-hydroxy-2-methylenehept-3-en-1-yl)-2,2-dimethyl-1,3-
dioxan-4-yl)acetyl)(phenyl)carbamate  
O OTESOO
PhN
Me Me
Boc 61
O OHOO
PhN
Me Me
Boc 62  
TES ether 61 (78.8 mg, 0.134 mg) was dissolved in a mixture of 3 mL CH2Cl2 and 0.6 
mL MeOH. This mixture was cooled to 0 °C and a crystal of PPTS was added. TLC after 
15 minutes (20% EtOAc/hexanes) showed complete consumption of starting material so 
the reaction was quenched with 1 mL saturated NaHCO3(aq). This was diluted with 30 mL 
90% EtOAc/hexanes, washed with brine, dried over Na2SO4 and concentrated in vacuo to 
yield a residue. Purification by flash chromatography (40% EtOAc/hexanes) yielded 58.2 
mg of alcohol 62 (0.123 mmol, 92%) as a clear colourless oil. 
 
Rf = 0.15 (40% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -9.0 (c 2.91, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.41- 7.37 (m, 2H), 7.35- 7.31 (m, 1H), 7.09- 7.06 (m, 
2H), 5.80 (d, J = 11.6 Hz, 1H), 5.49 (dt, J = 11.6, 6.9 Hz, 1H), 5.06 (s, 1H), 4.93 (s, 1H), 
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4.42- 4.36 (m, 1H), 3.98- 3.92 (m, 1H), 3.60- 3.56 (m, 2H), 3.18 (dd, J = 17.3, 6.6 Hz, 
1H), 2.97 (dd, J = 17.2, 6.0 Hz, 1H), 2.42 (dd, J = 13.5, 5.6 Hz, 1H), 2.36 (pent. d, J = 
8.0, 1.3 Hz, 1H), 2.27- 2.18 (m, 1H), 2.14 (dd, J = 13.6, 7.8 Hz, 1H), 1.72- 1.67 (m, 1H), 
1.66- 1.60 (m, 2H), 1.45 (s, 3H), 1.38 (s, 3H), 1.37 (s, 9H), 1.16 (q, J = 11.8 Hz, 1H); 
 
13C NMR (125 MHz, CDCl3) δ 173.2, 152.4, 140.9, 138.7, 132.0, 130.1, 128.9, 128.1, 
127.8, 116.2, 98.7, 83.2, 67.8, 66.0, 62.2, 44.6, 44.2, 36.3, 32.9, 30.1, 27.7, 24.9, 19.7; 
 
IR(film) 3484.1, 2990.4, 2938.4, 1737.2, 1370.2, 1293.8, 1257.8, 1154.8, 1089.4, 758.2, 
694.4; 
 
Exact Mass Calc. for C27H39NO6 [M + Na]+ : 496.2670  ; found : 496.2681 (ESI) 
 
tert-butyl (2-((4S,6S)-2,2-dimethyl-6-((Z)-2-methylene-7-oxohept-3-en-1-yl)-1,3-
dioxan-4-yl)acetyl)(phenyl)carbamate  
O OHOO
PhN
Me Me
Boc
O OOO
PhN
Me Me
Boc
H
62 63  
Alcohol 62 (60 mg, 0.127 mmol, 1eq) was dissolved in CH2Cl2 and cooled to 0 °C. 
Hunig’s base (0.070 mL, 0.380 mmol, 3 eq) was added, followed by DMSO (0.053 mL, 
0.760 mmol, 6 eq). SO3-Py complex (40 mg, 0.253 mmol, 2 eq) was added, and TLC 
(40% EtOAc/hexanes) after 10 minutes showed the completion of the reaction. Volatiles 
were removed in vacuo and the residue was purified by flash chromatography (20% 
EtOAc/hexanes) to yield aldehyde 63 (50.1 mg, 0.106 mmol, 83%) as a clear colourless 
oil. 
 
Rf = 0.25 (20% EtOAc/hexanes, UV active, stains blue in CAM) 
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[α]20D = +1.6 (c 2.50, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 9.72 (t, J = 1.4 Hz, 1H), 7.39- 7.36 (m, 2H), 7.33- 7.30 (m, 
1H), 7.09- 7.06 (m, 2H), 5.83 (d, J = 11.6, 1H), 5.46- 5.41 (m, 1H), 5.08 (s, 1H), 4.91 (s, 
1H), 4.44- 4.38 (m, 1H), 4.38- 4.32 (m, 1H), 3.20 (dd, J = 17.1, 6.9 Hz, 1H), 2.96 (dd, J = 
7.3, 4.4 Hz, 1H), 2.38 (dd, J = 13.6, 6.1 Hz, 1H), 2.14 (dd, J = 13.8, 4.9 Hz, 1H), 1.64 (dt, 
J = 12.8, 2.3 Hz, 1H), 1.44 (s, 3H), 1.37 (s, 3H), 1.36 (s, 9H), 1.19 (q, J = 11.6 Hz, 1H); 
 
13C NMR (125 MHz, CDCl3) δ 201.7,173.0, 152.9, 140.9, 138.8, 131.2, 129.8, 128.9 (2 
peaks), 128.1, 127.7, 116.4, 98.7, 83.1, 67.7, 66.0, 44.6, 44.1, 43.9, 36.4, 30.1, 27.7, 21.3, 
19.6; 
 
IR(film) 2989.4, 2939.3, 1736.1, 1493.2, 1379.6, 1294.1, 1257.7, 1199.1, 1155.3, 1088.2, 
756.6, 694.5 cm-1; 
 
Exact Mass Calc. for C27H37NO6 [M + Na]+ : 494.2513  ; found : 494.2507 (ESI) 
 
 
tert-butyl (2-((4S,6S)-6-((3Z,7E,10S,11R)-10-((tert-butyldimethylsilyl)oxy)-12-((tert-
butyldiphenylsilyl)oxy)-11-methyl-2-methylene-9-oxododeca-3,7-dien-1-yl)-2,2-
dimethyl-1,3-dioxan-4-yl)acetyl)(phenyl)carbamate  
O OOO
PhN
Me Me
Boc
H
OTBDPS
Me
TBSO
O
P
O
MeO
MeO
63
64
OOO
PhN
Me Me
Boc
OTBDPS
Me
TBSO
O
65  
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Phosphonate 64 (126 mg, 0.213 mmol, 2.0 eq) was dissolved in 1 mL THF and cooled to 
0 °C. Freshly titrated nBuLi (45 µL, 3.5 M, 0.16 mmol, 1.5 eq) was added dropwise and 
the clear colourless solution was stirred for 25 minutes. A solution of aldehyde 63 (50.1 
mg, 0.106 mol, 1 eq) in 1 + 1 mL THF was added and the reaction was protected from 
light. The cooling bath was allowed to decay naturally over 2 hours. After 20 hours, TLC 
(20% EtOAc/hexanes, CAM visualization) indicated consumption of the aldehyde, so the 
reaction was quenched by addition of saturated NH4Cl(aq) and diluted with 40 mL 90% 
EtOAc/hexanes. This was washed with brine, then dried over Na2SO4. Concentration in 
vacuo  gave a residue that was purified by flash chromatography  (20% EtOAc/hexanes) 
to afford 98.8 mg (0.105 mmol, 99%) of enone 65 as a very pale yellow oil. 
 
Rf = 0.50 (20% EtOAc/hexanes, strongly UV active, stains blue in CAM) 
 
[α]20D = -6.1 (c 4.94, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.67- 7.65 (m, 4H), 7.44- 7.40 (m, 2H), 7.40- 7.36 (m, 
6H), 7.33- 7.30 (m, 1H), 7.08- 7.06 (m, 2H), 6.93 (dt, J = 15.7, 6.7 Hz, 1H), 5.81 (d, J = 
14.2 Hz, 1H), 5.44 (dt, J = 11.6, 7.2 Hz, 1H), 5.04 (br. s, 1H), 4.88 (br. s, 1H), 4.45 (d, J 
= 3.4 Hz, 1H), 4.44- 4.39 (m, 1H), 3.97- 3.92 (m, 1H), 3.61 (dd, J = 9.9, 8.2), 3.44 (dd,  J 
= 10.1, 5.7 Hz, 1H), 3.20 (dd, J = 17.7, 7.2 Hz, 1H), 2.95 (dd, J = 17.1, 5.0 Hz, 1H), 2.40- 
2.33 (m, 2H), 2.29- 2.25 (m, 1H), 2.13 (dd, J = 13.9, 6.6 Hz, 1H), 2.05- 2.00 (m, 1H), 
1.65- 1.60 (m, 1H), 1.43 (s, 3H), 1.37 (s, 12H), 1.06 (s, 9H), 0.90 (s, 9H), 0.75 (d, J = 6.9 
Hz, 1H), 0.01 (s, 6H);  
 
13C NMR (125 MHz, CDCl3) δ201.6, 173.0, 152.5, 146.5, 141.0, 138.8, 135.5 (2 signals), 
133.7, 133.6, 130.8, 130.5, 129.6, 129.5, 128.9, 128.2, 127.7, 127.6 (2 signals), 126.0, 
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116.1, 98.7, 83.1, 77.4, 67.7, 66.0, 65.4, 44.6, 44.1, 40.4, 36.4, 32.9, 30.1, 29.6, 27.7, 
27.1, 26.9, 25.8, 19.6, 19.2, 18.2, 10.4, -4.6, -5.2; 
 
IR(film) 2930.5, 2857.2, 1737.6, 1707.7, 1624.1, 1471.9, 1369.7, 1293.8, 1256.2, 1155.2, 
1089.6, 837.3, 777.4, 702.4 cm-1; 
 
Exact Mass Calc. for C55H79NO8Si2 [M + Na]+ : 960.52364  ; found : 960.5101 (ESI) 
 
 
tert-butyl (2-((4S,6S)-6-((3Z,7E,9S,10S,11R)-10-((tert-butyldimethylsilyl)oxy)-12-
((tert-butyldiphenylsilyl)oxy)-9-hydroxy-11-methyl-2-methylenedodeca-3,7-dien-1-
yl)-2,2-dimethyl-1,3-dioxan-4-yl)acetyl)(phenyl)carbamate  
OOO
PhN
Me Me
Boc
OTBDPS
Me
TBSO
O
65
OOO
PhN
Me Me
Boc
OTBDPS
Me
TBSO
OH
66
 
Enone 65 (98.8 mg, 0.105 mmol, 1 eq) was dissolved in 2.5 mL THF and 1.0 mL MeOH 
was added under N2. To the solution was added CeCl3•7H2O (0.168 mmol, 1.6 eq), 
which was allowed to dissolve, and the solution was cooled to -60 °C. The septum was  
briefly removed and 6 mg (0.158 mmol, 1.5 eq) NaBH4 were added. TLC analysis is 
complicated by the fact that the product and starting material have the same Rf and the 
reaction proceeds rapidly to overreduction upon warming in the spotter. After 30 minutes, 
the reaction was quenched by the addition of 0.1 mL acetone, immediately followed by 1 
mL saturated NH4Cl(aq). The reaction was diluted with 40 mL 90% EtOAc/hexanes and 
washed with brine, then dried over Na2SO4. Concentration in vacuo and purification of 
the residue by flash chromatography (10% EtOAc/hexanes), yielded 60.4 mg (0.0642 
mmol, 61%) of allylic alcohol 66 as a clear colourless oil. 
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Rf = 0.50 (20% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -0.9 (c 3.02, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.68- 7.63 (m, 4H), 7.45 – 7.41 (m, 2H), 7.40- 7.36 (m, 
6H), 7.34- 7.31 (m, 1H), 7.10- 7.07 (m, 2H), 5.79 (ap. d, J = 11.7 Hz, 1H), 5.71 (dt, J = 
15.4, 6.6 Hz, 1H), 5.53- 5.44 (m, 2H), 5.03 (br. s, 1H), 4.92 (br. s, 1H), 4.45- 4.39 (m, 
1H), 4.02- 3.97 (m, 1H), 3.97- 3.93 (m, 1H), 3.80- 3.77 (m, 1H), 3.61- 3.58 (m, 1H), 
3.55- 3.51 (m, 1H), 3.20 (dd, J =17.3, 7.3 Hz, 1H), 2.96 (dd, J = 12.2, 5.0 Hz, 1H), 2.55 
(d, J = 4.7 Hz, 1H), 2.39 (dd, J = 13.7, 6.1 Hz, 1H), 2.34- 2.30 (m, 1H), 2.17- 2.11 (m, 
3H), 1.90- 1.84 (m, 1H), 1.64 (dt, J = 12.7, 2.2), 1.44 (s, 3H), 1.38 (s, 3H), 1.37 (s, 9H), 
1.06 (s, 9H), 0.89 (s, 9H), 0.84 (d, J = 6.9 Hz, 1H), 0.10 (s, 3H), 0.05 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 173.1, 152.6, 141.1, 138.9, 135.5, 133.7, 133.6, 132.3, 
131.7, 130.9, 130.0, 129.6, 128.9, 128.2, 127.7, 127.6, 116.0, 98.7, 83.1, 75.6, 73.6, 67.7, 
66.0, 65.9, 44.6, 44.2, 38.9, 36.4, 32.8, 30.1, 28.2, 27.8, 26.8, 26.0, 19.6, 19.2, 18.3, 11.3, 
-4.1, -4.4; 
 
IR(film) 3541.2, 2930.4, 2856.5, 1737.4, 1707.8, 1471.9, 1369.9, 1293.5, 1256.0, 1154.8, 
1111.6, 1089.0, 834.7, 776.0, 702.1; 
 
Exact Mass Calc. for C55H81NO8Si2 [M + Na]+ : 962.53929  ; found : 962.5288 (ESI) 
 
2-((4S,6S)-6-((3Z,7E,9S,10S,11R)-10-((tert-butyldimethylsilyl)oxy)-12-((tert-
butyldiphenylsilyl)oxy)-9-hydroxy-11-methyl-2-methylenedodeca-3,7-dien-1-yl)-2,2-
dimethyl-1,3-dioxan-4-yl)acetic acid 
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Amide 66 (60.4 mg, 0.0685 mmol, 1 eq,) was dissolved in  2 mL THF, cooled to 0 ºC , 
0.2 mL of 30 % H2O2(aq), 0.1 mL LiOH(aq) (1M). After 1h, TLC (50 % EtOAc/hexanes) 
showed complete consumption of the starting material. The reaction was quenched with 
saturated Na2SO3(aq) until neutral to peroxide test paper, and then acidified with pH 2 
buffer and extracted with 90% EtOAc/hexanes, washed with brine, and dried over 
Na2SO4. Solvent was removed in vacuo  and the residue was purified by flash 
chromatography using 50% EtOAc/hexanes to afford 30.0 mg (0.0392 mmol, 57 %) of 
seco acid 67 as a clear colourless oil. 
 
 [α]20D = -22.1 (c 1.50, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 7.67- 7.63 (m, 4H), 7.46- 7.41 (m, 2H), 7.41- 7.36 (m, 
4H), 5.81- 5.74 (m, 2H), 5.55- 5.49 (m, 1H), 5.46 (dd, J = 15.4, 7.3 Hz, 1H), 5.07 (br. s, 
1H), 4.92 (br. s, 1H), 4.24- 4.18 (m, 1H), 4.10- 4.07 (m, 1H), 3.92- 3.87 (m, 1H), 3.82- 
3.79 (m, 1H), 3.57 (d, J = 6.6 Hz, 1H), 2.60 (dd, J = 14.8, 5.4 Hz, 1H), 2.48- 2.35 (m, 
3H), 2.31- 2.23 (m, 1H), 2.20- 2.05 (m, 3H), 1.88- 1.82 (m, 1H), 1.62 (d, J = 13.0 Hz, 
1H), 1.47 (s, 3H), 1.41 (s, 3H), 1.14 (q, J = 12.6 Hz, 1H), 1.06 (s, 9H), 0.89 (s, 9H), 0.84 
(d, J = 6.9 Hz, 3H), 0.11 (s, 3H), 0.04 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 174.0, 140.8, 135.6, 133.6, 133.5, 132.9, 132.0, 130.1, 
130.0, 129.6, 127.6, 116.5, 99.0, 75.5, 73.7, 67.6, 66.1, 65.7, 44.2, 41.3, 39.0, 35.9, 32.6, 
30.0, 27.9, 26.9, 26.0, 19.7, 19.2, 18.3, 11.3, -4.1, -4.3; 
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IR(film) 3544.5, 2930.0, 2857.0, 1714.1, 1471.9, 1428.1, 1380.3, 1254.2, 1200.9, 1167.9, 
111.8, 834.8, 776.8, 702.1 cm-1; 
 
Exact Mass Calc. for C44H68O7Si2 [M + Na]+ : 787.4396  ; found : 787.4380 (ESI) 
 
 
(1S,5S,6E,10Z,14S)-5-((5S,6R)-2,2,3,3,6,10,10-heptamethyl-9,9-diphenyl-4,8-dioxa-
3,9-disilaundecan-5-yl)-16,16-dimethyl-12-methylene-4,15,17-
trioxabicyclo[12.3.1]octadeca-6,10-dien-3-one 
 
Me
TBSO
O
O
O
O
OTBDPS
57
Me
Me
OOO
Me Me
OTBDPS
Me
TBSO
OH
HO
67
 
Seco acid 67 (30 mg, 0.0392 mmol) was dissolved in 5 mL CH2Cl2 and added over a 
period of 2 hours to a solution of 23.9 mg DMAP (0.196 mmol, 5 eq) and 33.7 mg 
MNBA (0.098 mmol, 2.5 eq) in 1 mL CH2Cl2 by syringe pump. After the addition was 
complete, the syringe was washed with a further 1 mL CH2Cl2. The reaction was 
concentrated after a further hour, and the residue was purified by flash chromatography 
(20 % EtOAc/hexanes) to afford 29.8 mg (quant) of macrocycle 57 as a clear colourless 
oil. 
 
TLC Rf = 0.75 (20 % EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = +14.9 (c 1.49, CHCl3); 
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1H NMR (600 MHz, CDCl3) δ 7.67- 7.63 (m, 4H), 7.46- 7.42 (m, 2H), 7.41 – 7.36 (m, 
4H), 5.79 (d, J = 11.7 Hz, 1H), 5.72- 5.66 (m, 1H), 5.47- 5.38 (m, 2H), 5.15 (br. s, 1H), 
5.13 (ap. t, J = 7.7 Hz, 1H), 4.97 (br. s, 1H), 4.25- 4.20 (m, 1H), 4.06 (dd, J =  8.8, 1.1, 
1H), 3.91- 3.85 (m, 1H), 3.57 (t, J = 8.l), 3.39 (dd, J = 10.1, 6.2 Hz, 1H), 2.68- 2.61 (m, 
2H), 2.41- 2.31 (m, 2H), 2.31- 2.26 (m, 1H), 2.15- 2.09 (m, 1H), 1.95 (ap. t, J = 11.3 Hz, 
1H), 1.78- 1.71 (m, 1H), 1.49 (s, 3H), 1.41 (s, 3H), 1.08 (s, 9H), 0.81 (s, 9H), 0.72 (d, J = 
6.9 Hz, 1H), 0.06 (s, 3H), 0.05 (s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 170.5, 140.0, 135.6 (broad signal), 133.6, 133.0, 132.1, 
129.6 (2 signals), 127.6, 127.2, 117.5, 98.9, 76.5, 72.4, 70.1, 67.5, 66.0, 43.5, 42.5, 37.6, 
35.4, 32.6, 30.1, 29.7, 28.3, 26.9, 25.8, 20.0, 19.2, 18.3, 9.3, -4.1, -4.4; 
 
IR(film)2930.0, 2967.0, 1714.1, 1471.9, 1429.1, 1380.3, 1254.2, 1111.9, 834.8, 776.8, 
702.1; 
 
Exact Mass Calc. for C44H68O6Si2 [M + Na]+ : 769.42901  ; found : 769.4251 (ESI) 
 
PTAD Adduct with Z Acetonide  
Me
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O
O
O
O
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Macrocycle 57, 2 mg, was dissolved in 1 mL CDCl3 and a solution of 1 mg PTAD in 
CDCl3 was added dropwise. As each drop was added, the colour persisted for several 
seconds. When the colour did not fade, the addition was stopped. Solvent was removed in 
vacuo  and the residue was purified by flash chromatography (50 % EtOAc/hexanes) to 
give a clear colourless oil. 
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Partial Characterization data: 
1H NMR (600 MHz, CDCl3) δ 
 
Exact Mass Calc. for C52H71N3O8Si2 [M + Na]+ : 944.4672  ; found : 944.4648 (ESI) 
 
 
 
 
(4S,6S,9Z,13E,15S)-15-((5S,6R)-2,2,3,3,6,10,10-heptamethyl-9,9-diphenyl-4,8-dioxa-
3,9-disilaundecan-5-yl)-4,6-dihydroxy-8-methyleneoxacyclopentadeca-9,13-dien-2-
one  
Me
TBSO
O
O
O
O
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O
O
OH
OH
OTBDPS
71
 
 
Macrocycle 57  (15 mg, 0.0199 mmol, 1 eq) was dissolved in 2 mL of a 1: 1 mixture of 
CH2Cl2 and MeOH and cooled to 0 ºC. A crystal of CSA was added. After 1 hour, TLC 
(20% EtOAc/hexanes)  shows complete consumption of starting material. The reaction 
was diluted with 20 mL EtOAc/hexanes, washed with NaHCO3(aq) and dried over 
Na2SO4. The solvent was removed in vacuo and the residue was purified by flash 
chromatography (20% EtOAc/hexanes) to give 6.4 mg of 71  (0.0091 mmol, 45 %) as a 
clear colourless oil.  
Partial Characterization Data: 
 
TLC Rf = 0.15 (20 % EtOAc/hexanes, stains blue in CAM) 
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1H NMR (600 MHz, CDCl3) δ 7.67- 7.63 (m, 4H), 7.45- 7.42 (m, 2H), 7.41- 7.36 (m, 
1H), 5.75- 5.69 (m, 2H), 5.46- 5.42 (m, 1H), 5.35 (dd, J = 15.4, 7.3 Hz, 1H), 5.14- 5.10 
(m, 2H), 4.95 (m, 1H), 4.36- 4.31 (m, 1H), 4.05 (dd, J = 8.7. 1.3 Hz, 1H), 3.85- 3.80 (m, 
1H), 3.58 (t , J = 10.0 Hz, 1H), 3.39 (dd, J = 10.1, 6.2 Hz), 3.07 (br. s, 1H), 2.68 (dd, J = 
15.3, 2.9 Hz, 1H), 2.56 (dd, J = 13.5, 5.4 Hz, 1H), 2.45 (dd, J = 15.4, 10.7 Hz, 1H), 2.41- 
2.34 (m, 1H) 2.30- 2.23 (m, 1H), 2.16- 2.09 (m, 2H), 1.75- 1.69 (m, 1H), 1.56 (br. s, 1H), 
1.52- 1.40 (m, 1H), 1.07 (s, 9 H), 0.83 (s, 9H), 0.71 (d, J = 6.7 Hz, 3H), 0.07 (s, 3H), 0.05 
(s, 3H); 
 
13C NMR (125 MHz, CDCl3) δ 170.8. 140.5, 135.6, 135.5, 134.8, 133.8 (2 signals), 
133.6, 130.5, 129.6, 127.6, 126.9, 117.6, 72.1, 72.0, 69.2, 65.9, 46.8, 52.8, 42.1, 37.7, 
32.5, 29.7, 28.7, 26.9, 25.9, 19.2, 18.2, 9.2, -4.0, -4.4; 
 
Exact Mass Calc. for C41H62O6Si2 [M + Na]+ : 729.3977  ; found : 729.3977 (ESI) 
 
 
Major PTAD Adduct with Z Diol 
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Diol 71 ( 1 mg) was mixed with 0.5 mg PTAD in 1 mL CDCl3. After complete 
consumption of 71, the residue was purified by flash chromatography (40 % 
EtOAc/hexanes) to give 69 as a clear colourless oil. 
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Elaborate Diels Alder 
O
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To 800 µL of 1,2 Dichloroethane, feshly passed through a column of 80- 200 mesh 
Aluminia, Basic Brockman activity 1, were added 10 µL 3- fluoropyridine (0.116 mmol). 
Seperately, Z macrocycle 1 (41 mg, 0.028 mmol, 1 eq) and iminium 3 (29 mg, 0.083 
mmol, 3.0 eq) were mixed in 1 mL DCM in a 5 mL conical flask and the solvent was 
immediately removed in vacuo. The resulting tan foam was held under high vacuum with 
a stir bar for 15 minutes. Subsequently, the flask was backfilled with nitrogen and 200 µL 
of the 3-fluoropyridine solution (0.029 mmol, 1 eq) was added. The mixture was swirled 
to dissolve the foam and then was sealed and placed in a 40 °C oil bath. The reaction was 
stirred for 72 hours, after which time the solvent was removed in vacuo. Analysis by 1H 
NMR indicated a roughly 1: 3 ratio of unconsumed Z macrocycle 1 to desired product. 
The ratio of desired product to undesired diastereomer was 9 : 1. The residue was 
redissolved in 20 mL CH2Cl2 and washed with 2x 5 mL 1.0 M NaOH(aq). Purification was 
accomplished by chromatography with 50 % EtOAc/hexanes. The first fractions 
contained 12.7 mg of  recovered diene (0.0086 mmol, 31 %).  All product containing 
fractions were concentrated and re-dissolved in 2 mL CH2Cl2. A drop of TFA was added 
and volatiles were removed in vacuo. The residue was taken up in 10 mL CH2Cl2 and 
washed 2x with saturated NaPF6(aq). Concentration in vacuo gave 25 mg (0.014 mmol, 49 
%) of 74 as a tan foam 
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Rf = 0.15 (50% EtOAc/hexanes, UV active, stains blue in CAM) 
 
[α]20D = -33.0 (c 0.735, CHCl3); 
 
1H NMR (600 MHz, CDCl3) δ 10.76 (br. s, 1H), 7.24 (ap. d, J = 8.5 Hz, 2H), 6.89- 6.86 
(m, 4H), 6.64- 6.61 (m, 1H), 5.73 (ddd, J = 17.4, 10.2, 7.9 Hz, 1H), 5.66 (ddd, J = 17.9, 
10.3, 7.8 Hz, 1H), 5.41 (td, J = 14.5, 2.5 Hz, 1H), 5.26 (br. s, 1H), 5.24- 5.21 (m, 1H), 
5.06- 5.03 (m, 1H), 5.00 (ap. d, J = 17.4 Hz, 1H), 4.93 (ap. d, J = 10.2 Hz, 1H), 4.84- 
4.79 (m, 3H), 4.68- 4.64 (m, 2H), 4.61 (d, J = 17.0 Hz, 1H), 4.59 (d, J = 17.3 Hz, 1H), 
4.48 (d, J = 11.1 Hz, 1H), 4.45 (d, J = 11.6 Hz, 1H), 4.23- 4.19 (m, 1H), 4.00- 3.93 (m, 
1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.80 (s, 3H), 3.76 (d, J = 8.2 Hz, 1H), 3.73- 3.70 (m, 1H), 
3.63- 3.59 (m, 1H), 3.53- 3.48 (m, 1H), 3.42- 3.39 (m, 1H), 3.22- 3.19 (m, 1H), 2.95- 
2.88 (m, 1H), 2.88- 2.82 (m, 2H), 2.46- 2.41 (m, 1H), 2.40- 2.31 (m, 3H), 2.22- 2.14 (m, 
3H), 2.13- 2.03 (m, 4H), 1.97- 1.91 (m, 1H), 1.84- 1.77 (m, 2H), 1.77- 1.68 (m, 4H), 
1.65- 1.56 (m, 2H), 1.49- 1.42 (m, 4H), 1.09 (d, J = 6.9 Hz, 3H), 1.01 (d, J = 6.7 Hz, 3H), 
0.96 (d, J = 6.6 Hz, 3H), 0.92- 0.91 (m, 12H), 0.90 (s, 9H), 0.90 (s, 9H), 0.88 (s, 9H), 
0.85 (s, 9H), 0.12- 0.09 (m, 21H), 0.09 (s, 3H), 0.08 (s, 3H), 0.03 (s, 3H); 
 
1H NMR (600 MHz, C6D6) δ 11.5 (br. s, 1H), 7.35 (d, J = 8.6 Hz, 2H), 7.03- 7.00 (m, 
2H), 6.85 (d, J = 8.7 Hz, 2H), 6.67 (d, J = 8.8 Hz, 1H), 5.87- 5.79 (m, 2H), 5.68- 5.59 (m, 
1H), 5.31- 5.18 (m, 4H), 5.16- 5.08 (m, 3H), 5.02 (d, J = 6.7 Hz, 1H), 4.98 (d, J = 6.7 Hz, 
1H), 4.86- 4.82 (m, 2H), 4.79 (d, J = 6.7 Hz, 1H), 4.73 (d, J = 11.7 Hz, 1H), 4.62 (d, J = 
8.5 Hz, 1H), 4.60 (d, J = 8.4 Hz, 1H), 4.49- 4.45 (m, 1H), 4.05 (ap. d, J = 8.2 Hz, 1H), 
4.96- 4.93 (m, 1H), 4.92- 3.89 (m, 1H), 3.84- 3.78 (m, 2H), 3.70- 3.67 (m, 1H), 3.53- 
3.49 (m, 1H), 3.51 (s, 3H), 3.45 (s, 3H), 3.33 (s, 3H), 3.00- 2.95 (m, 2H), 2.87- 2.80 (m, 
1H), 2.67- 2.63 (m, 1H), 2.56 (dd, J = 9.2, 3.7 Hz, 1H), 2.53- 2.48 (m, 1H), 2.45- 2.38 
(m, 2H), 2.30- 2.25 (m, 1H), 2.24- 2.19 (m, 1H), 2.17- 2.12 (m, 2H), 2.06- 1.96 (m, 4H), 
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1.94- 1.86 (m, 3H), 1.81- 1.74 (m, 2H), 1.71- 1.68 (m, 1H), 1.67- 1.61 (m, 1H), 1.61- 
1.55 (m, 2H), 1.27 (d, J = 6.6 Hz, 3H), 1.14 (d, J = 7.7 Hz, 3H), 1.10- 1.07 (m, 12H), 
1.05 (s, 9H), 1.02 (s, 9H), 1.00 (s, 9H), 1.00 (s, 9H), 0.69 (d, J = 6.9 Hz, 3H), 0.28 (s, 
3H), 0.27 (s, 6H), 0.26 (s, 3H), 0.25 (s, 3H), 0.20 (s, 3H), 0.20 (s, 3H), 0.19 (s, 3H), 0.18 
(s, 6H); 
 
13C NMR (125 MHz, CDCl3) δ 198.7, 170.5, 159.2, 149.0, 148.6, 143.6, 139.1, 135.0, 
133.9, 130.5, 129.9, 129.2, 127.9, 122.6, 120.4, 117.3, 113.8, 113.4, 111.2, 111.0, 93.7, 
91.6, 84.7, 81.9, 80.3, 77.1, 76.9, 75.6, 75.5, 75.0, 73.1, 72.8, 73.1, 72.8, 69.6, 69.2, 68.7, 
66.8, 55.9, 55.8, 55.1, 47.4, 47.3, 46.3, 45.4, 42.9, 41.0, 39.0, 38.7, 37.1, 35.9, 33.5, 31.8, 
30.9, 30.8, 29.7, 29.3, 28.8, 28.5, 28.3, 26.3, 26.1, 26.0, 25.9, 25.8 (2 signals), 24.5, 24.1, 
22.7, 19.9, 18.5, 18.0 (3 signals), 17.9, 17.1, 13.6, 13.4, -3.2, 3.9 (3 signals), -4.0 (2 
signals), -4,5 (2 signals); 
 
IR(film) 3338.9, 3281.0, 2929.9, 2856.5, 1720.1, 1671.4, 1612.5, 1515.3, 1463.3, 1380.2, 
1251.0, 1096.4, 1032.8, 838.2, 775.0;  
 
Exact Mass Calc. for C93H164NO15Si5+ [M]+ : 1675.0941; found : 1675.0897 (ESI) 
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Appendix A 
Proposal for a Bioinspired Synthesis of Spiro-Prorocentrimine 
Inherent in the design of the intramolecular Diels- Alder substrate was the idea that the 
Diels–Alder event is a feasible macrocyclizing reaction. No studies on the biogenesis of 
the spiro-iminium natural products has been done with the exception of a feeding study 
preformed on the spirolide producing organism Alexandrium  ostenfeldii conducted at the 
Institute for Marine Biosciences, National Research Council in Halifax, Nova Scotia.1 In 
this work, feeding studies with [1,2- 13C2]acetate, [1-13C]acetate and [15N]glycine showed 
a glycine origin for the terminal nitrogen, and incorporation of acetate for some but not 
all of the carbon backbone. Gene sequencing efforts of any polyketide synthetase relevant 
to the spiro-imines has been elusive.2 However, it seems reasonable that an Diels–Alder 
reaction may be operative in the formation of all of the members of the spiro-iminium 
family of natural products. 
 
With the assumption that nature produced spiro-prorocentrimine via a Diels–Alder 
reaction, a logical assumption is that iminium formation and ion separation3 may provide 
means of enhancing the reactivity of the dienophile in the Diels–Alder reaction. In the 
absence of biosynthetic evidence from the organism that produces spiro-prorocentrimine, 
this can only be speculative, but there are no compelling reasons to doubt this hypothesis. 
 
                                                
(1) McKinnon, S. L.; Cembella, A. D.; Burton, I. W.; Lewis, N.; LeBlanc, P.; Walter, J. A. J. Org. Chem. 
2006, 71, 8724- 8731. 
 
(2) Yang, I.; John, E.; Beszteri, S.; Glöckner, G.; Krock, B.; Goesmann, A.; Cembella, A. D. BMC 
Genomics. 2010, 11, 248. Open access link: http://www.biomedcentral.com/1471-2164/11/248. 
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Figure A.1 Iminium ion based biosynthetic hypothesis for 2 and 4 
A compound such as 1 could give rise to pinnatoxins 2, while a compound such as 3 
could give rise to spiro-prorocentrimine 4 (Figure A.1). 
 
The failure of the intramolecular Diels- Alder in the Pero-Juhl route may be attributable 
to the fact that the reaction was attempted on a fully protected substrate. The transannular 
interactions between the bulky protecting groups may disrupt the desired Diels- Alder 
reaction. It certainly can be anticipated that removing protecting groups from the 
molecule would alleviate steric interactions in the approach of the diene and the 
dienophile. However, another possibility arises, that the removal of the protecting groups 
will actually result in attractive transannular interactions through the process of metal ion 
templating by coordination to the abundant oxygen atoms in 1 and 3. The ion 
concentration of various cations within the cytoplasm of marine algae is kept relatively 
isotonic with seawater. Many of the intermolecular Diels–Alder reactions conducted in 
the course of this work were conducted at a concentration lower than that of several ions 
in sea water. For example, the concentration of Na+ in seawater is 0.47 M, and the 
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concentration of Mg2+ is 0.05 M.4 Accordingly, it is possible that a Diels–Alder reaction 
to form spiro-prorocentrimine could be aided by the complexation of ions to a 
zwitterionic intermediate that lacks the 23 membered ring. Pinnatoxin also looks suited 
for such a templation. A possible arrangement is shown for pinnatoxin and spiro-
prorocentrimine is shown in Figure A.2.  
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Figure A.2 Metal ion templated Diels–Alder precursors 
Such complexes could potentially bring the diene and dienophile parts much closer in 
space, promoting the reaction. A strategy to test this hypothesis could readily be based on 
the a synthesis of 3 employing chemistry described earlier in this thesis. Specifically, the 
diene containing fragment 7 (or its geometric isomer), enal 8, central linker 9 and pyran 
enal 10 could all be conserved.5 
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Figure A.3 Components that may be conserved in the synthesis of 3. 
                                                
(4) Krumgalz, B. S.; Holzer, R. Limnol. Oceanogr. 1980, 15, 367- 370. 
 
(5) Based on the robustness of Pinnatoxin A, as shown by Kishi, and the fragility of many of the spiro-
prorocentrimine intermediates shown in the previous chapter, it may be worth considering testing the 
templating theory in a synthesis of Pinnatoxin rather than spiro-prorocentrimine. 
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Since the results from the previous chapter showed that a macrolactone ring contraction 
occurs during the deprotection of certain intermediates, and that the Z macrocycle is not 
readily isomerized to the E macrocycle with an acetonide or free hydroxyls at C3 and C5, 
the first order of business is to determine if the macrolactonization can be suppressed, 
and if the macrocycles with free hydroxyls do react with iminiums. Accordingly, known 
Z acetonide diene 10 would be remade, and E acetonide diene 11 would be prepared from 
an acyclic E diene. I recently observed that compound 7a is cleanly and quantitatively 
isomerized to E diene 7b by 1 mol% I2 in CDCl3.6 This would simplify the contruction of 
E diene macrocycles. It is also possible I2 could directly isomerize the macrocycles. 
These macrocycles would be treated with an anionic fluoride source to remove the silyl 
groups, while preserving the acetonides, then mild acid to attempt to remove the 
acetonides without rearrangement. If macrocycles 12 and 13 could be prepared, their 
reactivity and facial selectivity with dienophile 14 would be assessed (Scheme A.1) 
Scheme A.1 
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(6) The protecting group at C12 appears to be necessary for this clean transformation: Dr. Pero tried the 
same isomerization with a free OH at C12 and complete decomposition, potentially through 
iodoetherification followed by HI production was observed. 
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In the course of my studies, I made several observations that will affect the order of 
introduction of functional groups and choice of protecting groups. Since the synthesis of 
3 requires installation of the sulfate before the Diels–Alder, the protecting group must be 
compatible with the diene. The Z diene is rapidly destroyed by DDQ. A silyl protecting 
group more labile than fluoride may be useful for sulfate installation before the global 
deprotection. Compound 14 is stable in the presence of both HF•py or TBAF in THF. 
The following strategy to test installation of the sulfate is proposed: 
 
Glycal  15 would be epoxidized and opened by a simple Grignard to give alcohol 16 
(Scheme A.2). This is protected by a candidate protecting group such as 
dimethylphenylsilyl to give compound 17. The terminal protective group is then cleaved 
and and alkyl iodide 18 is prepared. An alkylation with a metalloenamine derived from 
19,7 readily prepared from compound 8 is added to effect alkylation to give compound 
20. Finally deprotection of the group at C19 and sulfation by exposure to SO3•py would 
give zwitterion 21.8 Deprotection conditions would be screened to give compound 22. If 
the alkylation did not work, the NHK reaction employed by Dr. Borg in chapter 3 could 
be used, however the preparation of the alkenyl iodide employed would have to be 
improved. 
 
 
 
 
 
                                                
(7) Dr. Bindschädler showed that Metalloenamines may be prepared from compound 14 and acylated on N 
to form diene-carbamates with high yield. It is hoped the iodide would enable C-alkylation. 
 
(8) Preliminary attempts I made to sulfate deprotected Diels–Alder adducts with SO3•py gave species I 
believed to be zwitterionic, based on a decrease in polarity and on the absence of fluorinated anions by 19F 
NMR and signals corresponding to pyridinium cations in 1H NMR. 
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A tin free synthesis of compound 15 is proposed, starting from compound 10. Addition of 
the anion of 24 to 10 would produce a inconsequential mixture of allylic alcohols 25. 
Hydrogenation of this mixture with Brown catalyst 26 should yield enone 27. Elaboration 
with known conditions should yield 15. The hydrogenative coupling is predicated on an 
observation I made in which compound 28 was hydrogenated to enone 29 by Brown 
catalyst. Such rearrangements are known. 9 
 
 
                                                
(9) Tanaka, K.; Shoji, T.; Hirano, M. Eur. J. Org. Chem. 2007, 2687- 2699. 
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Scheme A.3 
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Subsequently, the chemistry described in Scheme A.2 would be applied to the real system 
to make compound 30. Deprotection and sulfation to make 31 would be followed by 
global silyl removal to give 32. Finally acetonide removal would give either Z compound 
3, or E compound 33. At this point, the behaviour of the compound in the presence and 
asbsence of metal ions would be observed (Scheme A.4). 
 
This strategy is attractive, as it represents a synthesis of spiro-prorocentrimine that could 
potentially be as few as 23 linear steps from tri-O-acetal-D-glycal. This would also 
enable the testing of the hypothesis that a metal ion template could facilitate an 
intramolecular Diels–Alder reaction in the synthesis of the spiro-imine toxins. 
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Scheme A.4 
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Appendix B 
NMR Spectra 
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I. NMR Spectra From Chapter 2 
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II. NMR Spectra From Chapter 4 
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III. NMR Spectra From Chapter 5 
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IV. NMR Spectra from Chapter 6 
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V. Spectra of Hydrogenation Bicycle and Diels—Alder Adducts 
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